[go: up one dir, main page]

WO2024213664A1 - Imidazo bicyclic derivatives - Google Patents

Imidazo bicyclic derivatives Download PDF

Info

Publication number
WO2024213664A1
WO2024213664A1 PCT/EP2024/059884 EP2024059884W WO2024213664A1 WO 2024213664 A1 WO2024213664 A1 WO 2024213664A1 EP 2024059884 W EP2024059884 W EP 2024059884W WO 2024213664 A1 WO2024213664 A1 WO 2024213664A1
Authority
WO
WIPO (PCT)
Prior art keywords
6alkyl
6alkoxy
formula
ch2och3
ch2ch3
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2024/059884
Other languages
French (fr)
Inventor
Martin Pouliot
Nicolas Germain
Stephane André Marie JEANMART
Alexandre Franco Jean Camille LUMBROSO
Camille LE CHAPELAIN
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Syngenta Crop Protection AG Switzerland
Original Assignee
Syngenta Crop Protection AG Switzerland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syngenta Crop Protection AG Switzerland filed Critical Syngenta Crop Protection AG Switzerland
Priority to KR1020257037423A priority Critical patent/KR20250169286A/en
Priority to AU2024251657A priority patent/AU2024251657A1/en
Priority to CN202480022808.1A priority patent/CN120981461A/en
Publication of WO2024213664A1 publication Critical patent/WO2024213664A1/en
Priority to IL323692A priority patent/IL323692A/en
Priority to MX2025011788A priority patent/MX2025011788A/en
Anticipated expiration legal-status Critical
Priority to CONC2025/0015578A priority patent/CO2025015578A2/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/90—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having two or more relevant hetero rings, condensed among themselves or with a common carbocyclic ring system
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01P—BIOCIDAL, PEST REPELLANT, PEST ATTRACTANT OR PLANT GROWTH REGULATORY ACTIVITY OF CHEMICAL COMPOUNDS OR PREPARATIONS
    • A01P3/00—Fungicides

Definitions

  • the present invention relates to microbiocidal imidazo bicyclic derivatives, e.g. as active ingredients, which have microbiocidal activity, in particular fungicidal activity, more particularly activity against oomycetes.
  • the invention also relates to preparation of these imidazo bicyclic derivatives, to intermediates useful in the preparation of these imidazo bicyclic derivatives, to the preparation of these intermediates, to agrochemical compositions which comprise at least one of the imidazo bicyclic derivatives, to preparation of these compositions and to the use of the imidazo bicyclic derivatives or compositions in agriculture or horticulture for combating, controlling or preventing infestation of plants, harvested food crops, seeds or non-living materials by phytopathogenic microorganisms, in particular fungi, more particularly oomycetes. It has now surprisingly been found that certain novel imidazo bicyclic derivatives have favourable fungicidal properties, in particular against oomycetes.
  • the present invention provides compounds of formula (I) wherein Z is O or S, and preferably Z is O; each A 1 is N, or one A 1 is N and one A 1 is CR 1 ; and preferably one A 1 is N and one A 1 is CR 1 ; R 1 are independently selected from hydrogen, hydroxy, halogen, CN, C1-6alkyl, C3-6cycloalkyl, C1- 6alkoxy-C1-6alkyl, C3-6cycloalkyl-C1-4alkyl, C1-6alkylsulfanyl, C1-6alkylsulfinyl, C1-6alkylsulfonyl, C1-6alkoxy, amino, and -NHC(O)C1-6alkyl; A 2 are independently CR 2 or N, with the proviso that no more than three A 2 are N, preferably no more than two A 2 are N, preferably no more than one A 2 is N, and more preferably the four A 2 are CR 2 ; R 2 are independently
  • the present invention provides an agrochemical composition comprising a compound of formula (I), and more particularly an agrochemical composition comprising a fungicidally effective amount of a compound of formula (I).
  • Said composition can further comprise at least one compound selected among an additional active ingredient, an appropriate formulation inert, a carrier, an adjuvant, and any mixtures thereof.
  • Compounds of formula (I) may be used to control phytopathogenic microorganisms.
  • a compound of formula (I), or a composition comprising a compound of formula (I) according to the invention may be applied directly to the phytopathogen, to the locus of a phytopathogen, in particular to a plant susceptible to attack by phytopathogens, or to a propagation material of a plant.
  • the present invention provides the use of a compound of formula (I), or a composition comprising a compound of formula (I), as described herein to combat, prevent or control a phytopathogen.
  • the present invention provides a method of combating, preventing or controlling phytopathogens, comprising applying a compound of formula (I), or a composition comprising a compound of formula (I), as described herein to said phytopathogen, to the locus of said phytopathogen, in particular to a plant susceptible to attack by a phytopathogen, or to a propagation material of a plant.
  • the method may exclude methods for the treatment of the human or animal body by surgery or therapy.
  • Compounds of formula (I) are particularly effective in combating, preventing or controlling phytopathogenic fungi, in particular oomycetes.
  • the present invention provides the use of a compound of formula (I), or a composition comprising a compound of formula (I), as described herein to control phytopathogenic fungi, in particular oomycetes.
  • the present invention provides a method of combating, preventing or controlling phytopathogenic disease, such as phytopathogenic fungi, comprising applying a compound of formula (I), or a composition comprising a compound of formula (I), as described herein to said phytopathogenic fungi, or to the locus of said phytopathogenic fungi, in particular to a plant susceptible to attack by phytopathogenic fungi, in particular oomycetes, or to a propagation material of a plant.
  • the method may exclude methods for the treatment of the human or animal body by surgery or therapy.
  • a group is indicated as being substituted, e.g. alkyl, this includes those groups that are part of other groups, e.g. the alkyl in alkylthio.
  • halogen or “halo” refers to fluorine (fluoro or F), chlorine (chloro or Cl), bromine (bromo or Br) or iodine (iodo or I), preferably fluorine, chlorine or bromine.
  • amino refers to a -NH2 group.
  • Alkyl as used herein- in isolation or as part of a chemical group – represents straight-chain or branched hydrocarbons, preferably with 1 to 6 carbon atoms, for example methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, s-butyl, t-butyl, pentyl, 1- methylbutyl, 2-methylbutyl, 3-methylbutyl, 1,2- dimethylpropyl, 1,1 -dimethylpropyl, 2,2- dimethylpropyl, 1 -ethylpropyl, hexyl, 1 -methylpentyl, 2- methylpentyl, 3-methylpentyl, 4- methylpentyl, 1,2-dimethylpropyl, 1,3-dimethylbutyl, 1,4-dimethylbutyl, 2,3-dimethylbutyl, 1,1- dimethylbutyl, 2,2-dimethylbut
  • Alkyl groups with 1 to 4 carbon atoms are preferred, for example methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, s-butyl or t-butyl.
  • Alkenyl in isolation or as part of a chemical group - represents straight-chain or branched hydrocarbons, preferably with 2 to 6 carbon atoms and at least one double bond, for example vinyl, 2- propenyl, 2-butenyl, 3-butenyl, 1- methyl-2-propenyl, 2-methyl-2-propenyl, 2-pentenyl, 3-pentenyl, 4- pentenyl, 1-methyl-2-butenyl, 2- methyl-2-butenyl, 3-methyl-2-butenyl, 1-methyl-3-butenyl, 2-methyl-3- butenyl, 3-methyl-3-butenyl, 1,1 - dimethyl-2-propenyl, 1,2-dimethyl-2-propenyl, 1 -ethyl-2-propenyl, 2- hexenyl, 3-hexenyl, 4- hexenyl, 5-hexenyl, 1 -methyl-2-pentenyl, 2-methyl-2-pentenyl, 2-methyl-2-penten
  • Alkenyl groups with 2 to 4 carbon atoms are preferred, for example 2-propenyl, 2-butenyl or 1-methyl-2-propenyl.
  • the term "Alkynyl" - in isolation or as part of a chemical group - represents straight-chain or branched hydrocarbons, preferably with 2 to 6 carbon atoms and at least one triple bond, for example 2-propynyl, 2-butynyl, 3-butynyl, 1-methyl-2- propynyl, 2-pentynyl, 3-pentynyl, 4-pentynyl, 1-methyl-3-butynyl, 2- methyl-3-butynyl, 1-methyl-2- butynyl, 1,1 -dimethyl-2-propynyl, 1 -ethyl-2-propynyl, 2-hexynyl, 3- hexynyl, 4-hexynyl, 5-hexynyl, 1- methyl-2-pentyn
  • Alkynyls with 2 to 4 carbon atoms are preferred, for example ethynyl, 2- propynyl or 2-butynyl-2-propenyl.
  • haloalkyl refers to an alkyl radical as generally defined above substituted by one or more of the same or different halogen atoms, for examples fluoromethyl, fluoroethyl, difluoromethyl, trifluoromethyl, or 2,2,2-trifluoroethyl.
  • cyanoalkyl refers to an alkyl radical as generally defined above substituted by one or more cyano groups.
  • cycloalkyl in isolation or as part of a chemical group - represents saturated or partially unsaturated mono-, bi- or tricyclic hydrocarbons, preferably with 3 to 10 carbon atoms, for example cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, bicyclo[2.2.1]heptyl, bicyclo[2.2.2]octyl or adamantyl. Cycloalkyls with 3, 4, 5, 6 or 7 carbon atoms are preferred, for example cyclopropyl or cyclobutyl.
  • halocycloalkyl refers to a cycloalkyl ring as defined above substituted by one or more of the same or different halogen atoms.
  • cyanocycloalkyl refers to a cycloalkyl radical as generally defined above substituted by one or more cyano groups.
  • alkoxy refers to a radical of the formula -ORa wherein Ra is an alkyl radical as generally defined above. Examples of alkoxy include, but are not limited to methoxy, ethoxy, propoxy, iso-propoxy, and tert-butoxy.
  • alkoxyalkyl refers to an alkyl radical (as mentioned above) substituted with said alkoxy group. Examples are methoxymethyl, methoxyethyl, ethoxymethyl and propoxymethyl.
  • alkylsulfanyl refers to a radical of the formula -SRa wherein Ra is an alkyl radical as generally defined above.
  • alkylsulfinyl refers to a radical of the formula -S(O)Ra wherein Ra is an alkyl radical as generally defined above.
  • alkylsulfonyl refers to a radical of the formula -S(O)2Ra wherein Ra is an alkyl radical as generally defined above.
  • alkylcarbonyl refers to a radical of the formula RaC(O)- wherein Ra is an alkyl radical as generally defined above.
  • alkoxycarbonyl refers to a radical of the formula RaOC(O)-, wherein Ra is an alkyl radical as generally defined above.
  • alkylamino refers to a radical of the formula RaNH- wherein Ra is an alkyl radical as generally defined above.
  • cycloalkylamino refers to a radical of the formula RaNH- wherein Ra is a cycloalkyl radical as generally defined above.
  • alkoxyamino refers to a radical of the formula RaNH-, wherein Ra is an alkoxy radical as generally defined above.
  • alkylaminocarbonyl refers to a radical of the formula RaNHC(O)- wherein Ra is an alkyl radical as generally defined above.
  • Hydroxyl or hydroxy stands for a –OH group.
  • the term "effective amount” refers to the amount of the compound, a salt, or N-oxide thereof, which, upon single or multiple applications provides the desired effect. An effective amount is readily determined by the skilled person in the art, by the use of known techniques and by observing results obtained under analogous circumstances.
  • Compounds of formula (I) which have at least one basic centre can form, for example, acid addition salts, for example with strong inorganic acids such as mineral acids, for example perchloric acid, sulfuric acid, nitric acid, nitrous acid, a phosphorus acid or a hydrohalic acid, with strong organic carboxylic acids, such as C1-C4alkanecarboxylic acids which are unsubstituted or substituted, for example by halogen, for example acetic acid, such as saturated or unsaturated dicarboxylic acids, for example oxalic acid, malonic acid, succinic acid, maleic acid, fumaric acid or phthalic acid, such as hydroxycarboxylic acids, for example ascorbic acid, lactic acid, malic acid,
  • Compounds of formula (I) which have at least one acidic group can form, for example, salts with bases, for example mineral salts such as alkali metal or alkaline earth metal salts, for example sodium, potassium or magnesium salts, or salts with ammonia or an organic amine, such as morpholine, piperidine, pyrrolidine, a mono-, di- or tri-lower-alkylamine, for example ethyl-, diethyl-, triethyl- or dimethylpropylamine, or a mono-, di- or trihydroxy-lower-alkylamine, for example mono-, di- or triethanolamine.
  • bases for example mineral salts such as alkali metal or alkaline earth metal salts, for example sodium, potassium or magnesium salts
  • salts with ammonia or an organic amine such as morpholine, piperidine, pyrrolidine, a mono-, di- or tri-lower-alkylamine, for example ethyl-, die
  • the compounds of formula (I) according to the invention are in free form, in oxidized form as an N-oxide, in covalently hydrated form, or in salt form, e.g., an agronomically usable or agrochemically acceptable salt form.
  • N-oxides are oxidized forms of tertiary amines or oxidized forms of nitrogen containing heteroaromatic compounds. They are described for instance in the book “Heterocyclic N-oxides” by A. Albini and S. Pietra, CRC Press, Boca Raton 1991.
  • the compounds of formula (I) according to the invention also include hydrates, which may be formed during salt formation.
  • the compounds of formula (I) according to the invention also include hydrates which may be formed during the salt formation.
  • R 1 are independently selected from hydrogen, C1-6alkyl, C3-6cycloalkyl, C1-6alkoxy-C1-6alkyl, C3- 6cycloalkyl-C1-4alkyl, and C1-6alkoxy, and more preferably R 1 are independently selected from hydrogen and C1-6alkyl.
  • R 2 are independently selected from hydrogen, hydroxy, halogen, CN, C1-6alkyl, C1-6alkoxy, C1- 6alkoxy-C1-6alkyl, C1-6alkoxy-C1-6alkoxy, C1-6alkoxycarbonyl, C1-6alkylaminocarbonyl, diC1- 6alkylaminocarbonyl, and C1-6alkylcarbonyl, wherein each of the C1-6alkyl, C1-6alkoxy, C1-6alkoxy-C1- 6alkyl, C1-6alkoxy-C1-6alkoxy, C1-6alkoxycarbonyl, C1-6alkylaminocarbonyl, diC1-6alkylaminocarbonyl, and C1-6alkylcarbonyl groups is optionally substituted with one to three substituents independently selected from halogen, hydroxy, and CN; preferably R 2 are independently selected from hydrogen, halogen, CN, C1-6
  • R 3 is selected from hydroxy, halogen, CN, C1-6alkyl, C1-6alkoxy, C1-6alkoxy-C1-6alkyl, C1-6alkoxy- C1-6alkoxy, C3-6cycloalkyl, C3-6cycloalkyl-C1-6alkyl, amino, C1-6alkylamino, diC1-6-alkylamino, and C3- 6cycloalkylamino, wherein each of the C1-6alkyl, C1-6alkoxy, C1-6alkoxy-C1-6alkyl, C1-6alkoxy-C1-6alkoxy, C3-6cycloalkyl, C3-6cycloalkyl-C1-6alkyl, amino, C1-6alkylamino, diC1-6-alkylamino and C3-6cycloalkylamino groups is optionally substituted with one to three substituents independently selected from halogen, hydroxy, and CN; and preferably R 3
  • a compound of formula (I) according to the present invention wherein four A 2 are CR 2 and A 3 is N.
  • a compound of formula (I) according to the present invention wherein preferably the three A 2 are CR 2 and A 3 is CR 3 .
  • a compound of formula (I) according to the present invention wherein preferably the three A 2 are CR 2 and A 3 is CR 3 .
  • a compound of formula (I) according to the present invention wherein four A 2 are CR 2 and A 3 is CR 3 , and preferably .
  • R 2 are as defined in the present invention; preferably R 2 are independently selected from hydrogen, hydroxy, halogen, CN, C1-6alkyl, C1- 6alkoxy, C1-6alkoxy-C1-6alkyl, C1-6alkoxy-C1-6alkoxy, C3-6cycloalkyl, C3-6cycloalkyl-C1-6alkyl, C1- 6alkoxycarbonyl, C1-6alkylaminocarbonyl, diC1-6alkylaminocarbonyl, and C1-6alkylcarbonyl, wherein each of the C 1-6 alkyl, C 1-6 alkoxy, C 1-6 alkoxy-C 1-6 alkyl, C 1-6 alkoxy-C 1-6 alkoxy, C 3-6 cycloalkyl, C 3- 6cycloalkyl-C1-6alkyl, C1-6alkoxycarbonyl, C1-6alkylaminocarbonyl, diC1-6alkylaminocarbonyl, and C1- 6alkylcarbonyl, wherein each of
  • R 4 is selected from C1-6alkyl, C1-6alkoxy-C1-6alkyl, C3-6cycloalkyl, C3-6cycloalkyl-C1-4alkyl, C2- 6alkenyl, C2-6alkynyl, and C1-6alkoxy, wherein each of the C1-6alkyl, C1-6alkoxy-C1-6alkyl, C3-6cycloalkyl, C3-6cycloalkyl-C1-4alkyl, C2-6alkenyl, C2-6alkynyl, and C1-6alkoxy groups is optionally substituted with one to three substituents independently selected from halogen and CN; and preferably R 4 is selected from C1-6alkyl, C1-6alkoxy-C1-6alkyl, C3-6cycloalkyl, C3-6cycloalkyl-C1-4alkyl, and C1-6alkoxy, wherein each of the C 1-6 alkyl, C 1-6
  • a compound of formula (I) according to the present invention, wherein A 3 is CR 3 and wherein R 3 and R 4 taken together form a ring, preferably a 5-8-membered heterocycle, preferably a 6-membered heterocycle, and more preferably one of the rings W1, W2 or W3 as described in the compounds of the formula (I) below:
  • the carbon and/or the nitrogen atoms forming said ring (W1, W2 or W3) can be substituted, especially by a R 3’ group, wherein R 3’ is selected from hydrogen, C1-6alkyl, and C3-6cycloalkyl, wherein each of the C1-6alkyl and C3-6cycloalkyl groups is optionally substituted with one to three substituents independently selected from halogen and CN.
  • the compounds of the formula (I-W3) can be as follows: (I-W3)
  • the compounds of the formula (I-W1), (I-W2) and (I-W3) can be as described below: (I-W1) (I-W2) (I-W3)
  • the carbon and/or the nitrogen atoms forming said ring (W1, W2 or W3) can be substituted, especially by a R 3’ group, wherein R 3’ is selected from hydrogen, C1-6alkyl, and C3-6cycloalkyl, wherein each of the C1-6alkyl and C3-6cycloalkyl groups is optionally substituted with one to three substituents independently selected from halogen and CN.
  • the compounds of the formula (I-W3) can be as follows:
  • R 5 is selected from C1-6alkyl, C1-6alkoxy, C3-6cycloalkyl, C3-6cycloalkyl-C1-6alkyl, and C1- 6alkoxyC1-6alkyl, wherein each of said groups is optionally substituted with one to three substituents independently selected from halogen and CN.
  • a compound of formula (I) wherein Z is O; one A 1 is N and one A 1 is CR 1 ; R 1 are independently selected from hydrogen, C1-6alkyl, C3-6cycloalkyl, C1-6alkoxy-C1-6alkyl, C3- 6cycloalkyl-C1-4alkyl, and C1-6alkoxy, and more preferably R 1 are independently selected from hydrogen and C1-6alkyl; the four A 2 are CR 2 ; with R 2 being independently selected from hydrogen, hydroxy, halogen, CN, C1- 6alkyl, C1-6alkoxy, C1-6alkoxy-C1-6alkyl, C1-6alkoxy-C1-6alkoxy, C2-6alkenyl, C2-6alkynyl, C3-6cycloalkyl, C3- 6cycloalkyl-C1-6alkyl, C1-6alkylsulfanyl, C1-6alkylsulfinyl, and C1-6alky
  • R 2 are as defined in the present invention; preferably R 2 are independently selected from hydrogen, hydroxy, halogen, CN, C1-6alkyl, C1-6alkoxy, C1-6alkoxy-C1-6alkyl, C1-6alkoxy-C1-6alkoxy, C3-6cycloalkyl, C3-6cycloalkyl-C1-6alkyl, C1-6alkoxycarbonyl, C1-6alkylaminocarbonyl, diC1-6alkylaminocarbonyl, and C1-6alkylcarbonyl, wherein each of the C1-6alkyl, C1-6alkoxy, C1-6alkoxy-C1-6alkyl, C1-6alkoxy-C1-6alkoxy, C3-6cycloalkyl, C3-6cycloalkyl-C1-6alkyl, C1- 6alkoxycarbonyl, C1-6alkylaminocarbonyl, diC1-6alkylaminocarbonyl, and C1-6alkylcarbonyl groups is optionally substituted with one to three substitu
  • the compound according to the present invention is selected from: methyl N-[5-[6-[(4-fluoro-3-methyl-phenyl)-methyl-carbamoyl]-8-methyl-imidazo[1,2-b]pyridazin-3-yl]-2- pyridyl]carbamate; methyl N-[5-[6-(6-fluoro-3,4-dihydro-2H-quinoline-1-carbonyl)-8-methyl-imidazo[1,2-b]pyridazin-3-yl]-2- pyridyl]carbamate; methyl N-[5-[6-[(4-fluorophenyl)-methyl-carbamoyl]-8-methyl-imidazo[1,2-b]pyridazin-3-yl]-2- pyridyl]carbamate; methyl N-[5-[6-[(4-fluorophenyl)-methyl-carbamoyl]-8-methyl-imid
  • the method according to the present invention has advantageous properties for protecting plants against pathogenic, such as phytopathogenic, especially fungi such as oomycetes, attack or infestation, which result in a disease and damage to the plant; particularly in instance of plants, the present invention can control, limit or prevent pathogenic damage on plant, parts of plant, plant propagation material and/or plant grown.
  • pathogenic such as phytopathogenic, especially fungi such as oomycetes, attack or infestation
  • the present invention can control, limit or prevent pathogenic damage on plant, parts of plant, plant propagation material and/or plant grown.
  • Tables 1.1 to 1.100 and in Tables 2.1 to 2.50 below illustrate specific compounds of the invention.
  • Table 1.1 provides compounds E1.1 to E1.952 of formula (Ia) are as defined in table Z 1 . More particularly, table Z 1 also includes compounds wherein R 3 and R 4 taken together form a ring.
  • said ring is depicted in the R 3 and R 4 columns (table Z 1 ) merged together, along the amide atom linked to the bicycle core of the formula (Ia).
  • said ring is depicted in the R 3 and R 4 columns (table Z 1 ) merged together, along the amide atom linked to the bicycle core of the formula (Ia).
  • Table 1.3 provides compounds E3.1 to E3.952 of formula (Ia) wherein R 2 is H, R 5 is OCH3, A 4 is CH and R 1a , R 3 , R 4 , A 2a , A 2b are as defined in table Z 1 .
  • Table 1.4 provides compounds E4.1 to E4.952 of formula (Ia) wherein R 2 is H, R 5 is OCH3, A 4 is N and R 1a , R 3 , R 4 , A 2a , A 2b are as defined in table Z 1 .
  • Table 1.5 provides compounds E5.1 to E5.952 of formula (Ia) wherein R 2 is H, R 5 is cyclopropyl, A 4 is CH and R 1a , R 3 , R 4 , A 2a , A 2b are as defined in table Z 1 .
  • Table 1.6 provides compounds E6.1 to E6.952 of formula (Ia) wherein R 2 is H, R 5 is cyclopropyl, A 4 is N and R 1a , R 3 , R 4 , A 2a , A 2b are as defined in table Z 1 .
  • Table 1.7 provides compounds E7.1 to E7.952 of formula (Ia) wherein R 2 is H, R 5 is CH2OCH3, A 4 is CH and R 1a , R 3 , R 4 , A 2a , A 2b are as defined in table Z 1 .
  • Table 1.8 provides compounds E8.1 to E8.952 of formula (Ia) wherein R 2 is H, R 5 is CH2OCH3, A 4 is N and R 1a , R 3 , R 4 , A 2a , A 2b are as defined in table Z 1 .
  • Table 1.9 provides compounds E9.1 to E9.952 of formula (Ia) wherein R 2 is H, R 5 is NHCH2CH3, A 4 is CH and R 1a , R 3 , R 4 , A 2a , A 2b are as defined in table Z 1 .
  • Table 1.10 provides compounds E10.1 to E10.952 of formula (Ia) wherein R 2 is H, R 5 is NHCH2CH3, A4 is N and R 1a , R 3 , R 4 , A 2a , A 2b are as defined in table Z 1 .
  • Table 1.11 provides compounds E11.1 to E11.952 of formula (Ia) wherein R 2 is CH3, R 5 is CH3, A 4 is CH and R 1a , R 3 , R 4 , A 2a , A 2b are as defined in table Z 1 .
  • Table 1.12 provides compounds E12.1 to E12.952 of formula (Ia) wherein R 2 is CH3, R 5 is CH3, A 4 is N and R 1a , R 3 , R 4 , A 2a , A 2b are as defined in table Z 1 .
  • Table 1.13 provides compounds E13.1 to E13.952 of formula (Ia) wherein R 2 is CH3, R 5 is OCH3, A 4 is CH and R 1a , R 3 , R 4 , A 2a , A 2b are as defined in table Z 1 .
  • Table 1.14 provides compounds E14.1 to E14.952 of formula (Ia) wherein R 2 is CH3, R 5 is OCH3, A 4 is N and R 1a , R 3 , R 4 , A 2a , A 2b are as defined in table Z 1 .
  • Table 1.15 provides compounds E15.1 to E15.952 of formula (Ia) wherein R 2 is CH3, R 5 is cyclopropyl, A 4 is CH and R 1a , R 3 , R 4 , A 2a , A 2b are as defined in table Z 1 .
  • Table 1.16 provides compounds E16.1 to E16.952 of formula (Ia) wherein R 2 is CH3, R 5 is cyclopropyl, A 4 is N and R 1a , R 3 , R 4 , A 2a , A 2b are as defined in table Z 1 .
  • Table 1.17 provides compounds E17.1 to E17.952 of formula (Ia) wherein R 2 is CH3, R 5 is CH2OCH3, A 4 is CH and R 1a , R 3 , R 4 , A 2a , A 2b are as defined in table Z 1 .
  • Table 1.18 provides compounds E18.1 to E18.952 of formula (Ia) wherein R 2 is CH3, R 5 is CH2OCH3, A 4 is N and R 1a , R 3 , R 4 , A 2a , A 2b are as defined in table Z 1 .
  • Table 1.19 provides compounds E19.1 to E19.952 of formula (Ia) wherein R 2 is CH3, R 5 is NHCH2CH3, A 4 is CH and R 1a , R 3 , R 4 , A 2a , A 2b are as defined in table Z 1 .
  • Table 1.20 provides compounds E20.1 to E20.952 of formula (Ia) wherein R 2 is CH3, R 5 is NHCH2CH3, A 4 is N and R 1a , R 3 , R 4 , A 2a , A 2b are as defined in table Z 1 .
  • Table 1.21 provides compounds E21.1 to E21.952 of formula (Ia) wherein R 2 is CH2CH3, R 5 is CH3, A 4 is CH and R 1a , R 3 , R 4 , A 2a , A 2b are as defined in table Z 1 .
  • Table 1.22 provides compounds E22.1 to E22.952 of formula (Ia) wherein R 2 is CH2CH3, R 5 is CH3, A4 is N and R 1a , R 3 , R 4 , A 2a , A 2b are as defined in table Z 1 .
  • Table 1.23 provides compounds E23.1 to E23.952 of formula (Ia) wherein R 2 is CH2CH3, R 5 is OCH3, A 4 is CH and R 1a , R 3 , R 4 , A 2a , A 2b are as defined in table Z 1 .
  • Table 1.24 provides compounds E24.1 to E24.952 of formula (Ia) wherein R 2 is CH2CH3, R 5 is OCH3, A 4 is N and R 1a , R 3 , R 4 , A 2a , A 2b are as defined in table Z 1 .
  • Table 1.25 provides compounds E25.1 to E25.952 of formula (Ia) wherein R 2 is CH2CH3, R 5 is cyclopropyl, A 4 is CH and R 1a , R 3 , R 4 , A 2a , A 2b are as defined in table Z 1 .
  • Table 1.26 provides compounds E26.1 to E26.952 of formula (Ia) wherein R 2 is CH2CH3, R 5 is cyclopropyl, A 4 is N and R 1a , R 3 , R 4 , A 2a , A 2b are as defined in table Z 1 .
  • Table 1.27 provides compounds E27.1 to E27.952 of formula (Ia) wherein R 2 is CH2CH3, R 5 is CH2OCH3, A 4 is CH and R 1a , R 3 , R 4 , A 2a , A 2b are as defined in table Z 1 .
  • Table 1.28 provides compounds E28.1 to E28.952 of formula (Ia) wherein R 2 is CH2CH3, R 5 is CH2OCH3, A 4 is N and R 1a , R 3 , R 4 , A 2a , A 2b are as defined in table Z 1 .
  • Table 1.29 provides compounds E29.1 to E29.952 of formula (Ia) wherein R 2 is CH2CH3, R 5 is NHCH2CH3, A 4 is CH and R 1a , R 3 , R 4 , A 2a , A 2b are as defined in table Z 1 .
  • Table 1.30 provides compounds E30.1 to E30.952 of formula (Ia) wherein R 2 is CH2CH3, R 5 is NHCH2CH3, A 4 is N and R 1a , R 3 , R 4 , A 2a , A 2b are as defined in table Z 1 .
  • Table 1.31 provides compounds E31.1 to E31.952 of formula (Ia) wherein R 2 is F, R 5 is CH3, A 4 is CH and R 1a , R 3 , R 4 , A 2a , A 2b are as defined in table Z 1 .
  • Table 1.32 provides compounds E32.1 to E32.952 of formula (Ia) wherein R 2 is F, R 5 is CH3, A 4 is N and R 1a , R 3 , R 4 , A 2a , A 2b are as defined in table Z 1 .
  • Table 1.33 provides compounds E33.1 to E33.952 of formula (Ia) wherein R 2 is F, R 5 is OCH3, A 4 is CH and R 1a , R 3 , R 4 , A 2a , A 2b are as defined in table Z 1 .
  • Table 1.34 provides compounds E34.1 to E34.952 of formula (Ia) wherein R 2 is F, R 5 is OCH3, A 4 is N and R 1a , R 3 , R 4 , A 2a , A 2b are as defined in table Z 1 .
  • Table 1.35 provides compounds E35.1 to E35.952 of formula (Ia) wherein R 2 is F, R 5 is cyclopropyl, A 4 is CH and R 1a , R 3 , R 4 , A 2a , A 2b are as defined in table Z 1 .
  • Table 1.36 provides compounds E36.1 to E36.952 of formula (Ia) wherein R 2 is F, R 5 is cyclopropyl, A 4 is N and R 1a , R 3 , R 4 , A 2a , A 2b are as defined in table Z 1 .
  • Table 1.37 provides compounds E37.1 to E37.952 of formula (Ia) wherein R 2 is F, R 5 is CH2OCH3, A 4 is CH and R 1a , R 3 , R 4 , A 2a , A 2b are as defined in table Z 1 .
  • Table 1.38 provides compounds E38.1 to E38.952 of formula (Ia) wherein R 2 is F, R 5 is CH2OCH3, A 4 is N and R 1a , R 3 , R 4 , A 2a , A 2b are as defined in table Z 1 .
  • Table 1.39 provides compounds E39.1 to E39.952 of formula (Ia) wherein R 2 is F, R 5 is NHCH2CH3, A4 is CH and R 1a , R 3 , R 4 , A 2a , A 2b are as defined in table Z 1 .
  • Table 1.40 provides compounds E40.1 to E40.952 of formula (Ia) wherein R 2 is F, R 5 is NHCH2CH3, A4 is N and R 1a , R 3 , R 4 , A 2a , A 2b are as defined in table Z 1 .
  • Table 1.41 provides compounds E41.1 to E41.952 of formula (Ia) wherein R 2 is Cl, R 5 is CH3, A 4 is CH and R 1a , R 3 , R 4 , A 2a , A 2b are as defined in table Z 1 .
  • Table 1.42 provides compounds E42.1 to E42.952 of formula (Ia) wherein R 2 is Cl, R 5 is CH3, A 4 is N and R 1a , R 3 , R 4 , A 2a , A 2b are as defined in table Z 1 .
  • Table 1.43 provides compounds E43.1 to E43.952 of formula (Ia) wherein R 2 is Cl, R 5 is OCH3, A 4 is CH and R 1a , R 3 , R 4 , A 2a , A 2b are as defined in table Z 1 .
  • Table 1.44 provides compounds E44.1 to E44.952 of formula (Ia) wherein R 2 is Cl, R 5 is OCH3, A 4 is N and R 1a , R 3 , R 4 , A 2a , A 2b are as defined in table Z 1 .
  • Table 1.45 provides compounds E45.1 to E45.952 of formula (Ia) wherein R 2 is Cl, R 5 is cyclopropyl, A 4 is CH and R 1a , R 3 , R 4 , A 2a , A 2b are as defined in table Z 1 .
  • Table 1.46 provides compounds E46.1 to E46.952 of formula (Ia) wherein R 2 is Cl, R 5 is cyclopropyl, A 4 is N and R 1a , R 3 , R 4 , A 2a , A 2b are as defined in table Z 1 .
  • Table 1.47 provides compounds E47.1 to E47.952 of formula (Ia) wherein R 2 is Cl, R 5 is CH2OCH3, A4 is CH and R 1a , R 3 , R 4 , A 2a , A 2b are as defined in table Z 1 .
  • Table 1.48 provides compounds E48.1 to E48.952 of formula (Ia) wherein R 2 is Cl, R 5 is CH2OCH3, A4 is N and R 1a , R 3 , R 4 , A 2a , A 2b are as defined in table Z 1 .
  • Table 1.49 provides compounds E49.1 to E49.952 of formula (Ia) wherein R 2 is Cl, R 5 is NHCH2CH3, A4 is CH and R 1a , R 3 , R 4 , A 2a , A 2b are as defined in table Z 1 .
  • Table 1.50 provides compounds E50.1 to E50.952 of formula (Ia) wherein R 2 is Cl, R 5 is NHCH2CH3, A4 is N and R 1a , R 3 , R 4 , A 2a , A 2b are as defined in table Z 1 .
  • Table 1.51 provides compounds E51.1 to E51.952 of formula (Ia) wherein R 2 is Br, R 5 is CH3, A 4 is CH and R 1a , R 3 , R 4 , A 2a , A 2b are as defined in table Z 1 .
  • Table 1.52 provides compounds E52.1 to E52.952 of formula (Ia) wherein R 2 is Br, R 5 is CH3, A 4 is N and R 1a , R 3 , R 4 , A 2a , A 2b are as defined in table Z 1 .
  • Table 1.53 provides compounds E53.1 to E53.952 of formula (Ia) wherein R 2 is Br, R 5 is OCH3, A 4 is CH and R 1a , R 3 , R 4 , A 2a , A 2b are as defined in table Z 1 .
  • Table 1.54 provides compounds E54.1 to E54.952 of formula (Ia) wherein R 2 is Br, R 5 is OCH3, A 4 is N and R 1a , R 3 , R 4 , A 2a , A 2b are as defined in table Z 1 .
  • Table 1.55 provides compounds E55.1 to E55.952 of formula (Ia) wherein R 2 is Br, R 5 is cyclopropyl, A 4 is CH and R 1a , R 3 , R 4 , A 2a , A 2b are as defined in table Z 1 .
  • Table 1.56 provides compounds E56.1 to E56.952 of formula (Ia) wherein R 2 is Br, R 5 is cyclopropyl, A 4 is N and R 1a , R 3 , R 4 , A 2a , A 2b are as defined in table Z 1 .
  • Table 1.57 provides compounds E57.1 to E57.952 of formula (Ia) wherein R 2 is Br, R 5 is CH2OCH3, A4 is CH and R 1a , R 3 , R 4 , A 2a , A 2b are as defined in table Z 1 .
  • Table 1.58 provides compounds E58.1 to E58.952 of formula (Ia) wherein R 2 is Br, R 5 is CH2OCH3, A4 is N and R 1a , R 3 , R 4 , A 2a , A 2b are as defined in table Z 1 .
  • Table 1.59 provides compounds E59.1 to E59.952 of formula (Ia) wherein R 2 is Br, R 5 is NHCH2CH3, A4 is CH and R 1a , R 3 , R 4 , A 2a , A 2b are as defined in table Z 1 .
  • Table 1.60 provides compounds E60.1 to E60.952 of formula (Ia) wherein R 2 is Br, R 5 is NHCH2CH3, A4 is N and R 1a , R 3 , R 4 , A 2a , A 2b are as defined in table Z 1 .
  • Table 1.61 provides compounds E61.1 to E61.952 of formula (Ia) wherein R 2 is CN, R 5 is CH3, A 4 is CH and R 1a , R 3 , R 4 , A 2a , A 2b are as defined in table Z 1 .
  • Table 1.62 provides compounds E62.1 to E62.952 of formula (Ia) wherein R 2 is CN, R 5 is CH3, A 4 is N and R 1a , R 3 , R 4 , A 2a , A 2b are as defined in table Z 1 .
  • Table 1.63 provides compounds E63.1 to E63.952 of formula (Ia) wherein R 2 is CN, R 5 is OCH3, A 4 is CH and R 1a , R 3 , R 4 , A 2a , A 2b are as defined in table Z 1 .
  • Table 1.64 provides compounds E64.1 to E64.952 of formula (Ia) wherein R 2 is CN, R 5 is OCH3, A 4 is N and R 1a , R 3 , R 4 , A 2a , A 2b are as defined in table Z 1 .
  • Table 1.65 provides compounds E65.1 to E65.952 of formula (Ia) wherein R 2 is CN, R 5 is cyclopropyl, A 4 is CH and R 1a , R 3 , R 4 , A 2a , A 2b are as defined in table Z 1 .
  • Table 1.66 provides compounds E66.1 to E66.952 of formula (Ia) wherein R 2 is CN, R 5 is cyclopropyl, A 4 is N and R 1a , R 3 , R 4 , A 2a , A 2b are as defined in table Z 1 .
  • Table 1.67 provides compounds E67.1 to E67.952 of formula (Ia) wherein R 2 is CN, R 5 is CH2OCH3, A4 is CH and R 1a , R 3 , R 4 , A 2a , A 2b are as defined in table Z 1 .
  • Table 1.68 provides compounds E68.1 to E68.952 of formula (Ia) wherein R 2 is CN, R 5 is CH2OCH3, A4 is N and R 1a , R 3 , R 4 , A 2a , A 2b are as defined in table Z 1 .
  • Table 1.69 provides compounds E69.1 to E69.952 of formula (Ia) wherein R 2 is CN, R 5 is NHCH2CH3, A 4 is CH and R 1a , R 3 , R 4 , A 2a , A 2b are as defined in table Z 1 .
  • Table 1.70 provides compounds E70.1 to E70.952 of formula (Ia) wherein R 2 is CN, R 5 is NHCH2CH3, A 4 is N and R 1a , R 3 , R 4 , A 2a , A 2b are as defined in table Z 1 .
  • Table 1.71 provides compounds E71.1 to E71.952 of formula (Ia) wherein R 2 is OCH3, R 5 is CH3, A 4 is CH and R 1a , R 3 , R 4 , A 2a , A 2b are as defined in table Z 1 .
  • Table 1.72 provides compounds E72.1 to E72.952 of formula (Ia) wherein R 2 is OCH3, R 5 is CH3, A 4 is N and R 1a , R 3 , R 4 , A 2a , A 2b are as defined in table Z 1 .
  • Table 1.73 provides compounds E73.1 to E73.952 of formula (Ia) wherein R 2 is OCH3, R 5 is OCH3, A4 is CH and R 1a , R 3 , R 4 , A 2a , A 2b are as defined in table Z 1 .
  • Table 1.74 provides compounds E74.1 to E74.952 of formula (Ia) wherein R 2 is OCH3, R 5 is OCH3, A4 is N and R 1a , R 3 , R 4 , A 2a , A 2b are as defined in table Z 1 .
  • Table 1.75 provides compounds E75.1 to E75.952 of formula (Ia) wherein R 2 is OCH3, R 5 is cyclopropyl, A 4 is CH and R 1a , R 3 , R 4 , A 2a , A 2b are as defined in table Z 1 .
  • Table 1.76 provides compounds E76.1 to E76.952 of formula (Ia) wherein R 2 is OCH3, R 5 is cyclopropyl, A 4 is N and R 1a , R 3 , R 4 , A 2a , A 2b are as defined in table Z 1 .
  • Table 1.77 provides compounds E77.1 to E77.952 of formula (Ia) wherein R 2 is OCH3, R 5 is CH2OCH3, A 4 is CH and R 1a , R 3 , R 4 , A 2a , A 2b are as defined in table Z 1 .
  • Table 1.78 provides compounds E78.1 to E78.952 of formula (Ia) wherein R 2 is OCH3, R 5 is CH2OCH3, A 4 is N and R 1a , R 3 , R 4 , A 2a , A 2b are as defined in table Z 1 .
  • Table 1.79 provides compounds E79.1 to E79.952 of formula (Ia) wherein R 2 is OCH3, R 5 is NHCH2CH3, A 4 is CH and R 1a , R 3 , R 4 , A 2a , A 2b are as defined in table Z 1 .
  • Table 1.80 provides compounds E80.1 to E80.952 of formula (Ia) wherein R 2 is OCH3, R 5 is NHCH2CH3, A 4 is N and R 1a , R 3 , R 4 , A 2a , A 2b are as defined in table Z 1 .
  • Table 1.81 provides compounds E81.1 to E81.952 of formula (Ia) wherein R 2 is OCH2CH3, R 5 is CH 3 , A 4 is CH and R 1a , R 3 , R 4 , A 2a , A 2b are as defined in table Z 1 .
  • Table 1.82 provides compounds E82.1 to E82.952 of formula (Ia) wherein R 2 is OCH2CH3, R 5 is CH3, A 4 is N and R 1a , R 3 , R 4 , A 2a , A 2b are as defined in table Z 1 .
  • Table 1.83 provides compounds E83.1 to E83.952 of formula (Ia) wherein R 2 is OCH2CH3, R 5 is OCH3, A 4 is CH and R 1a , R 3 , R 4 , A 2a , A 2b are as defined in table Z 1 .
  • Table 1.84 provides compounds E84.1 to E84.952 of formula (Ia) wherein R 2 is OCH2CH3, R 5 is OCH3, A 4 is N and R 1a , R 3 , R 4 , A 2a , A 2b are as defined in table Z 1 .
  • Table 1.85 provides compounds E85.1 to E85.952 of formula (Ia) wherein R 2 is OCH2CH3, R 5 is cyclopropyl, A 4 is CH and R 1a , R 3 , R 4 , A 2a , A 2b are as defined in table Z 1 .
  • Table 1.86 provides compounds E86.1 to E86.952 of formula (Ia) wherein R 2 is OCH2CH3, R 5 is cyclopropyl, A 4 is N and R 1a , R 3 , R 4 , A 2a , A 2b are as defined in table Z 1 .
  • Table 1.87 provides compounds E87.1 to E87.952 of formula (Ia) wherein R 2 is OCH2CH3, R 5 is CH2OCH3, A 4 is CH and R 1a , R 3 , R 4 , A 2a , A 2b are as defined in table Z 1 .
  • Table 1.88 provides compounds E88.1 to E88.952 of formula (Ia) wherein R 2 is OCH2CH3, R 5 is CH2OCH3, A 4 is N and R 1a , R 3 , R 4 , A 2a , A 2b are as defined in table Z 1 .
  • Table 1.89 provides compounds E89.1 to E89.952 of formula (Ia) wherein R 2 is OCH2CH3, R 5 is NHCH2CH3, A 4 is CH and R 1a , R 3 , R 4 , A 2a , A 2b are as defined in table Z 1 .
  • Table 1.90 provides compounds E90.1 to E90.952 of formula (Ia) wherein R 2 is OCH2CH3, R 5 is NHCH2CH3, A 4 is N and R 1a , R 3 , R 4 , A 2a , A 2b are as defined in table Z 1 .
  • Table 1.91 provides compounds E91.1 to E91.952 of formula (Ia) wherein R 2 is CO2CH3, R 5 is CH3, A 4 is CH and R 1a , R 3 , R 4 , A 2a , A 2b are as defined in table Z 1 .
  • Table 1.92 provides compounds E92.1 to E92.952 of formula (Ia) wherein R 2 is CO2CH3, R 5 is CH3, A4 is N and R 1a , R 3 , R 4 , A 2a , A 2b are as defined in table Z 1 .
  • Table 1.93 provides compounds E93.1 to E93.952 of formula (Ia) wherein R 2 is CO2CH3, R 5 is OCH3, A 4 is CH and R 1a , R 3 , R 4 , A 2a , A 2b are as defined in table Z 1 .
  • Table 1.94 provides compounds E94.1 to E94.952 of formula (Ia) wherein R 2 is CO2CH3, R 5 is OCH3, A 4 is N and R 1a , R 3 , R 4 , A 2a , A 2b are as defined in table Z 1 .
  • Table 1.95 provides compounds E95.1 to E95.952 of formula (Ia) wherein R 2 is CO2CH3, R 5 is cyclopropyl, A 4 is CH and R 1a , R 3 , R 4 , A 2a , A 2b are as defined in table Z 1 .
  • Table 1.96 provides compounds E96.1 to E96.952 of formula (Ia) wherein R 2 is CO2CH3, R 5 is cyclopropyl, A 4 is N and R 1a , R 3 , R 4 , A 2a , A 2b are as defined in table Z 1 .
  • Table 1.97 provides compounds E97.1 to E97.952 of formula (Ia) wherein R 2 is CO2CH3, R 5 is CH2OCH3, A 4 is CH and R 1a , R 3 , R 4 , A 2a , A 2b are as defined in table Z 1 .
  • Table 1.98 provides compounds E98.1 to E98.952 of formula (Ia) wherein R 2 is CO2CH3, R 5 is CH2OCH3, A 4 is N and R 1a , R 3 , R 4 , A 2a , A 2b are as defined in table Z 1 .
  • Table 1.99 provides compounds E99.1 to E99.952 of formula (Ia) wherein R 2 is CO2CH3, R 5 is NHCH2CH3, A 4 is CH and R 1a , R 3 , R 4 , A 2a , A 2b are as defined in table Z 1 .
  • Table 1.100 provides compounds E100.1 to E100.952 of formula (Ia) wherein R 2 is CO2CH3, R 5 is NHCH2CH3, A 4 is N and R 1a , R 3 , R 4 , A 2a , A 2b are as defined in table Z 1 .
  • Table 2.1 provides compounds F1.1 to F1.288 of formula (Ic) wherein R 2 is H, R 5 is CH3 and R 3 , R 4 , A 2a , A 2b , A 4 are as defined in table Z 2 . More particularly, table Z 2 also includes compounds wherein R 3 and R 4 taken together form a ring. In this case, said ring is depicted in the R 3 and R 4 columns (table Z 2 ) merged together, along the amide atom linked to the bicycle core of the formula (Ic). For example, see the R 3 and R 4 columns of the compound F1.217.
  • Table 2.3 provides compounds F3.1 to F3.288 of formula (Ic) wherein R 2 is H, R 5 is cyclopropyl and R 3 , R 4 , A 2a , A 2b , A 4 are as defined in table Z 2 .
  • Table 2.4 provides compounds F4.1 to F4.288 of formula (Ic) wherein R 2 is H, R 5 is CH2OCH3 and R 3 , R 4 , A 2a , A 2b , A 4 are as defined in table Z 2 .
  • Table 2.5 provides compounds F5.1 to F5.288 of formula (Ic) wherein R 2 is H, R 5 is NHCH2CH3 and R 3 , R 4 , A 2a , A 2b , A 4 are as defined in table Z 2 .
  • Table 2.6 provides compounds F6.1 to F6.288 of formula (Ic) wherein R 2 is CH3, R 5 is CH3 and R 3 , R 4 , A 2a , A 2b , A 4 are as defined in table Z 2 .
  • Table 2.7 provides compounds F7.1 to F7.288 of formula (Ic) wherein R 2 is CH3, R 5 is OCH3 and R 3 , R 4 , A 2a , A 2b , A 4 are as defined in table Z 2 .
  • Table 2.8 provides compounds F8.1 to F8.288 of formula (Ic) wherein R 2 is CH3, R 5 is cyclopropyl and R 3 , R 4 , A 2a , A 2b , A 4 are as defined in table Z 2 .
  • Table 2.9 provides compounds F9.1 to F9.288 of formula (Ic) wherein R 2 is CH3, R 5 is CH2OCH3 and R 3 , R 4 , A 2a , A 2b , A 4 are as defined in table Z 2 .
  • Table 2.10 provides compounds F10.1 to F10.288 of formula (Ic) wherein R 2 is CH3, R 5 is NHCH2CH3 and R 3 , R 4 , A 2a , A 2b , A 4 are as defined in table Z 2 .
  • Table 2.11 provides compounds F11.1 to F11.288 of formula (Ic) wherein R 2 is CH2CH3, R 5 is CH3 and R 3 , R 4 , A 2a , A 2b , A 4 are as defined in table Z 2 .
  • Table 2.12 provides compounds F12.1 to F12.288 of formula (Ic) wherein R 2 is CH2CH3, R 5 is OCH3 and R 3 , R 4 , A 2a , A 2b , A 4 are as defined in table Z 2 .
  • Table 2.13 provides compounds F13.1 to F13.288 of formula (Ic) wherein R 2 is CH2CH3, R 5 is cyclopropyl and R 3 , R 4 , A 2a , A 2b , A 4 are as defined in table Z 2 .
  • Table 2.14 provides compounds F14.1 to F14.288 of formula (Ic) wherein R 2 is CH2CH3, R 5 is CH2OCH3 and R 3 , R 4 , A 2a , A 2b , A 4 are as defined in table Z 2 .
  • Table 2.15 provides compounds F15.1 to F15.288 of formula (Ic) wherein R 2 is CH2CH3, R 5 is NHCH2CH3 and R 3 , R 4 , A 2a , A 2b , A 4 are as defined in table Z 2 .
  • Table 2.16 provides compounds F16.1 to F16.288 of formula (Ic) wherein R 2 is F, R 5 is CH3 and R 3 , R 4 , A 2a , A 2b , A 4 are as defined in table Z 2 .
  • Table 2.17 provides compounds F17.1 to F17.288 of formula (Ic) wherein R 2 is F, R 5 is OCH3 and R 3 , R 4 , A 2a , A 2b , A 4 are as defined in table Z 2 .
  • Table 2.18 provides compounds F18.1 to F18.288 of formula (Ic) wherein R 2 is F, R 5 is cyclopropyl and R 3 , R 4 , A 2a , A 2b , A 4 are as defined in table Z 2 .
  • Table 2.19 provides compounds F19.1 to F19.288 of formula (Ic) wherein R 2 is F, R 5 is CH2OCH3 and R 3 , R 4 , A 2a , A 2b , A 4 are as defined in table Z 2 .
  • Table 2.20 provides compounds F20.1 to F20.288 of formula (Ic) wherein R 2 is F, R 5 is NHCH2CH3 and R 3 , R 4 , A 2a , A 2b , A 4 are as defined in table Z 2 .
  • Table 2.21 provides compounds F21.1 to F21.288 of formula (Ic) wherein R 2 is Cl, R 5 is CH3 and R 3 , R 4 , A 2a , A 2b , A 4 are as defined in table Z 2 .
  • Table 2.22 provides compounds F22.1 to F22.288 of formula (Ic) wherein R 2 is Cl, R 5 is OCH3 and R 3 , R 4 , A 2a , A 2b , A 4 are as defined in table Z 2 .
  • Table 2.23 provides compounds F23.1 to F23.288 of formula (Ic) wherein R 2 is Cl, R 5 is cyclopropyl and R 3 , R 4 , A 2a , A 2b , A 4 are as defined in table Z 2 .
  • Table 2.24 provides compounds F24.1 to F24.288 of formula (Ic) wherein R 2 is Cl, R 5 is CH2OCH3 and R 3 , R 4 , A 2a , A 2b , A 4 are as defined in table Z 2 .
  • Table 2.25 provides compounds F25.1 to F25.288 of formula (Ic) wherein R 2 is Cl, R 5 is NHCH2CH3 and R 3 , R 4 , A 2a , A 2b , A 4 are as defined in table Z 2 .
  • Table 2.26 provides compounds F26.1 to F26.288 of formula (Ic) wherein R 2 is Br, R 5 is CH3 and R 3 , R 4 , A 2a , A 2b , A 4 are as defined in table Z 2 .
  • Table 2.27 provides compounds F27.1 to F27.288 of formula (Ic) wherein R 2 is Br, R 5 is OCH3 and R 3 , R 4 , A 2a , A 2b , A 4 are as defined in table Z 2 .
  • Table 2.28 provides compounds F28.1 to F28.288 of formula (Ic) wherein R 2 is Br, R 5 is cyclopropyl and R 3 , R 4 , A 2a , A 2b , A 4 are as defined in table Z 2 .
  • Table 2.29 provides compounds F29.1 to F29.288 of formula (Ic) wherein R 2 is Br, R 5 is CH2OCH3 and R 3 , R 4 , A 2a , A 2b , A 4 are as defined in table Z 2 .
  • Table 2.30 provides compounds F30.1 to F30.288 of formula (Ic) wherein R 2 is Br, R 5 is NHCH2CH3 and R 3 , R 4 , A 2a , A 2b , A 4 are as defined in table Z 2 .
  • Table 2.31 provides compounds F31.1 to F31.288 of formula (Ic) wherein R 2 is CN, R 5 is CH3 and R 3 , R 4 , A 2a , A 2b , A 4 are as defined in table Z 2 .
  • Table 2.32 provides compounds F32.1 to F32.288 of formula (Ic) wherein R 2 is CN, R 5 is OCH3 and R 3 , R 4 , A 2a , A 2b , A 4 are as defined in table Z 2 .
  • Table 2.33 provides compounds F33.1 to F33.288 of formula (Ic) wherein R 2 is CN, R 5 is cyclopropyl and R 3 , R 4 , A 2a , A 2b , A 4 are as defined in table Z 2 .
  • Table 2.34 provides compounds F34.1 to F34.288 of formula (Ic) wherein R 2 is CN, R 5 is CH2OCH3 and R 3 , R 4 , A 2a , A 2b , A 4 are as defined in table Z 2 .
  • Table 2.35 provides compounds F35.1 to F35.288 of formula (Ic) wherein R 2 is CN, R 5 is NHCH2CH3 and R 3 , R 4 , A 2a , A 2b , A 4 are as defined in table Z 2 .
  • Table 2.36 provides compounds F36.1 to F36.288 of formula (Ic) wherein R 2 is OCH3, R 5 is CH3 and R 3 , R 4 , A 2a , A 2b , A 4 are as defined in table Z 2 .
  • Table 2.37 provides compounds F37.1 to F37.288 of formula (Ic) wherein R 2 is OCH3, R 5 is OCH3 and R 3 , R 4 , A 2a , A 2b , A 4 are as defined in table Z 2 .
  • Table 2.38 provides compounds F38.1 to F38.288 of formula (Ic) wherein R 2 is OCH3, R 5 is cyclopropyl and R 3 , R 4 , A 2a , A 2b , A 4 are as defined in table Z 2 .
  • Table 2.39 provides compounds F39.1 to F39.288 of formula (Ic) wherein R 2 is OCH3, R 5 is CH2OCH3 and R 3 , R 4 , A 2a , A 2b , A 4 are as defined in table Z 2 .
  • Table 2.40 provides compounds F40.1 to F40.288 of formula (Ic) wherein R 2 is OCH3, R 5 is NHCH2CH3 and R 3 , R 4 , A 2a , A 2b , A 4 are as defined in table Z 2 .
  • Table 2.41 provides compounds F41.1 to F41.288 of formula (Ic) wherein R 2 is OCH2CH3, R 5 is CH3 and R 3 , R 4 , A 2a , A 2b , A 4 are as defined in table Z 2 .
  • Table 2.42 provides compounds F42.1 to F42.288 of formula (Ic) wherein R 2 is OCH2CH3, R 5 is OCH3 and R 3 , R 4 , A 2a , A 2b , A 4 are as defined in table Z 2 .
  • Table 2.43 provides compounds F43.1 to F43.288 of formula (Ic) wherein R 2 is OCH2CH3, R 5 is cyclopropyl and R 3 , R 4 , A 2a , A 2b , A 4 are as defined in table Z 2 .
  • Table 2.44 provides compounds F44.1 to F44.288 of formula (Ic) wherein R 2 is OCH2CH3, R 5 is CH2OCH3 and R 3 , R 4 , A 2a , A 2b , A 4 are as defined in table Z 2 .
  • Table 2.45 provides compounds F45.1 to F45.288 of formula (Ic) wherein R 2 is OCH2CH3, R 5 is NHCH2CH3 and R 3 , R 4 , A 2a , A 2b , A 4 are as defined in table Z 2 .
  • Table 2.46 provides compounds F46.1 to F46.288 of formula (Ic) wherein R 2 is CO2CH3, R 5 is CH3 and R 3 , R 4 , A 2a , A 2b , A 4 are as defined in table Z 2 .
  • Table 2.47 provides compounds F47.1 to F47.288 of formula (Ic) wherein R 2 is CO2CH3, R 5 is OCH3 and R 3 , R 4 , A 2a , A 2b , A 4 are as defined in table Z 2 .
  • Table 2.48 provides compounds F48.1 to F48.288 of formula (Ic) wherein R 2 is CO2CH3, R 5 is cyclopropyl and R 3 , R 4 , A 2a , A 2b , A 4 are as defined in table Z 2 .
  • Table 2.49 provides compounds F49.1 to F49.288 of formula (Ic) wherein R 2 is CO2CH3, R 5 is CH2OCH3 and R 3 , R 4 , A 2a , A 2b , A 4 are as defined in table Z 2 .
  • Table 2.50 provides compounds F50.1 to F50.288 of formula (Ic) wherein R 2 is CO2CH3, R 5 is NHCH2CH3 and R 3 , R 4 , A 2a , A 2b , A 4 are as defined in table Z 2 .
  • Compounds according to the invention may possess any number of benefits including, inter alia, advantageous levels of biological activity for protecting plants against diseases that are caused by fungi or superior properties for use as agrochemical active ingredients (for example, greater biological activity, an advantageous spectrum of activity, an increased safety profile, improved physico-chemical properties, or increased biodegradability).
  • Compounds according to the invention have particularly advantageous levels of biological activity for protecting plants against oomycetes such as Phytophthora, Plasmopara and Pythium.
  • Compounds of formula (I), wherein Z is O, can be made as shown in the following schemes 1 to 18, in which, unless otherwise stated, the definition of each variable is as defined in the present invention.
  • Compounds of formula (I) can be prepared via Suzuki cross coupling of compounds of formula (II), wherein X is Cl, Br or I, and a compound of formula (III), wherein either R 6 is independently from each other hydrogen, C1-6alkyl or wherein two R 6 together can form a C3-8cycloalkyl, in the presence of a base, such as Cs2CO3, K2CO3 or NaOtBu, and a suitable palladium catalyst, such as tetrakistriphenylphosphinepalladium, [1,1-bis(diphenylphosphino)ferrocene]dichloropalladium(II), bis(diphenylphosphine)palladium(II) chloride, palladium dichloride or palladium acetate, in a suitable
  • Compounds of formula (IV), wherein X is Cl, Br or I can be prepared by a peptide-coupling reaction between a compound of formula (VII), wherein X is Cl, Br or I, and X 2 is OH, and an amine of formula (VIII), and by activating the carboxylic acid function of the compounds of formula (VII), a process that usually takes place by converting the -OH of the carboxylic acid into a good leaving group, such as a chloride group, for example by using (COCl)2 or SOCl2, prior to treatment with amines of formula (VIII), preferably in a suitable solvent (e.g., N-methylpyrrolidone, acetonitrile, dimethylacetamide, dichloromethane or tetrahydrofuran), preferably at temperatures between 25
  • Compounds of formula (IX) are commercially available or can be obtained by reaction of compounds of formula (VIII) with a compound of formula (V) wherein X 1 is a good leaving group such as Cl, Br, I, triflate, tosyl or mesyl, in the presence of a base such as Cs2CO3, K2CO3, NaH or NaOtBu.
  • compounds of formula (IX) can also be synthesized by reacting compounds of formula (VIII) with compounds of formula (VI), wherein R 7 is an electron-withdrawing group such as cyano or ester, optionnally in the presence of a base such as triethylamine or 1,8-diazabicyclo[5.4.0]undec-7-ene.
  • compounds of formula (IX) can be obtained from amines of formula (VIII) by a reductive amination with aldehydes of formula (X), wherein R 11 is C1-5alkyl, C1-6alkoxy-C1-5alkyl, C3-5cycloalkyl, C3- cycloalkyl-C1-3alkyl, C2-5alkenyl, C2-5alkynyl, C1-5alkoxy, C1-6alkylsulfanyl-C1-5alkyl, C1-6alkylsulfinyl-C1- 5alkyl, C1-6alkylsulfonyl-C1-5alkyl, C1-6alkoxycarbonyl-C1-5alkyl, C1-6alkylaminocarbonyl-C1-5alkyl, diC1- 6alkylaminocarbonyl-C1-5alkyl, or CN, e.g.
  • compounds of formula (II), wherein X is Cl, Br or I can be prepared from the reaction of a compound of formula (XI) and a halogenating agent, such as N-chlorosuccinimide, N-bromosuccinimide, N-iodosuccinimide or bromine in a suitable solvent, such as dichloromethane, chloroform, tetrahydrofuran or acetonitrile.
  • a halogenating agent such as N-chlorosuccinimide, N-bromosuccinimide, N-iodosuccinimide or bromine
  • a suitable solvent such as dichloromethane, chloroform, tetrahydrofuran or acetonitrile.
  • Compounds of formula (XI) can be obtained by an amide-coupling transformation of amines of formula (IX) with compounds of formula (XII), wherein X 2 is OH, and by activating the carboxylic acid function of the compounds of formula (XII), a process that usually takes place by converting the -OH of the carboxylic acid into a good leaving group, such as a chloride group, for example by using (COCl)2 or SOCl2, prior to treatment with amines of formula (IX), preferably in a suitable solvent (e.g., N-methylpyrrolidone, acetonitrile, dimethylacetamide, dichloromethane or tetrahydrofuran), preferably at temperatures between 25 °C and 60 °C, and optionally in the presence of a base such as triethylamine or N,N-diisopropylethylamine; or alternatively under conditions described in the literature for an amide coupling such as 1-propanephosphonic
  • compounds of formula (XI) can be obtained by alkylation of compounds of formula (XIII) with compounds of formula (V), wherein X 1 is a good leaving group such as Cl, Br, I, triflate, tosyl or mesyl, in the presence of a base such as Cs2CO3, K2CO3, NaH or NaOtBu.
  • compounds of formula (XI) can also be synthesized by reacting compounds of formula (XIII) with compounds of formula (VI), wherein R 7 is an electron-withdrawing group such as cyano or ester, optionally in the presence of a base such as triethylamine or 1,8-diazabicyclo[5.4.0]undec-7-ene.
  • Suzuki cross-couplings can be achieved by using a suitable palladium catalyst, such as tetrakistriphenylphosphinepalladium, [1,1- bis(diphenylphosphino)ferrocene]dichloropalladium(II), bis(diphenylphosphine)palladium(II) chloride, palladium dichloride or palladium acetate, in the presence of a base, such as Cs2CO3, K2CO3 or NaOtBu, in a suitable solvent, such as dimethylformamide, dioxane, tetrahydrofuran, ethanol or water.
  • a suitable palladium catalyst such as tetrakistriphenylphosphinepalladium, [1,1- bis(diphenylphosphino)ferrocene]dichloropalladium(II), bis(diphenylphosphine)palladium(II) chloride, palladium dichloride or palladium
  • Stille couplings can be achieved a suitable palladium catalyst such as tetrakistriphenylphosphinepalladium, tris(dibenzylideneacetone)dipalladium, palladium dichloride or palladium acetate in the presence of a base, such as Cs2CO3 or sodium acetate, in a suitable solvent, such as dimethylformamide, dioxane or acetonitrile.
  • a base such as Cs2CO3 or sodium acetate
  • a suitable solvent such as dimethylformamide, dioxane or acetonitrile.
  • a base such as pyridine or diisopropylethylamine.
  • Amines of formula (XIXa), R 9 is C1-6alkyl can be prepared by treatment of compounds of formula (XXIa), R 9 is C1-6alkyl, with an acid, typically hydrochloric acid, or with sodium acetate and hydroxyamine hydrochloride in a protic solvent such as methanol.
  • Compounds of formula (XXIa), wherein R 9 is C1-6alkyl can be synthesized by reaction of compounds of formula (XVIa), wherein X is Cl, Br or I, and R 9 is C1-6alkyl, with diphenylmethanimine (CAS number 1013-88-3) in the presence of a catalyst, such as palladium acetate or tris(dibenzylideneacetone)dipalladium, optionally a ligand such as 1,1′-[1,1′-binaphthalene]-2,2′-diylbis[1,1-diphenylphosphine] or (9,9- dimethyl-9H-xanthene-4,5-diyl)bis(diphenylphosphane), and in the presence of a base such as cesium carbonate or sodium tert-butoxide.
  • a catalyst such as palladium acetate or tris(dibenzylideneacetone)dipalladium
  • a ligand such
  • the outcome of the reaction can be improved by using a base, such as sodium bicarbonate or potassium carbonate, or by using an acid, such as p-toluenesulfonic acid or hydrogen bromide.
  • a base such as sodium bicarbonate or potassium carbonate
  • an acid such as p-toluenesulfonic acid or hydrogen bromide.
  • Compounds of formula (XXIIa), wherein X is Cl, Br or I, and R 9 is C1-6alkyl, compounds of formula (XXIII), wherein X is Cl, Br or I, and compounds of formula (XXIV) wherein X is Cl, Br or I, and either R 10 is independently from each other C 1-6 alkyl or wherein two R 10 together can form a C 3-8 cycloalkyl, are commercially available or prepared using known methods by those skilled in the art. These transformations are depicted in Scheme 8.
  • the outcome of the reaction can be improved by using a base, such as sodium bicarbonate or potassium carbonate, or by using an acid, such as p- toluenesulfonic acid or hydrogen bromide.
  • a base such as sodium bicarbonate or potassium carbonate
  • an acid such as p- toluenesulfonic acid or hydrogen bromide.
  • the outcome of the reaction can be improved by using a base, such as sodium bicarbonate or potassium carbonate, or by using an acid, such as p-toluenesulfonic acid or hydrogen bromide.
  • a base such as sodium bicarbonate or potassium carbonate
  • an acid such as p-toluenesulfonic acid or hydrogen bromide.
  • Compounds of formula (XXVIII), wherein R 9 is C1-6alkyl are commercially available or prepared using known methods by those skilled in the art. These transformations are depicted in Scheme 11.
  • Scheme 11 Compounds of formula (VII), wherein X is Cl, Br or I, and X 2 is OH can be prepared by hydrolysis of esters of formula (XXIX), wherein X is Cl, Br or I, and R 9 is C1-6alkyl, for instance by using a base such as lithium hydroxide or sodium hydroxide.
  • Esters of formula (XXIX), wherein X is Cl, Br or I, and R 9 is C1-6alkyl can be obtained by halogenation of compounds of formula (XV), wherein R 9 is C1-6alkyl, by using a halogenating reagent such as N-chlorosuccinimide, N-bromosuccinimide, N-iodosuccinimide or bromine in a suitable solvent, such as dichloromethane, chloroform, tetrahydrofuran or acetonitrile.
  • a halogenating reagent such as N-chlorosuccinimide, N-bromosuccinimide, N-iodosuccinimide or bromine in a suitable solvent, such as dichloromethane, chloroform, tetrahydrofuran or acetonitrile.
  • compounds of formula (I) can be prepared by an amide-coupling transformation of amines of formula (IX) with compounds of formula (XXX), wherein X 2 is OH, and by activating the carboxylic acid function of the compounds of formula (XXX), a process that usually takes place by converting the -OH of the carboxylic acid into a good leaving group, such as a chloride group, for example by using (COCl)2 or SOCl2, prior to treatment with amines of formula (IX), preferably in a suitable solvent (e.g., N-methylpyrrolidone, acetonitrile, dimethylacetamide, dichloromethane or tetrahydrofuran), preferably at temperatures between 25 °C and 60 °C, and optionally in the presence of a base such as triethylamine or N,N-diisopropylethylamine; or alternatively under conditions described in the literature for an amide coupling such as 1-propanephosphonadi
  • Compounds of formula (I) can alternatively be prepared by alkylation of compounds of formula (XXXI) with compounds of formula (V), wherein X 1 is a good leaving group such as Cl, Br, I, triflate, tosyl or mesyl, in the presence of a base such as Cs2CO3, K2CO3, NaH or NaOtBu.
  • compounds of formula (I) can also be synthesized by reacting compounds of formula (XXXI) with compounds of formula (VI), wherein R 7 is an electron-withdrawing group such as cyano or ester, optionally in the presence of a base such as triethylamine or 1,8-diazabicyclo[5.4.0]undec-7-ene.
  • compounds of formula (I) can be synthesized by reacting compounds of formula (XXXIII), wherein X is Cl, Br or I, with amines of formula (IX) and carbon monoxide in the presence of a catalyst such as [1,1-bis(diphenylphosphino)ferrocene]dichloropalladium(II), and, optionally, a base such as triethylamine.
  • a catalyst such as [1,1-bis(diphenylphosphino)ferrocene]dichloropalladium(II)
  • a base such as triethylamine.
  • Scheme 15 compounds of formula (I) can be prepared by the reaction of a compound of formula (XXXV) with compounds of formula (XXXVI), wherein X 2 is OH, in a peptide-coupling transformation, using the conditions described above.
  • Compounds of formula (XXXV) can be prepared via Suzuki cross coupling of a compound of formula (II) and a compound of formula (XXXVII), wherein either R 6 is independently from each other hydrogen, C1-6alkyl or wherein two R 6 together can form a C3-8cycloalkyl, in the presence of a base, such as Cs2CO3, K2CO3 or NaOtBu, and a suitable palladium catalyst, such as tetrakistriphenylphosphinepalladium, [1,1-bis(diphenylphosphino)ferrocene]dichloropalladium(II), bis(diphenylphosphine)palladium(II) chloride, palladium dichloride or palladium acetate, in a suitable solvent, such as dimethylformamide, dioxane, tetrahydrofuran, ethanol or water.
  • a base such as Cs2CO3, K2CO3 or NaOtBu
  • compounds of formula (Ib), wherein Z is S can be prepared by the reaction of a compound of formula (XXXVb) with compounds of formula (XXXVI), wherein X 2 is OH, in a peptide-coupling transformation, using the conditions described above.
  • Compounds of formula (XXXVb) can be prepared by the reaction of a compound of formula (XXXV), with phosphorus pentasulfide or Lawesson’s reagent (CAS: 19172-47-5) in a suitable solvent such as toluene, xylene or dichloromethane. This transformation is depicted in Scheme 18.
  • Non-exhaustive examples include oxidation reactions, reduction reactions, hydrolysis reactions, coupling reactions, aromatic nucleophilic or electrophilic substitution reactions, nucleophilic substitution reactions, nucleophilic addition reactions, olefination reactions, oxime formation, alkylation and halogenation reactions.
  • a compound according to the present invention can be converted in a manner known per se into another compound according to the present invention by replacing one or more substituents of the starting compound according to the present invention in the customary manner by (an)other substituent(s) according to the invention.
  • Salts of the compounds according to the present invention can be prepared in a manner known per se.
  • acid addition salts of the compounds according to the present invention are obtained by treatment with a suitable acid or a suitable ion exchanger reagent and salts with bases are obtained by treatment with a suitable base or with a suitable ion exchanger reagent.
  • Salts of compounds the compounds according to the present invention can be converted in the customary manner into the free compounds, acid addition salts, for example, by treatment with a suitable basic compound or with a suitable ion exchanger reagent and salts with bases, for example, by treatment with a suitable acid or with a suitable ion exchanger reagent.
  • Salts of the compounds according to the present invention can be converted in a manner known per se into other salts of the compounds according to the present invention, acid addition salts, for example, into other acid addition salts, for example by treatment of a salt of inorganic acid such as hydrochloride with a suitable metal salt such as a sodium, barium or silver salt, of an acid, for example with silver acetate, in a suitable solvent in which an inorganic salt which forms, for example silver chloride, is insoluble and thus precipitates from the reaction mixture.
  • a salt of inorganic acid such as hydrochloride
  • a suitable metal salt such as a sodium, barium or silver salt
  • an acid for example with silver acetate
  • a suitable solvent in which an inorganic salt which forms, for example silver chloride, is insoluble and thus precipitates from the reaction mixture.
  • the compounds according to the present invention, which have salt-forming properties can be obtained in free form or in the form of salts.
  • the compounds according to the present invention and, where appropriate, the tautomers thereof, in each case in free form or in salt form, can be present in the form of one of the stereoisomers which are possible or as a mixture of these, for example in the form of pure stereoisomers, such as antipodes and/or diastereomers, or as stereoisomer mixtures, such as enantiomer mixtures, for example racemates, diastereomer mixtures or racemate mixtures, depending on the number, absolute and relative configuration of asymmetric carbon atoms which occur in the molecule and/or depending on the configuration of non-aromatic double bonds which occur in the molecule; the invention relates to the pure stereoisomers and also to all stereoisomer mixtures which are possible and is to be understood in each case in this sense hereinabove and hereinbelow, even when stereochemical details are not mentioned specifically in each case.
  • Diastereomer mixtures or racemate mixtures of the compounds according to the present invention in free form or in salt form, which can be obtained depending on which starting materials and procedures have been chosen can be separated in a known manner into the pure diasteromers or racemates on the basis of the physicochemical differences of the components, for example by fractional crystallization, distillation and/or chromatography.
  • Enantiomer mixtures such as racemates, which can be obtained in a similar manner can be resolved into the optical antipodes by known methods, for example by recrystallization from an optically active solvent, by chromatography on chiral adsorbents, for example high-performance liquid chromatography (HPLC) on acetyl celulose, with the aid of suitable microorganisms, by cleavage with specific, immobilized enzymes, via the formation of inclusion compounds, for example using chiral crown ethers, where only one enantiomer is complexed, or by conversion into diastereomeric salts, for example by reacting a basic end-product racemate with an optically active acid, such as a carboxylic acid, for example camphor, tartaric or malic acid, or sulfonic acid, for example camphorsulfonic acid, and separating the diastereomer mixture which can be obtained in this manner, for example by fractional crystallization based on their differing solubilities, to give the
  • N-oxides can be prepared by reacting a compound according to the present invention with a suitable oxidizing agent, for example the H2O2/urea adduct in the presence of an acid anhydride, e.g. trifluoroacetic anhydride.
  • a suitable oxidizing agent for example the H2O2/urea adduct in the presence of an acid anhydride, e.g. trifluoroacetic anhydride.
  • stereoisomer for example enantiomer or diastereomer, or stereoisomer mixture, for example enantiomer mixture or diastereomer mixture
  • the individual components have a different biological activity.
  • the compounds according to the present invention and, where appropriate, the tautomers thereof, in each case in free form or in salt form, can, if appropriate, also be obtained in the form of hydrates and/or include other solvents, for example those which may have been used for the crystallization of compounds which are present in solid form.
  • the following Examples illustrate, but do not limit, the invention.
  • the present invention also provides intermediates useful for the preparation of compounds according to the present invention. The below intermediates form a further aspect of the invention.
  • a compound of formula (XXX) one A 1 is CR 1 ; and preferably one A 1 is N and one A 1 is CR 1 ; R 1 are independently selected from hydrogen, hydroxy, halogen, CN, C1-6alkyl, C3-6cycloalkyl, C1- 6alkoxy-C1-6alkyl, C3-6cycloalkyl-C1-4alkyl, C1-6alkylsulfonyl, C1-6alkoxy, amino, and -NHC(O)C1-6alkyl; and preferably R 1 are independently selected from hydrogen and C1-6alkyl; A 4 is CH or N; and R 5 is selected from C1-6alkyl, C1-6alkoxy, C3-6cycloalkyl, C3-6cycloalkyl-C1-6alkyl, C1-6alkoxyC1-6alkyl, C1- 6alkylamino, diC1-6alkylamino, C1-6alkoxyamino, and C1-6alkylC1-6alkoxyamino, wherein each of the C
  • R 1 are independently selected from hydrogen, hydroxy, halogen, CN, C1-6alkyl, C3-6cycloalkyl, C1- 6alkoxy-C1-6alkyl, C3-6cycloalkyl-C1-4alkyl, C1-6alkylsulfonyl, C1-6alkoxy, amino, and -NHC(O)C1-6alkyl; and preferably R 1 are independently selected from hydrogen and C1-6alkyl;
  • a 2 are independently CR 2 or N, with the proviso that no more than three A 2 are N, preferably the four A 2 are CR 2 ;
  • R 2 are independently selected from hydrogen, hydroxy, halogen, CN, C1-6alkyl, C1-6alkoxy, C1-6alkoxy- C1-6alkyl, C1-6alkoxy-C1-6al
  • R 1 are independently selected from hydrogen, hydroxy, halogen, CN, C1-6alkyl, C3-6cycloalkyl, C1- 6alkoxy-C1-6alkyl, C3-6cycloalkyl-C1-4alkyl, C1-6alkylsulfonyl, C1-6alkoxy, amino, and -NHC(O)C1-6alkyl; and preferably R 1 are independently selected from hydrogen and C1-6alkyl;
  • a 2 are independently CR 2 or N, with the proviso that no more than three A 2 are N, preferably the four A 2 are CR 2 ;
  • R 2 are independently selected from hydrogen, hydroxy, halogen, CN, C1-6alkyl, C1-6alkoxy, C1-6alkoxy- C1-6alkyl, C1-6alkoxy-C1-6al
  • the compounds of formula (I) as defined in the present invention can be used in the agricultural sector and related fields of use e.g. as active ingredients for controlling plant pathogens or on non-living materials for control of spoilage microorganisms or organisms potentially harmful to man.
  • the novel compounds are distinguished by excellent activity at low rates of application, by being well tolerated by plants and by being environmentally safe. They have very useful curative, preventive and systemic properties and may be used for protecting numerous cultivated plants.
  • the compounds of formula (I) as defined in the present invention can be used to inhibit or destroy the pathogens that occur on plants or parts of plants (fruit, blossoms, leaves, stems, tubers, roots) of different crops of useful plants, while at the same time protecting also those parts of the plants that grow later e.g.
  • fungicide as used herein means a compound that controls, modifies, or prevents the growth of fungi.
  • fungicidally effective amount means the quantity of such a compound or combination of such compounds that is capable of producing an effect on the growth of fungi. Controlling or modifying effects include all deviation from natural development, such as killing, retardation and the like, and prevention includes barrier or other defensive formation in or on a plant to prevent fungal infection.
  • compounds of formula (I) as defined in the present invention as dressing agents for the treatment of plant propagation material, e.g., seed, such as fruits, tubers or grains, or plant cuttings (for example rice), for the protection against fungal infections as well as against phytopathogenic fungi occurring in the soil.
  • plant propagation material e.g., seed, such as fruits, tubers or grains, or plant cuttings (for example rice)
  • the propagation material can be treated with a composition comprising a compound of formula (I) as defined in the present invention before planting: seed, for example, can be dressed before being sown.
  • the compounds of formula (I) as defined in the present invention can also be applied to grains (coating), either by impregnating the seeds in a liquid formulation or by coating them with a solid formulation.
  • the composition can also be applied to the planting site when the propagation material is being planted, for example, to the seed furrow during sowing.
  • the invention relates also to such methods of treating plant propagation material and to the plant propagation material so treated.
  • the compounds of formula (I) as defined in the present invention can be used for controlling fungi in related areas, for example in the protection of technical materials, including wood and wood related technical products, in food storage, in hygiene management.
  • the invention could be used to protect non-living materials from fungal attack, e.g. lumber, wall boards and paint.
  • Compounds of formula (I) as defined in the present invention and fungicidal compositions containing them may be used to control plant diseases caused by a broad spectrum of fungal plant pathogens.
  • fungi and fungal vectors of disease are for example: Absidia corymbifera, Alternaria spp, Aphanomyces spp, Ascochyta spp, Aspergillus spp. including A. flavus, A. fumigatus, A. nidulans, A. niger, A. terrus, Aureobasidium spp. including A.
  • Botryosphaeria spp. including B. dothidea, B. obtusa, Botrytis spp. contributing B. cinerea, Candida spp. including C. albicans, C. glabrata, C. krusei, C. lusitaniae, C. parapsilosis, C. tropicalis, Cephaloascus fragrans, Ceratocystis spp, Cercospora spp. including C.
  • capsulatum Laetisaria fuciformis, Leptographium lindbergi, Leveillula taurica, Lophodermium seditiosum, Microdochium nivale, Microsporum spp, Monilinia spp, Mucor spp, Mycosphaerella spp. including M. graminicola, M. pomi, Oncobasidium theobromaeon, Ophiostoma piceae, Paracoccidioides spp, Penicillium spp. including P. digitatum, P. italicum, Petriellidium spp, Peronosclerospora spp. Including P. maydis, P.
  • leucotricha Polymyxa graminis, Polymyxa betae, Pseudocercosporella herpotrichoides, Pseudomonas spp, Pseudoperonospora spp. including P. cubensis, P. humuli, Pseudopeziza tracheiphila, Puccinia Spp. including P. hordei, P. recondita, P. striiformis, P. triticina, Pyrenopeziza spp, Pyrenophora spp, Pyricularia spp. including P. oryzae, Pythium spp. including P.
  • compounds of formula (I) as defined in the present invention and fungicidal compositions containing them may be used to control plant diseases caused by a broad spectrum of fungal plant pathogens in the Basidiomycete, Ascomycete, Oomycete and/or Deuteromycete, Blasocladiomycete, Chrytidiomycete, Glomeromycete and/or Mucoromycete classes. More particularly, the compounds of formula (I) as defined in the present invention may be used to conrol oomycetes.
  • pathogens may include: Oomycetes, including Phytophthora diseases such as those caused by Phytophthora capsici, Phytophthora infestans, Phytophthora sojae, Phytophthora fragariae, Phytophthora nicotianae, Phytophthora cinnamomi, Phytophthora citricola, Phytophthora citrophthora and Phytophthora erythroseptica; Pythium diseases such as those caused by Pythium aphanidermatum, Pythium arrhenomanes, Pythium graminicola, Pythium irregulare, Pythium sylvaticum and Pythium ultimum; diseases caused by Peronosporales such as Peronospora destructor, Peronospora parasitica, Plasmopara viticola, Plasmopara halstedii, Pseudoperonospora cubens
  • Ascomycetes including blotch, spot, blast or blight diseases and/or rots for example those caused by Pleosporales such as Stemphylium solani, Stagonospora tainanensis, Spilocaea oleaginea, Setosphaeria turcica, Pyrenochaeta lycoperisici, Pleospora herbarum, Phoma destructiva, Phaeosphaeria herpotrichoides, Phaeocryptocus gaeumannii, Ophiosphaerella graminicola, Ophiobolus graminis, Leptosphaeria maculans, Hendersonia creberrima, Helminthosporium triticirepentis, Setosphaeria turcica, Drechslera glycines, Didymella bryoniae, Cycloconium oleagineum, Corynespora cassiicola, Cochliobolus sativus, Bi
  • Gerlachia nivale Gibberella fujikuroi
  • Gibberella zeae Gibberella zeae
  • Gliocladium spp. Myrothecium verrucaria
  • Nectria ramulariae Trichoderma viride
  • Trichothecium roseum Trichothecium roseum
  • Verticillium theobromae Myrothecium verrucaria
  • Basidiomycetes including smuts for example those caused by Ustilaginales such as Ustilaginoidea virens, Ustilago nuda, Ustilago tritici, Ustilago zeae, rusts for example those caused by Pucciniales such as Cerotelium fici, Chrysomyxa arctostaphyli, Coleosporium ipomoeae, Hemileia vastatrix, Puccinia arachidis, Puccinia cacabata, Puccinia graminis, Puccinia recondita, Puccinia sorghi, Puccinia hordei, Puccinia striiformis f.sp.
  • Ustilaginales such as Ustilaginoidea virens, Ustilago nuda, Ustilago tritici, Ustilago zeae
  • rusts for example those caused by Pucciniales such as Cerotelium fici, Chr
  • Puccinia striiformis f.sp. Secalis Pucciniastrum coryli, or Uredinales such as Cronartium ribicola, Gymnosporangium juniperi-viginianae, Melampsora medusae, Phakopsora pachyrhizi, Phragmidium mucronatum, Physopella ampelosidis, Tranzschelia discolor and Uromyces viciae-fabae; and other rots and diseases such as those caused by Cryptococcus spp., Exobasidium vexans, Marasmiellus inoderma, Mycena spp., Sphacelotheca reiliana, Typhula ishikariensis, Urocystis agropyri, Itersonilia perplexans, Corticium invisum, Laetisaria fuciformis, Waitea circinata, Rhizoctonia solani, Tha
  • Blastocladiomycetes such as Physoderma maydis. Mucoromycetes, such as Choanephora cucurbitarum.; Mucor spp.; Rhizopus arrhizus. As well as diseases caused by other species and genera closely related to those listed above.
  • the compounds and compositions comprising compounds of formula (I) as defined in the present invention may also have activity against bacteria such as Erwinia amylovora, Erwinia caratovora, Xanthomonas campestris, Pseudomonas syringae, Strptomyces scabies and other related species as well as certain protozoa.
  • target crops and/or useful plants to be protected typically comprise perennial and annual crops, such as berry plants for example blackberries, blueberries, cranberries, raspberries and strawberries; cereals for example barley, maize (corn), millet, oats, rice, rye, sorghum triticale and wheat; fibre plants for example cotton, flax, hemp, jute and sisal; field crops for example sugar and fodder beet, coffee, hops, mustard, oilseed rape (canola), poppy, sugar cane, sunflower, tea and tobacco; fruit trees for example apple, apricot, avocado, banana, cherry, citrus, nectarine, peach, pear and plum; grasses for example Bermuda grass, bluegrass, bentgrass, centipede grass, fescue, ryegrass, St.
  • perennial and annual crops such as berry plants for example blackberries, blueberries, cranberries, raspberries and strawberries
  • cereals for example barley, maize (corn), millet, oats
  • Augustine grass and Zoysia grass herbs such as basil, borage, chives, coriander, lavender, lovage, mint, oregano, parsley, rosemary, sage and thyme; legumes for example beans, lentils, peas and soya beans; nuts for example almond, cashew, ground nut, hazelnut, peanut, pecan, pistachio and walnut; palms for example oil palm; ornamentals for example flowers, shrubs and trees; other trees, for example cacao, coconut, olive and rubber; vegetables for example asparagus, aubergine, broccoli, cabbage, carrot, cucumber, garlic, lettuce, marrow, melon, okra, onion, pepper, potato, pumpkin, rhubarb, spinach and tomato; and vines for example grapes.
  • herbs such as basil, borage, chives, coriander, lavender, lovage, mint, oregano, parsley, rosemary, sage and thyme
  • legumes for example beans, lentils, peas and soya beans
  • the useful plants and / or target crops in accordance with the invention include conventional as well as genetically enhanced or engineered varieties such as, for example, insect resistant (e.g. Bt. and VIP varieties) as well as disease resistant, herbicide tolerant (e.g. glyphosate- and glufosinate-resistant maize varieties commercially available under the trade names RoundupReady® and LibertyLink®) and nematode tolerant varieties.
  • suitable genetically enhanced or engineered crop varieties include the Stoneville 5599BR cotton and Stoneville 4892BR cotton varieties.
  • useful plants and/or “target crops” is to be understood as including also useful plants that have been rendered tolerant to herbicides like bromoxynil or classes of herbicides (such as, for example, HPPD inhibitors, ALS inhibitors, for example primisulfuron, prosulfuron and trifloxysulfuron, EPSPS (5- enol-pyrovyl-shikimate-3-phosphate-synthase) inhibitors, GS (glutamine synthetase) inhibitors or PPO (protoporphyrinogen-oxidase) inhibitors) as a result of conventional methods of breeding or genetic engineering.
  • herbicides like bromoxynil or classes of herbicides
  • EPSPS 5- enol-pyrovyl-shikimate-3-phosphate-synthase
  • GS glutamine synthetase
  • PPO protoporphyrinogen-oxidase
  • An example of a crop that has been rendered tolerant to imidazolinones, e.g. imazamox, by conventional methods of breeding (mutagenesis) is Clearfield® summer rape (Canola).
  • crops that have been rendered tolerant to herbicides or classes of herbicides by genetic engineering methods include glyphosate- and glufosinate-resistant maize varieties commercially available under the trade names RoundupReady® , Herculex I® and LibertyLink®.
  • the term "useful plants" and/or “target crops” is to be understood as including those which naturally are or have been rendered resistant to harmful insects.
  • toxins which can be expressed include ⁇ -endotoxins, vegetative insecticidal proteins (Vip), insecticidal proteins of bacteria colonising nematodes, and toxins produced by scorpions, arachnids, wasps and fungi.
  • An example of a crop that has been modified to express the Bacillus thuringiensis toxin is the Bt maize KnockOut ⁇ (Syngenta Seeds).
  • VipCot ⁇ Surgera Seeds
  • Crops or seed material thereof can also be resistant to multiple types of pests (so-called stacked transgenic events when created by genetic modification).
  • a plant can have the ability to express an insecticidal protein while at the same time being herbicide tolerant, for example Herculex I ⁇ (Dow AgroSciences, Pioneer Hi-Bred International).
  • useful plants and/or “target crops” is to be understood as including also useful plants which have been so transformed by the use of recombinant DNA techniques that they are capable of synthesising antipathogenic substances having a selective action, such as, for example, the so-called "pathogenesis-related proteins" (PRPs, see e.g. EP-A-0392225).
  • PRPs pathogenesis-related proteins
  • Examples of such antipathogenic substances and transgenic plants capable of synthesising such antipathogenic substances are known, for example, from EP-A-0392225, WO 95/33818, and EP-A-0353191.
  • the methods of producing such transgenic plants are generally known to the person skilled in the art and are described, for example, in the publications mentioned above.
  • Toxins that can be expressed by transgenic plants include, for example, insecticidal proteins from Bacillus cereus or Bacillus popilliae; or insecticidal proteins from Bacillus thuringiensis, such as ⁇ - endotoxins, e.g. Cry1Ab, Cry1Ac, Cry1F, Cry1Fa2, Cry2Ab, Cry3A, Cry3Bb1 or Cry9C, or vegetative insecticidal proteins (Vip), e.g. Vip1, Vip2, Vip3 or Vip3A; or insecticidal proteins of bacteria colonising nematodes, for example Photorhabdus spp.
  • insecticidal proteins from Bacillus cereus or Bacillus popilliae such as ⁇ - endotoxins, e.g. Cry1Ab, Cry1Ac, Cry1F, Cry1Fa2, Cry2Ab, Cry3A, Cry3Bb1 or Cry9C, or vegetative
  • Xenorhabdus spp. such as Photorhabdus luminescens, Xenorhabdus nematophilus
  • toxins produced by animals such as scorpion toxins, arachnid toxins, wasp toxins and other insect-specific neurotoxins
  • toxins produced by fungi such as Streptomycetes toxins, plant lectins, such as pea lectins, barley lectins or snowdrop lectins
  • agglutinins proteinase inhibitors, such as trypsin inhibitors, serine protease inhibitors, patatin, cystatin, papain inhibitors
  • ribosome- inactivating proteins (RIP) such as ricin, maize-RIP, abrin, luffin, saporin or bryodin
  • steroid metabolism enzymes such as 3-hydroxysteroidoxidase, ecdysteroid-UDP-glycosyl-transferase, cholesterol oxidases, ecd
  • ⁇ -endotoxins for example Cry1Ab, Cry1Ac, Cry1F, Cry1Fa2, Cry2Ab, Cry3A, Cry3Bb1 or Cry9C, or vegetative insecticidal proteins (Vip), for example Vip1, Vip2, Vip3 or Vip3A
  • Vip vegetative insecticidal proteins
  • Hybrid toxins are produced recombinantly by a new combination of different domains of those proteins (see, for example, WO 02/15701).
  • Truncated toxins for example a truncated Cry1Ab, are known.
  • modified toxins one or more amino acids of the naturally occurring toxin are replaced.
  • preferably non-naturally present protease recognition sequences are inserted into the toxin, such as, for example, in the case of Cry3A055, a cathepsin-G- recognition sequence is inserted into a Cry3A toxin (see WO03/018810).
  • More examples of such toxins or transgenic plants capable of synthesising such toxins are disclosed, for example, in EP-A-0374753, WO93/07278, WO95/34656, EP-A-0427529, EP-A-451878 and WO03/052073.
  • transgenic plants are generally known to the person skilled in the art and are described, for example, in the publications mentioned above.
  • CryI-type deoxyribonucleic acids and their preparation are known, for example, from WO 95/34656, EP-A-0367 474, EP-A-0401979 and WO 90/13651.
  • the toxin contained in the transgenic plants imparts to the plants tolerance to harmful insects.
  • Such insects can occur in any taxonomic group of insects, but are especially commonly found in the beetles (Coleoptera), two-winged insects (Diptera) and butterflies (Lepidoptera).
  • Transgenic plants containing one or more genes that code for an insecticidal resistance and express one or more toxins are known and some of them are commercially available. Examples of such plants are: YieldGard ⁇ (maize variety that expresses a Cry1Ab toxin); YieldGard Rootworm ⁇ (maize variety that expresses a Cry3Bb1 toxin); YieldGard Plus ⁇ (maize variety that expresses a Cry1Ab and a Cry3Bb1 toxin); Starlink ⁇ (maize variety that expresses a Cry9C toxin); Herculex I ⁇ (maize variety that expresses a Cry1Fa2 toxin and the enzyme phosphinothricine N-acetyltransferase (PAT) to achieve tolerance to the herbicide glufosinate ammonium); NuCOTN 33B ⁇ (cotton variety that expresses a Cry1Ac toxin); Bollgard I
  • transgenic crops are: 1. Bt11 Maize from Syngenta Seeds SAS, Chemin de l'Hobit 27, F-31 790 St. Sauveur, France, registration number C/FR/96/05/10. Genetically modified Zea mays which has been rendered resistant to attack by the European corn borer (Ostrinia nubilalis and Sesamia nonagrioides) by transgenic expression of a truncated Cry1Ab toxin. Bt11 maize also transgenically expresses the enzyme PAT to achieve tolerance to the herbicide glufosinate ammonium. 2. Bt176 Maize from Syngenta Seeds SAS, Chemin de l'Hobit 27, F-31790 St.
  • This toxin is Cry3A055 modified by insertion of a cathepsin-G- protease recognition sequence.
  • the preparation of such transgenic maize plants is described in WO 03/018810.
  • MON 863 Maize from Monsanto Europe S.A. 270-272 Avenue de Tervuren, B-1150 Brussels, Belgium, registration number C/DE/02/9.
  • MON 863 expresses a Cry3Bb1 toxin and has resistance to certain Coleoptera insects. 5.
  • NK603 ⁇ MON 810 Maize transgenically expresses the protein CP4 EPSPS, obtained from Agrobacterium sp. strain CP4, which imparts tolerance to the herbicide Roundup® (contains glyphosate), and also a Cry1Ab toxin obtained from Bacillus thuringiensis subsp. kurstaki which brings about tolerance to certain Lepidoptera, include the European corn borer.
  • locus as used herein means fields in or on which plants are growing, or where seeds of cultivated plants are sown, or where seed will be placed into the soil. It includes soil, seeds, and seedlings, as well as established vegetation.
  • plants refers to all physical parts of a plant, including seeds, seedlings, saplings, roots, tubers, stems, stalks, foliage, and fruits.
  • plant propagation material is understood to denote generative parts of the plant, such as seeds, which can be used for the multiplication of the latter, and vegetative material, such as cuttings or tubers, for example potatoes.
  • seeds in the strict sense
  • Germinated plants and young plants which are to be transplanted after germination or after emergence from the soil, may also be mentioned. These young plants may be protected before transplantation by a total or partial treatment by immersion.
  • plant propagation material is understood to denote seeds.
  • Pesticidal agents referred to herein using their common name are known, for example, from "The Pesticide Manual", 19th Ed., British Crop Protection Council 2021.
  • the compounds of formula (I) as defined in the present invention may be used in unmodified form or, preferably, together with the adjuvants conventionally employed in the art of formulation. To this end they may be conveniently formulated in known manner to emulsifiable concentrates, coatable pastes, directly sprayable or dilutable solutions or suspensions, dilute emulsions, wettable powders, soluble powders, dusts, granulates, and also encapsulations e.g. in polymeric substances.
  • compositions may also contain further adjuvants such as stabilizers, antifoams, viscosity regulators, binders or tackifiers as well as fertilizers, micronutrient donors or other formulations for obtaining special effects.
  • Suitable carriers and/or adjuvants e.g. for agricultural use, can be solid or liquid and are substances useful in formulation technology, e.g. natural or regenerated mineral substances, solvents, dispersants, wetting agents, tackifiers, thickeners, binders or fertilizers.
  • Suspension concentrates are aqueous formulations in which finely divided solid particles of the active compound are suspended.
  • Such formulations include anti-settling agents and dispersing agents and may further include a wetting agent to enhance activity as well an anti-foam and a crystal growth inhibitor.
  • these concentrates are diluted in water and normally applied as a spray to the area to be treated.
  • the amount of active ingredient may range from 0.5% to 95% of the concentrate.
  • Wettable powders are in the form of finely divided particles which disperse readily in water or other liquid carriers. The particles contain the active ingredient retained in a solid matrix.
  • Typical solid matrices include fuller’s earth, kaolin clays, silicas and other readily wet organic or inorganic solids.
  • Wettable powders normally contain from 5% to 95% of the active ingredient plus a small amount of wetting, dispersing or emulsifying agent.
  • Emulsifiable concentrates are homogeneous liquid compositions dispersible in water or other liquid and may consist entirely of the active compound with a liquid or solid emulsifying agent, or may also contain a liquid carrier, such as xylene, heavy aromatic naphthas, isophorone and other non-volatile organic solvents. In use, these concentrates are dispersed in water or other liquid and normally applied as a spray to the area to be treated.
  • the amount of active ingredient may range from 0.5% to 95% of the concentrate.
  • Granular formulations include both extrudates and relatively coarse particles and are usually applied without dilution to the area in which treatment is required.
  • Typical carriers for granular formulations include sand, fuller’s earth, attapulgite clay, bentonite clays, montmorillonite clay, vermiculite, perlite, calcium carbonate, brick, pumice, pyrophyllite, kaolin, dolomite, plaster, wood flour, ground corn cobs, ground peanut hulls, sugars, sodium chloride, sodium sulphate, sodium silicate, sodium borate, magnesia, mica, iron oxide, zinc oxide, titanium oxide, antimony oxide, cryolite, gypsum, diatomaceous earth, calcium sulphate and other organic or inorganic materials which absorb or which can be coated with the active compound.
  • Granular formulations normally contain 5% to 25% of active ingredients which may include surface-active agents such as heavy aromatic naphthas, kerosene and other petroleum fractions, or vegetable oils; and/or stickers such as dextrins, glue or synthetic resins.
  • Dusts are free-flowing admixtures of the active ingredient with finely divided solids such as talc, clays, flours and other organic and inorganic solids which act as dispersants and carriers.
  • Microcapsules are typically droplets or granules of the active ingredient enclosed in an inert porous shell which allows escape of the enclosed material to the surroundings at controlled rates. Encapsulated droplets are typically 1 to 50 microns in diameter.
  • the enclosed liquid typically constitutes 50 to 95% of the weight of the capsule and may include solvent in addition to the active compound.
  • Encapsulated granules are generally porous granules with porous membranes sealing the granule pore openings, retaining the active species in liquid form inside the granule pores.
  • Granules typically range from 1 millimetre to 1 centimetre and preferably 1 to 2 millimetres in diameter.
  • Granules are formed by extrusion, agglomeration or prilling, or are naturally occurring. Examples of such materials are vermiculite, sintered clay, kaolin, attapulgite clay, sawdust and granular carbon.
  • Shell or membrane materials include natural and synthetic rubbers, cellulosic materials, styrene-butadiene copolymers, polyacrylonitriles, polyacrylates, polyesters, polyamides, polyureas, polyurethanes and starch xanthates.
  • Other useful formulations for agrochemical applications include simple solutions of the active ingredient in a solvent in which it is completely soluble at the desired concentration, such as acetone, alkylated naphthalenes, xylene and other organic solvents.
  • Pressurised sprayers wherein the active ingredient is dispersed in finely-divided form as a result of vaporisation of a low boiling dispersant solvent carrier, may also be used.
  • Liquid carriers that can be employed include, for example, water, toluene, xylene, petroleum naphtha, crop oil, acetone, methyl ethyl ketone, cyclohexanone, acetic anhydride, acetonitrile, acetophenone, amyl acetate, 2-butanone, chlorobenzene, cyclohexane, cyclohexanol, alkyl acetates, diacetonalcohol, 1,2-dichloropropane, diethanolamine, p-diethylbenzene, diethylene glycol, diethylene glycol abietate, diethylene glycol butyl ether, diethylene glycol ethyl ether, diethylene glycol methyl ether, N,N-dimethyl formamide, dimethyl sulfoxide,
  • Water is generally the carrier of choice for the dilution of concentrates.
  • suitable solid carriers include, for example, talc, titanium dioxide, pyrophyllite clay, silica, attapulgite clay, kieselguhr, chalk, diatomaxeous earth, lime, calcium carbonate, bentonite clay, fuller’s earth, cotton seed hulls, wheat flour, soybean flour, pumice, wood flour, walnut shell flour and lignin.
  • a broad range of surface-active agents are advantageously employed in both said liquid and solid compositions, especially those designed to be diluted with carrier before application. These agents, when used, normally comprise from 0.1% to 15% by weight of the formulation.
  • Typical surface active agents include salts of alkyl sulfates, such as diethanolammonium lauryl sulphate; alkylarylsulfonate salts, such as calcium dodecylbenzenesulfonate; alkylphenol-alkylene oxide addition products, such as nonylphenol-C.sub.18 ethoxylate; alcohol-alkylene oxide addition products, such as tridecyl alcohol-C.sub.
  • soaps such as sodium stearate
  • alkylnaphthalenesulfonate salts such as sodium dibutylnaphthalenesulfonate
  • dialkyl esters of sulfosuccinate salts such as sodium di(2-ethylhexyl) sulfosuccinate
  • sorbitol esters such as sorbitol oleate
  • quaternary amines such as lauryl trimethylammonium chloride
  • polyethylene glycol esters of fatty acids such as polyethylene glycol stearate
  • block copolymers of ethylene oxide and propylene oxide and salts of mono and dialkyl phosphate esters.
  • compositions of the invention include crystallisation inhibitors, viscosity modifiers, suspending agents, spray droplet modifiers, pigments, antioxidants, foaming agents, anti- foaming agents, light-blocking agents, compatibilizing agents, antifoam agents, sequestering agents, neutralising agents and buffers, corrosion inhibitors, dyes, odorants, spreading agents, penetration aids, micronutrients, emollients, lubricants and sticking agents.
  • biocidally active ingredients or compositions may be combined with the compositions of the invention and used in the methods of the invention and applied simultaneously or sequentially with the compositions of the invention.
  • these further active ingredients may be formulated together with the compositions of the invention or mixed in, for example, the spray tank.
  • These further biocidally active ingredients may be fungicides, herbicides, insecticides, bactericides, acaricides, nematicides, plant growth regulators, and/or biologicals.
  • TX means “one compound selected from the compounds defined in the Tables 1.1 to 1.100, in the Tables 2.1 to 2.50, and Table A): (7E,9Z)-dodeca-7,9-dien-1-yl acetate + TX, (9Z,11E)-tetradeca-9,11-dien-1-yl acetate + TX, (9Z,12E)- tetradeca-9,12-dien-1-yl acetate + TX, (E)-6-methylhept-2-en-4-ol + TX, (E)-dec-5-en-1-yl acetate with (E)-dec-5-en-1-ol + TX, (E)-tridec-4-en-1-yl acetate + TX, (E,Z)-tetradeca-4,10-dien-1-yl acetate + TX, (
  • Israelensis + TX Bacillus thuringiensis subsp. Japonensis + TX, Bacillus thuringiensis subsp. Kurstaki + TX, Bacillus thuringiensis subsp. Tenebrionis + TX, Bacillus thuringiensis subspec.
  • lecontei NPV + TX nickel bis(dimethyldithiocarbamate) + TX, niclosamide + TX, niclosamide-olamine + TX, nicofluprole + TX, nitenpyram + TX, nithiazine + TX, nitrapyrin + TX, octadeca-2,13-dien-1-yl acetate + TX, octadeca-3,13-dien-1-yl acetate + TX, octhilinone + TX, omethoate + TX, orfralure + TX, Orius spp.
  • TX trifenmorph + TX, trifluenfuronate + TX, triflumezopyrim + TX, trimedlure + TX, trimedlure A + TX, trimedlure B1 + TX, trimedlure B2 + TX, trimedlure C + TX, trimethacarb + TX, triphenyltin acetate + TX, triphenyltin hydroxide + TX, trunc-call + TX, tyclopyrazoflor + TX, Typhlodromus occidentalis + TX, uredepa + TX, Verticillium lecanii + TX, Verticillium spp.
  • acridum + TX Metarhizium anisopliae var. anisopliae + TX, metarylpicoxamid + TX, metconazole + TX, metepa + TX, methacrifos + TX, methanesulfonyl fluoride + TX, methasulfocarb + TX, methiotepa + TX, methocrotophos + TX, methoprene + TX, methoquin-butyl + TX, methothrin + TX, methoxychlor + TX, methyl (Z)-2-(5- cyclohexyl-2-methyl-phenoxy)-3-methoxy-prop-2-enoate + TX, methyl (Z)-2-(5-cyclopentyl-2-methyl- phenoxy)-3-methoxy-prop-2-enoate (these compounds may be prepared from the methods described in WO2020/193387) + TX,
  • Bacillus subtilis strain AQ178 + TX Bacillus subtilis strain AQ153 + TX, Bacillus subtilis strain AQ743 + TX, Bacillus subtilis strain QST 713 (CEASE®, Serenade®, Rhapsody®) + TX, Bacillus subtilis strain QST 714 (JAZZ®) + TX, Bacillus subtilis strain QST3002 + TX, Bacillus subtilis strain QST3004 + TX, Bacillus subtilis var.
  • amyloliquefaciens strain FZB24 (Taegro®, Rhizopro®) + TX, Bacillus thuringiensis aizawai GC 91 (Agree®) + TX, Bacillus thuringiensis Cry 2Ae + TX, Bacillus thuringiensis Cry1Ab + TX, Bacillus thuringiensis israelensis (BMP123®, Aquabac®, VectoBac®) + TX, Bacillus thuringiensis kurstaki (Javelin®, Deliver®, CryMax®, Bonide®, Scutella WP®, Turilav WP ®, Astuto®, Dipel WP®, Biobit®, Foray®) + TX, Bacillus thuringiensis kurstaki BMP 123 (Baritone®) + TX, Bacillus thuringiensis kurstaki HD-1 (Bioprotec-CAF / 3P®) + TX
  • TX Botrytis cineria + TX, Bradyrhizobium japonicum (TerraMax®) + TX, Brevibacillus brevis + TX, Burkholderia cepacia (Deny®, Intercept®, Blue Circle®) + TX, Burkholderia gladii + TX, Burkholderia gladioli + TX, Burkholderia spp.
  • TX Canadian thistle fungus (CBH Canadian Bioherbicide®) + TX, Candida butyri + TX, Candida famata + TX, Candida fructus + TX, Candida glabrata + TX, Candida guilliermondii + TX, Candida melibiosica + TX, Candida oleophila strain O + TX, Candida parapsilosis + TX, Candida pelliculosa + TX, Candida pulcherrima + TX, Candida reuêtii + TX, Candida saitoana (Bio-Coat®, Biocure®) + TX, Candida sake + TX, Candida spp.
  • TX Cladosporium tenuissimum + TX, Clonostachys rosea (EndoFine®) + TX, Colletotrichum acutatum + TX, Coniothyrium minitans (Cotans WG®) + TX, Coniothyrium spp.
  • TX Filobasidium floriforme + TX, Fusarium acuminatum + TX, Fusarium chlamydosporum + TX, Fusarium oxysporum (Fusaclean®, Biofox C®) + TX, Fusarium proliferatum + TX, Fusarium spp. + TX, Galactomyces geotrichum + TX, Gliocladium catenulatum (Primastop®, Prestop®) + TX, Gliocladium roseum + TX, Gliocladium spp.
  • TX Lagenidium giganteum (Laginex®) + TX, Lecanicillium lecanii (formerly known as Verticillium lecanii (Mycotal®) conidia of strain KV01 (e.g. Vertalec® by Koppert/Arysta) + TX, Lecanicillium longisporum (Vertiblast®) + TX, Lecanicillium muscarium (Vertikil®) + TX, Lymantria Dispar nucleopolyhedrosis virus (Disparvirus®) + TX, Marinococcus halophilus + TX, Meira geulakonigii + TX, Metarhizium anisopliae (Destruxin WP®) + TX, Metarhizium anisopliae (Met52®) + TX, Metschnikowia fruticola (Shemer®) + TX, Metschnikowia pulcherrima + TX, Microdochium dimerum (Antibot®) + TX
  • NRRL 305408 + TX, Mycorrhizae spp. (AMykor®, Root Maximizer®) + TX, Myrothecium verrucaria strain AARC-0255 (DiTera®, BROS PLUS®) + TX, Ophiostoma piliferum strain D97 (Sylvanex®) + TX, Paecilomyces farinosus + TX, Paecilomyces lilacinus strain 251 (MeloCon WG®) + TX, Paecilomyces linacinus (Biostat WP®) + TX, Paenibacillus polymyxa + TX, Pantoea agglomerans (BlightBan C9-1®) + TX, Pantoea spp.
  • TX Pasteuria nishizawae in particular strain Pn1 (CLARIVA from Syngenta/ChemChina); + TX, Pasteuria spp. (Econem®) + TX, Penicillium aurantiogriseum + TX, Penicillium billai (Jumpstart®, TagTeam®) + TX, Penicillium brevicompactum + TX, Penicillium frequentans + TX, Penicillium griseofulvum + TX, Penicillium purpurogenum + TX, Penicillium spp.
  • TX Penicillium viridicatum + TX, Phlebiopsis gigantean (Rotstop®) + TX, phosphate solubilizing bacteria (Phosphomeal®) + TX, Phytophthora cryptogea + TX, Phytophthora palmivora (Devine®) + TX, Pichia anomala + TX, Pichia guilliermondii + TX, Pichia membranaefaciens + TX, Pichia onychis + TX, Pichia stipites + TX, Pseudomonas aeruginosa + TX, Pseudomonas aureofasciens (Spot-Less Biofungicide®) + TX, Pseudomonas cepacia + TX, Pseudomonas chlororaphis (AtEze®) + TX, Pseudomonas corrugate + TX, P
  • TX Pseudomonas syringae (Bio-Save®) + TX, Pseudomonas viridiflava + TX, Pseudozyma flocculosa strain PF-A22 UL (Sporodex L®) + TX, Puccinia canaliculata + TX, Puccinia thlaspeos (Wood Warrior®) + TX, Pythium paroecandrum + TX, Pythium oligandrum (Polygandron®, Polyversum®) + TX, Pythium periplocum + TX, Rhanella aquatilis + TX, Rhanella spp.
  • Rhizobia Distal®, Vault®
  • Rhizoctonia + TX Rhodococcus globerulus strain AQ719 + TX, Rhodosporidium diobovatum + TX, Rhodosporidium toruloides + TX, Rhodotorula glutinis + TX, Rhodotorula graminis + TX, Rhodotorula mucilagnosa + TX, Rhodotorula rubra + TX, Rhodotorula spp.
  • Trichoderma asperellum T34 Biocontrol®
  • TX Trichoderma atroviride
  • Trichoderma gamsii TX
  • Trichoderma hamatum TH 382 + TX Trichoderma harzianum rifai (Mycostar®) + TX
  • Trichoderma harzianum T-22 Trianum- P®, PlantShield HC®, RootShield®, Trianum-G® + TX, Trichoderma harzianum T-39 (Trichodex®) + TX, Trichoderma inhamatum + TX, Trichoderma koningii + TX, Trichoderma lignorum + TX, Trichoderma longibrachiatum + TX, Trichoderma polysporum (Binab T®) + TX, Trichoderma spp.
  • LC 52 (Sentinel®) + TX, Trichoderma taxi + TX, Trichoderma virens (formerly Gliocladium virens GL-21) (SoilGuard®) + TX, Trichoderma virens + TX, Trichoderma viride + TX, Trichoderma viride strain ICC 080 (Remedier®) + TX, Trichosporon pullulans + TX, Trichosporon spp. + TX, Trichothecium roseum + TX, Trichothecium spp.
  • TX maydis + TX, various bacteria and supplementary micronutrients (Natural II®) + TX, various fungi (Millennium Microbes®) + TX, Verticillium chlamydosporium + TX, Vip3Aa20 (VIPtera®) + TX, Virgibaclillus marismortui + TX, Xanthomonas campestris pv.
  • TX Bombus terrestris (Beeline®, Tripol®) + TX, Bombus terrestris (Natupol Beehive®) + TX, Cephalonomia stephanoderis + TX, Chilocorus nigritus + TX, Chrysoperla carnea (Chrysoline®, Chrysopa®) + TX, Chrysoperla rufilabris + TX, Cirrospilus ingenuus + TX, Cirrospilus quadristriatus + TX, Citrostichus phyllocnistoides + TX, Closterocerus chamaeleon + TX, Closterocerus spp.
  • TX Coccidoxenoides perminutus (Planopar®) + TX, Coccophagus cowperi + TX, Coccophagus lycimnia + TX, Cotesia flavipes + TX, Cotesia plutellae + TX, Cryptolaemus montrouzieri (Cryptobug®, Cryptoline®) + TX, Cybocephalus nipponicus + TX, Dacnusa sibirica (Minusa®, DacDigline®, Minex®) + TX, Delphastus catalinae (Delphastus®) + TX, Delphastus pusillus + TX, Diachasmimorpha krausii + TX, Diachasmimorpha longicaudata + TX, Diaparsis jucunda + TX, Diaphorencyrtus aligarhensis + TX, Diglyphus isaea (Diminex®, Miglyphus,
  • TX Steinernematid spp. (Guardian Nematodes®) + TX, Stethorus punctillum (Stethorus®) + TX, Tamarixia radiate + TX, Tetrastichus setifer + TX, Thripobius semiluteus + TX, Torymus sinensis + TX, Trichogramma brassicae (Tricholine b®) + TX, Trichogramma brassicae (Tricho-Strip®) + TX, Trichogramma evanescens + TX, Trichogramma minutum + TX, Trichogramma ostriniae + TX, Trichogramma platneri + TX, Trichogramma pretiosum + TX, Xanthopimpla stemmator + TX; abscisic acid + TX, Aminomite® + TX, BioGain® + TX, bioSea® + TX, CAS Number: 2643947-26-4 + TX, Chondroster
  • NCAIM (P) B001389) (WO 2013/034938) from Certis USA LLC + TX
  • Bacillus pumilus in particular strain BU F-33, having NRRL Accession No. 50185 (CARTISSA® from BASF, EPA Reg. No.71840-19) + TX
  • Bacillus subtilis CX-9060 from Certis USA LLC
  • Bacillus sp. in particular strain D747 (available as DOUBLE NICKEL® from Kumiai Chemical Industry Co., Ltd.), having Accession No. FERM BP-8234, U.S.
  • Patent No.7,094,592 + TX Bacillus subtilis strain BU1814, (VELONDIS® PLUS, VELONDIS® FLEX and VELONDIS® EXTRA from BASF SE) + TX, Bacillus subtilis var. amyloliquefaciens strain FZB24 having Accession No. DSM 10271 (available from Novozymes as TAEGRO® or TAEGRO® ECO (EPA Registration No.70127-5)) + TX, Bacillus subtilis, in particular strain QST713/AQ713 (having NRRL Accession No. B-21661 and described in U.S.
  • Patent No.6,060,051 available as SERENADE® OPTI or SERENADE® ASO from Bayer CropScience LP, US
  • TX Paenibacillus polymyxa
  • strain AC-1 e.g. TOPSEED® from Green Biotech Company Ltd.
  • TX Paenibacillus sp. strain having Accession No. NRRL B-50972 or Accession No. NRRL B-67129, WO 2016/154297 + TX, Pantoea agglomerans, in particular strain E325 (Accession No.
  • NRRL B-21856 (available as BLOOMTIME BIOLOGICALTM FD BIOPESTICIDE from Northwest Agri Products) + TX, Pseudomonas proradix (e.g. PRORADIX® from Sourcon Padena) + TX; Aureobasidium pullulans, in particular blastospores of strain DSM14940, blastospores of strain DSM 14941 or mixtures of blastospores of strains DSM14940 and DSM14941 (e.g., BOTECTOR® and BLOSSOM PROTECT® from bio-ferm, CH) + TX, Pseudozyma aphidis (as disclosed in WO2011/151819 by Yissum Research Development Company of the Hebrew University of Jerusalem) + TX, Saccharomyces cerevisiae, in particular strains CNCM No.1-3936, CNCM No.1-3937, CNCM No.1-3938 or CNCM No.1-3939 (WO 2010/086790) from
  • DSM 23117 (available as RHIZOVITAL® from ABiTEP, DE) + TX
  • Bacillus amyloliquefaciens in particular strain D747 (available as Double NickelTM from Kumiai Chemical Industry Co., Ltd., having accession number FERM BP-8234, US Patent No.7,094,592) + TX
  • Bacillus licheniformis FMCH001 and Bacillus subtilis FMCH002 (QUARTZO® (WG) and PRESENCE® (WP) from FMC Corporation) + TX
  • Bacillus licheniformis in particular strain SB3086, having Accession No.
  • ATCC 55406, WO 2003/000051 (available as ECOGUARD® Biofungicide and GREEN RELEAFTM from Novozymes) + TX, Bacillus methylotrophicus strain BAC-9912 (from Chinese Academy of Sciences’ Institute of Applied Ecology) + TX, Bacillus mycoides, isolate, having Accession No. B-30890 (available as BMJ TGAI® or WG and LifeGardTM from Certis USA LLC) + TX, Bacillus pumilus, in particular strain GB34 (available as Yield Shield® from Bayer AG, DE) + TX, Bacillus pumilus, in particular strain QST2808 (available as SONATA® from Bayer CropScience LP, US, having Accession No.
  • Patent No.5,061,495 + TX Bacillus subtilis strain Y1336 (available as BIOBAC® WP from Bion- Tech, Taiwan, registered as a biological fungicide in Taiwan under Registration Nos.4764, 5454, 5096 and 5277) + TX, Bacillus subtilis var. amyloliquefaciens strain FZB24 having Accession No. DSM 10271 (available from Novozymes as TAEGRO® or TAEGRO® ECO (EPA Registration No.70127-5)) + TX, Bacillus subtilis Y1336 (available as BIOBAC® WP from Bion-Tech, Taiwan, registered as a biological fungicide in Taiwan under Registration Nos.
  • NRRL B-50897, WO 2017/019448 e.g., HOWLERTM and ZIO® from AgBiome Innovations, US
  • TX Pseudomonas chlororaphis
  • strain MA342 e.g. CEDOMON®, CERALL®, and CEDRESS® by Bioagri and Koppert
  • TX Pseudomonas fluorescens strain A506 (e.g. BLIGHTBAN® A506 by NuFarm) + TX
  • Pseudomonas proradix e.g.
  • PRORADIX® from Sourcon Padena + TX
  • Streptomyces griseoviridis strain K61 also known as Streptomyces galbus strain K61
  • DSM 7206 Streptomyces galbus strain K61
  • MYCOSTOP® from Verdera, PREFENCE® from BioWorks, cf.
  • BIOKUPRUMTM by AgriLife + TX
  • Chaetomium globosum available as RIVADIOM® by Rivale
  • TX Cladosporium cladosporioides
  • strain H39 having Accession No. CBS122244, US 2010/0291039 (by Stichting Moowgrass Onderzoek) + TX
  • Coniothyrium minitans in particular strain CON/M/91-8 (Accession No. DSM9660, e.g.
  • strain ICC 080 having Accession No. IMI 392151 (e.g., BIO-TAMTM from Isagro USA, Inc. or BIODERMA® by Agrobiosol de Mexico, S.A. de C.V.) + TX, Penicillium vermiculatum + TX, Phlebiopsis gigantea strain VRA 1992 (ROTSTOP® C from danstar Ferment) + TX, Pseudozyma flocculosa, strain PF-A22 UL (available as SPORODEX® L by Plant Products Co., CA) + TX, Saccharomyces cerevisiae strain LAS117 cell walls (CEREVISANE® from Lesaffre, ROMEO® from BASF SE) + TX, Saccharomyces cerevisiae strains CNCM No.1-3936, CNCM No.1-3937, CNCM No.1-3938, CNCM No.1-3939 (WO 2010/086790) from Lesaffre et Compag
  • T- Gro from Andermatt Biocontrol + TX
  • Trichoderma atroviride strain 77B T77 from Andermatt Biocontrol
  • Trichoderma atroviride strain ATCC 20476 IMI 206040
  • Trichoderma atroviride strain LC52 e.g. Tenet by Agrimm Technologies Limited
  • Trichoderma atroviride strain LU132 e.g. Sentinel from Agrimm Technologies Limited
  • TX Trichoderma atroviride strain NMI no. V08/002388 + TX
  • Trichoderma atroviride strain NMI no. V08/002389 + TX Trichoderma atroviride strain NMI no.
  • Patent No.8,431,120 (from Bi-PA)) + TX, Trichoderma atroviride,strain CNCM 1-1237 (e.g. Esquive® WP from Agrauxine, FR) + TX, Trichoderma fertile (e.g. product TrichoPlus from BASF) + TX, Trichoderma gamsii (formerly T. viride) + TX, Trichoderma gamsii (formerly T. viride) strain ICC 080 (IMI CC 392151 CABI) (available as BIODERMA® by AGROBIOSOL DE MEXICO, S.A.
  • Trichoderma gamsii strain ICC080 IMI CC 392151 CABI, e.g. BioDerma by AGROBIOSOL DE MEXICO, S.A. DE C.V.
  • + TX Trichoderma harmatum + TX
  • Trichoderma harmatum having Accession No. ATCC 28012 + TX, Trichoderma harzianum + TX, Trichoderma harzianum rifai T39 (e.g.
  • Trichodex® from Makhteshim, US + TX, Trichoderma harzianum strain Cepa SimbT5 (from Simbiose Agro), + TX, Trichoderma harzianum strain DB 103 (available as T-GRO® 7456 by Dagutat Biolab) + TX, Trichoderma harzianum strain ITEM 908 (e.g. Trianum-P from Koppert) + TX, Trichoderma harzianum strain T-22 (e.g. Trianum-P from Andermatt Biocontrol or Koppert) + TX, Trichoderma harzianum strain TH35 (e.g.
  • Trichoderma polysporum strain IMI 206039 e.g. Binab TF WP by BINAB Bio- Innovation AB, Sweden
  • TX Trichoderma stromaticum having Accession No. Ts3550 (e.g. Tricovab by CEPLAC, Brazil) + TX
  • Trichoderma virens also known as Gliocladium virens
  • strain GL-21 e.g. SoilGard by Certis, US
  • Trichoderma virens strain G-41 formerly known as Gliocladium virens (Accession No.
  • ATCC 20906 (e.g., ROOTSHIELD® PLUS WP and TURFSHIELD® PLUS WP from BioWorks, US) + TX, Trichoderma viride in particular strain B35 (Pietr et al., 1993, Zesz. Nauk. A R w Szczecinie 161: 125-137) + TX, Trichoderma viride strain TV1(e.g. Trianum-P by Koppert) + TX, Ulocladium oudemansii strain U3, having Accession No.
  • NM 99/06216 e.g., BOTRY-ZEN® by Botry-Zen Ltd, New Zealand and BOTRYSTOP® from BioWorks, Inc.
  • TX Verticillium albo-atrum (formerly V. dahliae) strain WCS850 having Accession No.
  • WCS850 deposited at the Central Bureau for Fungi Cultures (e.g., DUTCH TRIG® by Tree Care Innovations) + TX, Verticillium chlamydosporium + TX; a mixture of Azotobacter vinelandii and Clostridium pasteurianum (available as INVIGORATE® from Agrinos) + TX, a mixture of Bacillus licheniformis FMCH001 and Bacillus subtilis FMCH002 (available as QUARTZO® (WG), PRESENCE® (WP) from FMC Corporation) + TX, Azorhizobium caulinodans, in particular strain ZB-SK-5 + TX, Azospirillum brasilense (e.g., VIGOR® from KALO, Inc.) + TX, Azospirillum lipoferum (e.g., VERTEX-IFTM from TerraMax, Inc.) + TX, Azotobacter chroococcum, in particular strain H
  • NRRL B-5015 + TX
  • Bacillus amyloliquefaciens in particular strain FZB42 e.g. RHIZOVITAL® from ABiTEP, DE
  • Bacillus amyloliquefaciens in particular strain IN937a + TX Bacillus amyloliquefaciens pm414 (LOLI-PEPTA® from Biofilm Crop Protection) + TX
  • Bacillus amyloliquefaciens SB3281 ATCC # PTA-7542, WO 2017/205258
  • Bacillus amyloliquefaciens TJ1000 available as QUIKROOTS® from Novozymes
  • Bacillus cereus family member EE128 NRRL No.
  • YIELD SHIELD® from Bayer Crop Science, DE
  • + TX Bacillus pumilus in particular strain QST2808 (Accession No. NRRL No. B-30087) + TX, Bacillus siamensis in particular strain KCTC 13613T + TX, Bacillus subtilis in particular strain AQ30002 (Accession No. NRRL No. B-50421 and described in U.S. Patent Application No.13/330,576) + TX, Bacillus subtilis in particular strain AQ30004 (NRRL No. B-50455 and described in U.S. Patent Application No. 13/330,576) + TX, Bacillus subtilis in particular strain MBI 600 (e.g.
  • BIOBOOST® from Brett Young Seeds + TX, Lactobacillus sp. (e.g. LACTOPLANT® from LactoPAFI) + TX, Mesorhizobium cicer (e.g., NODULATOR from BASF SE) + TX, Paenibacillus polymyxa in particular strain AC-1 (e.g. TOPSEED® from Green Biotech Company Ltd.) + TX, Pseudomonas aeruginosa in particular strain PN1 + TX, Pseudomonas proradix (e.g.
  • PRORADIX® from Sourcon Padena + TX, Rhizobium leguminosarium biovar viciae (e.g., NODULATOR from BASF SE) + TX, Rhizobium leguminosarum in particular bv. viceae strain Z25 (Accession No. CECT 4585) + TX, Serratia marcescens in particular strain SRM (Accession No. MTCC 8708), + TX, Sinorhizobium meliloti strain NRG-185-1 (NITRAGIN® GOLD from Bayer CropScience) + TX, Thiobacillus sp. (e.g.
  • Trichoderma atroviride strain SC1 (described in WO2009/116106) + TX, Trichoderma harzianum strain 1295-22 + TX, Trichoderma harzianum strain ITEM 908 + TX, Trichoderma harzianum strain T-22 (e.g. Trianum-P from Andermatt Biocontrol or Koppert) + TX, Trichoderma harzianum strain TSTh20, + TX, Trichoderma virens strain GI-3 + TX, Trichoderma virens strain GL-21 (e.g.
  • aizawai in particular serotype H-7 (e.g. FLORBAC® WG from Valent BioSciences, US) + TX, Bacillus thuringiensis subsp. aizawai, in particular strain ABTS-1857 (SD-1372, e.g. XENTARI® from Valent BioSciences) + TX, Bacillus thuringiensis subsp. israelensis (serotype H-14) strain AM65-52 (Accession No. ATCC 1276) (e.g. VECTOBAC® by Valent BioSciences, US) + TX, Bacillus thuringiensis subsp.
  • serotype H-7 e.g. FLORBAC® WG from Valent BioSciences, US
  • TX Bacillus thuringiensis subsp. aizawai, in particular strain ABTS-1857 (SD-1372, e.g. XENTARI® from Valent BioSciences) + TX
  • israeltaki strain ABTS 351 + TX Bacillus thuringiensis subsp. kurstaki strain BMP 123 (from Becker Microbial Products, IL, BARITONE from Bayer CropScience) + TX, Bacillus thuringiensis subsp. kurstaki strain EG 2348 (LEPINOX from Certis, US) + TX, Bacillus thuringiensis subsp. kurstaki strain EG 7841 (CRYMAX from Certis, US) + TX, Bacillus thuringiensis subsp. kurstaki strain HD-1 (e.g. DIPEL® ES from Valent BioSciences, US) + TX, Bacillus thuringiensis subsp.
  • BMP 123 from Becker Microbial Products, IL, BARITONE from Bayer CropScience
  • TX Bacillus thuringiensis subsp. kurstaki strain EG 2348 (LEPINOX from Certis, US) + TX
  • israeltaki strain PB 54 + TX Bacillus thuringiensis subsp. kurstaki strain SA 11 (JAVELIN from Certis, US) + TX, Bacillus thuringiensis subsp. kurstaki strain SA 12 (THURICIDE from Certis, US) + TX, Bacillus thuringiensis subsp. tenebrionis strain NB 176 (SD-5428, e.g. NOVODOR® FC from BioFa DE) + TX, Bacillus thuringiensis var. Colmeri (e.g. TIANBAOBTC by Changzhou Jianghai Chemical Factory) + TX, Bacillus thuringiensis var.
  • SD-5428 e.g. NOVODOR® FC from BioFa DE
  • Bacillus thuringiensis var. Colmeri e.g. TIANBAOBTC by Changzhou Jianghai Chemical Factory
  • MBI206 TGAI and ZELTO® from Marrone Bio Innovations + TX
  • Chromobacterium subtsugae in particular strain PRAA4-1T e.g. MBI-203, e.g. GRANDEVO® from Marrone Bio Innovations
  • TX Chromobacterium subtsugae in particular strain PRAA4-1T
  • MBI-203 e.g. GRANDEVO® from Marrone Bio Innovations
  • TX Lecanicillium muscarium Ve6 (MYCOTAL from Koppert) + TX
  • Paenibacillus popilliae (formerly Bacillus popilliae, e.g. MILKY SPORE POWDERTM or MILKY SPORE GRANULARTM from St. Gabriel Laboratories) + TX
  • Serratia entomophila e.g.
  • ATCC74250 e.g. BOTANIGUARD® ES and MYCONTROL-O® from Laverlam International Corporation
  • TX Metarhizium anisopliae 3213-1 (deposited under NRRL accession number 67074 disclosed in WO 2017/066094, Pioneer Hi-Bred International) + TX, Metarhizium robertsii 15013-1 (deposited under NRRL accession number 67073) + TX, Metarhizium robertsii 23013-3 (deposited under NRRL accession number 67075) + TX, Paecilomyces lilacinus strain 251 (MELOCON from Certis, US) + TX; Cydia pomonella (codling moth) granulosis virus (GV) + TX, Helicoverpa armigera (cotton bollworm) nuclear polyhedrosis virus (NPV) + TX, of Adoxophyes orana (summer fruit tortrix) granul
  • Burkholderia cepacia (formerly known as Pseudomonas cepacia) + TX, Gigaspora spp. + TX, Glomus spp. + TX, Laccaria spp. + TX, LactoBacillus buchneri + TX, Paraglomus spp. + TX, Pisolithus tinctorus + TX, Pseudomonas spp. + TX, Rhizobium spp. in particular Rhizobium trifolii + TX, Rhizopogon spp. + TX, Scleroderma spp. + TX, Streptomyces spp. + TX, Suillus spp.
  • compositions of the invention may also be applied with one or more systemically acquired resistance inducers (“SAR” inducer).
  • SAR inducers are known and described in, for example, United States Patent No. US 6,919,298 and include, for example, salicylates and the commercial SAR inducer acibenzolar-S-methyl.
  • the compounds of formula (I) as defined in the present invention are normally used in the form of compositions and can be applied to the crop area or plant to be treated, simultaneously or in succession with further compounds. These further compounds can be e.g. fertilizers or micronutrient donors or other preparations, which influence the growth of plants.
  • the compounds of formula (I) as defined in the present invention may be used in the form of (fungicidal) compositions for controlling or protecting against phytopathogenic microorganisms, comprising as active ingredient at least one compound of formula (I) as defined in the present invention or of at least one preferred individual compound as above-defined, in free form or in agrochemically usable salt form, and at least one of the above-mentioned adjuvants.
  • the invention therefore provides a composition, preferably a fungicidal composition, comprising at least one compound of formula (I) as defined in the present invention, an agriculturally acceptable carrier and optionally an adjuvant.
  • An agricultural acceptable carrier is for example a carrier that is suitable for agricultural use.
  • Agricultural carriers are well known in the art.
  • said composition may comprise at least one or more pesticidally active compounds, for example an additional fungicidal active ingredient in addition to the compound of formula (I) as defined in the present invention.
  • a further aspect of invention is related to a method of controlling or preventing an infestation of plants, e.g. useful plants such as crop plants, propagation material thereof, e.g. seeds, harvested crops, e.g.
  • Controlling or preventing means reducing infestation by insects or by phytopathogenic or spoilage microorganisms or organisms potentially harmful to man, especially fungal organisms, to such a level that an improvement is demonstrated.
  • a preferred method of controlling or preventing an infestation of crop plants by phytopathogenic microorganisms, especially fungal organisms, which comprises the application of a compound of formula (I) as defined in the present invention, or an agrochemical composition which contains at least one of said compounds, is foliar application.
  • the frequency of application and the rate of application will depend on the risk of infestation by the corresponding pathogen or insect.
  • the compounds of formula (I) as defined in the present invention can also penetrate the plant through the roots via the soil (systemic action) by drenching the locus of the plant with a liquid formulation, or by applying the compounds in solid form to the soil, e.g. in granular form (soil application). In crops of water rice such granulates can be applied to the flooded rice field.
  • the compounds of formula (I) as defined in any the present invention may also be applied to seeds (coating) by impregnating the seeds or tubers either with a liquid formulation of the fungicide or coating them with a solid formulation.
  • a formulation e.g. a composition containing the compound of formula (I) as defined in the present invention, and, if desired, a solid or liquid adjuvant or monomers for encapsulating the compound of formula (I) as defined in the present invention, may be prepared in a known manner, typically by intimately mixing and/or grinding the compound with extenders, for example solvents, solid carriers and, optionally, surface active compounds (surfactants).
  • compositions that is the methods of controlling pathogens of the abovementioned type, such as spraying, atomizing, dusting, brushing on, dressing, scattering or pouring - which are to be selected to suit the intended aims of the prevailing circumstances - and the use of the compositions for controlling pathogens of the abovementioned type are other subjects of the invention.
  • Typical rates of concentration are between 0.1 and 1000 ppm, preferably between 0.1 and 500 ppm, of active ingredient.
  • the rate of application per hectare is preferably 1g to 2000 g of active ingredient per hectare, more preferably 10 to 1000 g/ha, most preferably 10 to 600 g/ha.
  • a composition comprising a compound of formula (I) as defined in the present invention according to the present invention is applied either preventative, meaning prior to disease development or curative, meaning after disease development.
  • compositions of the invention may be employed in any conventional form, for example in the form of a twin pack, a powder for dry seed treatment (DS), an emulsion for seed treatment (ES), a flowable concentrate for seed treatment (FS), a solution for seed treatment (LS), a water dispersible powder for seed treatment (WS), a capsule suspension for seed treatment (CF), a gel for seed treatment (GF), an emulsion concentrate (EC), a suspension concentrate (SC), a suspo-emulsion (SE), a capsule suspension (CS), a water dispersible granule (WG), an emulsifiable granule (EG), an emulsion, water in oil (EO), an emulsion, oil in water (EW), a micro-emulsion (ME), an oil dispersion (OD), an oil miscible flowable (OF), an oil miscible liquid (OL), a soluble concentrate (SL), an ultra-low volume suspension (SU), an ultra-low volume liquid (UL), a technical concentrate (TK
  • compositions may be produced in conventional manner, e.g. by mixing the active ingredients with appropriate formulation inerts (diluents, solvents, fillers and optionally other formulating ingredients such as surfactants, biocides, anti-freeze, stickers, thickeners and compounds that provide adjuvancy effects).
  • appropriate formulation inerts diiluents, solvents, fillers and optionally other formulating ingredients such as surfactants, biocides, anti-freeze, stickers, thickeners and compounds that provide adjuvancy effects.
  • conventional slow release formulations may be employed where long lasting efficacy is intended.
  • Particularly formulations to be applied in spraying forms such as water dispersible concentrates (e.g. EC, SC, DC, OD, SE, EW, EO and the like), wettable powders and granules, may contain surfactants such as wetting and dispersing agents and other compounds that provide adjuvancy effects, e.g.
  • a seed dressing formulation is applied in a manner known per se to the seeds employing the combination of the invention and a diluent in suitable seed dressing formulation form, e.g. as an aqueous suspension or in a dry powder form having good adherence to the seeds.
  • suitable seed dressing formulation form e.g. as an aqueous suspension or in a dry powder form having good adherence to the seeds.
  • seed dressing formulations are known in the art.
  • Seed dressing formulations may contain the single active ingredients or the combination of active ingredients in encapsulated form, e.g.
  • the formulations include from 0.01 to 90% by weight of active agent, from 0 to 20% agriculturally acceptable surfactant and 10 to 99.99% solid or liquid formulation inerts and adjuvant(s), the active agent consisting of at least the compound of formula (I) as defined in the present invention together with component (B) and (C), and optionally other active agents, particularly microbiocides or conservatives or the like.
  • Concentrated forms of compositions generally contain in between about 2 and 80%, preferably between about 5 and 70% by weight of active agent.
  • Application forms of formulation may for example contain from 0.01 to 20% by weight, preferably from 0.01 to 5% by weight of active agent.
  • Wettable powders a) b) c) active ingredient [compound of formula (I)] 25 % 50 % 75 % sodium lignosulfonate 5 % 5 % - sodium lauryl sulfate 3 % - 5 % sodium diisobutylnaphthalenesulfonate - 6 % 10 % phenol polyethylene glycol ether - 2 % - (7-8 mol of ethylene oxide) highly dispersed silicic acid 5 % 10 % 10 % Kaolin 62 % 27 % -
  • the active ingredient is thoroughly mixed with the adjuvants and the mixture is thoroughly ground in a suitable mill, affording wettable powders that can be diluted with water to give suspensions of the desired concentration.
  • Powders for dry seed treatment a) b) c) active ingredient [compound of formula (I)] 25 % 50 % 75 % light mineral oil 5 % 5 % 5 % highly dispersed silicic acid 5 % 5 % - Kaolin 65 % 40 % - Talcum - 20%
  • active ingredient is thoroughly mixed with the adjuvants and the mixture is thoroughly ground in a suitable mill, affording powders that can be used directly for seed treatment.
  • Emulsifiable concentrate active ingredient [compound of formula (I)] 10 % octylphenol polyethylene glycol ether 3 % (4-5 mol of ethylene oxide) calcium dodecylbenzenesulfonate 3 % castor oil polyglycol ether (35 mol of ethylene oxide) 4 % Cyclohexanone 30 % xylene mixture 50 % Emulsions of any required dilution, which can be used in plant protection, can be obtained from this concentrate by dilution with water.
  • Coated granules Active ingredient [compound of formula (I)] 8 % polyethylene glycol (mol. wt.200) 3 % Kaolin 89 % The finely ground active ingredient is uniformly applied, in a mixer, to the kaolin moistened with polyethylene glycol. Non-dusty coated granules are obtained in this manner.
  • Suspension concentrate active ingredient [compound of formula (I)] 40 % propylene glycol 10 % nonylphenol polyethylene glycol ether (15 mol of ethylene oxide) 6 % Sodium lignosulfonate 10 % carboxymethylcellulose 1 % silicone oil (in the form of a 75 % emulsion in water) 1 % Water 32 %
  • the finely ground active ingredient is intimately mixed with the adjuvants, giving a suspension concentrate from which suspensions of any desired dilution can be obtained by dilution with water. Using such dilutions, living plants as well as plant propagation material can be treated and protected against infestation by microorganisms, by spraying, pouring or immersion.
  • Flowable concentrate for seed treatment active ingredient [compound of formula (I)] 40 % propylene glycol 5 % copolymer butanol PO/EO 2 % tristyrenephenole with 10-20 moles EO 2 % 1,2-benzisothiazolin-3-one (in the form of a 20% solution in water) 0.5 % monoazo-pigment calcium salt 5 % Silicone oil (in the form of a 75 % emulsion in water) 0.2 % Water 45.3 % The finely ground active ingredient is intimately mixed with the adjuvants, giving a suspension concentrate from which suspensions of any desired dilution can be obtained by dilution with water.
  • LC/MS means Liquid Chromatography Mass Spectrometry and the description of the apparatus and the method is as follows: Method A: Spectra were recorded on a Mass Spectrometer from Waters (Acquity QDa Mass Spectrometer) equipped with an electrospray source (Polarity: Positive and Negative Polarity Switch), Capillary: 0.8 kV, Cone range: 25 V, Extractor: V (No extractor voltage for QDa detector) Source Temperature: 120°C, Desolvation Temperature: 600°C, Cone Gas Flow: 50 L/h, Desolvation Gas Flow: 1000 L/h, Mass range: 110 to 850 Da) and an Acquity UPLC from Waters: Quaternary solvent manager, heated column compartment , diode-array detector.
  • Method A Spectra were recorded on a Mass Spectrometer from Waters (Acquity QDa Mass Spectrometer) equipped with an electrospray source (Polarity: Positive and Negative Polar
  • Method B Spectra were recorded on a Mass Spectrometer from Waters Corporation (SQD, SQDII or QDA Single quadrupole mass spectrometer) equipped with an electrospray source (Polarity: positive and negative ions), Capillary: 0.8-3.00 kV, Cone: 5-30 V, Source Temperature: 120-150°C, Desolvation Temperature: 350-600°C, Cone Gas Flow: 50-150 l/h, Desolvation Gas Flow: 650-1000 l/h, Mass range: 110 to 950 Da and an Acquity UPLC from Waters Corporation: Binary pump, heated column compartment , diode- array detector and ELSD.
  • Method C Spectra were recorded on a Mass Spectrometer from Agilent (Single quad mass spectrometer) equipped with a Multimode- Electron Spray and APCI (Polarity: positive and negative ions), Capillary: 4.00 kV, Corona Current 4.0 ⁇ A, Charging Voltage, 2.00 kV, Nitrogen Gas Flow: 12.0 L/min, Nebulizer Pressure: 40 psig, Mass range: 100 to 1000 m/z), dry gas temperature 250 °C, Vaporizer temperature 200 °C and an UPLC from Waters: quaternary pump, heated column compartment, Variable wave length detector.
  • Agilent Single quad mass spectrometer
  • APCI Multimode- Electron Spray and APCI
  • reaction mixture was stirred at refluxed for 3 hours.
  • the reaction mixture was diluted with water and extracted with ethyl acetate.
  • the combined organic layers were washed with brine, dried over sodium sulfate, filtered, and concentrated under reduced pressure to afford 6-chloro-8-methyl-imidazo[1,2-b]pyridazine.
  • Step B Preparation of N-(4-fluoro-3-methyl-phenyl)-N,8-dimethyl-imidazo[1,2-b]pyridazine-6- carboxamide A mixture of 6-chloro-8-methyl-imidazo[1,2-b]pyridazine (Compound X-1, 0.700 g, 4,17 mmol, 1.00 equiv.), 4-fluoro-N,3-dimethyl-aniline (0.58 g, 4.2 mmol, 1.0 equiv.), triethylamine (0.88 mL, 16 mmol,
  • the vial was pressurized with nitrogen and then with CO gas.
  • the reaction mixture was stirred at 110 °C for 12 hours.
  • the reaction mixture was filtered through celite and concentrated under reduce pressure.
  • the crude residue was purified over a silica gel cartridge (cyclohexane/ethyl acetate) to afford N-(4-fluoro-3-methyl-phenyl)-N,8-dimethyl-imidazo[1,2- b]pyridazine-6-carboxamide.
  • Step C Preparation of 3-bromo-N-(4-fluoro-3-methyl-phenyl)-N,8-dimethyl-imidazo[1,2-b]pyridazine-6- carboxamide
  • N-(4-fluoro-3-methyl-phenyl)-N,8-dimethyl-imidazo[1,2-b]pyridazine-6-carboxamide (0.400 g, 1.34 mmol, 1.00 equiv.) and N-bromosuccinimide (0.268 g, 1.47 mmol, 1.10 equiv.) in acetonitrile (5.36 mL) was stirred at room temperature for 16 hours.
  • the reaction mixture was degassed with argon and then stirred in the microwave at 80 °C for 2 hours. After cooling down to room temperature, the reaction mixture was filtered through a Celite pad and washed with methanol. The filtrate was concentrated under reduced pressure. The crude residue was purified over a silica gel cartridge (cyclohexane/ethyl acetate) to afford methyl N-[5-[6-[(4-fluoro-3-methyl-phenyl)- methyl-carbamoyl]-8-methyl-imidazo[1,2-b]pyridazin-3-yl]-2-pyridyl]carbamate.
  • Example 2 Preparation of methyl N-[5-[6-(6-fluoro-3,4-dihydro-2H-quinoline-1-carbonyl)-8- methyl-imidazo[1,2-b]pyridazin-3-yl]-2-pyridyl]carbamate (Compound 2) (Compound 2) Step A: Preparation of (6-fluoro-3,4-dihydro-2H-quinolin-1-yl)-(8-methylimidazo[1,2-b]pyridazin-6- yl)methanone A mixture of 6-chloro-8-methyl-imidazo[1,2-b]pyridazine (Compound X-1) (0.500 g, 2.98 mmol, 1.00 equiv.), 6-fluoro-1,2,3,4-tetrahydroquinoline (0.47 g, 3.1 mmol, 1.1 equiv.) triethylamine (0.624 mL, 4.47 mmol, 1.50 equi
  • the vial was pressurized with nitrogen and then with CO gas.
  • the reaction mixture was stirred at 110 °C for 6 hours.
  • the reaction mixture was filtered through celite and concentrated under reduce pressure.
  • the crude residue was purified over a silica gel cartridge (cyclohexane/ethyl acetate) to afford (6-fluoro-3,4-dihydro-2H-quinolin-1-yl)-(8- methylimidazo[1,2-b]pyridazin-6-yl)methanone.
  • Step B Preparation of (3-bromo-8-methyl-imidazo[1,2-b]pyridazin-6-yl)-(6-fluoro-3,4-dihydro-2H- quinolin-1-yl)methanone
  • a solution of (6-fluoro-3,4-dihydro-2H-quinolin-1-yl)-(8-methylimidazo[1,2-b]pyridazin-6-yl)methanone (0.450 g, 1.23 mmol) and N-bromosuccinimide (0.246 g, 1.36 mmol, 1.10 equiv.) in acetonitrile (4.93 mL) was stirred at room temperature for 1 hour.
  • reaction mixture was degassed with argon and then stirred in the microwave at 80 °C for 2.5 hours. After cooling down to room temperature, the reaction mixture was filtered through a Celite pad and concentrated under reduced pressure. The crude residue was purified over a silica gel cartridge (cyclohexane/ethyl acetate) to afford methyl N-[5-[6-(6-fluoro-3,4-dihydro-2H-quinoline-1-carbonyl)-8-methyl-imidazo[1,2- b]pyridazin-3-yl]-2-pyridyl]carbamate as a yellow solid.
  • the vial was pressurized with nitrogen and then with CO gas.
  • the reaction mixture was stirred at 110 °C for 6 hours.
  • the reaction mixture was filtered through celite and concentrated under reduce pressure.
  • the crude residue was purified over a silica gel cartridge (cyclohexane/ethyl acetate) to afford N-(4-fluoro-3-methoxy-phenyl)-N,8-dimethyl-imidazo[1,2- b]pyridazine-6-carboxamide.
  • Step B Preparation of 3-bromo-N-(4-fluoro-3-methoxy-phenyl)-N,8-dimethyl-imidazo[1,2-b]pyridazine- 6-carboxamide
  • a solution of N-(4-fluoro-3-methoxy-phenyl)-N,8-dimethyl-imidazo[1,2-b]pyridazine-6-carboxamide (0.662 g, 2.11 mmol, 1.00 equiv.) and N-bromosuccinimide (0.412 g, 2.32 mmol, 1.10 equiv.) in acetonitrile (8.42 mL) was stirred at room temperature for 1 hour.
  • reaction mixture was degassed with argon and then stirred in the microwave at 80 °C for 2.5 hours. After cooling down to room temperature, the reaction mixture was filtered through a Celite pad and washed with methanol. The filtrate was washed with water, then brine, dried over sodium sulfate, filtered, and concentrated under reduced pressure.
  • Example 4 Preparation of methyl N-[5-[6-[(4-fluoro-3-methyl-phenyl)-methyl- carbamoyl]imidazo[1,2-b]pyridazin-3-yl]-2-pyridyl]carbamate (Compound 7) (Compound 7) To a mixture of 3-bromo-N-(4-fluoro-3-methyl-phenyl)-N-methyl-imidazo[1,2-b]pyridazine-6- carboxamide (0.400 g, 1.10 mmol, 1.00 equiv.), 2-methoxycarbonylaminopyridine-5-boronic acid pinacol ester (0.419 g, 1.43 mmol, 1.30 equiv.) and sodium carbonate (0.350 g, 3.30 mmol, 3.00 equiv.) in acetonitrile (8.81 mL) was added chloro(2-dicyclohexylphosphino-2',4',6'-
  • the reaction mixture was degassed with argon and then stirred in the microwave at 100 °C for 2 hours. After cooling down to room temperature, the reaction mixture was filtered through a Celite pad and washed with methanol. The filtrate was concentrated under reduced pressure. The crude residue was purified over a silica gel cartridge (ethyl acetate/ methanol) to afford methyl N-[5-[6-[(4-fluoro-3-methyl-phenyl)-methyl- carbamoyl]imidazo[1,2-b]pyridazin-3-yl]-2-pyridyl]carbamate as a yellow solid.
  • Step B Preparation of 3-bromoimidazo[1,2-b]pyridazine-6-carboxylic acid To a solution of methyl 3-bromoimidazo[1,2-b]pyridazine-6-carboxylate (0.700 g, 2.00 mmol, 1.00 equiv.) in water (4 mL) and methanol (10 mL) was added lithium hydroxide (0.100 g, 3.00 mmol, 1.10 equiv.).
  • the reaction mixture was stirred at room temperature for 16 hours.
  • the reaction mixture was concentrated under reduce pressure and adjusted to pH 4 with citric acid.
  • the obtained solid was filtered off and dried under reduce pressure to 3-bromoimidazo[1,2-b]pyridazine-6-carboxylic acid.
  • reaction mixture was stirred at room temperature for 16 hours.
  • the reaction mixture was diluted with ethyl acetate and quenched with water.
  • the combined organic layers were dried over sodium sulfate, filtered, and concentrated under reduced pressure.
  • the crude residue was purified over silica gel cartridge (cyclohexane / ethyl acetate) to afford 3-bromo-N-(4-fluoro-3-methoxy-phenyl)-N-methyl-imidazo[1,2-b]pyridazine-6-carboxamide as a light yellow solid.
  • the reaction mixture was degassed with argon and then stirred in the microwave at 100 °C for 1 hour. After cooling down to room temperature, the reaction mixture was filtered through a Celite pad and washed with methanol. The filtrate was concentrated under reduced pressure. The crude residue was purified over a silica gel cartridge (ethyl acetate/ methanol) to afford methyl N-[5-[6-[(4-fluoro-3-methoxy-phenyl)-methyl-carbamoyl]imidazo[1,2-b]pyridazin-3-yl]-2- pyridyl]carbamateas a yellow solid.
  • the mixture was stirred at 80 °C for 16 hours.
  • the reaction mixture was concentrated under reduce pressure then diluted with aqueous sodium bicarbonate solution, then extracted with 10% methanol in dichloromethane.
  • the organic layer was washed with water, then brine, dried over sodium sulfate, filtered, and concentrated under reduced pressure.
  • the crude residue was purified over a silica gel cartridge (dichloromethane/ methanol) to afford ethyl imidazo[1,2-a]pyrimidine-6-carboxylate as an off-white solid.
  • Step B Preparation of ethyl 3-bromoimidazo[1,2-a]pyrimidine-6-carboxylate
  • ethyl imidazo[1,2-a]pyrimidine-6-carboxylate 20.0 mg, 0.105 mmol
  • dichloromethane 2 mL
  • N-bromosuccinimide 27.9 mg, 0.157 mmol, 1.5 equiv.
  • Step C Preparation of ethyl 3-(4-acetamidophenyl)imidazo[1,2-a]pyrimidine-6-carboxylate
  • ethyl 3-bromoimidazo[1,2-a]pyrimidine-6-carboxylate 300 mg, 1.09 mmol
  • toluene 2.0 mL
  • ethanol 1.0 mL
  • 4-acetamidophenyl boronic acid
  • tris(o-tolyl)phosphine 36.4 mg, 0.120 mmol, 0.11 equiv.
  • potassium fluoride 158 mg, 2.72 mmol, 2.50 equiv.
  • the mixture was degassed with argon for 2 minutes. Then tris(dibenzylideneacetone)dipalladium(0) (62.6 mg, 0.109 mmol, 0.10 equiv.) was added. The mixture was degassed with argon for another 1 minute and irradiated in microwave at 100 °C for 20 minutes. The reaction mixture was cooled down to room temperature and filtered through a pad of Celite. The filtrate was diluted with ethyl acetate and washed with water. The combined organic layers were dried over sodium sulfate, filtered, and concentrated under reduced pressure.
  • the crude micture was purified over a silica gel cartridge (hexane/ethyl acetate) to afford ethyl 3-(4-acetamidophenyl)imidazo[1,2-a]pyrimidine-6-carboxylate as a pale yellow solid.
  • Step D Preparation of 3-(4-acetamidophenyl)imidazo[1,2-a]pyrimidine-6-carboxylic acid Lithium hydroxide hydrate (13.6 mg, 0.323 mmol, 3 equiv.) was added to a stirred solution of ethyl 3-(4- acetamidophenyl)imidazo[1,2-a]pyrimidine-6-carboxylate (40.0 mg, 0.108 mmol) in tetrahydrofuran (1.0 mL) and water (1.0 mL).
  • reaction mixture was stirred at 80 °C for 16 hours.
  • the reaction mixture was concentrated under reduce pressure and the crude residue was purified was purified over a silica gel cartridge (dichloromethane/ methanol) to afford ethyl imidazo[1,2-b]pyridazine-6-carboxylate as an off white solid.
  • Step B Preparation of ethyl 3-bromoimidazo[1,2-b]pyridazine-6-carboxylate To an ice-cooled solution of ethyl imidazo[1,2-b]pyridazine-6-carboxylate (0.300 g, 1.57 mmol) in dimethylformamide (5.00 mL) was added N-bromosuccinimide (0.307 g, 1.73 mmol, 1.10 equiv.).
  • reaction mixture was stirred at 0 °C for 30 minutes.
  • the reaction mixture was poured into water and extracted with ethyl acetate.
  • the combined organic layers were washed with brine, dried over sodium sulfate, filtered, and concentrated under reduced pressure.
  • the crude residue was purified over a silica gel cartridge (dichloromethane/methanol) to afford ethyl 3-bromoimidazo[1,2-b]pyridazine-6-carboxylate as an off white solid.
  • Step C Preparation of ethyl 3-(4-acetamidophenyl)imidazo[1,2-b]pyridazine-6-carboxylate
  • ethyl 3-bromoimidazo[1,2-b]pyridazine-6-carboxylate (0.210 g, 0.778 mmol) in toluene (6.00 mL) and ethanol (4.00 mL) were added 4-acetamidophenylboronic acid (0.278 g, 1.56 mmol, 2.00 equiv.), tris(o-tolyl)phosphine (0.047 mg, 0.16 mmol, 0.20 equiv.), potassium fluoride (2.0 M in water, 2.5 mL, 1.94
  • the reaction mixture was stirred in the microwave at 110 °C for 15 minutes.
  • the reaction mixture was filtered through a Celite pad and washed with methanol.
  • the filtrate was washed with water, then brine, dried over sodium sulfate, filtered, and concentrated under reduced pressure.
  • the crude residue was purified over a reverse phase combiflash chromatography (10 to 100% acetonitrile in water) to afford ethyl 3-(4-acetamidophenyl)imidazo[1,2-b]pyridazine-6-carboxylate as a light yellow color solid.
  • Step D Preparation of 3-(4-acetamidophenyl)imidazo[1,2-b]pyridazine-6-carboxylic acid
  • ethyl 3-(4-acetamidophenyl)imidazo[1,2-b]pyridazine-6-carboxylate 0.02 g, 0.0617 mmol, 1.00 equiv.
  • tetrahydrofuran 0.50 mL
  • water 0.50 mL
  • methanol 0.20 mL
  • reaction mixture was stirred at room temperature for 3 hours.
  • the reaction mixture was concentrated under reduced pressure, dissolved in water and the pH was adjusted to pH 2 by using 1.0 N hydrogen chloride solution.
  • the formed precipitate was washed with cold water and dried under reduce pressure to afford 3-(4- acetamidophenyl)imidazo[1,2-b]pyridazine-6-carboxylic acid as an off white solid.
  • the leaf disks are inoculated with a spore suspension of the fungus 1 day after application.
  • the inoculated leaf disks are incubated at 16 °C and 75% rh under a light regime of 24 h darkness followed by 12 h light / 12 h darkness in a climate cabinet and the activity of a compound is assessed as percent disease control compared to untreated when an appropriate level of disease damage appears in untreated check leaf disks (5 - 7 days after application).
  • the following compounds gave at least 80% control of Phytophthora infestans at 200 ppm when compared to untreated control under the same conditions, which showed extensive disease development: 2, 3, 4, 8 Plasmopara viticola / grape / leaf disc preventative (late blight) Grape vine leaf disks are placed on water agar in multiwell plates (24-well format) and sprayed with the formulated test compound diluted in water. The leaf disks are inoculated with a spore suspension of the fungus 1 day after application.
  • the inoculated leaf disks are incubated at 19 °C and 80% rh under a light regime of 12 h light / 12 h darkness in a climate cabinet and the activity of a compound is assessed as percent disease control compared to untreated when an appropriate level of disease damage appears in untreated check leaf disks (6 - 8 days after application).
  • the following compounds gave at least 80% control of Plasmopara viticola at 200 ppm when compared to untreated control under the same conditions, which showed extensive disease development: 1, 3, 4, 8 Pythium ultimum / liquid culture (seedling damping off) Mycelia fragments and oospores of a newly grown liquid culture of the fungus are directly mixed into nutrient broth (PDB potato dextrose broth).
  • test compound After placing a (DMSO) solution of test compound into a microtiter plate (96-well format), the nutrient broth containing the fungal mycelia/spore mixture is added. The test plates are incubated at 24 °C and the inhibition of growth is determined photometrically 2-3 days after application. The following compounds gave at least 80% control of Pythium ultimum at 20 ppm when compared to untreated control under the same conditions, which showed extensive disease development: 4, 8

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Environmental Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Agronomy & Crop Science (AREA)
  • Health & Medical Sciences (AREA)
  • Dentistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

The current invention relates to compounds of the formula (I) wherein the substituents are as defined in claim 1, to processes and methods for preparing compounds of formula (I), to agrochemical compositions comprising compounds of formula (I) as defined in claim 1, to preparation of these compositions and to the use of the compounds or compositions in agriculture or horticulture for combating, preventing or controlling infestation of plants, harvested food crops, seeds or non-living materials by phytopathogenic microorganisms, in particular fungi.

Description

IMIDAZO BICYCLIC DERIVATIVES The present invention relates to microbiocidal imidazo bicyclic derivatives, e.g. as active ingredients, which have microbiocidal activity, in particular fungicidal activity, more particularly activity against oomycetes. The invention also relates to preparation of these imidazo bicyclic derivatives, to intermediates useful in the preparation of these imidazo bicyclic derivatives, to the preparation of these intermediates, to agrochemical compositions which comprise at least one of the imidazo bicyclic derivatives, to preparation of these compositions and to the use of the imidazo bicyclic derivatives or compositions in agriculture or horticulture for combating, controlling or preventing infestation of plants, harvested food crops, seeds or non-living materials by phytopathogenic microorganisms, in particular fungi, more particularly oomycetes. It has now surprisingly been found that certain novel imidazo bicyclic derivatives have favourable fungicidal properties, in particular against oomycetes. Therefore, in a first aspect, the present invention provides compounds of formula (I)
Figure imgf000002_0001
wherein Z is O or S, and preferably Z is O; each A1 is N, or one A1 is N and one A1 is CR1; and preferably one A1 is N and one A1 is CR1; R1 are independently selected from hydrogen, hydroxy, halogen, CN, C1-6alkyl, C3-6cycloalkyl, C1- 6alkoxy-C1-6alkyl, C3-6cycloalkyl-C1-4alkyl, C1-6alkylsulfanyl, C1-6alkylsulfinyl, C1-6alkylsulfonyl, C1-6alkoxy, amino, and -NHC(O)C1-6alkyl; A2 are independently CR2 or N, with the proviso that no more than three A2 are N, preferably no more than two A2 are N, preferably no more than one A2 is N, and more preferably the four A2 are CR2; R2 are independently selected from hydrogen, hydroxy, halogen, CN, C1-6alkyl, C1-6alkoxy, C1-6alkoxy- C1-6alkyl, C1-6alkoxy-C1-6alkoxy, C2-6alkenyl, C2-6alkynyl, C3-6cycloalkyl, C3-6cycloalkyl-C1-6alkyl, C1- 6alkylsulfanyl, C1-6alkylsulfinyl, C1-6alkylsulfonyl, C1-6alkoxycarbonyl, C1-6alkylaminocarbonyl, diC1- 6alkylaminocarbonyl, and C1-6alkylcarbonyl, wherein each of the C1-6alkyl, C1-6alkoxy, C1-6alkoxy-C1- 6alkyl, C1-6alkoxy-C1-6alkoxy, C2-6alkenyl, C2-6alkynyl, C3-6cycloalkyl, C3-6cycloalkyl-C1-6alkyl, C1- 6alkylsulfanyl, C1-6alkylsulfinyl, C1-6alkylsulfonyl, C1-6alkoxycarbonyl, C1-6alkylaminocarbonyl, diC1- 6alkylaminocarbonyl, and C1-6alkylcarbonyl groups is optionally substituted with one to three substituents independently selected from halogen, hydroxy, and CN; A3 is CR3 or N; R3 is selected from hydrogen, hydroxy, halogen, CN, C1-6alkyl, C1-6alkoxy, C1-6alkoxy-C1-6alkyl, C1- 6alkoxy-C1-6alkoxy, C2-6alkenyl, C2-6alkynyl, C3-6cycloalkyl, C3-6cycloalkyl-C1-6alkyl, C1-6alkylsulfanyl, C1- 6alkylsulfinyl, C1-6alkylsulfonyl, amino, C1-6alkylamino, diC1-6-alkylamino, and C3-6cycloalkylamino, wherein each of the C1-6alkyl, C1-6alkoxy, C1-6alkoxy-C1-6alkyl, C1-6alkoxy-C1-6alkoxy, C2-6alkenyl, C2- 6alkynyl, C3-6cycloalkyl, C3-6cycloalkyl-C1-6alkyl, C1-6alkylsulfanyl, C1-6alkylsulfinyl, C1-6alkylsulfonyl, amino, C1-6alkylamino, diC1-6-alkylamino, and C3-6cycloalkylamino groups is optionally substituted with one to three substituents independently selected from halogen, hydroxy, and CN; A4 is CH or N; R4 is selected from C1-6alkyl, C1-6alkoxy-C1-6alkyl, C3-6cycloalkyl, C3-6cycloalkyl-C1-4alkyl, C2-6alkenyl, C2- 6alkynyl, C1-6alkoxy, C1-6alkylsulfanyl-C1-6alkyl, C1-6alkylsulfinyl-C1-6alkyl, C1-6alkylsulfonyl-C1-6alkyl, C1- 6alkoxycarbonyl-C1-6alkyl, C1-6alkylaminocarbonyl-C1-6alkyl, diC1-6alkylaminocarbonyl-C1-6alkyl, and CN, wherein each of the C1-6alkyl, C1-6alkoxy-C1-6alkyl, C3-6cycloalkyl, C3-6cycloalkyl-C1-4alkyl, C2-6alkenyl, C2- 6alkynyl, C1-6alkoxy, C1-6alkylsulfanyl-C1-6alkyl, C1-6alkylsulfinyl-C1-6alkyl, C1-6alkylsulfonyl-C1-6alkyl, C1- 6alkoxycarbonyl-C1-6alkyl, C1-6alkylaminocarbonyl-C1-6alkyl and diC1-6alkylaminocarbonyl-C1-6alkyl groups is optionally substituted with one to three substituents independently selected from halogen and CN; wherein A3 and R4 taken together optionally form a ring, preferably a 5-8-membered heterocycle, and more preferably a 6-membered heterocycle; and R5 is selected from C1-6alkyl, C1-6alkoxy, C3-6cycloalkyl, C3-6cycloalkyl-C1-6alkyl, C1-6alkoxyC1-6alkyl, C1- 6alkylamino, diC1-6alkylamino, C1-6alkoxyamino, and C1-6alkylC1-6alkoxyamino, wherein each of the C1- 6alkyl, C1-6alkoxy, C3-6cycloalkyl, C3-6cycloalkyl-C1-6alkyl, C1-6alkoxyC1-6alkyl, C1-6alkylamino, diC1- 6alkylamino, C1-6alkoxyamino, and C1-6alkylC1-6alkoxyamino groups is optionally substituted with one to three substituents independently selected from halogen and CN; or a salt or N-oxide thereof. In a second aspect the present invention provides an agrochemical composition comprising a compound of formula (I), and more particularly an agrochemical composition comprising a fungicidally effective amount of a compound of formula (I). Said composition can further comprise at least one compound selected among an additional active ingredient, an appropriate formulation inert, a carrier, an adjuvant, and any mixtures thereof. Compounds of formula (I) may be used to control phytopathogenic microorganisms. Thus, in order to control a phytopathogen a compound of formula (I), or a composition comprising a compound of formula (I) according to the invention, may be applied directly to the phytopathogen, to the locus of a phytopathogen, in particular to a plant susceptible to attack by phytopathogens, or to a propagation material of a plant. Thus, in a third aspect the present invention provides the use of a compound of formula (I), or a composition comprising a compound of formula (I), as described herein to combat, prevent or control a phytopathogen. In a fourth aspect the present invention provides a method of combating, preventing or controlling phytopathogens, comprising applying a compound of formula (I), or a composition comprising a compound of formula (I), as described herein to said phytopathogen, to the locus of said phytopathogen, in particular to a plant susceptible to attack by a phytopathogen, or to a propagation material of a plant. According to this fourth aspect of the invention, the method may exclude methods for the treatment of the human or animal body by surgery or therapy. Compounds of formula (I) are particularly effective in combating, preventing or controlling phytopathogenic fungi, in particular oomycetes. Thus, in a fifth aspect the present invention provides the use of a compound of formula (I), or a composition comprising a compound of formula (I), as described herein to control phytopathogenic fungi, in particular oomycetes. In a sixth aspect the present invention provides a method of combating, preventing or controlling phytopathogenic disease, such as phytopathogenic fungi, comprising applying a compound of formula (I), or a composition comprising a compound of formula (I), as described herein to said phytopathogenic fungi, or to the locus of said phytopathogenic fungi, in particular to a plant susceptible to attack by phytopathogenic fungi, in particular oomycetes, or to a propagation material of a plant. According to this sixth aspect of the invention, the method may exclude methods for the treatment of the human or animal body by surgery or therapy. Where a group is indicated as being substituted, e.g. alkyl, this includes those groups that are part of other groups, e.g. the alkyl in alkylthio. Definitions: - The term "halogen" or “halo” refers to fluorine (fluoro or F), chlorine (chloro or Cl), bromine (bromo or Br) or iodine (iodo or I), preferably fluorine, chlorine or bromine. - The term “amino” refers to a -NH2 group. - The term "Alkyl" as used herein- in isolation or as part of a chemical group – represents straight-chain or branched hydrocarbons, preferably with 1 to 6 carbon atoms, for example methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, s-butyl, t-butyl, pentyl, 1- methylbutyl, 2-methylbutyl, 3-methylbutyl, 1,2- dimethylpropyl, 1,1 -dimethylpropyl, 2,2- dimethylpropyl, 1 -ethylpropyl, hexyl, 1 -methylpentyl, 2- methylpentyl, 3-methylpentyl, 4- methylpentyl, 1,2-dimethylpropyl, 1,3-dimethylbutyl, 1,4-dimethylbutyl, 2,3-dimethylbutyl, 1,1- dimethylbutyl, 2,2-dimethylbutyl, 3,3-dimethylbutyl, 1,1,2-trimethylpropyl, 1,2,2- trimethylpropyl, 1- ethylbutyl and 2-ethylbutyl. Alkyl groups with 1 to 4 carbon atoms are preferred, for example methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, s-butyl or t-butyl. - The term "Alkenyl" - in isolation or as part of a chemical group - represents straight-chain or branched hydrocarbons, preferably with 2 to 6 carbon atoms and at least one double bond, for example vinyl, 2- propenyl, 2-butenyl, 3-butenyl, 1- methyl-2-propenyl, 2-methyl-2-propenyl, 2-pentenyl, 3-pentenyl, 4- pentenyl, 1-methyl-2-butenyl, 2- methyl-2-butenyl, 3-methyl-2-butenyl, 1-methyl-3-butenyl, 2-methyl-3- butenyl, 3-methyl-3-butenyl, 1,1 - dimethyl-2-propenyl, 1,2-dimethyl-2-propenyl, 1 -ethyl-2-propenyl, 2- hexenyl, 3-hexenyl, 4- hexenyl, 5-hexenyl, 1 -methyl-2-pentenyl, 2-methyl-2-pentenyl, 3-methyl-2- pentenyl, 4-methyl-2- pentenyl, 3-methyl-3-pentenyl, 4-methyl-3-pentenyl, 1 -methyl-4-pentenyl, 2- methyl-4-pentenyl, 3- methyl-4-pentenyl, 4-methyl-4-pentenyl, 1, 1 -dimethyl-2-butenyl, 1,1-dimethyl-3- butenyl, 1,2- dimethyl-2-butenyl, 1,2-dimethyl-3-butenyl, 1,3-dimethyl-2-butenyl, 2,2-dimethyl-3-butenyl, 2,3- dimethyl-2-butenyl, 2,3-dimethyl-3-butenyl, 1 -ethyl-2-butenyl, 1-ethyl-3-butenyl, 2-ethyl-2-butenyl, 2-ethyl-3-butenyl, 1, 1,2-trimethyl-2-propenyl, 1 -ethyl- 1 -methyl-2-propenyl und 1-ethyl-2-methyl-2- propenyl. Alkenyl groups with 2 to 4 carbon atoms are preferred, for example 2-propenyl, 2-butenyl or 1-methyl-2-propenyl. - The term "Alkynyl" - in isolation or as part of a chemical group - represents straight-chain or branched hydrocarbons, preferably with 2 to 6 carbon atoms and at least one triple bond, for example 2-propynyl, 2-butynyl, 3-butynyl, 1-methyl-2- propynyl, 2-pentynyl, 3-pentynyl, 4-pentynyl, 1-methyl-3-butynyl, 2- methyl-3-butynyl, 1-methyl-2- butynyl, 1,1 -dimethyl-2-propynyl, 1 -ethyl-2-propynyl, 2-hexynyl, 3- hexynyl, 4-hexynyl, 5-hexynyl, 1- methyl-2-pentynyl, 1-methyl-3-pentynyl, 1 -methyl-4-pentynyl, 2- methyl-3-pentynyl, 2-methyl-4- pentynyl, 3 -methyl-4-pentynyl, 4-methyl-2-pentynyl, 1,1 -dimethyl-3 - butynyl, 1,2-dimethyl-3 –butynyl, 2,2- dimethyl-3-butynyl, 1-ethyl-3-butynyl, 2-ethyl-3-butynyl, 1-ethyl-1- methyl-2-propynyl and 2,5-hexadiynyl. Alkynyls with 2 to 4 carbon atoms are preferred, for example ethynyl, 2- propynyl or 2-butynyl-2-propenyl. - The term "haloalkyl" refers to an alkyl radical as generally defined above substituted by one or more of the same or different halogen atoms, for examples fluoromethyl, fluoroethyl, difluoromethyl, trifluoromethyl, or 2,2,2-trifluoroethyl. - The term cyanoalkyl” refers to an alkyl radical as generally defined above substituted by one or more cyano groups. - The term "cycloalkyl" - in isolation or as part of a chemical group - represents saturated or partially unsaturated mono-, bi- or tricyclic hydrocarbons, preferably with 3 to 10 carbon atoms, for example cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, bicyclo[2.2.1]heptyl, bicyclo[2.2.2]octyl or adamantyl. Cycloalkyls with 3, 4, 5, 6 or 7 carbon atoms are preferred, for example cyclopropyl or cyclobutyl. - The term “halocycloalkyl" refers to a cycloalkyl ring as defined above substituted by one or more of the same or different halogen atoms. - The term cyanocycloalkyl” refers to a cycloalkyl radical as generally defined above substituted by one or more cyano groups. - The term “alkoxy" refers to a radical of the formula -ORa wherein Ra is an alkyl radical as generally defined above. Examples of alkoxy include, but are not limited to methoxy, ethoxy, propoxy, iso-propoxy, and tert-butoxy. The term “alkoxyalkyl” refers to an alkyl radical (as mentioned above) substituted with said alkoxy group. Examples are methoxymethyl, methoxyethyl, ethoxymethyl and propoxymethyl. - The term “alkylsulfanyl” refers to a radical of the formula -SRa wherein Ra is an alkyl radical as generally defined above. - The term “alkylsulfinyl” refers to a radical of the formula -S(O)Ra wherein Ra is an alkyl radical as generally defined above. - The term “alkylsulfonyl” refers to a radical of the formula -S(O)2Ra wherein Ra is an alkyl radical as generally defined above. - The term “alkylcarbonyl” refers to a radical of the formula RaC(O)- wherein Ra is an alkyl radical as generally defined above. - the term “alkoxycarbonyl” refers to a radical of the formula RaOC(O)-, wherein Ra is an alkyl radical as generally defined above. - The term “alkylamino” refers to a radical of the formula RaNH- wherein Ra is an alkyl radical as generally defined above. - The term “cycloalkylamino” refers to a radical of the formula RaNH- wherein Ra is a cycloalkyl radical as generally defined above. - The term “alkoxyamino” refers to a radical of the formula RaNH-, wherein Ra is an alkoxy radical as generally defined above. - The term “alkylaminocarbonyl” refers to a radical of the formula RaNHC(O)- wherein Ra is an alkyl radical as generally defined above. - Hydroxyl or hydroxy stands for a –OH group. The term ”combating”, “preventing” or “controlling”, and its inflections, within the context of the present invention, mean reducing any undesired effect, such as pathogenic and more particularly phytopathogenic, especially fungi such as oomycetes, infestation or attack of, and pathogenic damage to a plant or to a plant derived product to such a level that an improvement is demonstrated. As used herein, the term "effective amount" refers to the amount of the compound, a salt, or N-oxide thereof, which, upon single or multiple applications provides the desired effect. An effective amount is readily determined by the skilled person in the art, by the use of known techniques and by observing results obtained under analogous circumstances. In determining the effective amount a number of factors are considered including, but not limited to: the type of plant or derived product to be applied; the pathogen to be controlled & its lifecycle; the particular compound applied; the type of application; and other relevant circumstances. Compounds of formula (I) which have at least one basic centre can form, for example, acid addition salts, for example with strong inorganic acids such as mineral acids, for example perchloric acid, sulfuric acid, nitric acid, nitrous acid, a phosphorus acid or a hydrohalic acid, with strong organic carboxylic acids, such as C1-C4alkanecarboxylic acids which are unsubstituted or substituted, for example by halogen, for example acetic acid, such as saturated or unsaturated dicarboxylic acids, for example oxalic acid, malonic acid, succinic acid, maleic acid, fumaric acid or phthalic acid, such as hydroxycarboxylic acids, for example ascorbic acid, lactic acid, malic acid, tartaric acid or citric acid, or such as benzoic acid, or with organic sulfonic acids, such as C1-C4alkane- or arylsulfonic acids which are unsubstituted or substituted, for example by halogen, for example methane- or p-toluenesulfonic acid. Compounds of formula (I) which have at least one acidic group can form, for example, salts with bases, for example mineral salts such as alkali metal or alkaline earth metal salts, for example sodium, potassium or magnesium salts, or salts with ammonia or an organic amine, such as morpholine, piperidine, pyrrolidine, a mono-, di- or tri-lower-alkylamine, for example ethyl-, diethyl-, triethyl- or dimethylpropylamine, or a mono-, di- or trihydroxy-lower-alkylamine, for example mono-, di- or triethanolamine. In each case, the compounds of formula (I) according to the invention are in free form, in oxidized form as an N-oxide, in covalently hydrated form, or in salt form, e.g., an agronomically usable or agrochemically acceptable salt form. N-oxides are oxidized forms of tertiary amines or oxidized forms of nitrogen containing heteroaromatic compounds. They are described for instance in the book “Heterocyclic N-oxides” by A. Albini and S. Pietra, CRC Press, Boca Raton 1991. The compounds of formula (I) according to the invention also include hydrates, which may be formed during salt formation. The compounds of formula (I) according to the invention also include hydrates which may be formed during the salt formation. In a further embodiment, there is provided a compound of formula (I) according to the present invention, wherein R1 are independently selected from hydrogen, C1-6alkyl, C3-6cycloalkyl, C1-6alkoxy-C1-6alkyl, C3- 6cycloalkyl-C1-4alkyl, and C1-6alkoxy, and more preferably R1 are independently selected from hydrogen and C1-6alkyl. In a further embodiment, there is provided a compound of formula (I) according to the present invention, wherein R2 are independently selected from hydrogen, hydroxy, halogen, CN, C1-6alkyl, C1-6alkoxy, C1- 6alkoxy-C1-6alkyl, C1-6alkoxy-C1-6alkoxy, C1-6alkoxycarbonyl, C1-6alkylaminocarbonyl, diC1- 6alkylaminocarbonyl, and C1-6alkylcarbonyl, wherein each of the C1-6alkyl, C1-6alkoxy, C1-6alkoxy-C1- 6alkyl, C1-6alkoxy-C1-6alkoxy, C1-6alkoxycarbonyl, C1-6alkylaminocarbonyl, diC1-6alkylaminocarbonyl, and C1-6alkylcarbonyl groups is optionally substituted with one to three substituents independently selected from halogen, hydroxy, and CN; preferably R2 are independently selected from hydrogen, halogen, CN, C1-6alkyl, C1-6alkoxy, C1-6alkoxy-C1-6alkyl, C1-6alkoxycarbonyl, and C1-6alkoxy-C1-6alkoxy, wherein each of the C1-6alkyl, C1-6alkoxy, C1-6alkoxy-C1-6alkyl, C1-6alkoxycarbonyl, and C1-6alkoxy-C1- 6alkoxy groups is optionally substituted with one to three substituents independently selected from halogen, hydroxy, and CN; and more preferably R2 are independently selected from hydrogen, halogen, CN, C1-6alkyl, C1-6alkoxy, and C1-6alkoxy-C1-6alkyl. In a further embodiment, there is provided a compound of formula (I) according to the present invention, wherein R3 is selected from hydroxy, halogen, CN, C1-6alkyl, C1-6alkoxy, C1-6alkoxy-C1-6alkyl, C1-6alkoxy- C1-6alkoxy, C3-6cycloalkyl, C3-6cycloalkyl-C1-6alkyl, amino, C1-6alkylamino, diC1-6-alkylamino, and C3- 6cycloalkylamino, wherein each of the C1-6alkyl, C1-6alkoxy, C1-6alkoxy-C1-6alkyl, C1-6alkoxy-C1-6alkoxy, C3-6cycloalkyl, C3-6cycloalkyl-C1-6alkyl, amino, C1-6alkylamino, diC1-6-alkylamino and C3-6cycloalkylamino groups is optionally substituted with one to three substituents independently selected from halogen, hydroxy, and CN; and preferably R3 is hydrogen. In a further embodiment, there is provided a compound of formula (I) according to the present invention, wherein four A2 are CR2 and A3 is N. In a further embodiment, there is provided a compound of formula (I) according to the present invention, wherein
Figure imgf000008_0001
preferably the three A2 are CR2 and A3 is CR3. In a further embodiment, there is provided a compound of formula (I) according to the present invention, wherein
Figure imgf000009_0001
preferably the three A2 are CR2 and A3 is CR3. In a further embodiment, there is provided a compound of formula (I) according to the present invention, wherein four A2 are CR2 and A3 is CR3, and preferably
Figure imgf000009_0002
. In the particular embodiment wherein
Figure imgf000009_0003
, R2 are as defined in the present invention; preferably R2 are independently selected from hydrogen, hydroxy, halogen, CN, C1-6alkyl, C1- 6alkoxy, C1-6alkoxy-C1-6alkyl, C1-6alkoxy-C1-6alkoxy, C3-6cycloalkyl, C3-6cycloalkyl-C1-6alkyl, C1- 6alkoxycarbonyl, C1-6alkylaminocarbonyl, diC1-6alkylaminocarbonyl, and C1-6alkylcarbonyl, wherein each of the C1-6alkyl, C1-6alkoxy, C1-6alkoxy-C1-6alkyl, C1-6alkoxy-C1-6alkoxy, C3-6cycloalkyl, C3- 6cycloalkyl-C1-6alkyl, C1-6alkoxycarbonyl, C1-6alkylaminocarbonyl, diC1-6alkylaminocarbonyl, and C1- 6alkylcarbonyl groups is optionally substituted with one to three substituents independently selected from halogen, hydroxy, and CN; more preferably R2 are independently selected from hydrogen, halogen, CN, C1-6alkoxy, C1-6alkoxy-C1-6alkyl, C1-6alkoxycarbonyl, and C1-6alkoxy-C1-6alkoxy, wherein each of the C1-6alkoxy, C1-6alkoxy-C1-6alkyl, C1-6alkoxycarbonyl, and C1-6alkoxy-C1-6alkoxy groups is optionally substituted with one to three substituents independently selected from halogen, hydroxy, and CN; and even more preferably R2 are independently selected from hydrogen, halogen, CN, C1-6alkyl, C1-6alkoxy, and C1-6alkoxy-C1-6alkyl. In a further embodiment, there is provided a compound of formula (I) according to the present invention, wherein R4 is selected from C1-6alkyl, C1-6alkoxy-C1-6alkyl, C3-6cycloalkyl, C3-6cycloalkyl-C1-4alkyl, C2- 6alkenyl, C2-6alkynyl, and C1-6alkoxy, wherein each of the C1-6alkyl, C1-6alkoxy-C1-6alkyl, C3-6cycloalkyl, C3-6cycloalkyl-C1-4alkyl, C2-6alkenyl, C2-6alkynyl, and C1-6alkoxy groups is optionally substituted with one to three substituents independently selected from halogen and CN; and preferably R4 is selected from C1-6alkyl, C1-6alkoxy-C1-6alkyl, C3-6cycloalkyl, C3-6cycloalkyl-C1-4alkyl, and C1-6alkoxy, wherein each of the C1-6alkyl, C1-6alkoxy-C1-6alkyl, C3-6cycloalkyl, C3-6cycloalkyl-C1-4alkyl, and C1-6alkoxy groups is optionally substituted with one to three substituents independently selected from halogen and CN; and wherein A3 and R4 taken together optionally form a ring, preferably a 5-8-membered heterocycle, and more preferably a 6-membered heterocycle. In a further embodiment, there is provided a compound of formula (I) according to the present invention, wherein A3 is CR3 and wherein R3 and R4 taken together form a ring, preferably a 5-8-membered heterocycle, preferably a 6-membered heterocycle, and more preferably one of the rings W1, W2 or W3 as described in the compounds of the formula (I) below:
Figure imgf000010_0001
The carbon and/or the nitrogen atoms forming said ring (W1, W2 or W3) can be substituted, especially by a R3’ group, wherein R3’ is selected from hydrogen, C1-6alkyl, and C3-6cycloalkyl, wherein each of the C1-6alkyl and C3-6cycloalkyl groups is optionally substituted with one to three substituents independently selected from halogen and CN. For example, the compounds of the formula (I-W3) can be as follows:
Figure imgf000010_0002
(I-W3) In a preferred embodiment, the compounds of the formula (I-W1), (I-W2) and (I-W3) can be as described below:
Figure imgf000010_0003
(I-W1) (I-W2) (I-W3) The carbon and/or the nitrogen atoms forming said ring (W1, W2 or W3) can be substituted, especially by a R3’ group, wherein R3’ is selected from hydrogen, C1-6alkyl, and C3-6cycloalkyl, wherein each of the C1-6alkyl and C3-6cycloalkyl groups is optionally substituted with one to three substituents independently selected from halogen and CN. For example, the compounds of the formula (I-W3) can be as follows:
Figure imgf000011_0001
In a further embodiment, there is provided a compound of formula (I) according to the present invention, wherein R5 is selected from C1-6alkyl, C1-6alkoxy, C3-6cycloalkyl, C3-6cycloalkyl-C1-6alkyl, and C1- 6alkoxyC1-6alkyl, wherein each of said groups is optionally substituted with one to three substituents independently selected from halogen and CN. In a particular embodiment, there is provided a compound of formula (I) according to the present invention, wherein Z is O; one A1 is N and one A1 is CR1; R1 are independently selected from hydrogen, C1-6alkyl, C3-6cycloalkyl, C1-6alkoxy-C1-6alkyl, C3- 6cycloalkyl-C1-4alkyl, and C1-6alkoxy, and more preferably R1 are independently selected from hydrogen and C1-6alkyl; the four A2 are CR2; with R2 being independently selected from hydrogen, hydroxy, halogen, CN, C1- 6alkyl, C1-6alkoxy, C1-6alkoxy-C1-6alkyl, C1-6alkoxy-C1-6alkoxy, C2-6alkenyl, C2-6alkynyl, C3-6cycloalkyl, C3- 6cycloalkyl-C1-6alkyl, C1-6alkylsulfanyl, C1-6alkylsulfinyl, and C1-6alkylsulfonyl, wherein each of the C1- 6alkyl, C1-6alkoxy, C1-6alkoxy-C1-6alkyl, C1-6alkoxy-C1-6alkoxy, C2-6alkenyl, C2-6alkynyl, C3-6cycloalkyl, C3- 6cycloalkyl-C1-6alkyl, C1-6alkylsulfanyl, C1-6alkylsulfinyl and C1-6alkylsulfonyl groups is optionally substituted with one to three substituents independently selected from halogen, hydroxy, and CN; preferably R2 being independently selected from hydrogen, halogen, CN, C1-6alkyl, C1-6alkoxy, C1- 6alkoxy-C1-6alkyl, and C1-6alkoxy-C1-6alkoxy, wherein each of the C1-6alkyl, C1-6alkoxy, C1-6alkoxy-C1- 6alkyl, and C1-6alkoxy-C1-6alkoxy groups is optionally substituted with one to three substituents independently selected from halogen, hydroxy, and CN; and more preferably R2 being independently selected from hydrogen, halogen, CN, C1-6alkyl, C1-6alkoxy, C1-6alkoxy-C1-6alkyl, C1-6alkoxycarbonyl, and C1-6alkoxy-C1-6alkoxy, wherein each of the C1-6alkyl, C1-6alkoxy, C1-6alkoxy-C1-6alkyl, C1-6alkoxycarbonyl, and C1-6alkoxy-C1-6alkoxy groups is optionally substituted with one to three substituents independently selected from halogen, hydroxy, and CN; A3 is CR3 with R3 being independently selected from hydrogen, hydroxy, halogen, CN, C1-6alkyl, C1- 6alkoxy, C1-6alkoxy-C1-6alkyl, C1-6alkoxy-C1-6alkoxy, C2-6alkenyl, C2-6alkynyl, C3-6cycloalkyl, C3- 6cycloalkyl-C1-6alkyl, C1-6alkylsulfanyl, C1-6alkylsulfinyl, C1-6alkylsulfonyl, amino, C1-6alkylamino, diC1-6- alkylamino, and C3-6cycloalkylamino, wherein each of the C1-6alkyl, C1-6alkoxy, C1-6alkoxy-C1-6alkyl, C1- 6alkoxy-C1-6alkoxy, C2-6alkenyl, C2-6alkynyl, C3-6cycloalkyl, C3-6cycloalkyl-C1-6alkyl, C1-6alkylsulfanyl, C1- 6alkylsulfinyl, C1-6alkylsulfonyl, amino, C1-6alkylamino, diC1-6-alkylamino and C3-6cycloalkylamino groups is optionally substituted with one to three substituents independently selected from halogen, hydroxy, and CN; and preferably R3 being hydrogen; A4 is CH or N, preferably N; R4 is selected from C1-6alkyl, C1-6alkoxy-C1-6alkyl, C3-6cycloalkyl, C3-6cycloalkyl-C1-4alkyl, and C1-6alkoxy, wherein each of the C1-6alkyl, C1-6alkoxy-C1-6alkyl, C3-6cycloalkyl, C3-6cycloalkyl-C1-4alkyl, and C1-6alkoxy groups is optionally substituted with one to three substituents independently selected from halogen and CN; and wherein A3 and R4 taken together optionally form a ring, preferably a 5-8-membered heterocycle, and more preferably a 6-membered heterocycle; and R5 is selected from C1-6alkyl, C1-6alkoxy, C3-6cycloalkyl, C3-6cycloalkyl-C1-6alkyl, C1-6alkoxyC1-6 alkyl, C1- 6alkylamino, diC1-6alkylamino, and C1-6alkylC1-6alkoxyamino, wherein each of said groups is optionally substituted with one to three substituents independently selected from halogen and CN, and preferably R5 is selected from C1-6alkyl, C1-6alkoxy, C3-6cycloalkyl, C3-6cycloalkyl-C1-6alkyl, and C1-6alkoxyC1-6alkyl, wherein each of said groups is optionally substituted with one to three substituents independently selected from halogen and CN. In a preferred embodiment,
Figure imgf000012_0001
wherein R2 are as defined in the present invention; preferably R2 are independently selected from hydrogen, hydroxy, halogen, CN, C1-6alkyl, C1-6alkoxy, C1-6alkoxy-C1-6alkyl, C1-6alkoxy-C1-6alkoxy, C3-6cycloalkyl, C3-6cycloalkyl-C1-6alkyl, C1-6alkoxycarbonyl, C1-6alkylaminocarbonyl, diC1-6alkylaminocarbonyl, and C1-6alkylcarbonyl, wherein each of the C1-6alkyl, C1-6alkoxy, C1-6alkoxy-C1-6alkyl, C1-6alkoxy-C1-6alkoxy, C3-6cycloalkyl, C3-6cycloalkyl-C1-6alkyl, C1- 6alkoxycarbonyl, C1-6alkylaminocarbonyl, diC1-6alkylaminocarbonyl, and C1-6alkylcarbonyl groups is optionally substituted with one to three substituents independently selected from halogen, hydroxy, and CN; more preferably R2 are independently selected from hydrogen, halogen, CN, C1-6alkoxy, C1-6alkoxy- C1-6alkyl, C1-6alkoxycarbonyl, and C1-6alkoxy-C1-6alkoxy, wherein each of the C1-6alkoxy, C1-6alkoxy-C1- 6alkyl, C1-6alkoxycarbonyl, and C1-6alkoxy-C1-6alkoxy groups is optionally substituted with one to three substituents independently selected from halogen, hydroxy, and CN; and even more preferably R2 are independently selected from hydrogen, halogen, CN, C1-6alkyl, and C1-6alkoxy. In a further embodiment, the compound according to the present invention is selected from: methyl N-[5-[6-[(4-fluoro-3-methyl-phenyl)-methyl-carbamoyl]-8-methyl-imidazo[1,2-b]pyridazin-3-yl]-2- pyridyl]carbamate; methyl N-[5-[6-(6-fluoro-3,4-dihydro-2H-quinoline-1-carbonyl)-8-methyl-imidazo[1,2-b]pyridazin-3-yl]-2- pyridyl]carbamate; methyl N-[5-[6-[(4-fluorophenyl)-methyl-carbamoyl]-8-methyl-imidazo[1,2-b]pyridazin-3-yl]-2- pyridyl]carbamate; methyl N-[5-[6-[(4-fluoro-3-methoxy-phenyl)-methyl-carbamoyl]-8-methyl-imidazo[1,2-b]pyridazin-3-yl]- 2-pyridyl]carbamate; methyl N-[5-[6-(6-fluoro-3,4-dihydro-2H-quinoline-1-carbonyl)imidazo[1,2-b]pyridazin-3-yl]-2- pyridyl]carbamate; methyl N-[5-[6-[(4-fluorophenyl)-methyl-carbamoyl]imidazo[1,2-b]pyridazin-3-yl]-2-pyridyl]carbamate; methyl N-[5-[6-[(4-fluoro-3-methyl-phenyl)-methyl-carbamoyl]imidazo[1,2-b]pyridazin-3-yl]-2- pyridyl]carbamate; methyl N-[5-[6-[(4-fluoro-3-methoxy-phenyl)-methyl-carbamoyl]imidazo[1,2-b]pyridazin-3-yl]-2- pyridyl]carbamate; 3-(4-acetamidophenyl)-N-(4-chlorophenyl)-N-methyl-imidazo[1,2-a]pyrimidine-6-carboxamide; and 3-(4-acetamidophenyl)-N-(4-chlorophenyl)-N-methyl-imidazo[1,2-b]pyridazine-6-carboxamide. The method according to the present invention has advantageous properties for protecting plants against pathogenic, such as phytopathogenic, especially fungi such as oomycetes, attack or infestation, which result in a disease and damage to the plant; particularly in instance of plants, the present invention can control, limit or prevent pathogenic damage on plant, parts of plant, plant propagation material and/or plant grown. The compounds in Tables 1.1 to 1.100 and in Tables 2.1 to 2.50 below illustrate specific compounds of the invention. Table 1.1 provides compounds E1.1 to E1.952 of formula (Ia)
Figure imgf000013_0001
are as defined in table Z1. More particularly, table Z1 also includes compounds wherein R3 and R4 taken together form a ring. In this case, said ring is depicted in the R3 and R4 columns (table Z1) merged together, along the amide atom linked to the bicycle core of the formula (Ia). For example, see the R3 and R4 columns of the compound E1.103. Table Z1: Substituent definitions of R1a, R3, R4, A2a and A2b: Compounds R3 R4 A2a A2b R1a E1.1 H CH3 N CH H E1.2 H CH3 CH CH H Compounds R3 R4 A2a A2b R1a E1.3 H CH3 CH N H E1.4 H CH3 CF CH H E1.5 H CH3 CF N H E1.6 H CH3 CCl CH H E1.7 H CH3 CCl N H E1.8 H CH3 CBr CH H E1.9 H CH3 CBr N H E1.10 H CH3 CCH3 CH H E1.11 H CH3 CCH3 N H E1.12 H CH3 CCH2CH3 CH H E1.13 H CH3 CCH2CH3 N H E1.14 H CH3 CCN CH H E1.15 H CH3 CCN N H E1.16 H CH3 COCH3 CH H E1.17 H CH3 COCH3 N H E1.18 H CH2CH3 N CH H E1.19 H CH2CH3 CH CH H E1.20 H CH2CH3 CH N H E1.21 H CH2CH3 CF CH H E1.22 H CH2CH3 CF N H E1.23 H CH2CH3 CCl CH H E1.24 H CH2CH3 CCl N H E1.25 H CH2CH3 CBr CH H E1.26 H CH2CH3 CBr N H E1.27 H CH2CH3 CCH3 CH H E1.28 H CH2CH3 CCH3 N H E1.29 H CH2CH3 CCH2CH3 CH H E1.30 H CH2CH3 CCH2CH3 N H E1.31 H CH2CH3 CCN CH H E1.32 H CH2CH3 CCN N H E1.33 H CH2CH3 COCH3 CH H E1.34 H CH2CH3 COCH3 N H E1.35 H CH2OCH3 N CH H E1.36 H CH2OCH3 CH CH H E1.37 H CH2OCH3 CH N H E1.38 H CH2OCH3 CF CH H E1.39 H CH2OCH3 CF N H E1.40 H CH2OCH3 CCl CH H Compounds R3 R4 A2a A2b R1a E1.41 H CH2OCH3 CCl N H E1.42 H CH2OCH3 CBr CH H E1.43 H CH2OCH3 CBr N H E1.44 H CH2OCH3 CCH3 CH H E1.45 H CH2OCH3 CCH3 N H E1.46 H CH2OCH3 CCH2CH3 CH H E1.47 H CH2OCH3 CCH2CH3 N H E1.48 H CH2OCH3 CCN CH H E1.49 H CH2OCH3 CCN N H E1.50 H CH2OCH3 COCH3 CH H E1.51 H CH2OCH3 COCH3 N H E1.52 H CH2CH2OCH3 N CH H E1.53 H CH2CH2OCH3 CH CH H E1.54 H CH2CH2OCH3 CH N H E1.55 H CH2CH2OCH3 CF CH H E1.56 H CH2CH2OCH3 CF N H E1.57 H CH2CH2OCH3 CCl CH H E1.58 H CH2CH2OCH3 CCl N H E1.59 H CH2CH2OCH3 CBr CH H E1.60 H CH2CH2OCH3 CBr N H E1.61 H CH2CH2OCH3 CCH3 CH H E1.62 H CH2CH2OCH3 CCH3 N H E1.63 H CH2CH2OCH3 CCH2CH3 CH H E1.64 H CH2CH2OCH3 CCH2CH3 N H E1.65 H CH2CH2OCH3 CCN CH H E1.66 H CH2CH2OCH3 CCN N H E1.67 H CH2CH2OCH3 COCH3 CH H E1.68 H CH2CH2OCH3 COCH3 N H E1.69 H CH2CN N CH H E1.70 H CH2CN CH CH H E1.71 H CH2CN CH N H E1.72 H CH2CN CF CH H E1.73 H CH2CN CF N H E1.74 H CH2CN CCl CH H E1.75 H CH2CN CCl N H E1.76 H CH2CN CBr CH H E1.77 H CH2CN CBr N H E1.78 H CH2CN CCH3 CH H Compounds R3 R4 A2a A2b R1a E1.79 H CH2CN CCH3 N H E1.80 H CH2CN CCH2CH3 CH H E1.81 H CH2CN CCH2CH3 N H E1.82 H CH2CN CCN CH H E1.83 H CH2CN CCN N H E1.84 H CH2CN COCH3 CH H E1.85 H CH2CN COCH3 N H E1.86 H CH2CH2CN N CH H E1.87 H CH2CH2CN CH CH H E1.88 H CH2CH2CN CH N H E1.89 H CH2CH2CN CF CH H E1.90 H CH2CH2CN CF N H E1.91 H CH2CH2CN CCl CH H E1.92 H CH2CH2CN CCl N H E1.93 H CH2CH2CN CBr CH H E1.94 H CH2CH2CN CBr N H E1.95 H CH2CH2CN CCH3 CH H E1.96 H CH2CH2CN CCH3 N H E1.97 H CH2CH2CN CCH2CH3 CH H E1.98 H CH2CH2CN CCH2CH3 N H E1.99 H CH2CH2CN CCN CH H E1.100 H CH2CH2CN CCN N H E1.101 H CH2CH2CN COCH3 CH H E1.102 H CH2CH2CN COCH3 N H E1.103 N CH H E1.104 CH CH H E1.105 CH N H E1.106 CF CH H Compounds R3 R4 A2a A2b R1a E1.107 CF N H E1.108 CCl CH H E1.109 CCl N H E1.110 CBr CH H E1.111 CBr N H E1.112 CCH3 CH H E1.113 CCH3 N H E1.114 CCH2CH3 CH H E1.115 CCH2CH3 N H E1.116 CCN CH H E1.117 CCN N H E1.118 COCH3 CH H Compounds R3 R4 A2a A2b R1a E1.119 COCH3 N H E1.120 N CH H E1.121 CH CH H E1.122 CH N H E1.123 CF CH H E1.124 CF N H E1.125 CCl CH H E1.126 CCl N H E1.127 CBr CH H E1.128 CBr N H Compounds R3 R4 A2a A2b R1a E1.129 CCH3 CH H E1.130 CCH3 N H E1.131 CCH2CH3 CH H E1.132 CCH2CH3 N H E1.133 CCN CH H E1.134 CCN N H E1.135 COCH3 CH H E1.136 COCH3 N H E1.137 H CH3 N CH CH3 E1.138 H CH3 CH CH CH3 E1.139 H CH3 CH N CH3 E1.140 H CH3 CF CH CH3 E1.141 H CH3 CF N CH3 E1.142 H CH3 CCl CH CH3 E1.143 H CH3 CCl N CH3 E1.144 H CH3 CBr CH CH3 E1.145 H CH3 CBr N CH3 Compounds R3 R4 A2a A2b R1a E1.146 H CH3 CCH3 CH CH3 E1.147 H CH3 CCH3 N CH3 E1.148 H CH3 CCH2CH3 CH CH3 E1.149 H CH3 CCH2CH3 N CH3 E1.150 H CH3 CCN CH CH3 E1.151 H CH3 CCN N CH3 E1.152 H CH3 COCH3 CH CH3 E1.153 H CH3 COCH3 N CH3 E1.154 H CH2CH3 N CH CH3 E1.155 H CH2CH3 CH CH CH3 E1.156 H CH2CH3 CH N CH3 E1.157 H CH2CH3 CF CH CH3 E1.158 H CH2CH3 CF N CH3 E1.159 H CH2CH3 CCl CH CH3 E1.160 H CH2CH3 CCl N CH3 E1.161 H CH2CH3 CBr CH CH3 E1.162 H CH2CH3 CBr N CH3 E1.163 H CH2CH3 CCH3 CH CH3 E1.164 H CH2CH3 CCH3 N CH3 E1.165 H CH2CH3 CCH2CH3 CH CH3 E1.166 H CH2CH3 CCH2CH3 N CH3 E1.167 H CH2CH3 CCN CH CH3 E1.168 H CH2CH3 CCN N CH3 E1.169 H CH2CH3 COCH3 CH CH3 E1.170 H CH2CH3 COCH3 N CH3 E1.171 H CH2OCH3 N CH CH3 E1.172 H CH2OCH3 CH CH CH3 E1.173 H CH2OCH3 CH N CH3 E1.174 H CH2OCH3 CF CH CH3 E1.175 H CH2OCH3 CF N CH3 E1.176 H CH2OCH3 CCl CH CH3 E1.177 H CH2OCH3 CCl N CH3 E1.178 H CH2OCH3 CBr CH CH3 E1.179 H CH2OCH3 CBr N CH3 E1.180 H CH2OCH3 CCH3 CH CH3 E1.181 H CH2OCH3 CCH3 N CH3 E1.182 H CH2OCH3 CCH2CH3 CH CH3 E1.183 H CH2OCH3 CCH2CH3 N CH3 Compounds R3 R4 A2a A2b R1a E1.184 H CH2OCH3 CCN CH CH3 E1.185 H CH2OCH3 CCN N CH3 E1.186 H CH2OCH3 COCH3 CH CH3 E1.187 H CH2OCH3 COCH3 N CH3 E1.188 H CH2CH2OCH3 N CH CH3 E1.189 H CH2CH2OCH3 CH CH CH3 E1.190 H CH2CH2OCH3 CH N CH3 E1.191 H CH2CH2OCH3 CF CH CH3 E1.192 H CH2CH2OCH3 CF N CH3 E1.193 H CH2CH2OCH3 CCl CH CH3 E1.194 H CH2CH2OCH3 CCl N CH3 E1.195 H CH2CH2OCH3 CBr CH CH3 E1.196 H CH2CH2OCH3 CBr N CH3 E1.197 H CH2CH2OCH3 CCH3 CH CH3 E1.198 H CH2CH2OCH3 CCH3 N CH3 E1.199 H CH2CH2OCH3 CCH2CH3 CH CH3 E1.200 H CH2CH2OCH3 CCH2CH3 N CH3 E1.201 H CH2CH2OCH3 CCN CH CH3 E1.202 H CH2CH2OCH3 CCN N CH3 E1.203 H CH2CH2OCH3 COCH3 CH CH3 E1.204 H CH2CH2OCH3 COCH3 N CH3 E1.205 H CH2CN N CH CH3 E1.206 H CH2CN CH CH CH3 E1.207 H CH2CN CH N CH3 E1.208 H CH2CN CF CH CH3 E1.209 H CH2CN CF N CH3 E1.210 H CH2CN CCl CH CH3 E1.211 H CH2CN CCl N CH3 E1.212 H CH2CN CBr CH CH3 E1.213 H CH2CN CBr N CH3 E1.214 H CH2CN CCH3 CH CH3 E1.215 H CH2CN CCH3 N CH3 E1.216 H CH2CN CCH2CH3 CH CH3 E1.217 H CH2CN CCH2CH3 N CH3 E1.218 H CH2CN CCN CH CH3 E1.219 H CH2CN CCN N CH3 E1.220 H CH2CN COCH3 CH CH3 E1.221 H CH2CN COCH3 N CH3 Compounds R3 R4 A2a A2b R1a E1.222 H CH2CH2CN N CH CH3 E1.223 H CH2CH2CN CH CH CH3 E1.224 H CH2CH2CN CH N CH3 E1.225 H CH2CH2CN CF CH CH3 E1.226 H CH2CH2CN CF N CH3 E1.227 H CH2CH2CN CCl CH CH3 E1.228 H CH2CH2CN CCl N CH3 E1.229 H CH2CH2CN CBr CH CH3 E1.230 H CH2CH2CN CBr N CH3 E1.231 H CH2CH2CN CCH3 CH CH3 E1.232 H CH2CH2CN CCH3 N CH3 E1.233 H CH2CH2CN CCH2CH3 CH CH3 E1.234 H CH2CH2CN CCH2CH3 N CH3 E1.235 H CH2CH2CN CCN CH CH3 E1.236 H CH2CH2CN CCN N CH3 E1.237 H CH2CH2CN COCH3 CH CH3 E1.238 H CH2CH2CN COCH3 N CH3 E1.239 N CH CH3 E1.240 CH CH CH3 E1.241 CH N CH3 E1.242 CF CH CH3 E1.243 CF N CH3 E1.244 CCl CH CH3 E1.245 CCl N CH3 Compounds R3 R4 A2a A2b R1a E1.246 CBr CH CH3 E1.247 CBr N CH3 E1.248 CCH3 CH CH3 E1.249 CCH3 N CH3 E1.250 CCH2CH3 CH CH3 E1.251 CCH2CH3 N CH3 E1.252 CCN CH CH3 E1.253 CCN N CH3 E1.254 COCH3 CH CH3 E1.255 COCH3 N CH3 E1.256 N CH CH3 E1.257 CH CH CH3 Compounds R3 R4 A2a A2b R1a E1.258 CH N CH3 E1.259 CF CH CH3 E1.260 CF N CH3 E1.261 CCl CH CH3 E1.262 CCl N CH3 E1.263 CBr CH CH3 E1.264 CBr N CH3 E1.265 CCH3 CH CH3 E1.266 CCH3 N CH3 E1.267 CCH2CH3 CH CH3 Compounds R3 R4 A2a A2b R1a E1.268 CCH2CH3 N CH3 E1.269 CCN CH CH3 E1.270 CCN N CH3 E1.271 COCH3 CH CH3 E1.272 COCH3 N CH3 E1.273 H CH3 N CH CH2CH3 E1.274 H CH3 CH CH CH2CH3 E1.275 H CH3 CH N CH2CH3 E1.276 H CH3 CF CH CH2CH3 E1.277 H CH3 CF N CH2CH3 E1.278 H CH3 CCl CH CH2CH3 E1.279 H CH3 CCl N CH2CH3 E1.280 H CH3 CBr CH CH2CH3 E1.281 H CH3 CBr N CH2CH3 E1.282 H CH3 CCH3 CH CH2CH3 E1.283 H CH3 CCH3 N CH2CH3 E1.284 H CH3 CCH2CH3 CH CH2CH3 E1.285 H CH3 CCH2CH3 N CH2CH3 E1.286 H CH3 CCN CH CH2CH3 E1.287 H CH3 CCN N CH2CH3 E1.288 H CH3 COCH3 CH CH2CH3 E1.289 H CH3 COCH3 N CH2CH3 E1.290 H CH2CH3 N CH CH2CH3 E1.291 H CH2CH3 CH CH CH2CH3 E1.292 H CH2CH3 CH N CH2CH3 Compounds R3 R4 A2a A2b R1a E1.293 H CH2CH3 CF CH CH2CH3 E1.294 H CH2CH3 CF N CH2CH3 E1.295 H CH2CH3 CCl CH CH2CH3 E1.296 H CH2CH3 CCl N CH2CH3 E1.297 H CH2CH3 CBr CH CH2CH3 E1.298 H CH2CH3 CBr N CH2CH3 E1.299 H CH2CH3 CCH3 CH CH2CH3 E1.300 H CH2CH3 CCH3 N CH2CH3 E1.301 H CH2CH3 CCH2CH3 CH CH2CH3 E1.302 H CH2CH3 CCH2CH3 N CH2CH3 E1.303 H CH2CH3 CCN CH CH2CH3 E1.304 H CH2CH3 CCN N CH2CH3 E1.305 H CH2CH3 COCH3 CH CH2CH3 E1.306 H CH2CH3 COCH3 N CH2CH3 E1.307 H CH2OCH3 N CH CH2CH3 E1.308 H CH2OCH3 CH CH CH2CH3 E1.309 H CH2OCH3 CH N CH2CH3 E1.310 H CH2OCH3 CF CH CH2CH3 E1.311 H CH2OCH3 CF N CH2CH3 E1.312 H CH2OCH3 CCl CH CH2CH3 E1.313 H CH2OCH3 CCl N CH2CH3 E1.314 H CH2OCH3 CBr CH CH2CH3 E1.315 H CH2OCH3 CBr N CH2CH3 E1.316 H CH2OCH3 CCH3 CH CH2CH3 E1.317 H CH2OCH3 CCH3 N CH2CH3 E1.318 H CH2OCH3 CCH2CH3 CH CH2CH3 E1.319 H CH2OCH3 CCH2CH3 N CH2CH3 E1.320 H CH2OCH3 CCN CH CH2CH3 E1.321 H CH2OCH3 CCN N CH2CH3 E1.322 H CH2OCH3 COCH3 CH CH2CH3 E1.323 H CH2OCH3 COCH3 N CH2CH3 E1.324 H CH2CH2OCH3 N CH CH2CH3 E1.325 H CH2CH2OCH3 CH CH CH2CH3 E1.326 H CH2CH2OCH3 CH N CH2CH3 E1.327 H CH2CH2OCH3 CF CH CH2CH3 E1.328 H CH2CH2OCH3 CF N CH2CH3 E1.329 H CH2CH2OCH3 CCl CH CH2CH3 E1.330 H CH2CH2OCH3 CCl N CH2CH3 Compounds R3 R4 A2a A2b R1a E1.331 H CH2CH2OCH3 CBr CH CH2CH3 E1.332 H CH2CH2OCH3 CBr N CH2CH3 E1.333 H CH2CH2OCH3 CCH3 CH CH2CH3 E1.334 H CH2CH2OCH3 CCH3 N CH2CH3 E1.335 H CH2CH2OCH3 CCH2CH3 CH CH2CH3 E1.336 H CH2CH2OCH3 CCH2CH3 N CH2CH3 E1.337 H CH2CH2OCH3 CCN CH CH2CH3 E1.338 H CH2CH2OCH3 CCN N CH2CH3 E1.339 H CH2CH2OCH3 COCH3 CH CH2CH3 E1.340 H CH2CH2OCH3 COCH3 N CH2CH3 E1.341 H CH2CN N CH CH2CH3 E1.342 H CH2CN CH CH CH2CH3 E1.343 H CH2CN CH N CH2CH3 E1.344 H CH2CN CF CH CH2CH3 E1.345 H CH2CN CF N CH2CH3 E1.346 H CH2CN CCl CH CH2CH3 E1.347 H CH2CN CCl N CH2CH3 E1.348 H CH2CN CBr CH CH2CH3 E1.349 H CH2CN CBr N CH2CH3 E1.350 H CH2CN CCH3 CH CH2CH3 E1.351 H CH2CN CCH3 N CH2CH3 E1.352 H CH2CN CCH2CH3 CH CH2CH3 E1.353 H CH2CN CCH2CH3 N CH2CH3 E1.354 H CH2CN CCN CH CH2CH3 E1.355 H CH2CN CCN N CH2CH3 E1.356 H CH2CN COCH3 CH CH2CH3 E1.357 H CH2CN COCH3 N CH2CH3 E1.358 H CH2CH2CN N CH CH2CH3 E1.359 H CH2CH2CN CH CH CH2CH3 E1.360 H CH2CH2CN CH N CH2CH3 E1.361 H CH2CH2CN CF CH CH2CH3 E1.362 H CH2CH2CN CF N CH2CH3 E1.363 H CH2CH2CN CCl CH CH2CH3 E1.364 H CH2CH2CN CCl N CH2CH3 E1.365 H CH2CH2CN CBr CH CH2CH3 E1.366 H CH2CH2CN CBr N CH2CH3 E1.367 H CH2CH2CN CCH3 CH CH2CH3 E1.368 H CH2CH2CN CCH3 N CH2CH3 Compounds R3 R4 A2a A2b R1a E1.369 H CH2CH2CN CCH2CH3 CH CH2CH3 E1.370 H CH2CH2CN CCH2CH3 N CH2CH3 E1.371 H CH2CH2CN CCN CH CH2CH3 E1.372 H CH2CH2CN CCN N CH2CH3 E1.373 H CH2CH2CN COCH3 CH CH2CH3 E1.374 H CH2CH2CN COCH3 N CH2CH3 E1.375 N CH CH2CH3 E1.376 CH CH CH2CH3 E1.377 CH N CH2CH3 E1.378 CF CH CH2CH3 E1.379 CF N CH2CH3 E1.380 CCl CH CH2CH3 E1.381 CCl N CH2CH3 E1.382 CBr CH CH2CH3 E1.383 CBr N CH2CH3 E1.384 CCH3 CH CH2CH3 Compounds R3 R4 A2a A2b R1a E1.385 CCH3 N CH2CH3 E1.386 CCH2CH3 CH CH2CH3 E1.387 CCH2CH3 N CH2CH3 E1.388 CCN CH CH2CH3 E1.389 CCN N CH2CH3 E1.390 COCH3 CH CH2CH3 E1.391 COCH3 N CH2CH3 E1.392 N CH CH2CH3 E1.393 CH CH CH2CH3 E1.394 CH N CH2CH3 E1.395 CF CH CH2CH3 Compounds R3 R4 A2a A2b R1a E1.396 CF N CH2CH3 E1.397 CCl CH CH2CH3 E1.398 CCl N CH2CH3 E1.399 CBr CH CH2CH3 E1.400 CBr N CH2CH3 E1.401 CCH3 CH CH2CH3 E1.402 CCH3 N CH2CH3 E1.403 CCH2CH3 CH CH2CH3 E1.404 CCH2CH3 N CH2CH3 E1.405 CCN CH CH2CH3 Compounds R3 R4 A2a A2b R1a E1.406 CCN N CH2CH3 E1.407 COCH3 CH CH2CH3 E1.408 COCH3 N CH2CH3 E1.409 H CH3 N CH CH2OCH3 E1.410 H CH3 CH CH CH2OCH3 E1.411 H CH3 CH N CH2OCH3 E1.412 H CH3 CF CH CH2OCH3 E1.413 H CH3 CF N CH2OCH3 E1.414 H CH3 CCl CH CH2OCH3 E1.415 H CH3 CCl N CH2OCH3 E1.416 H CH3 CBr CH CH2OCH3 E1.417 H CH3 CBr N CH2OCH3 E1.418 H CH3 CCH3 CH CH2OCH3 E1.419 H CH3 CCH3 N CH2OCH3 E1.420 H CH3 CCH2CH3 CH CH2OCH3 E1.421 H CH3 CCH2CH3 N CH2OCH3 E1.422 H CH3 CCN CH CH2OCH3 E1.423 H CH3 CCN N CH2OCH3 E1.424 H CH3 COCH3 CH CH2OCH3 E1.425 H CH3 COCH3 N CH2OCH3 E1.426 H CH2CH3 N CH CH2OCH3 E1.427 H CH2CH3 CH CH CH2OCH3 E1.428 H CH2CH3 CH N CH2OCH3 E1.429 H CH2CH3 CF CH CH2OCH3 E1.430 H CH2CH3 CF N CH2OCH3 E1.431 H CH2CH3 CCl CH CH2OCH3 E1.432 H CH2CH3 CCl N CH2OCH3 E1.433 H CH2CH3 CBr CH CH2OCH3 E1.434 H CH2CH3 CBr N CH2OCH3 E1.435 H CH2CH3 CCH3 CH CH2OCH3 Compounds R3 R4 A2a A2b R1a E1.436 H CH2CH3 CCH3 N CH2OCH3 E1.437 H CH2CH3 CCH2CH3 CH CH2OCH3 E1.438 H CH2CH3 CCH2CH3 N CH2OCH3 E1.439 H CH2CH3 CCN CH CH2OCH3 E1.440 H CH2CH3 CCN N CH2OCH3 E1.441 H CH2CH3 COCH3 CH CH2OCH3 E1.442 H CH2CH3 COCH3 N CH2OCH3 E1.443 H CH2OCH3 N CH CH2OCH3 E1.444 H CH2OCH3 CH CH CH2OCH3 E1.445 H CH2OCH3 CH N CH2OCH3 E1.446 H CH2OCH3 CF CH CH2OCH3 E1.447 H CH2OCH3 CF N CH2OCH3 E1.448 H CH2OCH3 CCl CH CH2OCH3 E1.449 H CH2OCH3 CCl N CH2OCH3 E1.450 H CH2OCH3 CBr CH CH2OCH3 E1.451 H CH2OCH3 CBr N CH2OCH3 E1.452 H CH2OCH3 CCH3 CH CH2OCH3 E1.453 H CH2OCH3 CCH3 N CH2OCH3 E1.454 H CH2OCH3 CCH2CH3 CH CH2OCH3 E1.455 H CH2OCH3 CCH2CH3 N CH2OCH3 E1.456 H CH2OCH3 CCN CH CH2OCH3 E1.457 H CH2OCH3 CCN N CH2OCH3 E1.458 H CH2OCH3 COCH3 CH CH2OCH3 E1.459 H CH2OCH3 COCH3 N CH2OCH3 E1.460 H CH2CH2OCH3 N CH CH2OCH3 E1.461 H CH2CH2OCH3 CH CH CH2OCH3 E1.462 H CH2CH2OCH3 CH N CH2OCH3 E1.463 H CH2CH2OCH3 CF CH CH2OCH3 E1.464 H CH2CH2OCH3 CF N CH2OCH3 E1.465 H CH2CH2OCH3 CCl CH CH2OCH3 E1.466 H CH2CH2OCH3 CCl N CH2OCH3 E1.467 H CH2CH2OCH3 CBr CH CH2OCH3 E1.468 H CH2CH2OCH3 CBr N CH2OCH3 E1.469 H CH2CH2OCH3 CCH3 CH CH2OCH3 E1.470 H CH2CH2OCH3 CCH3 N CH2OCH3 E1.471 H CH2CH2OCH3 CCH2CH3 CH CH2OCH3 E1.472 H CH2CH2OCH3 CCH2CH3 N CH2OCH3 E1.473 H CH2CH2OCH3 CCN CH CH2OCH3 Compounds R3 R4 A2a A2b R1a E1.474 H CH2CH2OCH3 CCN N CH2OCH3 E1.475 H CH2CH2OCH3 COCH3 CH CH2OCH3 E1.476 H CH2CH2OCH3 COCH3 N CH2OCH3 E1.477 H CH2CN N CH CH2OCH3 E1.478 H CH2CN CH CH CH2OCH3 E1.479 H CH2CN CH N CH2OCH3 E1.480 H CH2CN CF CH CH2OCH3 E1.481 H CH2CN CF N CH2OCH3 E1.482 H CH2CN CCl CH CH2OCH3 E1.483 H CH2CN CCl N CH2OCH3 E1.484 H CH2CN CBr CH CH2OCH3 E1.485 H CH2CN CBr N CH2OCH3 E1.486 H CH2CN CCH3 CH CH2OCH3 E1.487 H CH2CN CCH3 N CH2OCH3 E1.488 H CH2CN CCH2CH3 CH CH2OCH3 E1.489 H CH2CN CCH2CH3 N CH2OCH3 E1.490 H CH2CN CCN CH CH2OCH3 E1.491 H CH2CN CCN N CH2OCH3 E1.492 H CH2CN COCH3 CH CH2OCH3 E1.493 H CH2CN COCH3 N CH2OCH3 E1.494 H CH2CH2CN N CH CH2OCH3 E1.495 H CH2CH2CN CH CH CH2OCH3 E1.496 H CH2CH2CN CH N CH2OCH3 E1.497 H CH2CH2CN CF CH CH2OCH3 E1.498 H CH2CH2CN CF N CH2OCH3 E1.499 H CH2CH2CN CCl CH CH2OCH3 E1.500 H CH2CH2CN CCl N CH2OCH3 E1.501 H CH2CH2CN CBr CH CH2OCH3 E1.502 H CH2CH2CN CBr N CH2OCH3 E1.503 H CH2CH2CN CCH3 CH CH2OCH3 E1.504 H CH2CH2CN CCH3 N CH2OCH3 E1.505 H CH2CH2CN CCH2CH3 CH CH2OCH3 E1.506 H CH2CH2CN CCH2CH3 N CH2OCH3 E1.507 H CH2CH2CN CCN CH CH2OCH3 E1.508 H CH2CH2CN CCN N CH2OCH3 E1.509 H CH2CH2CN COCH3 CH CH2OCH3 E1.510 H CH2CH2CN COCH3 N CH2OCH3 Compounds R3 R4 A2a A2b R1a E1.511 N CH CH2OCH3 E1.512 CH CH CH2OCH3 E1.513 CH N CH2OCH3 E1.514 CF CH CH2OCH3 E1.515 CF N CH2OCH3 E1.516 CCl CH CH2OCH3 E1.517 CCl N CH2OCH3 E1.518 CBr CH CH2OCH3 E1.519 CBr N CH2OCH3 E1.520 CCH3 CH CH2OCH3 E1.521 CCH3 N CH2OCH3 E1.522 CCH2CH3 CH CH2OCH3 Compounds R3 R4 A2a A2b R1a E1.523 CCH2CH3 N CH2OCH3 E1.524 CCN CH CH2OCH3 E1.525 CCN N CH2OCH3 E1.526 COCH3 CH CH2OCH3 E1.527 COCH3 N CH2OCH3 E1.528 N CH CH2OCH3 E1.529 CH CH CH2OCH3 E1.530 CH N CH2OCH3 E1.531 CF CH CH2OCH3 E1.532 CF N CH2OCH3 E1.533 CCl CH CH2OCH3 Compounds R3 R4 A2a A2b R1a E1.534 CCl N CH2OCH3 E1.535 CBr CH CH2OCH3 E1.536 CBr N CH2OCH3 E1.537 CCH3 CH CH2OCH3 E1.538 CCH3 N CH2OCH3 E1.539 CCH2CH3 CH CH2OCH3 E1.540 CCH2CH3 N CH2OCH3 E1.541 CCN CH CH2OCH3 E1.542 CCN N CH2OCH3 E1.543 COCH3 CH CH2OCH3 Compounds R3 R4 A2a A2b R1a E1.544 COCH3 N CH2OCH3 E1.545 H CH3 N CH cyclopropyl E1.546 H CH3 CH CH cyclopropyl E1.547 H CH3 CH N cyclopropyl E1.548 H CH3 CF CH cyclopropyl E1.549 H CH3 CF N cyclopropyl E1.550 H CH3 CCl CH cyclopropyl E1.551 H CH3 CCl N cyclopropyl E1.552 H CH3 CBr CH cyclopropyl E1.553 H CH3 CBr N cyclopropyl E1.554 H CH3 CCH3 CH cyclopropyl E1.555 H CH3 CCH3 N cyclopropyl E1.556 H CH3 CCH2CH3 CH cyclopropyl E1.557 H CH3 CCH2CH3 N cyclopropyl E1.558 H CH3 CCN CH cyclopropyl E1.559 H CH3 CCN N cyclopropyl E1.560 H CH3 COCH3 CH cyclopropyl E1.561 H CH3 COCH3 N cyclopropyl E1.562 H CH2CH3 N CH cyclopropyl E1.563 H CH2CH3 CH CH cyclopropyl E1.564 H CH2CH3 CH N cyclopropyl E1.565 H CH2CH3 CF CH cyclopropyl E1.566 H CH2CH3 CF N cyclopropyl E1.567 H CH2CH3 CCl CH cyclopropyl E1.568 H CH2CH3 CCl N cyclopropyl E1.569 H CH2CH3 CBr CH cyclopropyl E1.570 H CH2CH3 CBr N cyclopropyl E1.571 H CH2CH3 CCH3 CH cyclopropyl E1.572 H CH2CH3 CCH3 N cyclopropyl E1.573 H CH2CH3 CCH2CH3 CH cyclopropyl E1.574 H CH2CH3 CCH2CH3 N cyclopropyl E1.575 H CH2CH3 CCN CH cyclopropyl E1.576 H CH2CH3 CCN N cyclopropyl E1.577 H CH2CH3 COCH3 CH cyclopropyl E1.578 H CH2CH3 COCH3 N cyclopropyl E1.579 H CH2OCH3 N CH cyclopropyl Compounds R3 R4 A2a A2b R1a E1.580 H CH2OCH3 CH CH cyclopropyl E1.581 H CH2OCH3 CH N cyclopropyl E1.582 H CH2OCH3 CF CH cyclopropyl E1.583 H CH2OCH3 CF N cyclopropyl E1.584 H CH2OCH3 CCl CH cyclopropyl E1.585 H CH2OCH3 CCl N cyclopropyl E1.586 H CH2OCH3 CBr CH cyclopropyl E1.587 H CH2OCH3 CBr N cyclopropyl E1.588 H CH2OCH3 CCH3 CH cyclopropyl E1.589 H CH2OCH3 CCH3 N cyclopropyl E1.590 H CH2OCH3 CCH2CH3 CH cyclopropyl E1.591 H CH2OCH3 CCH2CH3 N cyclopropyl E1.592 H CH2OCH3 CCN CH cyclopropyl E1.593 H CH2OCH3 CCN N cyclopropyl E1.594 H CH2OCH3 COCH3 CH cyclopropyl E1.595 H CH2OCH3 COCH3 N cyclopropyl E1.596 H CH2CH2OCH3 N CH cyclopropyl E1.597 H CH2CH2OCH3 CH CH cyclopropyl E1.598 H CH2CH2OCH3 CH N cyclopropyl E1.599 H CH2CH2OCH3 CF CH cyclopropyl E1.600 H CH2CH2OCH3 CF N cyclopropyl E1.601 H CH2CH2OCH3 CCl CH cyclopropyl E1.602 H CH2CH2OCH3 CCl N cyclopropyl E1.603 H CH2CH2OCH3 CBr CH cyclopropyl E1.604 H CH2CH2OCH3 CBr N cyclopropyl E1.605 H CH2CH2OCH3 CCH3 CH cyclopropyl E1.606 H CH2CH2OCH3 CCH3 N cyclopropyl E1.607 H CH2CH2OCH3 CCH2CH3 CH cyclopropyl E1.608 H CH2CH2OCH3 CCH2CH3 N cyclopropyl E1.609 H CH2CH2OCH3 CCN CH cyclopropyl E1.610 H CH2CH2OCH3 CCN N cyclopropyl E1.611 H CH2CH2OCH3 COCH3 CH cyclopropyl E1.612 H CH2CH2OCH3 COCH3 N cyclopropyl E1.613 H CH2CN N CH cyclopropyl E1.614 H CH2CN CH CH cyclopropyl E1.615 H CH2CN CH N cyclopropyl E1.616 H CH2CN CF CH cyclopropyl E1.617 H CH2CN CF N cyclopropyl Compounds R3 R4 A2a A2b R1a E1.618 H CH2CN CCl CH cyclopropyl E1.619 H CH2CN CCl N cyclopropyl E1.620 H CH2CN CBr CH cyclopropyl E1.621 H CH2CN CBr N cyclopropyl E1.622 H CH2CN CCH3 CH cyclopropyl E1.623 H CH2CN CCH3 N cyclopropyl E1.624 H CH2CN CCH2CH3 CH cyclopropyl E1.625 H CH2CN CCH2CH3 N cyclopropyl E1.626 H CH2CN CCN CH cyclopropyl E1.627 H CH2CN CCN N cyclopropyl E1.628 H CH2CN COCH3 CH cyclopropyl E1.629 H CH2CN COCH3 N cyclopropyl E1.630 H CH2CH2CN N CH cyclopropyl E1.631 H CH2CH2CN CH CH cyclopropyl E1.632 H CH2CH2CN CH N cyclopropyl E1.633 H CH2CH2CN CF CH cyclopropyl E1.634 H CH2CH2CN CF N cyclopropyl E1.635 H CH2CH2CN CCl CH cyclopropyl E1.636 H CH2CH2CN CCl N cyclopropyl E1.637 H CH2CH2CN CBr CH cyclopropyl E1.638 H CH2CH2CN CBr N cyclopropyl E1.639 H CH2CH2CN CCH3 CH cyclopropyl E1.640 H CH2CH2CN CCH3 N cyclopropyl E1.641 H CH2CH2CN CCH2CH3 CH cyclopropyl E1.642 H CH2CH2CN CCH2CH3 N cyclopropyl E1.643 H CH2CH2CN CCN CH cyclopropyl E1.644 H CH2CH2CN CCN N cyclopropyl E1.645 H CH2CH2CN COCH3 CH cyclopropyl E1.646 H CH2CH2CN COCH3 N cyclopropyl E1.647 N CH cyclopropyl E1.648 CH CH cyclopropyl E1.649 CH N cyclopropyl Compounds R3 R4 A2a A2b R1a E1.650 CF CH cyclopropyl E1.651 CF N cyclopropyl E1.652 CCl CH cyclopropyl E1.653 CCl N cyclopropyl E1.654 CBr CH cyclopropyl E1.655 CBr N cyclopropyl E1.656 CCH3 CH cyclopropyl E1.657 CCH3 N cyclopropyl E1.658 CCH2CH3 CH cyclopropyl E1.659 CCH2CH3 N cyclopropyl E1.660 CCN CH cyclopropyl E1.661 CCN N cyclopropyl Compounds R3 R4 A2a A2b R1a E1.662 COCH3 CH cyclopropyl E1.663 COCH3 N cyclopropyl E1.664 N CH cyclopropyl E1.665 CH CH cyclopropyl E1.666 CH N cyclopropyl E1.667 CF CH cyclopropyl E1.668 CF N cyclopropyl E1.669 CCl CH cyclopropyl E1.670 CCl N cyclopropyl E1.671 CBr CH cyclopropyl Compounds R3 R4 A2a A2b R1a E1.672 CBr N cyclopropyl E1.673 CCH3 CH cyclopropyl E1.674 CCH3 N cyclopropyl E1.675 CCH2CH3 CH cyclopropyl E1.676 CCH2CH3 N cyclopropyl E1.677 CCN CH cyclopropyl E1.678 CCN N cyclopropyl E1.679 COCH3 CH cyclopropyl E1.680 COCH3 N cyclopropyl E1.681 H CH3 N CH NHAc E1.682 H CH3 CH CH NHAc E1.683 H CH3 CH N NHAc E1.684 H CH3 CF CH NHAc E1.685 H CH3 CF N NHAc Compounds R3 R4 A2a A2b R1a E1.686 H CH3 CCl CH NHAc E1.687 H CH3 CCl N NHAc E1.688 H CH3 CBr CH NHAc E1.689 H CH3 CBr N NHAc E1.690 H CH3 CCH3 CH NHAc E1.691 H CH3 CCH3 N NHAc E1.692 H CH3 CCH2CH3 CH NHAc E1.693 H CH3 CCH2CH3 N NHAc E1.694 H CH3 CCN CH NHAc E1.695 H CH3 CCN N NHAc E1.696 H CH3 COCH3 CH NHAc E1.697 H CH3 COCH3 N NHAc E1.698 H CH2CH3 N CH NHAc E1.699 H CH2CH3 CH CH NHAc E1.700 H CH2CH3 CH N NHAc E1.701 H CH2CH3 CF CH NHAc E1.702 H CH2CH3 CF N NHAc E1.703 H CH2CH3 CCl CH NHAc E1.704 H CH2CH3 CCl N NHAc E1.705 H CH2CH3 CBr CH NHAc E1.706 H CH2CH3 CBr N NHAc E1.707 H CH2CH3 CCH3 CH NHAc E1.708 H CH2CH3 CCH3 N NHAc E1.709 H CH2CH3 CCH2CH3 CH NHAc E1.710 H CH2CH3 CCH2CH3 N NHAc E1.711 H CH2CH3 CCN CH NHAc E1.712 H CH2CH3 CCN N NHAc E1.713 H CH2CH3 COCH3 CH NHAc E1.714 H CH2CH3 COCH3 N NHAc E1.715 H CH2OCH3 N CH NHAc E1.716 H CH2OCH3 CH CH NHAc E1.717 H CH2OCH3 CH N NHAc E1.718 H CH2OCH3 CF CH NHAc E1.719 H CH2OCH3 CF N NHAc E1.720 H CH2OCH3 CCl CH NHAc E1.721 H CH2OCH3 CCl N NHAc E1.722 H CH2OCH3 CBr CH NHAc E1.723 H CH2OCH3 CBr N NHAc Compounds R3 R4 A2a A2b R1a E1.724 H CH2OCH3 CCH3 CH NHAc E1.725 H CH2OCH3 CCH3 N NHAc E1.726 H CH2OCH3 CCH2CH3 CH NHAc E1.727 H CH2OCH3 CCH2CH3 N NHAc E1.728 H CH2OCH3 CCN CH NHAc E1.729 H CH2OCH3 CCN N NHAc E1.730 H CH2OCH3 COCH3 CH NHAc E1.731 H CH2OCH3 COCH3 N NHAc E1.732 H CH2CH2OCH3 N CH NHAc E1.733 H CH2CH2OCH3 CH CH NHAc E1.734 H CH2CH2OCH3 CH N NHAc E1.735 H CH2CH2OCH3 CF CH NHAc E1.736 H CH2CH2OCH3 CF N NHAc E1.737 H CH2CH2OCH3 CCl CH NHAc E1.738 H CH2CH2OCH3 CCl N NHAc E1.739 H CH2CH2OCH3 CBr CH NHAc E1.740 H CH2CH2OCH3 CBr N NHAc E1.741 H CH2CH2OCH3 CCH3 CH NHAc E1.742 H CH2CH2OCH3 CCH3 N NHAc E1.743 H CH2CH2OCH3 CCH2CH3 CH NHAc E1.744 H CH2CH2OCH3 CCH2CH3 N NHAc E1.745 H CH2CH2OCH3 CCN CH NHAc E1.746 H CH2CH2OCH3 CCN N NHAc E1.747 H CH2CH2OCH3 COCH3 CH NHAc E1.748 H CH2CH2OCH3 COCH3 N NHAc E1.749 H CH2CN N CH NHAc E1.750 H CH2CN CH CH NHAc E1.751 H CH2CN CH N NHAc E1.752 H CH2CN CF CH NHAc E1.753 H CH2CN CF N NHAc E1.754 H CH2CN CCl CH NHAc E1.755 H CH2CN CCl N NHAc E1.756 H CH2CN CBr CH NHAc E1.757 H CH2CN CBr N NHAc E1.758 H CH2CN CCH3 CH NHAc E1.759 H CH2CN CCH3 N NHAc E1.760 H CH2CN CCH2CH3 CH NHAc E1.761 H CH2CN CCH2CH3 N NHAc Compounds R3 R4 A2a A2b R1a E1.762 H CH2CN CCN CH NHAc E1.763 H CH2CN CCN N NHAc E1.764 H CH2CN COCH3 CH NHAc E1.765 H CH2CN COCH3 N NHAc E1.766 H CH2CH2CN N CH NHAc E1.767 H CH2CH2CN CH CH NHAc E1.768 H CH2CH2CN CH N NHAc E1.769 H CH2CH2CN CF CH NHAc E1.770 H CH2CH2CN CF N NHAc E1.771 H CH2CH2CN CCl CH NHAc E1.772 H CH2CH2CN CCl N NHAc E1.773 H CH2CH2CN CBr CH NHAc E1.774 H CH2CH2CN CBr N NHAc E1.775 H CH2CH2CN CCH3 CH NHAc E1.776 H CH2CH2CN CCH3 N NHAc E1.777 H CH2CH2CN CCH2CH3 CH NHAc E1.778 H CH2CH2CN CCH2CH3 N NHAc E1.779 H CH2CH2CN CCN CH NHAc E1.780 H CH2CH2CN CCN N NHAc E1.781 H CH2CH2CN COCH3 CH NHAc E1.782 H CH2CH2CN COCH3 N NHAc E1.783 N CH NHAc E1.784 CH CH NHAc E1.785 CH N NHAc E1.786 CF CH NHAc E1.787 CF N NHAc Compounds R3 R4 A2a A2b R1a E1.788 CCl CH NHAc E1.789 CCl N NHAc E1.790 CBr CH NHAc E1.791 CBr N NHAc E1.792 CCH3 CH NHAc E1.793 CCH3 N NHAc E1.794 CCH2CH3 CH NHAc E1.795 CCH2CH3 N NHAc E1.796 CCN CH NHAc E1.797 CCN N NHAc E1.798 COCH3 CH NHAc E1.799 COCH3 N NHAc Compounds R3 R4 A2a A2b R1a E1.800 N CH NHAc E1.801 CH CH NHAc E1.802 CH N NHAc E1.803 CF CH NHAc E1.804 CF N NHAc E1.805 CCl CH NHAc E1.806 CCl N NHAc E1.807 CBr CH NHAc E1.808 CBr N NHAc E1.809 CCH3 CH NHAc Compounds R3 R4 A2a A2b R1a E1.810 CCH3 N NHAc E1.811 CCH2CH3 CH NHAc E1.812 CCH2CH3 N NHAc E1.813 CCN CH NHAc E1.814 CCN N NHAc E1.815 COCH3 CH NHAc E1.816 COCH3 N NHAc E1.817 H CH3 N CH CN E1.818 H CH3 CH CH CN E1.819 H CH3 CH N CN E1.820 H CH3 CF CH CN E1.821 H CH3 CF N CN E1.822 H CH3 CCl CH CN E1.823 H CH3 CCl N CN E1.824 H CH3 CBr CH CN E1.825 H CH3 CBr N CN E1.826 H CH3 CCH3 CH CN E1.827 H CH3 CCH3 N CN E1.828 H CH3 CCH2CH3 CH CN Compounds R3 R4 A2a A2b R1a E1.829 H CH3 CCH2CH3 N CN E1.830 H CH3 CCN CH CN E1.831 H CH3 CCN N CN E1.832 H CH3 COCH3 CH CN E1.833 H CH3 COCH3 N CN E1.834 H CH2CH3 N CH CN E1.835 H CH2CH3 CH CH CN E1.836 H CH2CH3 CH N CN E1.837 H CH2CH3 CF CH CN E1.838 H CH2CH3 CF N CN E1.839 H CH2CH3 CCl CH CN E1.840 H CH2CH3 CCl N CN E1.841 H CH2CH3 CBr CH CN E1.842 H CH2CH3 CBr N CN E1.843 H CH2CH3 CCH3 CH CN E1.844 H CH2CH3 CCH3 N CN E1.845 H CH2CH3 CCH2CH3 CH CN E1.846 H CH2CH3 CCH2CH3 N CN E1.847 H CH2CH3 CCN CH CN E1.848 H CH2CH3 CCN N CN E1.849 H CH2CH3 COCH3 CH CN E1.850 H CH2CH3 COCH3 N CN E1.851 H CH2OCH3 N CH CN E1.852 H CH2OCH3 CH CH CN E1.853 H CH2OCH3 CH N CN E1.854 H CH2OCH3 CF CH CN E1.855 H CH2OCH3 CF N CN E1.856 H CH2OCH3 CCl CH CN E1.857 H CH2OCH3 CCl N CN E1.858 H CH2OCH3 CBr CH CN E1.859 H CH2OCH3 CBr N CN E1.860 H CH2OCH3 CCH3 CH CN E1.861 H CH2OCH3 CCH3 N CN E1.862 H CH2OCH3 CCH2CH3 CH CN E1.863 H CH2OCH3 CCH2CH3 N CN E1.864 H CH2OCH3 CCN CH CN E1.865 H CH2OCH3 CCN N CN E1.866 H CH2OCH3 COCH3 CH CN Compounds R3 R4 A2a A2b R1a E1.867 H CH2OCH3 COCH3 N CN E1.868 H CH2CH2OCH3 N CH CN E1.869 H CH2CH2OCH3 CH CH CN E1.870 H CH2CH2OCH3 CH N CN E1.871 H CH2CH2OCH3 CF CH CN E1.872 H CH2CH2OCH3 CF N CN E1.873 H CH2CH2OCH3 CCl CH CN E1.874 H CH2CH2OCH3 CCl N CN E1.875 H CH2CH2OCH3 CBr CH CN E1.876 H CH2CH2OCH3 CBr N CN E1.877 H CH2CH2OCH3 CCH3 CH CN E1.878 H CH2CH2OCH3 CCH3 N CN E1.879 H CH2CH2OCH3 CCH2CH3 CH CN E1.880 H CH2CH2OCH3 CCH2CH3 N CN E1.881 H CH2CH2OCH3 CCN CH CN E1.882 H CH2CH2OCH3 CCN N CN E1.883 H CH2CH2OCH3 COCH3 CH CN E1.884 H CH2CH2OCH3 COCH3 N CN E1.885 H CH2CN N CH CN E1.886 H CH2CN CH CH CN E1.887 H CH2CN CH N CN E1.888 H CH2CN CF CH CN E1.889 H CH2CN CF N CN E1.890 H CH2CN CCl CH CN E1.891 H CH2CN CCl N CN E1.892 H CH2CN CBr CH CN E1.893 H CH2CN CBr N CN E1.894 H CH2CN CCH3 CH CN E1.895 H CH2CN CCH3 N CN E1.896 H CH2CN CCH2CH3 CH CN E1.897 H CH2CN CCH2CH3 N CN E1.898 H CH2CN CCN CH CN E1.899 H CH2CN CCN N CN E1.900 H CH2CN COCH3 CH CN E1.901 H CH2CN COCH3 N CN E1.902 H CH2CH2CN N CH CN E1.903 H CH2CH2CN CH CH CN E1.904 H CH2CH2CN CH N CN Compounds R3 R4 A2a A2b R1a E1.905 H CH2CH2CN CF CH CN E1.906 H CH2CH2CN CF N CN E1.907 H CH2CH2CN CCl CH CN E1.908 H CH2CH2CN CCl N CN E1.909 H CH2CH2CN CBr CH CN E1.910 H CH2CH2CN CBr N CN E1.911 H CH2CH2CN CCH3 CH CN E1.912 H CH2CH2CN CCH3 N CN E1.913 H CH2CH2CN CCH2CH3 CH CN E1.914 H CH2CH2CN CCH2CH3 N CN E1.915 H CH2CH2CN CCN CH CN E1.916 H CH2CH2CN CCN N CN E1.917 H CH2CH2CN COCH3 CH CN E1.918 H CH2CH2CN COCH3 N CN E1.919 N CH CN E1.920 CH CH CN E1.921 CH N CN E1.922 CF CH CN E1.923 CF N CN E1.924 CCl CH CN E1.925 CCl N CN E1.926 CBr CH CN Compounds R3 R4 A2a A2b R1a E1.927 CBr N CN E1.928 CCH3 CH CN E1.929 CCH3 N CN E1.930 CCH2CH3 CH CN E1.931 CCH2CH3 N CN E1.932 CCN CH CN E1.933 CCN N CN E1.934 COCH3 CH CN E1.935 COCH3 N CN E1.936 N CH CN E1.937 CH CH CN E1.938 CH N CN Compounds R3 R4 A2a A2b R1a E1.939 CF CH CN E1.940 CF N CN E1.941 CCl CH CN E1.942 CCl N CN E1.943 CBr CH CN E1.944 CBr N CN E1.945 CCH3 CH CN E1.946 CCH3 N CN E1.947 CCH2CH3 CH CN E1.948 CCH2CH3 N CN Compounds R3 R4 A2a A2b R1a E1.949 CCN CH CN E1.950 CCN N CN E1.951 COCH3 CH CN E1.952 COCH3 N CN Table 1.2 provides compounds E2.1 to E2.952 of formula (Ia) wherein R2 is H, R5 is CH3, A4 is N and R1a, R3, R4, A2a, A2b are as defined in table Z1. Table 1.3 provides compounds E3.1 to E3.952 of formula (Ia) wherein R2 is H, R5 is OCH3, A4 is CH and R1a, R3, R4, A2a, A2b are as defined in table Z1. Table 1.4 provides compounds E4.1 to E4.952 of formula (Ia) wherein R2 is H, R5 is OCH3, A4 is N and R1a, R3, R4, A2a, A2b are as defined in table Z1. Table 1.5 provides compounds E5.1 to E5.952 of formula (Ia) wherein R2 is H, R5 is cyclopropyl, A4 is CH and R1a, R3, R4, A2a, A2b are as defined in table Z1. Table 1.6 provides compounds E6.1 to E6.952 of formula (Ia) wherein R2 is H, R5 is cyclopropyl, A4 is N and R1a, R3, R4, A2a, A2b are as defined in table Z1. Table 1.7 provides compounds E7.1 to E7.952 of formula (Ia) wherein R2 is H, R5 is CH2OCH3, A4 is CH and R1a, R3, R4, A2a, A2b are as defined in table Z1. Table 1.8 provides compounds E8.1 to E8.952 of formula (Ia) wherein R2 is H, R5 is CH2OCH3, A4 is N and R1a, R3, R4, A2a, A2b are as defined in table Z1. Table 1.9 provides compounds E9.1 to E9.952 of formula (Ia) wherein R2 is H, R5 is NHCH2CH3, A4 is CH and R1a, R3, R4, A2a, A2b are as defined in table Z1. Table 1.10 provides compounds E10.1 to E10.952 of formula (Ia) wherein R2 is H, R5 is NHCH2CH3, A4 is N and R1a, R3, R4, A2a, A2b are as defined in table Z1. Table 1.11 provides compounds E11.1 to E11.952 of formula (Ia) wherein R2 is CH3, R5 is CH3, A4 is CH and R1a, R3, R4, A2a, A2b are as defined in table Z1. Table 1.12 provides compounds E12.1 to E12.952 of formula (Ia) wherein R2 is CH3, R5 is CH3, A4 is N and R1a, R3, R4, A2a, A2b are as defined in table Z1. Table 1.13 provides compounds E13.1 to E13.952 of formula (Ia) wherein R2 is CH3, R5 is OCH3, A4 is CH and R1a, R3, R4, A2a, A2b are as defined in table Z1. Table 1.14 provides compounds E14.1 to E14.952 of formula (Ia) wherein R2 is CH3, R5 is OCH3, A4 is N and R1a, R3, R4, A2a, A2b are as defined in table Z1. Table 1.15 provides compounds E15.1 to E15.952 of formula (Ia) wherein R2 is CH3, R5 is cyclopropyl, A4 is CH and R1a, R3, R4, A2a, A2b are as defined in table Z1. Table 1.16 provides compounds E16.1 to E16.952 of formula (Ia) wherein R2 is CH3, R5 is cyclopropyl, A4 is N and R1a, R3, R4, A2a, A2b are as defined in table Z1. Table 1.17 provides compounds E17.1 to E17.952 of formula (Ia) wherein R2 is CH3, R5 is CH2OCH3, A4 is CH and R1a, R3, R4, A2a, A2b are as defined in table Z1. Table 1.18 provides compounds E18.1 to E18.952 of formula (Ia) wherein R2 is CH3, R5 is CH2OCH3, A4 is N and R1a, R3, R4, A2a, A2b are as defined in table Z1. Table 1.19 provides compounds E19.1 to E19.952 of formula (Ia) wherein R2 is CH3, R5 is NHCH2CH3, A4 is CH and R1a, R3, R4, A2a, A2b are as defined in table Z1. Table 1.20 provides compounds E20.1 to E20.952 of formula (Ia) wherein R2 is CH3, R5 is NHCH2CH3, A4 is N and R1a, R3, R4, A2a, A2b are as defined in table Z1. Table 1.21 provides compounds E21.1 to E21.952 of formula (Ia) wherein R2 is CH2CH3, R5 is CH3, A4 is CH and R1a, R3, R4, A2a, A2b are as defined in table Z1. Table 1.22 provides compounds E22.1 to E22.952 of formula (Ia) wherein R2 is CH2CH3, R5 is CH3, A4 is N and R1a, R3, R4, A2a, A2b are as defined in table Z1. Table 1.23 provides compounds E23.1 to E23.952 of formula (Ia) wherein R2 is CH2CH3, R5 is OCH3, A4 is CH and R1a, R3, R4, A2a, A2b are as defined in table Z1. Table 1.24 provides compounds E24.1 to E24.952 of formula (Ia) wherein R2 is CH2CH3, R5 is OCH3, A4 is N and R1a, R3, R4, A2a, A2b are as defined in table Z1. Table 1.25 provides compounds E25.1 to E25.952 of formula (Ia) wherein R2 is CH2CH3, R5 is cyclopropyl, A4 is CH and R1a, R3, R4, A2a, A2b are as defined in table Z1. Table 1.26 provides compounds E26.1 to E26.952 of formula (Ia) wherein R2 is CH2CH3, R5 is cyclopropyl, A4 is N and R1a, R3, R4, A2a, A2b are as defined in table Z1. Table 1.27 provides compounds E27.1 to E27.952 of formula (Ia) wherein R2 is CH2CH3, R5 is CH2OCH3, A4 is CH and R1a, R3, R4, A2a, A2b are as defined in table Z1. Table 1.28 provides compounds E28.1 to E28.952 of formula (Ia) wherein R2 is CH2CH3, R5 is CH2OCH3, A4 is N and R1a, R3, R4, A2a, A2b are as defined in table Z1. Table 1.29 provides compounds E29.1 to E29.952 of formula (Ia) wherein R2 is CH2CH3, R5 is NHCH2CH3, A4 is CH and R1a, R3, R4, A2a, A2b are as defined in table Z1. Table 1.30 provides compounds E30.1 to E30.952 of formula (Ia) wherein R2 is CH2CH3, R5 is NHCH2CH3, A4 is N and R1a, R3, R4, A2a, A2b are as defined in table Z1. Table 1.31 provides compounds E31.1 to E31.952 of formula (Ia) wherein R2 is F, R5 is CH3, A4 is CH and R1a, R3, R4, A2a, A2b are as defined in table Z1. Table 1.32 provides compounds E32.1 to E32.952 of formula (Ia) wherein R2 is F, R5 is CH3, A4 is N and R1a, R3, R4, A2a, A2b are as defined in table Z1. Table 1.33 provides compounds E33.1 to E33.952 of formula (Ia) wherein R2 is F, R5 is OCH3, A4 is CH and R1a, R3, R4, A2a, A2b are as defined in table Z1. Table 1.34 provides compounds E34.1 to E34.952 of formula (Ia) wherein R2 is F, R5 is OCH3, A4 is N and R1a, R3, R4, A2a, A2b are as defined in table Z1. Table 1.35 provides compounds E35.1 to E35.952 of formula (Ia) wherein R2 is F, R5 is cyclopropyl, A4 is CH and R1a, R3, R4, A2a, A2b are as defined in table Z1. Table 1.36 provides compounds E36.1 to E36.952 of formula (Ia) wherein R2 is F, R5 is cyclopropyl, A4 is N and R1a, R3, R4, A2a, A2b are as defined in table Z1. Table 1.37 provides compounds E37.1 to E37.952 of formula (Ia) wherein R2 is F, R5 is CH2OCH3, A4 is CH and R1a, R3, R4, A2a, A2b are as defined in table Z1. Table 1.38 provides compounds E38.1 to E38.952 of formula (Ia) wherein R2 is F, R5 is CH2OCH3, A4 is N and R1a, R3, R4, A2a, A2b are as defined in table Z1. Table 1.39 provides compounds E39.1 to E39.952 of formula (Ia) wherein R2 is F, R5 is NHCH2CH3, A4 is CH and R1a, R3, R4, A2a, A2b are as defined in table Z1. Table 1.40 provides compounds E40.1 to E40.952 of formula (Ia) wherein R2 is F, R5 is NHCH2CH3, A4 is N and R1a, R3, R4, A2a, A2b are as defined in table Z1. Table 1.41 provides compounds E41.1 to E41.952 of formula (Ia) wherein R2 is Cl, R5 is CH3, A4 is CH and R1a, R3, R4, A2a, A2b are as defined in table Z1. Table 1.42 provides compounds E42.1 to E42.952 of formula (Ia) wherein R2 is Cl, R5 is CH3, A4 is N and R1a, R3, R4, A2a, A2b are as defined in table Z1. Table 1.43 provides compounds E43.1 to E43.952 of formula (Ia) wherein R2 is Cl, R5 is OCH3, A4 is CH and R1a, R3, R4, A2a, A2b are as defined in table Z1. Table 1.44 provides compounds E44.1 to E44.952 of formula (Ia) wherein R2 is Cl, R5 is OCH3, A4 is N and R1a, R3, R4, A2a, A2b are as defined in table Z1. Table 1.45 provides compounds E45.1 to E45.952 of formula (Ia) wherein R2 is Cl, R5 is cyclopropyl, A4 is CH and R1a, R3, R4, A2a, A2b are as defined in table Z1. Table 1.46 provides compounds E46.1 to E46.952 of formula (Ia) wherein R2 is Cl, R5 is cyclopropyl, A4 is N and R1a, R3, R4, A2a, A2b are as defined in table Z1. Table 1.47 provides compounds E47.1 to E47.952 of formula (Ia) wherein R2 is Cl, R5 is CH2OCH3, A4 is CH and R1a, R3, R4, A2a, A2b are as defined in table Z1. Table 1.48 provides compounds E48.1 to E48.952 of formula (Ia) wherein R2 is Cl, R5 is CH2OCH3, A4 is N and R1a, R3, R4, A2a, A2b are as defined in table Z1. Table 1.49 provides compounds E49.1 to E49.952 of formula (Ia) wherein R2 is Cl, R5 is NHCH2CH3, A4 is CH and R1a, R3, R4, A2a, A2b are as defined in table Z1. Table 1.50 provides compounds E50.1 to E50.952 of formula (Ia) wherein R2 is Cl, R5 is NHCH2CH3, A4 is N and R1a, R3, R4, A2a, A2b are as defined in table Z1. Table 1.51 provides compounds E51.1 to E51.952 of formula (Ia) wherein R2 is Br, R5 is CH3, A4 is CH and R1a, R3, R4, A2a, A2b are as defined in table Z1. Table 1.52 provides compounds E52.1 to E52.952 of formula (Ia) wherein R2 is Br, R5 is CH3, A4 is N and R1a, R3, R4, A2a, A2b are as defined in table Z1. Table 1.53 provides compounds E53.1 to E53.952 of formula (Ia) wherein R2 is Br, R5 is OCH3, A4 is CH and R1a, R3, R4, A2a, A2b are as defined in table Z1. Table 1.54 provides compounds E54.1 to E54.952 of formula (Ia) wherein R2 is Br, R5 is OCH3, A4 is N and R1a, R3, R4, A2a, A2b are as defined in table Z1. Table 1.55 provides compounds E55.1 to E55.952 of formula (Ia) wherein R2 is Br, R5 is cyclopropyl, A4 is CH and R1a, R3, R4, A2a, A2b are as defined in table Z1. Table 1.56 provides compounds E56.1 to E56.952 of formula (Ia) wherein R2 is Br, R5 is cyclopropyl, A4 is N and R1a, R3, R4, A2a, A2b are as defined in table Z1. Table 1.57 provides compounds E57.1 to E57.952 of formula (Ia) wherein R2 is Br, R5 is CH2OCH3, A4 is CH and R1a, R3, R4, A2a, A2b are as defined in table Z1. Table 1.58 provides compounds E58.1 to E58.952 of formula (Ia) wherein R2 is Br, R5 is CH2OCH3, A4 is N and R1a, R3, R4, A2a, A2b are as defined in table Z1. Table 1.59 provides compounds E59.1 to E59.952 of formula (Ia) wherein R2 is Br, R5 is NHCH2CH3, A4 is CH and R1a, R3, R4, A2a, A2b are as defined in table Z1. Table 1.60 provides compounds E60.1 to E60.952 of formula (Ia) wherein R2 is Br, R5 is NHCH2CH3, A4 is N and R1a, R3, R4, A2a, A2b are as defined in table Z1. Table 1.61 provides compounds E61.1 to E61.952 of formula (Ia) wherein R2 is CN, R5 is CH3, A4 is CH and R1a, R3, R4, A2a, A2b are as defined in table Z1. Table 1.62 provides compounds E62.1 to E62.952 of formula (Ia) wherein R2 is CN, R5 is CH3, A4 is N and R1a, R3, R4, A2a, A2b are as defined in table Z1. Table 1.63 provides compounds E63.1 to E63.952 of formula (Ia) wherein R2 is CN, R5 is OCH3, A4 is CH and R1a, R3, R4, A2a, A2b are as defined in table Z1. Table 1.64 provides compounds E64.1 to E64.952 of formula (Ia) wherein R2 is CN, R5 is OCH3, A4 is N and R1a, R3, R4, A2a, A2b are as defined in table Z1. Table 1.65 provides compounds E65.1 to E65.952 of formula (Ia) wherein R2 is CN, R5 is cyclopropyl, A4 is CH and R1a, R3, R4, A2a, A2b are as defined in table Z1. Table 1.66 provides compounds E66.1 to E66.952 of formula (Ia) wherein R2 is CN, R5 is cyclopropyl, A4 is N and R1a, R3, R4, A2a, A2b are as defined in table Z1. Table 1.67 provides compounds E67.1 to E67.952 of formula (Ia) wherein R2 is CN, R5 is CH2OCH3, A4 is CH and R1a, R3, R4, A2a, A2b are as defined in table Z1. Table 1.68 provides compounds E68.1 to E68.952 of formula (Ia) wherein R2 is CN, R5 is CH2OCH3, A4 is N and R1a, R3, R4, A2a, A2b are as defined in table Z1. Table 1.69 provides compounds E69.1 to E69.952 of formula (Ia) wherein R2 is CN, R5 is NHCH2CH3, A4 is CH and R1a, R3, R4, A2a, A2b are as defined in table Z1. Table 1.70 provides compounds E70.1 to E70.952 of formula (Ia) wherein R2 is CN, R5 is NHCH2CH3, A4 is N and R1a, R3, R4, A2a, A2b are as defined in table Z1. Table 1.71 provides compounds E71.1 to E71.952 of formula (Ia) wherein R2 is OCH3, R5 is CH3, A4 is CH and R1a, R3, R4, A2a, A2b are as defined in table Z1. Table 1.72 provides compounds E72.1 to E72.952 of formula (Ia) wherein R2 is OCH3, R5 is CH3, A4 is N and R1a, R3, R4, A2a, A2b are as defined in table Z1. Table 1.73 provides compounds E73.1 to E73.952 of formula (Ia) wherein R2 is OCH3, R5 is OCH3, A4 is CH and R1a, R3, R4, A2a, A2b are as defined in table Z1. Table 1.74 provides compounds E74.1 to E74.952 of formula (Ia) wherein R2 is OCH3, R5 is OCH3, A4 is N and R1a, R3, R4, A2a, A2b are as defined in table Z1. Table 1.75 provides compounds E75.1 to E75.952 of formula (Ia) wherein R2 is OCH3, R5 is cyclopropyl, A4 is CH and R1a, R3, R4, A2a, A2b are as defined in table Z1. Table 1.76 provides compounds E76.1 to E76.952 of formula (Ia) wherein R2 is OCH3, R5 is cyclopropyl, A4 is N and R1a, R3, R4, A2a, A2b are as defined in table Z1. Table 1.77 provides compounds E77.1 to E77.952 of formula (Ia) wherein R2 is OCH3, R5 is CH2OCH3, A4 is CH and R1a, R3, R4, A2a, A2b are as defined in table Z1. Table 1.78 provides compounds E78.1 to E78.952 of formula (Ia) wherein R2 is OCH3, R5 is CH2OCH3, A4 is N and R1a, R3, R4, A2a, A2b are as defined in table Z1. Table 1.79 provides compounds E79.1 to E79.952 of formula (Ia) wherein R2 is OCH3, R5 is NHCH2CH3, A4 is CH and R1a, R3, R4, A2a, A2b are as defined in table Z1. Table 1.80 provides compounds E80.1 to E80.952 of formula (Ia) wherein R2 is OCH3, R5 is NHCH2CH3, A4 is N and R1a, R3, R4, A2a, A2b are as defined in table Z1. Table 1.81 provides compounds E81.1 to E81.952 of formula (Ia) wherein R2 is OCH2CH3, R5 is CH3, A4 is CH and R1a, R3, R4, A2a, A2b are as defined in table Z1. Table 1.82 provides compounds E82.1 to E82.952 of formula (Ia) wherein R2 is OCH2CH3, R5 is CH3, A4 is N and R1a, R3, R4, A2a, A2b are as defined in table Z1. Table 1.83 provides compounds E83.1 to E83.952 of formula (Ia) wherein R2 is OCH2CH3, R5 is OCH3, A4 is CH and R1a, R3, R4, A2a, A2b are as defined in table Z1. Table 1.84 provides compounds E84.1 to E84.952 of formula (Ia) wherein R2 is OCH2CH3, R5 is OCH3, A4 is N and R1a, R3, R4, A2a, A2b are as defined in table Z1. Table 1.85 provides compounds E85.1 to E85.952 of formula (Ia) wherein R2 is OCH2CH3, R5 is cyclopropyl, A4 is CH and R1a, R3, R4, A2a, A2b are as defined in table Z1. Table 1.86 provides compounds E86.1 to E86.952 of formula (Ia) wherein R2 is OCH2CH3, R5 is cyclopropyl, A4 is N and R1a, R3, R4, A2a, A2b are as defined in table Z1. Table 1.87 provides compounds E87.1 to E87.952 of formula (Ia) wherein R2 is OCH2CH3, R5 is CH2OCH3, A4 is CH and R1a, R3, R4, A2a, A2b are as defined in table Z1. Table 1.88 provides compounds E88.1 to E88.952 of formula (Ia) wherein R2 is OCH2CH3, R5 is CH2OCH3, A4 is N and R1a, R3, R4, A2a, A2b are as defined in table Z1. Table 1.89 provides compounds E89.1 to E89.952 of formula (Ia) wherein R2 is OCH2CH3, R5 is NHCH2CH3, A4 is CH and R1a, R3, R4, A2a, A2b are as defined in table Z1. Table 1.90 provides compounds E90.1 to E90.952 of formula (Ia) wherein R2 is OCH2CH3, R5 is NHCH2CH3, A4 is N and R1a, R3, R4, A2a, A2b are as defined in table Z1. Table 1.91 provides compounds E91.1 to E91.952 of formula (Ia) wherein R2 is CO2CH3, R5 is CH3, A4 is CH and R1a, R3, R4, A2a, A2b are as defined in table Z1. Table 1.92 provides compounds E92.1 to E92.952 of formula (Ia) wherein R2 is CO2CH3, R5 is CH3, A4 is N and R1a, R3, R4, A2a, A2b are as defined in table Z1. Table 1.93 provides compounds E93.1 to E93.952 of formula (Ia) wherein R2 is CO2CH3, R5 is OCH3, A4 is CH and R1a, R3, R4, A2a, A2b are as defined in table Z1. Table 1.94 provides compounds E94.1 to E94.952 of formula (Ia) wherein R2 is CO2CH3, R5 is OCH3, A4 is N and R1a, R3, R4, A2a, A2b are as defined in table Z1. Table 1.95 provides compounds E95.1 to E95.952 of formula (Ia) wherein R2 is CO2CH3, R5 is cyclopropyl, A4 is CH and R1a, R3, R4, A2a, A2b are as defined in table Z1. Table 1.96 provides compounds E96.1 to E96.952 of formula (Ia) wherein R2 is CO2CH3, R5 is cyclopropyl, A4 is N and R1a, R3, R4, A2a, A2b are as defined in table Z1. Table 1.97 provides compounds E97.1 to E97.952 of formula (Ia) wherein R2 is CO2CH3, R5 is CH2OCH3, A4 is CH and R1a, R3, R4, A2a, A2b are as defined in table Z1. Table 1.98 provides compounds E98.1 to E98.952 of formula (Ia) wherein R2 is CO2CH3, R5 is CH2OCH3, A4 is N and R1a, R3, R4, A2a, A2b are as defined in table Z1. Table 1.99 provides compounds E99.1 to E99.952 of formula (Ia) wherein R2 is CO2CH3, R5 is NHCH2CH3, A4 is CH and R1a, R3, R4, A2a, A2b are as defined in table Z1. Table 1.100 provides compounds E100.1 to E100.952 of formula (Ia) wherein R2 is CO2CH3, R5 is NHCH2CH3, A4 is N and R1a, R3, R4, A2a, A2b are as defined in table Z1. Table 2.1 provides compounds F1.1 to F1.288 of formula (Ic)
Figure imgf000059_0001
wherein R2 is H, R5 is CH3 and R3, R4, A2a, A2b, A4 are as defined in table Z2. More particularly, table Z2 also includes compounds wherein R3 and R4 taken together form a ring. In this case, said ring is depicted in the R3 and R4 columns (table Z2) merged together, along the amide atom linked to the bicycle core of the formula (Ic). For example, see the R3 and R4 columns of the compound F1.217. Table Z2: Substituent definitions of R3, R4, A2a, A2b and A4: Compounds R3 R4 A2a A2b A4 F1.1 H CH3 N CH CH F1.2 H CH3 N CH N F1.3 H CH3 N N CH F1.4 H CH3 N N N F1.5 H CH3 CH CH CH F1.6 H CH3 CH CH N F1.7 H CH3 CH N CH F1.8 H CH3 CH N N F1.9 H CH3 CF CH CH F1.10 H CH3 CF CH N F1.11 H CH3 CF N CH F1.12 H CH3 CF N N F1.13 H CH3 CCl CH CH F1.14 H CH3 CCl CH N F1.15 H CH3 CCl N CH F1.16 H CH3 CCl N N F1.17 H CH3 CBr CH CH F1.18 H CH3 CBr CH N F1.19 H CH3 CBr N CH F1.20 H CH3 CBr N N F1.21 H CH3 CCH3 CH CH F1.22 H CH3 CCH3 CH N F1.23 H CH3 CCH3 N CH F1.24 H CH3 CCH3 N N F1.25 H CH3 CCH2CH3 CH CH F1.26 H CH3 CCH2CH3 CH N F1.27 H CH3 CCH2CH3 N CH F1.28 H CH3 CCH2CH3 N N F1.29 H CH3 CCN CH CH F1.30 H CH3 CCN CH N F1.31 H CH3 CCN N CH F1.32 H CH3 CCN N N F1.33 H CH3 COCH3 CH CH F1.34 H CH3 COCH3 CH N F1.35 H CH3 COCH3 N CH F1.36 H CH3 COCH3 N N F1.37 H CH2CH3 N CH CH F1.38 H CH2CH3 N CH N F1.39 H CH2CH3 N N CH F1.40 H CH2CH3 N N N F1.41 H CH2CH3 CH CH CH F1.42 H CH2CH3 CH CH N F1.43 H CH2CH3 CH N CH F1.44 H CH2CH3 CH N N F1.45 H CH2CH3 CF CH CH F1.46 H CH2CH3 CF CH N F1.47 H CH2CH3 CF N CH F1.48 H CH2CH3 CF N N F1.49 H CH2CH3 CCl CH CH F1.50 H CH2CH3 CCl CH N F1.51 H CH2CH3 CCl N CH F1.52 H CH2CH3 CCl N N F1.53 H CH2CH3 CBr CH CH F1.54 H CH2CH3 CBr CH N F1.55 H CH2CH3 CBr N CH F1.56 H CH2CH3 CBr N N F1.57 H CH2CH3 CCH3 CH CH F1.58 H CH2CH3 CCH3 CH N F1.59 H CH2CH3 CCH3 N CH F1.60 H CH2CH3 CCH3 N N F1.61 H CH2CH3 CCH2CH3 CH CH F1.62 H CH2CH3 CCH2CH3 CH N F1.63 H CH2CH3 CCH2CH3 N CH F1.64 H CH2CH3 CCH2CH3 N N F1.65 H CH2CH3 CCN CH CH F1.66 H CH2CH3 CCN CH N F1.67 H CH2CH3 CCN N CH F1.68 H CH2CH3 CCN N N F1.69 H CH2CH3 COCH3 CH CH F1.70 H CH2CH3 COCH3 CH N F1.71 H CH2CH3 COCH3 N CH F1.72 H CH2CH3 COCH3 N N F1.73 H CH2OCH3 N CH CH F1.74 H CH2OCH3 N CH N F1.75 H CH2OCH3 N N CH F1.76 H CH2OCH3 N N N F1.77 H CH2OCH3 CH CH CH F1.78 H CH2OCH3 CH CH N F1.79 H CH2OCH3 CH N CH F1.80 H CH2OCH3 CH N N F1.81 H CH2OCH3 CF CH CH F1.82 H CH2OCH3 CF CH N F1.83 H CH2OCH3 CF N CH F1.84 H CH2OCH3 CF N N F1.85 H CH2OCH3 CCl CH CH F1.86 H CH2OCH3 CCl CH N F1.87 H CH2OCH3 CCl N CH F1.88 H CH2OCH3 CCl N N F1.89 H CH2OCH3 CBr CH CH F1.90 H CH2OCH3 CBr CH N F1.91 H CH2OCH3 CBr N CH F1.92 H CH2OCH3 CBr N N F1.93 H CH2OCH3 CCH3 CH CH F1.94 H CH2OCH3 CCH3 CH N F1.95 H CH2OCH3 CCH3 N CH F1.96 H CH2OCH3 CCH3 N N F1.97 H CH2OCH3 CCH2CH3 CH CH F1.98 H CH2OCH3 CCH2CH3 CH N F1.99 H CH2OCH3 CCH2CH3 N CH F1.100 H CH2OCH3 CCH2CH3 N N F1.101 H CH2OCH3 CCN CH CH F1.102 H CH2OCH3 CCN CH N F1.103 H CH2OCH3 CCN N CH F1.104 H CH2OCH3 CCN N N F1.105 H CH2OCH3 COCH3 CH CH F1.106 H CH2OCH3 COCH3 CH N F1.107 H CH2OCH3 COCH3 N CH F1.108 H CH2OCH3 COCH3 N N F1.109 H CH2CH2OCH3 N CH CH F1.110 H CH2CH2OCH3 N CH N F1.111 H CH2CH2OCH3 N N CH F1.112 H CH2CH2OCH3 N N N F1.113 H CH2CH2OCH3 CH CH CH F1.114 H CH2CH2OCH3 CH CH N F1.115 H CH2CH2OCH3 CH N CH F1.116 H CH2CH2OCH3 CH N N F1.117 H CH2CH2OCH3 CF CH CH F1.118 H CH2CH2OCH3 CF CH N F1.119 H CH2CH2OCH3 CF N CH F1.120 H CH2CH2OCH3 CF N N F1.121 H CH2CH2OCH3 CCl CH CH F1.122 H CH2CH2OCH3 CCl CH N F1.123 H CH2CH2OCH3 CCl N CH F1.124 H CH2CH2OCH3 CCl N N F1.125 H CH2CH2OCH3 CBr CH CH F1.126 H CH2CH2OCH3 CBr CH N F1.127 H CH2CH2OCH3 CBr N CH F1.128 H CH2CH2OCH3 CBr N N F1.129 H CH2CH2OCH3 CCH3 CH CH F1.130 H CH2CH2OCH3 CCH3 CH N F1.131 H CH2CH2OCH3 CCH3 N CH F1.132 H CH2CH2OCH3 CCH3 N N F1.133 H CH2CH2OCH3 CCH2CH3 CH CH F1.134 H CH2CH2OCH3 CCH2CH3 CH N F1.135 H CH2CH2OCH3 CCH2CH3 N CH F1.136 H CH2CH2OCH3 CCH2CH3 N N F1.137 H CH2CH2OCH3 CCN CH CH F1.138 H CH2CH2OCH3 CCN CH N F1.139 H CH2CH2OCH3 CCN N CH F1.140 H CH2CH2OCH3 CCN N N F1.141 H CH2CH2OCH3 COCH3 CH CH F1.142 H CH2CH2OCH3 COCH3 CH N F1.143 H CH2CH2OCH3 COCH3 N CH F1.144 H CH2CH2OCH3 COCH3 N N F1.145 H CH2CN N CH CH F1.146 H CH2CN N CH N F1.147 H CH2CN N N CH F1.148 H CH2CN N N N F1.149 H CH2CN CH CH CH F1.150 H CH2CN CH CH N F1.151 H CH2CN CH N CH F1.152 H CH2CN CH N N F1.153 H CH2CN CF CH CH F1.154 H CH2CN CF CH N F1.155 H CH2CN CF N CH F1.156 H CH2CN CF N N F1.157 H CH2CN CCl CH CH F1.158 H CH2CN CCl CH N F1.159 H CH2CN CCl N CH F1.160 H CH2CN CCl N N F1.161 H CH2CN CBr CH CH F1.162 H CH2CN CBr CH N F1.163 H CH2CN CBr N CH F1.164 H CH2CN CBr N N F1.165 H CH2CN CCH3 CH CH F1.166 H CH2CN CCH3 CH N F1.167 H CH2CN CCH3 N CH F1.168 H CH2CN CCH3 N N F1.169 H CH2CN CCH2CH3 CH CH F1.170 H CH2CN CCH2CH3 CH N F1.171 H CH2CN CCH2CH3 N CH F1.172 H CH2CN CCH2CH3 N N F1.173 H CH2CN CCN CH CH F1.174 H CH2CN CCN CH N F1.175 H CH2CN CCN N CH F1.176 H CH2CN CCN N N F1.177 H CH2CN COCH3 CH CH F1.178 H CH2CN COCH3 CH N F1.179 H CH2CN COCH3 N CH F1.180 H CH2CN COCH3 N N F1.181 H CH2CH2CN N CH CH F1.182 H CH2CH2CN N CH N F1.183 H CH2CH2CN N N CH F1.184 H CH2CH2CN N N N F1.185 H CH2CH2CN CH CH CH F1.186 H CH2CH2CN CH CH N F1.187 H CH2CH2CN CH N CH F1.188 H CH2CH2CN CH N N F1.189 H CH2CH2CN CF CH CH F1.190 H CH2CH2CN CF CH N F1.191 H CH2CH2CN CF N CH F1.192 H CH2CH2CN CF N N F1.193 H CH2CH2CN CCl CH CH F1.194 H CH2CH2CN CCl CH N F1.195 H CH2CH2CN CCl N CH F1.196 H CH2CH2CN CCl N N F1.197 H CH2CH2CN CBr CH CH F1.198 H CH2CH2CN CBr CH N F1.199 H CH2CH2CN CBr N CH F1.200 H CH2CH2CN CBr N N F1.201 H CH2CH2CN CCH3 CH CH F1.202 H CH2CH2CN CCH3 CH N F1.203 H CH2CH2CN CCH3 N CH F1.204 H CH2CH2CN CCH3 N N F1.205 H CH2CH2CN CCH2CH3 CH CH F1.206 H CH2CH2CN CCH2CH3 CH N F1.207 H CH2CH2CN CCH2CH3 N CH F1.208 H CH2CH2CN CCH2CH3 N N F1.209 H CH2CH2CN CCN CH CH F1.210 H CH2CH2CN CCN CH N F1.211 H CH2CH2CN CCN N CH F1.212 H CH2CH2CN CCN N N F1.213 H CH2CH2CN COCH3 CH CH F1.214 H CH2CH2CN COCH3 CH N F1.215 H CH2CH2CN COCH3 N CH F1.216 H CH2CH2CN COCH3 N N F1.217 N CH CH F1.218 N CH N F1.219 N N CH F1.220 N N N F1.221 CH CH CH F1.222 CH CH N F1.223 CH N CH F1.224 CH N N F1.225 CF CH CH F1.226 CF CH N F1.227 CF N CH F1.228 CF N N F1.229 CCl CH CH F1.230 CCl CH N F1.231 CCl N CH F1.232 CCl N N F1.233 CBr CH CH F1.234 CBr CH N F1.235 CBr N CH F1.236 CBr N N F1.237 CCH3 CH CH F1.238 CCH3 CH N F1.239 CCH3 N CH F1.240 CCH3 N N F1.241 CCH2CH3 CH CH F1.242 CCH2CH3 CH N F1.243 CCH2CH3 N CH F1.244 CCH2CH3 N N F1.245 CCN CH CH F1.246 CCN CH N F1.247 CCN N CH F1.248 CCN N N F1.249 COCH3 CH CH F1.250 COCH3 CH N F1.251 COCH3 N CH F1.252 COCH3 N N F1.253 N CH CH F1.254 N CH N F1.255 N N CH F1.256 N N N F1.257 CH CH CH F1.258 CH CH N F1.259 CH N CH F1.260 CH N N F1.261 CF CH CH F1.262 CF CH N F1.263 CF N CH F1.264 CF N N F1.265 CCl CH CH F1.266 CCl CH N F1.267 CCl N CH F1.268 CCl N N F1.269 CBr CH CH F1.270 CBr CH N F1.271 CBr N CH F1.272 CBr N N F1.273 CCH3 CH CH F1.274 CCH3 CH N F1.275 CCH3 N CH F1.276 CCH3 N N F1.277 CCH2CH3 CH CH F1.278 CCH2CH3 CH N F1.279 CCH2CH3 N CH F1.280 CCH2CH3 N N F1.281 CCN CH CH F1.282 CCN CH N F1.283 CCN N CH F1.284 CCN N N F1.285 COCH3 CH CH F1.286 COCH3 CH N F1.287 COCH3 N CH F1.288 COCH3 N N Table 2.2 provides compounds F2.1 to F2.288 of formula (Ic) wherein R2 is H, R5 is OCH3 and R3, R4, A2a, A2b, A4 are as defined in table Z2. Table 2.3 provides compounds F3.1 to F3.288 of formula (Ic) wherein R2 is H, R5 is cyclopropyl and R3, R4, A2a, A2b, A4 are as defined in table Z2. Table 2.4 provides compounds F4.1 to F4.288 of formula (Ic) wherein R2 is H, R5 is CH2OCH3 and R3, R4, A2a, A2b, A4 are as defined in table Z2. Table 2.5 provides compounds F5.1 to F5.288 of formula (Ic) wherein R2 is H, R5 is NHCH2CH3 and R3, R4, A2a, A2b, A4 are as defined in table Z2. Table 2.6 provides compounds F6.1 to F6.288 of formula (Ic) wherein R2 is CH3, R5 is CH3 and R3, R4, A2a, A2b, A4 are as defined in table Z2. Table 2.7 provides compounds F7.1 to F7.288 of formula (Ic) wherein R2 is CH3, R5 is OCH3 and R3, R4, A2a, A2b, A4 are as defined in table Z2. Table 2.8 provides compounds F8.1 to F8.288 of formula (Ic) wherein R2 is CH3, R5 is cyclopropyl and R3, R4, A2a, A2b, A4 are as defined in table Z2. Table 2.9 provides compounds F9.1 to F9.288 of formula (Ic) wherein R2 is CH3, R5 is CH2OCH3 and R3, R4, A2a, A2b, A4 are as defined in table Z2. Table 2.10 provides compounds F10.1 to F10.288 of formula (Ic) wherein R2 is CH3, R5 is NHCH2CH3 and R3, R4, A2a, A2b, A4 are as defined in table Z2. Table 2.11 provides compounds F11.1 to F11.288 of formula (Ic) wherein R2 is CH2CH3, R5 is CH3 and R3, R4, A2a, A2b, A4 are as defined in table Z2. Table 2.12 provides compounds F12.1 to F12.288 of formula (Ic) wherein R2 is CH2CH3, R5 is OCH3 and R3, R4, A2a, A2b, A4 are as defined in table Z2. Table 2.13 provides compounds F13.1 to F13.288 of formula (Ic) wherein R2 is CH2CH3, R5 is cyclopropyl and R3, R4, A2a, A2b, A4 are as defined in table Z2. Table 2.14 provides compounds F14.1 to F14.288 of formula (Ic) wherein R2 is CH2CH3, R5 is CH2OCH3 and R3, R4, A2a, A2b, A4 are as defined in table Z2. Table 2.15 provides compounds F15.1 to F15.288 of formula (Ic) wherein R2 is CH2CH3, R5 is NHCH2CH3 and R3, R4, A2a, A2b, A4 are as defined in table Z2. Table 2.16 provides compounds F16.1 to F16.288 of formula (Ic) wherein R2 is F, R5 is CH3 and R3, R4, A2a, A2b, A4 are as defined in table Z2. Table 2.17 provides compounds F17.1 to F17.288 of formula (Ic) wherein R2 is F, R5 is OCH3 and R3, R4, A2a, A2b, A4 are as defined in table Z2. Table 2.18 provides compounds F18.1 to F18.288 of formula (Ic) wherein R2 is F, R5 is cyclopropyl and R3, R4, A2a, A2b, A4 are as defined in table Z2. Table 2.19 provides compounds F19.1 to F19.288 of formula (Ic) wherein R2 is F, R5 is CH2OCH3 and R3, R4, A2a, A2b, A4 are as defined in table Z2. Table 2.20 provides compounds F20.1 to F20.288 of formula (Ic) wherein R2 is F, R5 is NHCH2CH3 and R3, R4, A2a, A2b, A4 are as defined in table Z2. Table 2.21 provides compounds F21.1 to F21.288 of formula (Ic) wherein R2 is Cl, R5 is CH3 and R3, R4, A2a, A2b, A4 are as defined in table Z2. Table 2.22 provides compounds F22.1 to F22.288 of formula (Ic) wherein R2 is Cl, R5 is OCH3 and R3, R4, A2a, A2b, A4 are as defined in table Z2. Table 2.23 provides compounds F23.1 to F23.288 of formula (Ic) wherein R2 is Cl, R5 is cyclopropyl and R3, R4, A2a, A2b, A4 are as defined in table Z2. Table 2.24 provides compounds F24.1 to F24.288 of formula (Ic) wherein R2 is Cl, R5 is CH2OCH3 and R3, R4, A2a, A2b, A4 are as defined in table Z2. Table 2.25 provides compounds F25.1 to F25.288 of formula (Ic) wherein R2 is Cl, R5 is NHCH2CH3 and R3, R4, A2a, A2b, A4 are as defined in table Z2. Table 2.26 provides compounds F26.1 to F26.288 of formula (Ic) wherein R2 is Br, R5 is CH3 and R3, R4, A2a, A2b, A4 are as defined in table Z2. Table 2.27 provides compounds F27.1 to F27.288 of formula (Ic) wherein R2 is Br, R5 is OCH3 and R3, R4, A2a, A2b, A4 are as defined in table Z2. Table 2.28 provides compounds F28.1 to F28.288 of formula (Ic) wherein R2 is Br, R5 is cyclopropyl and R3, R4, A2a, A2b, A4 are as defined in table Z2. Table 2.29 provides compounds F29.1 to F29.288 of formula (Ic) wherein R2 is Br, R5 is CH2OCH3 and R3, R4, A2a, A2b, A4 are as defined in table Z2. Table 2.30 provides compounds F30.1 to F30.288 of formula (Ic) wherein R2 is Br, R5 is NHCH2CH3 and R3, R4, A2a, A2b, A4 are as defined in table Z2. Table 2.31 provides compounds F31.1 to F31.288 of formula (Ic) wherein R2 is CN, R5 is CH3 and R3, R4, A2a, A2b, A4 are as defined in table Z2. Table 2.32 provides compounds F32.1 to F32.288 of formula (Ic) wherein R2 is CN, R5 is OCH3 and R3, R4, A2a, A2b, A4 are as defined in table Z2. Table 2.33 provides compounds F33.1 to F33.288 of formula (Ic) wherein R2 is CN, R5 is cyclopropyl and R3, R4, A2a, A2b, A4 are as defined in table Z2. Table 2.34 provides compounds F34.1 to F34.288 of formula (Ic) wherein R2 is CN, R5 is CH2OCH3 and R3, R4, A2a, A2b, A4 are as defined in table Z2. Table 2.35 provides compounds F35.1 to F35.288 of formula (Ic) wherein R2 is CN, R5 is NHCH2CH3 and R3, R4, A2a, A2b, A4 are as defined in table Z2. Table 2.36 provides compounds F36.1 to F36.288 of formula (Ic) wherein R2 is OCH3, R5 is CH3 and R3, R4, A2a, A2b, A4 are as defined in table Z2. Table 2.37 provides compounds F37.1 to F37.288 of formula (Ic) wherein R2 is OCH3, R5 is OCH3 and R3, R4, A2a, A2b, A4 are as defined in table Z2. Table 2.38 provides compounds F38.1 to F38.288 of formula (Ic) wherein R2 is OCH3, R5 is cyclopropyl and R3, R4, A2a, A2b, A4 are as defined in table Z2. Table 2.39 provides compounds F39.1 to F39.288 of formula (Ic) wherein R2 is OCH3, R5 is CH2OCH3 and R3, R4, A2a, A2b, A4 are as defined in table Z2. Table 2.40 provides compounds F40.1 to F40.288 of formula (Ic) wherein R2 is OCH3, R5 is NHCH2CH3 and R3, R4, A2a, A2b, A4 are as defined in table Z2. Table 2.41 provides compounds F41.1 to F41.288 of formula (Ic) wherein R2 is OCH2CH3, R5 is CH3 and R3, R4, A2a, A2b, A4 are as defined in table Z2. Table 2.42 provides compounds F42.1 to F42.288 of formula (Ic) wherein R2 is OCH2CH3, R5 is OCH3 and R3, R4, A2a, A2b, A4 are as defined in table Z2. Table 2.43 provides compounds F43.1 to F43.288 of formula (Ic) wherein R2 is OCH2CH3, R5 is cyclopropyl and R3, R4, A2a, A2b, A4 are as defined in table Z2. Table 2.44 provides compounds F44.1 to F44.288 of formula (Ic) wherein R2 is OCH2CH3, R5 is CH2OCH3 and R3, R4, A2a, A2b, A4 are as defined in table Z2. Table 2.45 provides compounds F45.1 to F45.288 of formula (Ic) wherein R2 is OCH2CH3, R5 is NHCH2CH3 and R3, R4, A2a, A2b, A4 are as defined in table Z2. Table 2.46 provides compounds F46.1 to F46.288 of formula (Ic) wherein R2 is CO2CH3, R5 is CH3 and R3, R4, A2a, A2b, A4 are as defined in table Z2. Table 2.47 provides compounds F47.1 to F47.288 of formula (Ic) wherein R2 is CO2CH3, R5 is OCH3 and R3, R4, A2a, A2b, A4 are as defined in table Z2. Table 2.48 provides compounds F48.1 to F48.288 of formula (Ic) wherein R2 is CO2CH3, R5 is cyclopropyl and R3, R4, A2a, A2b, A4 are as defined in table Z2. Table 2.49 provides compounds F49.1 to F49.288 of formula (Ic) wherein R2 is CO2CH3, R5 is CH2OCH3 and R3, R4, A2a, A2b, A4 are as defined in table Z2. Table 2.50 provides compounds F50.1 to F50.288 of formula (Ic) wherein R2 is CO2CH3, R5 is NHCH2CH3 and R3, R4, A2a, A2b, A4 are as defined in table Z2. Compounds according to the invention may possess any number of benefits including, inter alia, advantageous levels of biological activity for protecting plants against diseases that are caused by fungi or superior properties for use as agrochemical active ingredients (for example, greater biological activity, an advantageous spectrum of activity, an increased safety profile, improved physico-chemical properties, or increased biodegradability). Compounds according to the invention have particularly advantageous levels of biological activity for protecting plants against oomycetes such as Phytophthora, Plasmopara and Pythium. Compounds of formula (I), wherein Z is O, can be made as shown in the following schemes 1 to 18, in which, unless otherwise stated, the definition of each variable is as defined in the present invention. Compounds of formula (I) can be prepared via Suzuki cross coupling of compounds of formula (II), wherein X is Cl, Br or I, and a compound of formula (III), wherein either R6 is independently from each other hydrogen, C1-6alkyl or wherein two R6 together can form a C3-8cycloalkyl, in the presence of a base, such as Cs2CO3, K2CO3 or NaOtBu, and a suitable palladium catalyst, such as tetrakistriphenylphosphinepalladium, [1,1-bis(diphenylphosphino)ferrocene]dichloropalladium(II), bis(diphenylphosphine)palladium(II) chloride, palladium dichloride or palladium acetate, in a suitable solvent, such as dimethylformamide, dioxane, tetrahydrofuran, ethanol or water. Compounds of formula (III), wherein either R6 is independently from each other hydrogen, C1-6alkyl or wherein two R6 together can form a C3-8cycloalkyl are prepared by known methods or are commercially available. This transformation is depicted in Scheme 1.
Figure imgf000074_0001
Scheme 1 Compounds of formula (II) can be prepared by reacting compounds of formula (IV), wherein X is Cl, Br or I, with an a reagent of formula (V), wherein X1 is a good leaving group such as Cl, Br, I, triflate, tosyl or mesyl, in the presence of a base such as Cs2CO3, K2CO3, NaH or NaOtBu. A compound of formula (VI), wherein R7 is an electron-withdrawing group such as a cyano or an ester, can alternatively be used to functionalize the amide nitrogen. Compounds of formula (IV), wherein X is Cl, Br or I, can be prepared by a peptide-coupling reaction between a compound of formula (VII), wherein X is Cl, Br or I, and X2 is OH, and an amine of formula (VIII), and by activating the carboxylic acid function of the compounds of formula (VII), a process that usually takes place by converting the -OH of the carboxylic acid into a good leaving group, such as a chloride group, for example by using (COCl)2 or SOCl2, prior to treatment with amines of formula (VIII), preferably in a suitable solvent (e.g., N-methylpyrrolidone, acetonitrile, dimethylacetamide, dichloromethane or tetrahydrofuran), preferably at temperatures between 25 °C and 60 °C, and optionally in the presence of a base such as triethylamine or N,N-diisopropylethylamine; or alternatively under conditions described in the literature for an amide coupling such as 1- propanephosphonic acid cyclic anhydride (T3P) in suitable solvent (e.g., acetonitrile) optionally in the presence of a base (e.g., triethylamine or N,N-diisopropylethylamine). For examples, see Chem. Soc. Rev.2009, 38, 606 and Chem. Soc. Rev.2011, 40, 5084. Alternatively, compounds of formula (II), wherein X is Cl, Br or I, can be obtained by an amide-coupling transformation between compounds of formula (VII), wherein X2 is OH, and X is Cl, Br or I,, and amines of formula (IX) using the conditions described above. These transformations are depicted in Scheme 2.
Figure imgf000075_0001
Compounds of formula (IX) are commercially available or can be obtained by reaction of compounds of formula (VIII) with a compound of formula (V) wherein X1 is a good leaving group such as Cl, Br, I, triflate, tosyl or mesyl, in the presence of a base such as Cs2CO3, K2CO3, NaH or NaOtBu. Alternatively, compounds of formula (IX) can also be synthesized by reacting compounds of formula (VIII) with compounds of formula (VI), wherein R7 is an electron-withdrawing group such as cyano or ester, optionnally in the presence of a base such as triethylamine or 1,8-diazabicyclo[5.4.0]undec-7-ene. Alternatively, compounds of formula (IX) can be obtained from amines of formula (VIII) by a reductive amination with aldehydes of formula (X), wherein R11 is C1-5alkyl, C1-6alkoxy-C1-5alkyl, C3-5cycloalkyl, C3- cycloalkyl-C1-3alkyl, C2-5alkenyl, C2-5alkynyl, C1-5alkoxy, C1-6alkylsulfanyl-C1-5alkyl, C1-6alkylsulfinyl-C1- 5alkyl, C1-6alkylsulfonyl-C1-5alkyl, C1-6alkoxycarbonyl-C1-5alkyl, C1-6alkylaminocarbonyl-C1-5alkyl, diC1- 6alkylaminocarbonyl-C1-5alkyl, or CN, e.g. in the presence of NaBH(OAc)3 or NaBH3CN, in a suitable solvent, optionally in the presence of a Brønsted or Lewis acid such as acetic acid. Alternatively, another reagent system for the reductive amination uses a combination of titanium isopropoxide and NaBH4. The synthesis of compounds of formula (IX) from amines of formula (VIII) is depicted in Scheme 3.
Figure imgf000076_0001
Scheme 3 Alternatively, compounds of formula (II), wherein X is Cl, Br or I, can be prepared from the reaction of a compound of formula (XI) and a halogenating agent, such as N-chlorosuccinimide, N-bromosuccinimide, N-iodosuccinimide or bromine in a suitable solvent, such as dichloromethane, chloroform, tetrahydrofuran or acetonitrile. Compounds of formula (XI) can be obtained by an amide-coupling transformation of amines of formula (IX) with compounds of formula (XII), wherein X2 is OH, and by activating the carboxylic acid function of the compounds of formula (XII), a process that usually takes place by converting the -OH of the carboxylic acid into a good leaving group, such as a chloride group, for example by using (COCl)2 or SOCl2, prior to treatment with amines of formula (IX), preferably in a suitable solvent (e.g., N-methylpyrrolidone, acetonitrile, dimethylacetamide, dichloromethane or tetrahydrofuran), preferably at temperatures between 25 °C and 60 °C, and optionally in the presence of a base such as triethylamine or N,N-diisopropylethylamine; or alternatively under conditions described in the literature for an amide coupling such as 1-propanephosphonic acid cyclic anhydride (T3P) in suitable solvent (e.g., acetonitrile) optionally in the presence of a base (e.g., triethylamine or N,N-diisopropylethylamine). Alternatively, compounds of formula (XI) can be obtained by alkylation of compounds of formula (XIII) with compounds of formula (V), wherein X1 is a good leaving group such as Cl, Br, I, triflate, tosyl or mesyl, in the presence of a base such as Cs2CO3, K2CO3, NaH or NaOtBu. Alternatively, compounds of formula (XI) can also be synthesized by reacting compounds of formula (XIII) with compounds of formula (VI), wherein R7 is an electron-withdrawing group such as cyano or ester, optionally in the presence of a base such as triethylamine or 1,8-diazabicyclo[5.4.0]undec-7-ene. Compounds of formula (XIII) can be prepared by a peptide-coupling transformation from compounds of formula (XII), wherein X2 is OH, with amines of formula (VIII) using the conditions described above. These transformations are depicted in Scheme 4.
Figure imgf000077_0001
Scheme 4 Alternatively, compounds of formula (XI) can be synthesized by reacting compounds of formula (XIV), wherein X is Cl, Br or I, with amines of formula (IX) and carbon monoxide in the presence of a catalyst such as [1,1-bis(diphenylphosphino)ferrocene]dichloropalladium(II), and, optionally, a base such as triethylamine. This transformation is depicted in Scheme 5.
Figure imgf000077_0002
Scheme 5 Compounds of formula (XIIa), wherein each R1 is independently from each other selected from hydrogen, hydroxy, halogen, CN, C1-6alkyl, C3-6cycloalkyl, C1-6alkoxy-C1-6alkyl, C3-6cycloalkyl-C1-4alkyl, C1-6alkylsulfanyl, C1-6alkylsulfinyl, C1-6alkylsulfonyl, C1-6alkoxy, amino, and NHC(O)C1-6alkyl, and X2 is OH, can be prepared by hydrolysis of esters of formula (XVa), wherein either R1 is independently from each other selected from hydrogen, hydroxy, halogen, CN, C1-6alkyl, C3-6cycloalkyl, C1-6alkoxy-C1-6alkyl, C3-6cycloalkyl-C1-4alkyl, C1-6alkylsulfanyl, C1-6alkylsulfinyl, C1-6alkylsulfonyl, C1-6alkoxy, amino, and NHC(O)C1-6alkyl, and R9 is C1-6alkyl, for instance by using a base such as lithium hydroxide or sodium hydroxide. Compounds of formula (XVa), wherein either R1 is independently from each other selected from hydrogen, hydroxy, halogen, CN, C1-6alkyl, C3-6cycloalkyl, C1-6alkoxy-C1-6alkyl, C3-6cycloalkyl-C1- 4alkyl, C1-6alkylsulfanyl, C1-6alkylsulfinyl, C1-6alkylsulfonyl, C1-6alkoxy, amino, and NHC(O)C1-6alkyl, and R9 is C1-6alkyl, can be obtained from compounds of formula (XVIa), wherein X is Cl, Br or I, by a cross- coupling transformation with a compound of formula (XVII), wherein either R6 is independently from each other hydrogen, C1-6alkyl or wherein two R6 together can form a C3-8cycloalkyl (Suzuki cross- coupling), or a compound of formula (XVIII) (Stille coupling). Suzuki cross-couplings can be achieved by using a suitable palladium catalyst, such as tetrakistriphenylphosphinepalladium, [1,1- bis(diphenylphosphino)ferrocene]dichloropalladium(II), bis(diphenylphosphine)palladium(II) chloride, palladium dichloride or palladium acetate, in the presence of a base, such as Cs2CO3, K2CO3 or NaOtBu, in a suitable solvent, such as dimethylformamide, dioxane, tetrahydrofuran, ethanol or water. Stille couplings can be achieved a suitable palladium catalyst such as tetrakistriphenylphosphinepalladium, tris(dibenzylideneacetone)dipalladium, palladium dichloride or palladium acetate in the presence of a base, such as Cs2CO3 or sodium acetate, in a suitable solvent, such as dimethylformamide, dioxane or acetonitrile. Compounds of formula (XVII), wherein either R6 is independently from each other hydrogen, C1-6alkyl or wherein two R6 together can form a C3-8cycloalkyl, and compounds of formula (XVIII) are prepared by known methods or are commercially available.These transformations are depicted in Scheme 6.
Figure imgf000078_0001
Alternatively, compounds of formula (XVa), wherein each R1 is independently from each other selected from hydrogen, hydroxy, halogen, CN, C1-6alkyl, C3-6cycloalkyl, C1-6alkoxy-C1-6alkyl, C3-6cycloalkyl-C1- 4alkyl, C1-6alkylsulfanyl, C1-6alkylsulfinyl, C1-6alkylsulfonyl, C1-6alkoxy, amino, and NHC(O)C1-6alkyl, and R9 is C1-6alkyl, can be obtained from compounds of formula (XIXa), wherein R9 is C1-6alkyl, by reaction with a compound of formula (XX), wherein X is Cl or Br and R8 is C1-6alkyl, in the presence of a base such as pyridine or diisopropylethylamine. Amines of formula (XIXa), R9 is C1-6alkyl, can be prepared by treatment of compounds of formula (XXIa), R9 is C1-6alkyl, with an acid, typically hydrochloric acid, or with sodium acetate and hydroxyamine hydrochloride in a protic solvent such as methanol. Compounds of formula (XXIa), wherein R9 is C1-6alkyl, can be synthesized by reaction of compounds of formula (XVIa), wherein X is Cl, Br or I, and R9 is C1-6alkyl, with diphenylmethanimine (CAS number 1013-88-3) in the presence of a catalyst, such as palladium acetate or tris(dibenzylideneacetone)dipalladium, optionally a ligand such as 1,1′-[1,1′-binaphthalene]-2,2′-diylbis[1,1-diphenylphosphine] or (9,9- dimethyl-9H-xanthene-4,5-diyl)bis(diphenylphosphane), and in the presence of a base such as cesium carbonate or sodium tert-butoxide. These transformations are depicted in Scheme 7.
Figure imgf000079_0001
Scheme 7 Compounds of formula (XVIa), wherein X is Cl, Br or I, and R9 is C1-6alkyl, can be synthesized by the condensation of a compound of formula (XXIIa), wherein X is Cl, Br or I, and R9 is C1-6alkyl, with a compound of formula (XXIII), wherein X is Cl, Br or I, or its corresponding acetal of formula (XXIV), wherein X is Cl, Br or I, and either R10 is independently from each other C1-6alkyl or wherein two R10 together can form a C3-8cycloalkyl, in a solvent, such as water, ethanol, acetone or acetonitrile. In some instance, the outcome of the reaction can be improved by using a base, such as sodium bicarbonate or potassium carbonate, or by using an acid, such as p-toluenesulfonic acid or hydrogen bromide. Compounds of formula (XXIIa), wherein X is Cl, Br or I, and R9 is C1-6alkyl, compounds of formula (XXIII), wherein X is Cl, Br or I, and compounds of formula (XXIV) wherein X is Cl, Br or I, and either R10 is independently from each other C1-6alkyl or wherein two R10 together can form a C3-8cycloalkyl, are commercially available or prepared using known methods by those skilled in the art. These transformations are depicted in Scheme 8.
Figure imgf000080_0001
Scheme 8 Compounds of formula (XIVa), wherein X is Cl, Br or I, and either R1 is independently from each other selected from hydrogen, hydroxy, halogen, CN, C1-6alkyl, C3-6cycloalkyl, C1-6alkoxy-C1-6alkyl, C3- 6cycloalkyl-C1-4alkyl, C1-6alkylsulfanyl, C1-6alkylsulfinyl, C1-6alkylsulfonyl, C1-6alkoxy, amino, and NHC(O)C1-6alkyl, are commercially available or can be prepared by the condensation of an amine of formula (XXVa), wherein X is Cl, Br or I, with a compound of formula (XXIII), wherein X is Cl, Br or I, or its corresponding acetal of formula (XXIV), wherein X is Cl, Br or I, and either R10 is independently from each other C1-6alkyl or wherein two R10 together can form a C3-8cycloalkyl, in a solvent, such as water, ethanol, acetone or acetonitrile. In some instance, the outcome of the reaction can be improved by using a base, such as sodium bicarbonate or potassium carbonate, or by using an acid, such as p- toluenesulfonic acid or hydrogen bromide. Compounds of formula (XXVa), wherein X is Cl, Br or I, are commercially available or prepared using known methods by those skilled in the art. These transformations are depicted in Scheme 9.
Figure imgf000080_0002
Scheme 9 Compounds of formula (XVb), wherein R9 is C1-6alkyl, can be prepared by the condensation of compounds of formula (XXVI), wherein R9 is C1-6alkyl, with compounds of formula (XXVII), using a solvent such as toluene and by heating, optionally in the presence of an acid such as acetic acid. Compounds of formula (XXVI), wherein R9 is C1-6alkyl, and compounds of formula (XXVII) are commercially available or can be synthesized using known methods by those skilled in the art. This transformation is depicted in Scheme 10.
Figure imgf000081_0001
Scheme 10 Compounds of formula (XVc), wherein R9 is C1-6alkyl, are commercially available or can be prepared by the condensation of an amine of formula (XXVIII), wherein R9 is C1-6alkyl, with a compound of formula (XXIII), wherein X is Cl, Br or I, or its corresponding acetal of formula (XXIV), wherein X is Cl, Br or I, and either R10 is independently from each other C1-6alkyl or wherein two R10 together can form a C3- 8cycloalkyl, in a solvent, such as water, ethanol, acetone or acetonitrile. In some instance, the outcome of the reaction can be improved by using a base, such as sodium bicarbonate or potassium carbonate, or by using an acid, such as p-toluenesulfonic acid or hydrogen bromide. Compounds of formula (XXVIII), wherein R9 is C1-6alkyl, are commercially available or prepared using known methods by those skilled in the art. These transformations are depicted in Scheme 11.
Figure imgf000081_0002
Scheme 11 Compounds of formula (VII), wherein X is Cl, Br or I, and X2 is OH can be prepared by hydrolysis of esters of formula (XXIX), wherein X is Cl, Br or I, and R9 is C1-6alkyl, for instance by using a base such as lithium hydroxide or sodium hydroxide. Esters of formula (XXIX), wherein X is Cl, Br or I, and R9 is C1-6alkyl, can be obtained by halogenation of compounds of formula (XV), wherein R9 is C1-6alkyl, by using a halogenating reagent such as N-chlorosuccinimide, N-bromosuccinimide, N-iodosuccinimide or bromine in a suitable solvent, such as dichloromethane, chloroform, tetrahydrofuran or acetonitrile. These transformations are depicted in Scheme 12.
Figure imgf000082_0001
Scheme 12 Alternatively, compounds of formula (I) can be prepared by an amide-coupling transformation of amines of formula (IX) with compounds of formula (XXX), wherein X2 is OH, and by activating the carboxylic acid function of the compounds of formula (XXX), a process that usually takes place by converting the -OH of the carboxylic acid into a good leaving group, such as a chloride group, for example by using (COCl)2 or SOCl2, prior to treatment with amines of formula (IX), preferably in a suitable solvent (e.g., N-methylpyrrolidone, acetonitrile, dimethylacetamide, dichloromethane or tetrahydrofuran), preferably at temperatures between 25 °C and 60 °C, and optionally in the presence of a base such as triethylamine or N,N-diisopropylethylamine; or alternatively under conditions described in the literature for an amide coupling such as 1-propanephosphonic acid cyclic anhydride (T3P) in suitable solvent (e.g., acetonitrile) optionally in the presence of a base (e.g., triethylamine or N,N-diisopropylethylamine). Compounds of formula (I) can alternatively be prepared by alkylation of compounds of formula (XXXI) with compounds of formula (V), wherein X1 is a good leaving group such as Cl, Br, I, triflate, tosyl or mesyl, in the presence of a base such as Cs2CO3, K2CO3, NaH or NaOtBu. Alternatively, compounds of formula (I) can also be synthesized by reacting compounds of formula (XXXI) with compounds of formula (VI), wherein R7 is an electron-withdrawing group such as cyano or ester, optionally in the presence of a base such as triethylamine or 1,8-diazabicyclo[5.4.0]undec-7-ene. Compounds of formula (XXXI) can be synthesized by a peptide-coupling transformation from compounds of formula (XXX), wherein X2 is OH, and amines of formula (VIII) using the conditions described above. These transformations are depicted in Scheme 13.
Figure imgf000083_0001
Compounds of formula (XXX), wherein X2 is OH, can be obtained by hydrolysis of the ester moiety of compounds of formula (XXXII), wherein R9 is C1-6alkyl. Compounds of formula (XXXII), wherein R9 is C1-6alkyl, can result from a Suzuki cross-coupling reaction between compounds of formula (XXIX), wherein X is Cl, Br or I, and R9 is C1-6alkyl, and compounds of formula (III), wherein either R6 is independently from each other hydrogen, C1-6alkyl or wherein two R6 together can form a C3-8cycloalkyl, in the presence of a base, such as Cs2CO3, K2CO3 or NaOtBu, and a suitable palladium catalyst, such as tetrakistriphenylphosphinepalladium, [1,1-bis(diphenylphosphino)ferrocene]dichloropalladium(II), bis(diphenylphosphine)palladium(II) chloride, palladium dichloride or palladium acetate, in a suitable solvent, such as dimethylformamide, dioxane, tetrahydrofuran, ethanol or water. These transformations are depicted in Scheme 14.
Figure imgf000084_0001
Scheme 14 Alternatively, compounds of formula (I) can be synthesized by reacting compounds of formula (XXXIII), wherein X is Cl, Br or I, with amines of formula (IX) and carbon monoxide in the presence of a catalyst such as [1,1-bis(diphenylphosphino)ferrocene]dichloropalladium(II), and, optionally, a base such as triethylamine. Compounds of formula (XXXIII), wherein X is Cl, Br or I, can be prepared from compounds of formula (XXXIV), wherein either X is independently from each other Cl, Br or I, through a Suzuki cross-coupling with compounds of formula (III), wherein either R6 is independently from each other hydrogen, C1-6alkyl or wherein two R6 together can form a C3-8cycloalkyl, in the presence of a base, such as Cs2CO3, K2CO3 or NaOtBu, and a suitable palladium catalyst, such as tetrakistriphenylphosphinepalladium, [1,1-bis(diphenylphosphino)ferrocene]dichloropalladium(II), bis(diphenylphosphine)palladium(II) chloride, palladium dichloride or palladium acetate, in a suitable solvent, such as dimethylformamide, dioxane, tetrahydrofuran, ethanol or water. These transformations are depicted in Scheme 15.
Figure imgf000085_0001
Scheme 15 Alternatively, compounds of formula (I) can be prepared by the reaction of a compound of formula (XXXV) with compounds of formula (XXXVI), wherein X2 is OH, in a peptide-coupling transformation, using the conditions described above. Compounds of formula (XXXV) can be prepared via Suzuki cross coupling of a compound of formula (II) and a compound of formula (XXXVII), wherein either R6 is independently from each other hydrogen, C1-6alkyl or wherein two R6 together can form a C3-8cycloalkyl, in the presence of a base, such as Cs2CO3, K2CO3 or NaOtBu, and a suitable palladium catalyst, such as tetrakistriphenylphosphinepalladium, [1,1-bis(diphenylphosphino)ferrocene]dichloropalladium(II), bis(diphenylphosphine)palladium(II) chloride, palladium dichloride or palladium acetate, in a suitable solvent, such as dimethylformamide, dioxane, tetrahydrofuran, ethanol or water. Compounds of formula (XXXVII), wherein either R6 is independently from each other hydrogen, C1-6alkyl or wherein two R6 together can form a C3-8cycloalkyl are prepared by known methods or are commercially available. These transformations are depicted in Scheme 16.
Figure imgf000086_0001
Scheme 16 Compounds of formula (Ib), wherein Z is S, can be prepared by the reaction of a compound of formula (I), wherein Z is O, with phosphorus pentasulfide or Lawesson’s reagent (CAS: 19172-47-5) in a suitable solvent such as toluene, xylene or dichloromethane. This transformation is depicted in Scheme 17.
Figure imgf000086_0002
Scheme 17 Alternatively, compounds of formula (Ib), wherein Z is S, can be prepared by the reaction of a compound of formula (XXXVb) with compounds of formula (XXXVI), wherein X2 is OH, in a peptide-coupling transformation, using the conditions described above. Compounds of formula (XXXVb) can be prepared by the reaction of a compound of formula (XXXV), with phosphorus pentasulfide or Lawesson’s reagent (CAS: 19172-47-5) in a suitable solvent such as toluene, xylene or dichloromethane. This transformation is depicted in Scheme 18.
Figure imgf000087_0001
Scheme 18 It is understood by the person skilled in the art that the amide coupling reactions described above between an acid, an amine and a coupling agent could also be performed using the corresponding acid chloride and amine. The transformation of an acid into its corresponding acid chloride is well known by the person skilled in the art. When the term “compound/compounds according to the invention” is used, then this refers to compounds according to the present invention. Alternatively, the compounds according to the present invention can be obtained by using standard synthesis techniques known to the person skilled in the art. Non-exhaustive examples include oxidation reactions, reduction reactions, hydrolysis reactions, coupling reactions, aromatic nucleophilic or electrophilic substitution reactions, nucleophilic substitution reactions, nucleophilic addition reactions, olefination reactions, oxime formation, alkylation and halogenation reactions. A compound according to the present invention can be converted in a manner known per se into another compound according to the present invention by replacing one or more substituents of the starting compound according to the present invention in the customary manner by (an)other substituent(s) according to the invention. Depending on the choice of the reaction conditions and starting materials which are suitable in each case, it is possible, for example, in one reaction step only to replace one substituent by another substituent according to the invention, or a plurality of substituents can be replaced by other substituents according to the invention in the same reaction step. Salts of the compounds according to the present invention can be prepared in a manner known per se. Thus, for example, acid addition salts of the compounds according to the present invention are obtained by treatment with a suitable acid or a suitable ion exchanger reagent and salts with bases are obtained by treatment with a suitable base or with a suitable ion exchanger reagent. Salts of compounds the compounds according to the present invention can be converted in the customary manner into the free compounds, acid addition salts, for example, by treatment with a suitable basic compound or with a suitable ion exchanger reagent and salts with bases, for example, by treatment with a suitable acid or with a suitable ion exchanger reagent. Salts of the compounds according to the present invention can be converted in a manner known per se into other salts of the compounds according to the present invention, acid addition salts, for example, into other acid addition salts, for example by treatment of a salt of inorganic acid such as hydrochloride with a suitable metal salt such as a sodium, barium or silver salt, of an acid, for example with silver acetate, in a suitable solvent in which an inorganic salt which forms, for example silver chloride, is insoluble and thus precipitates from the reaction mixture. Depending on the procedure or the reaction conditions, the compounds according to the present invention, which have salt-forming properties can be obtained in free form or in the form of salts. The compounds according to the present invention and, where appropriate, the tautomers thereof, in each case in free form or in salt form, can be present in the form of one of the stereoisomers which are possible or as a mixture of these, for example in the form of pure stereoisomers, such as antipodes and/or diastereomers, or as stereoisomer mixtures, such as enantiomer mixtures, for example racemates, diastereomer mixtures or racemate mixtures, depending on the number, absolute and relative configuration of asymmetric carbon atoms which occur in the molecule and/or depending on the configuration of non-aromatic double bonds which occur in the molecule; the invention relates to the pure stereoisomers and also to all stereoisomer mixtures which are possible and is to be understood in each case in this sense hereinabove and hereinbelow, even when stereochemical details are not mentioned specifically in each case. Diastereomer mixtures or racemate mixtures of the compounds according to the present invention, in free form or in salt form, which can be obtained depending on which starting materials and procedures have been chosen can be separated in a known manner into the pure diasteromers or racemates on the basis of the physicochemical differences of the components, for example by fractional crystallization, distillation and/or chromatography. Enantiomer mixtures, such as racemates, which can be obtained in a similar manner can be resolved into the optical antipodes by known methods, for example by recrystallization from an optically active solvent, by chromatography on chiral adsorbents, for example high-performance liquid chromatography (HPLC) on acetyl celulose, with the aid of suitable microorganisms, by cleavage with specific, immobilized enzymes, via the formation of inclusion compounds, for example using chiral crown ethers, where only one enantiomer is complexed, or by conversion into diastereomeric salts, for example by reacting a basic end-product racemate with an optically active acid, such as a carboxylic acid, for example camphor, tartaric or malic acid, or sulfonic acid, for example camphorsulfonic acid, and separating the diastereomer mixture which can be obtained in this manner, for example by fractional crystallization based on their differing solubilities, to give the diastereomers, from which the desired enantiomer can be set free by the action of suitable agents, for example basic agents. Pure diastereomers or enantiomers can be obtained according to the invention not only by separating suitable stereoisomer mixtures, but also by generally known methods of diastereoselective or enantioselective synthesis, for example by carrying out the process according to the invention with starting materials of a suitable stereochemistry. N-oxides can be prepared by reacting a compound according to the present invention with a suitable oxidizing agent, for example the H2O2/urea adduct in the presence of an acid anhydride, e.g. trifluoroacetic anhydride. Such oxidations are known from the literature, for example from J. Med. Chem., 32 (12), 2561-73, 1989 or WO 00/15615. It is advantageous to isolate or synthesize in each case the biologically more effective stereoisomer, for example enantiomer or diastereomer, or stereoisomer mixture, for example enantiomer mixture or diastereomer mixture, if the individual components have a different biological activity. The compounds according to the present invention and, where appropriate, the tautomers thereof, in each case in free form or in salt form, can, if appropriate, also be obtained in the form of hydrates and/or include other solvents, for example those which may have been used for the crystallization of compounds which are present in solid form. The following Examples illustrate, but do not limit, the invention. The present invention also provides intermediates useful for the preparation of compounds according to the present invention. The below intermediates form a further aspect of the invention. A compound of formula (XXX)
Figure imgf000090_0001
one A1 is CR1; and preferably one A1 is N and one A1 is CR1; R1 are independently selected from hydrogen, hydroxy, halogen, CN, C1-6alkyl, C3-6cycloalkyl, C1- 6alkoxy-C1-6alkyl, C3-6cycloalkyl-C1-4alkyl, C1-6alkylsulfonyl, C1-6alkoxy, amino, and -NHC(O)C1-6alkyl; and preferably R1 are independently selected from hydrogen and C1-6alkyl; A4 is CH or N; and R5 is selected from C1-6alkyl, C1-6alkoxy, C3-6cycloalkyl, C3-6cycloalkyl-C1-6alkyl, C1-6alkoxyC1-6alkyl, C1- 6alkylamino, diC1-6alkylamino, C1-6alkoxyamino, and C1-6alkylC1-6alkoxyamino, wherein each of the C1- 6alkyl, C1-6alkoxy, C3-6cycloalkyl, C3-6cycloalkyl-C1-6alkyl, C1-6alkoxyC1-6alkyl, C1-6alkylamino, diC1- 6alkylamino, C1-6alkoxyamino, and C1-6alkylC1-6alkoxyamino groups is optionally substituted with one to three substituents independently selected from halogen and CN; or a salt or N-oxide thereof. A compound of formula (XI)
Figure imgf000090_0002
wherein each A1 is N, or one A1 is N and one A1 is CR1; and preferably one A1 is N and one A1 is CR1; R1 are independently selected from hydrogen, hydroxy, halogen, CN, C1-6alkyl, C3-6cycloalkyl, C1- 6alkoxy-C1-6alkyl, C3-6cycloalkyl-C1-4alkyl, C1-6alkylsulfonyl, C1-6alkoxy, amino, and -NHC(O)C1-6alkyl; and preferably R1 are independently selected from hydrogen and C1-6alkyl; A2 are independently CR2 or N, with the proviso that no more than three A2 are N, preferably the four A2 are CR2; R2 are independently selected from hydrogen, hydroxy, halogen, CN, C1-6alkyl, C1-6alkoxy, C1-6alkoxy- C1-6alkyl, C1-6alkoxy-C1-6alkoxy, C3-6cycloalkyl, C1-6alkylsulfonyl, C1-6alkoxycarbonyl, C1- 6alkylaminocarbonyl, diC1-6alkylaminocarbonyl, and C1-6alkylcarbonyl, wherein each of the C1-6alkyl, C1- 6alkoxy, C1-6alkoxy-C1-6alkyl, C1-6alkoxy-C1-6alkoxy, C3-6cycloalkyl, C1-6alkylsulfonyl, C1-6alkoxycarbonyl, C1-6alkylaminocarbonyl, diC1-6alkylaminocarbonyl, and C1-6alkylcarbonyl groups is optionally substituted with one to three substituents selected from halogen, hydroxy, and CN; and preferably R2 are independently selected from hydrogen, halogen, CN, C1-6alkyl, C1-6alkoxy, and C1-6alkoxy-C1-6alkyl; A3 is CR3 or N; R3 is selected from hydrogen, halogen, CN, C1-6alkyl, C1-6alkoxy, C1-6alkoxy-C1-6alkyl, C3-6cycloalkyl, C1- 6alkylsulfonyl, amino, C1-6alkylamino, diC1-6-alkylamino, and C3-6cycloalkylamino, wherein each of the C1-6alkyl, C1-6alkoxy, C1-6alkoxy-C1-6alkyl, C3-6cycloalkyl, C1-6alkylsulfonyl, amino, C1-6alkylamino, diC1-6- alkylamino, and C3-6cycloalkylamino groups is optionally substituted with one to three substituents selected from halogen, hydroxy, and CN; and preferably R3 is hydrogen; R4 is selected from C1-6alkyl, C1-6alkoxy-C1-6alkyl, C3-6cycloalkyl, C3-6cycloalkyl-C1-4alkyl, C2-6alkenyl, C2- 6alkynyl, C1-6alkoxy, C1-6alkylsulfonyl-C1-6alkyl, C1-6alkoxycarbonyl-C1-6alkyl, C1-6alkylaminocarbonyl-C1- 6alkyl, diC1-6alkylaminocarbonyl-C1-6alkyl, and CN, wherein each of the C1-6alkyl, C1-6alkoxy-C1-6alkyl, C3-6cycloalkyl, C3-6cycloalkyl-C1-4alkyl, C2-6alkenyl, C2-6alkynyl, C1-6alkoxy, C1-6alkylsulfonyl-C1-6alkyl, C1- 6alkoxycarbonyl-C1-6alkyl, C1-6alkylaminocarbonyl-C1-6alkyl and diC1-6alkylaminocarbonyl-C1-6alkyl groups is optionally substituted with one to three substituents selected from halogen and CN; and preferably R4 is selected from C1-6alkyl, C1-6alkoxy-C1-6alkyl, C3-6cycloalkyl, C3-6cycloalkyl-C1-4alkyl, and C1-6alkoxy, wherein each of the C1-6alkyl, C1-6alkoxy-C1-6alkyl, C3-6cycloalkyl, C3-6cycloalkyl-C1-4alkyl, and C1-6alkoxy groups is optionally substituted with one to three substituents independently selected from halogen and CN; and wherein A3 and R4 taken together optionally form a ring, preferably a 6-membered heterocycle; or a salt or N-oxide thereof. A compound of formula (II)
Figure imgf000091_0001
wherein each A1 is N, or one A1 is N and one A1 is CR1; and preferably one A1 is N and one A1 is CR1; R1 are independently selected from hydrogen, hydroxy, halogen, CN, C1-6alkyl, C3-6cycloalkyl, C1- 6alkoxy-C1-6alkyl, C3-6cycloalkyl-C1-4alkyl, C1-6alkylsulfonyl, C1-6alkoxy, amino, and -NHC(O)C1-6alkyl; and preferably R1 are independently selected from hydrogen and C1-6alkyl; A2 are independently CR2 or N, with the proviso that no more than three A2 are N, preferably the four A2 are CR2; R2 are independently selected from hydrogen, hydroxy, halogen, CN, C1-6alkyl, C1-6alkoxy, C1-6alkoxy- C1-6alkyl, C1-6alkoxy-C1-6alkoxy, C3-6cycloalkyl, C1-6alkylsulfonyl, C1-6alkoxycarbonyl, C1- 6alkylaminocarbonyl, diC1-6alkylaminocarbonyl, and C1-6alkylcarbonyl, wherein each of the C1-6alkyl, C1- 6alkoxy, C1-6alkoxy-C1-6alkyl, C1-6alkoxy-C1-6alkoxy, C3-6cycloalkyl, C1-6alkylsulfonyl, C1-6alkoxycarbonyl, C1-6alkylaminocarbonyl, diC1-6alkylaminocarbonyl, and C1-6alkylcarbonyl groups is optionally substituted with one to three substituents selected from halogen, hydroxy, and CN; and preferably R2 are independently selected from hydrogen, halogen, CN, C1-6alkyl, C1-6alkoxy, and C1-6alkoxy-C1-6alkyl; A3 is CR3 or N; R3 is selected from hydrogen, halogen, CN, C1-6alkyl, C1-6alkoxy, C1-6alkoxy-C1-6alkyl, C3-6cycloalkyl, C1- 6alkylsulfonyl, amino, C1-6alkylamino, diC1-6-alkylamino, and C3-6cycloalkylamino, wherein each of the C1-6alkyl, C1-6alkoxy, C1-6alkoxy-C1-6alkyl, C3-6cycloalkyl, C1-6alkylsulfonyl, amino, C1-6alkylamino, diC1-6- alkylamino, and C3-6cycloalkylamino groups is optionally substituted with one to three substituents selected from halogen, hydroxy, and CN; and preferably R3 is hydrogen; R4 is selected from C1-6alkyl, C1-6alkoxy-C1-6alkyl, C3-6cycloalkyl, C3-6cycloalkyl-C1-4alkyl, C2-6alkenyl, C2- 6alkynyl, C1-6alkoxy, C1-6alkylsulfonyl-C1-6alkyl, C1-6alkoxycarbonyl-C1-6alkyl, C1-6alkylaminocarbonyl-C1- 6alkyl, diC1-6alkylaminocarbonyl-C1-6alkyl, and CN, wherein each of the C1-6alkyl, C1-6alkoxy-C1-6alkyl, C3-6cycloalkyl, C3-6cycloalkyl-C1-4alkyl, C2-6alkenyl, C2-6alkynyl, C1-6alkoxy, C1-6alkylsulfonyl-C1-6alkyl, C1- 6alkoxycarbonyl-C1-6alkyl, C1-6alkylaminocarbonyl-C1-6alkyl and diC1-6alkylaminocarbonyl-C1-6alkyl groups is optionally substituted with one to three substituents selected from halogen and CN; and preferably R4 is selected from C1-6alkyl, C1-6alkoxy-C1-6alkyl, C3-6cycloalkyl, C3-6cycloalkyl-C1-4alkyl, and C1-6alkoxy, wherein each of the C1-6alkyl, C1-6alkoxy-C1-6alkyl, C3-6cycloalkyl, C3-6cycloalkyl-C1-4alkyl, and C1-6alkoxy groups is optionally substituted with one to three substituents independently selected from halogen and CN; wherein A3 and R4 taken together optionally form a ring, preferably a 6-membered heterocycle; and X is Cl, Br or I; or a salt or N-oxide thereof. The compounds of formula (I) as defined in the present invention can be used in the agricultural sector and related fields of use e.g. as active ingredients for controlling plant pathogens or on non-living materials for control of spoilage microorganisms or organisms potentially harmful to man. The novel compounds are distinguished by excellent activity at low rates of application, by being well tolerated by plants and by being environmentally safe. They have very useful curative, preventive and systemic properties and may be used for protecting numerous cultivated plants. The compounds of formula (I) as defined in the present invention can be used to inhibit or destroy the pathogens that occur on plants or parts of plants (fruit, blossoms, leaves, stems, tubers, roots) of different crops of useful plants, while at the same time protecting also those parts of the plants that grow later e.g. from phytopathogenic microorganisms. It is also possible to use compounds of formula (I) as defined in the present invention as fungicide. The term “fungicide” as used herein means a compound that controls, modifies, or prevents the growth of fungi. The term “fungicidally effective amount” means the quantity of such a compound or combination of such compounds that is capable of producing an effect on the growth of fungi. Controlling or modifying effects include all deviation from natural development, such as killing, retardation and the like, and prevention includes barrier or other defensive formation in or on a plant to prevent fungal infection. It is also possible to use compounds of formula (I) as defined in the present invention as dressing agents for the treatment of plant propagation material, e.g., seed, such as fruits, tubers or grains, or plant cuttings (for example rice), for the protection against fungal infections as well as against phytopathogenic fungi occurring in the soil. The propagation material can be treated with a composition comprising a compound of formula (I) as defined in the present invention before planting: seed, for example, can be dressed before being sown. The compounds of formula (I) as defined in the present invention can also be applied to grains (coating), either by impregnating the seeds in a liquid formulation or by coating them with a solid formulation. The composition can also be applied to the planting site when the propagation material is being planted, for example, to the seed furrow during sowing. The invention relates also to such methods of treating plant propagation material and to the plant propagation material so treated. Furthermore the compounds of formula (I) as defined in the present invention can be used for controlling fungi in related areas, for example in the protection of technical materials, including wood and wood related technical products, in food storage, in hygiene management. In addition, the invention could be used to protect non-living materials from fungal attack, e.g. lumber, wall boards and paint. Compounds of formula (I) as defined in the present invention and fungicidal compositions containing them may be used to control plant diseases caused by a broad spectrum of fungal plant pathogens. They are effective in controlling a broad spectrum of plant diseases, such as foliar pathogens of ornamental, turf, vegetable, field, cereal, and fruit crops. These fungi and fungal vectors of disease, as well as phytopathogenic bacteria and viruses, which may be controlled are for example: Absidia corymbifera, Alternaria spp, Aphanomyces spp, Ascochyta spp, Aspergillus spp. including A. flavus, A. fumigatus, A. nidulans, A. niger, A. terrus, Aureobasidium spp. including A. pullulans, Blastomyces dermatitidis, Blumeria graminis, Bremia lactucae, Botryosphaeria spp. including B. dothidea, B. obtusa, Botrytis spp. inclusing B. cinerea, Candida spp. including C. albicans, C. glabrata, C. krusei, C. lusitaniae, C. parapsilosis, C. tropicalis, Cephaloascus fragrans, Ceratocystis spp, Cercospora spp. including C. arachidicola, Cercosporidium personatum, Cladosporium spp, Claviceps purpurea, Coccidioides immitis, Cochliobolus spp, Colletotrichum spp. including C. musae, Cryptococcus neoformans, Diaporthe spp, Didymella spp, Drechslera spp, Elsinoe spp, Epidermophyton spp, Erwinia amylovora, Erysiphe spp. including E. cichoracearum, Eutypa lata, Fusarium spp. including F. culmorum, F. graminearum, F. langsethiae, F. moniliforme, F. oxysporum, F. proliferatum, F. subglutinans, F. solani, Gaeumannomyces graminis, Gibberella fujikuroi, Gloeodes pomigena, Gloeosporium musarum, Glomerella cingulate, Guignardia bidwellii, Gymnosporangium juniperi-virginianae, Helminthosporium spp, Hemileia spp, Histoplasma spp. including H. capsulatum, Laetisaria fuciformis, Leptographium lindbergi, Leveillula taurica, Lophodermium seditiosum, Microdochium nivale, Microsporum spp, Monilinia spp, Mucor spp, Mycosphaerella spp. including M. graminicola, M. pomi, Oncobasidium theobromaeon, Ophiostoma piceae, Paracoccidioides spp, Penicillium spp. including P. digitatum, P. italicum, Petriellidium spp, Peronosclerospora spp. Including P. maydis, P. philippinensis and P. sorghi, Peronospora spp, Phaeosphaeria nodorum, Phakopsora pachyrhizi, Phellinus igniarus, Phialophora spp, Phoma spp, Phomopsis viticola, Phytophthora spp. including P. infestans, Plasmopara spp. including P. halstedii, P. viticola, Pleospora spp., Podosphaera spp. including P. leucotricha, Polymyxa graminis, Polymyxa betae, Pseudocercosporella herpotrichoides, Pseudomonas spp, Pseudoperonospora spp. including P. cubensis, P. humuli, Pseudopeziza tracheiphila, Puccinia Spp. including P. hordei, P. recondita, P. striiformis, P. triticina, Pyrenopeziza spp, Pyrenophora spp, Pyricularia spp. including P. oryzae, Pythium spp. including P. ultimum, Ramularia spp, Rhizoctonia spp, Rhizomucor pusillus, Rhizopus arrhizus, Rhynchosporium spp, Scedosporium spp. including S. apiospermum and S. prolificans, Schizothyrium pomi, Sclerotinia spp, Sclerotium spp, Septoria spp, including S. nodorum, S. tritici, Sphaerotheca macularis, Sphaerotheca fusca (Sphaerotheca fuliginea), Sporothorix spp, Stagonospora nodorum, Stemphylium spp,. Stereum hirsutum, Thanatephorus cucumeris, Thielaviopsis basicola, Tilletia spp, Trichoderma spp. including T. harzianum, T. pseudokoningii, T. viride, Trichophyton spp, Typhula spp, Uncinula necator, Urocystis spp, Ustilago spp, Venturia spp. including V. inaequalis, Verticillium spp, and Xanthomonas spp. In particular, compounds of formula (I) as defined in the present invention and fungicidal compositions containing them may be used to control plant diseases caused by a broad spectrum of fungal plant pathogens in the Basidiomycete, Ascomycete, Oomycete and/or Deuteromycete, Blasocladiomycete, Chrytidiomycete, Glomeromycete and/or Mucoromycete classes. More particularly, the compounds of formula (I) as defined in the present invention may be used to conrol oomycetes. These pathogens may include: Oomycetes, including Phytophthora diseases such as those caused by Phytophthora capsici, Phytophthora infestans, Phytophthora sojae, Phytophthora fragariae, Phytophthora nicotianae, Phytophthora cinnamomi, Phytophthora citricola, Phytophthora citrophthora and Phytophthora erythroseptica; Pythium diseases such as those caused by Pythium aphanidermatum, Pythium arrhenomanes, Pythium graminicola, Pythium irregulare, Pythium sylvaticum and Pythium ultimum; diseases caused by Peronosporales such as Peronospora destructor, Peronospora parasitica, Plasmopara viticola, Plasmopara halstedii, Pseudoperonospora cubensis, Albugo candida, Sclerophthora macrospora and Bremia lactucae; and others such as Aphanomyces cochlioides, Labyrinthula zosterae, Peronosclerospora sorghi and Sclerospora graminicola. Ascomycetes, including blotch, spot, blast or blight diseases and/or rots for example those caused by Pleosporales such as Stemphylium solani, Stagonospora tainanensis, Spilocaea oleaginea, Setosphaeria turcica, Pyrenochaeta lycoperisici, Pleospora herbarum, Phoma destructiva, Phaeosphaeria herpotrichoides, Phaeocryptocus gaeumannii, Ophiosphaerella graminicola, Ophiobolus graminis, Leptosphaeria maculans, Hendersonia creberrima, Helminthosporium triticirepentis, Setosphaeria turcica, Drechslera glycines, Didymella bryoniae, Cycloconium oleagineum, Corynespora cassiicola, Cochliobolus sativus, Bipolaris cactivora, Venturia inaequalis, Pyrenophora teres, Pyrenophora tritici-repentis, Alternaria alternata, Alternaria brassicicola, Alternaria solani and Alternaria tomatophila, Capnodiales such as Septoria tritici, Septoria nodorum, Septoria glycines, Cercospora arachidicola, Cercospora sojina, Cercospora zeae-maydis, Cercosporella capsellae and Cercosporella herpotrichoides, Cladosporium carpophilum, Cladosporium effusum, Passalora fulva, Cladosporium oxysporum, Dothistroma septosporum, Isariopsis clavispora, Mycosphaerella fijiensis, Mycosphaerella graminicola, Mycovellosiella koepkeii, Phaeoisariopsis bataticola, Pseudocercospora vitis, Pseudocercosporella herpotrichoides, Ramularia beticola, Ramularia collo-cygni, Magnaporthales such as Gaeumannomyces graminis, Magnaporthe grisea, Pyricularia oryzae, Diaporthales such as Anisogramma anomala, Apiognomonia errabunda, Cytospora platani, Diaporthe phaseolorum, Discula destructiva, Gnomonia fructicola, Greeneria uvicola, Melanconium juglandinum, Phomopsis viticola, Sirococcus clavigignenti-juglandacearum, Tubakia dryina, Dicarpella spp., Valsa ceratosperma, and others such as Actinothyrium graminis, Ascochyta pisi, Aspergillus flavus, Aspergillus fumigatus, Aspergillus nidulans, Asperisporium caricae, Blumeriella jaapii, Candida spp., Capnodium ramosum, Cephaloascus spp., Cephalosporium gramineum, Ceratocystis paradoxa, Chaetomium spp., Hymenoscyphus pseudoalbidus, Coccidioides spp., Cylindrosporium padi, Diplocarpon malae, Drepanopeziza campestris, Elsinoe ampelina, Epicoccum nigrum, Epidermophyton spp., Eutypa lata, Geotrichum candidum, Gibellina cerealis, Gloeocercospora sorghi, Gloeodes pomigena, Gloeosporium perennans; Gloeotinia temulenta, Griphospaeria corticola, Kabatiella lini, Leptographium microsporum, Leptosphaerulinia crassiasca, Lophodermium seditiosum, Marssonina graminicola, Microdochium nivale, Monilinia fructicola, Monographella albescens, Monosporascus cannonballus, Naemacyclus spp., Ophiostoma novo-ulmi, Paracoccidioides brasiliensis, Penicillium expansum, Pestalotia rhododendri, Petriellidium spp., Pezicula spp., Phialophora gregata, Phyllachora pomigena, Phymatotrichum omnivora, Physalospora abdita, Plectosporium tabacinum, Polyscytalum pustulans, Pseudopeziza medicaginis, Pyrenopeziza brassicae, Ramulispora sorghi, Rhabdocline pseudotsugae, Rhynchosporium secalis, Sacrocladium oryzae, Scedosporium spp., Schizothyrium pomi, Sclerotinia sclerotiorum, Sclerotinia minor; Sclerotium spp., Typhula ishikariensis, Seimatosporium mariae, Lepteutypa cupressi, Septocyta ruborum, Sphaceloma perseae, Sporonema phacidioides, Stigmina palmivora, Tapesia yallundae, Taphrina bullata, Thielviopsis basicola, Trichoseptoria fructigena, Zygophiala jamaicensis; powdery mildew diseases for example those caused by Erysiphales such as Blumeria graminis, Erysiphe polygoni, Uncinula necator, Sphaerotheca fuligena, Podosphaera leucotricha, Podospaera macularis Golovinomyces cichoracearum, Leveillula taurica, Microsphaera diffusa, Oidiopsis gossypii, Phyllactinia guttata and Oidium arachidis; molds for example those caused by Botryosphaeriales such as Dothiorella aromatica, Diplodia seriata, Guignardia bidwellii, Botrytis cinerea, Botryotinia allii, Botryotinia fabae, Fusicoccum amygdali, Lasiodiplodia theobromae, Macrophoma theicola, Macrophomina phaseolina, Phyllosticta cucurbitacearum; anthracnoses for example those caused by Glommerelales such as Colletotrichum gloeosporioides, Colletotrichum lagenarium, Colletotrichum gossypii, Glomerella cingulata, and Colletotrichum graminicola; and wilts or blights for example those caused by Hypocreales such as Acremonium strictum, Claviceps purpurea, Fusarium culmorum, Fusarium graminearum, Fusarium virguliforme, Fusarium oxysporum, Fusarium subglutinans, Fusarium oxysporum f.sp. cubense, Gerlachia nivale, Gibberella fujikuroi, Gibberella zeae, Gliocladium spp., Myrothecium verrucaria, Nectria ramulariae, Trichoderma viride, Trichothecium roseum, and Verticillium theobromae. Basidiomycetes, including smuts for example those caused by Ustilaginales such as Ustilaginoidea virens, Ustilago nuda, Ustilago tritici, Ustilago zeae, rusts for example those caused by Pucciniales such as Cerotelium fici, Chrysomyxa arctostaphyli, Coleosporium ipomoeae, Hemileia vastatrix, Puccinia arachidis, Puccinia cacabata, Puccinia graminis, Puccinia recondita, Puccinia sorghi, Puccinia hordei, Puccinia striiformis f.sp. Hordei, Puccinia striiformis f.sp. Secalis, Pucciniastrum coryli, or Uredinales such as Cronartium ribicola, Gymnosporangium juniperi-viginianae, Melampsora medusae, Phakopsora pachyrhizi, Phragmidium mucronatum, Physopella ampelosidis, Tranzschelia discolor and Uromyces viciae-fabae; and other rots and diseases such as those caused by Cryptococcus spp., Exobasidium vexans, Marasmiellus inoderma, Mycena spp., Sphacelotheca reiliana, Typhula ishikariensis, Urocystis agropyri, Itersonilia perplexans, Corticium invisum, Laetisaria fuciformis, Waitea circinata, Rhizoctonia solani, Thanetephorus cucurmeris, Entyloma dahliae, Entylomella microspora, Neovossia moliniae and Tilletia caries. Blastocladiomycetes, such as Physoderma maydis. Mucoromycetes, such as Choanephora cucurbitarum.; Mucor spp.; Rhizopus arrhizus. As well as diseases caused by other species and genera closely related to those listed above. In addition to their fungicidal activity, the compounds and compositions comprising compounds of formula (I) as defined in the present invention may also have activity against bacteria such as Erwinia amylovora, Erwinia caratovora, Xanthomonas campestris, Pseudomonas syringae, Strptomyces scabies and other related species as well as certain protozoa. Within the scope of the present invention, target crops and/or useful plants to be protected typically comprise perennial and annual crops, such as berry plants for example blackberries, blueberries, cranberries, raspberries and strawberries; cereals for example barley, maize (corn), millet, oats, rice, rye, sorghum triticale and wheat; fibre plants for example cotton, flax, hemp, jute and sisal; field crops for example sugar and fodder beet, coffee, hops, mustard, oilseed rape (canola), poppy, sugar cane, sunflower, tea and tobacco; fruit trees for example apple, apricot, avocado, banana, cherry, citrus, nectarine, peach, pear and plum; grasses for example Bermuda grass, bluegrass, bentgrass, centipede grass, fescue, ryegrass, St. Augustine grass and Zoysia grass; herbs such as basil, borage, chives, coriander, lavender, lovage, mint, oregano, parsley, rosemary, sage and thyme; legumes for example beans, lentils, peas and soya beans; nuts for example almond, cashew, ground nut, hazelnut, peanut, pecan, pistachio and walnut; palms for example oil palm; ornamentals for example flowers, shrubs and trees; other trees, for example cacao, coconut, olive and rubber; vegetables for example asparagus, aubergine, broccoli, cabbage, carrot, cucumber, garlic, lettuce, marrow, melon, okra, onion, pepper, potato, pumpkin, rhubarb, spinach and tomato; and vines for example grapes. The useful plants and / or target crops in accordance with the invention include conventional as well as genetically enhanced or engineered varieties such as, for example, insect resistant (e.g. Bt. and VIP varieties) as well as disease resistant, herbicide tolerant (e.g. glyphosate- and glufosinate-resistant maize varieties commercially available under the trade names RoundupReady® and LibertyLink®) and nematode tolerant varieties. By way of example, suitable genetically enhanced or engineered crop varieties include the Stoneville 5599BR cotton and Stoneville 4892BR cotton varieties. The term "useful plants" and/or “target crops” is to be understood as including also useful plants that have been rendered tolerant to herbicides like bromoxynil or classes of herbicides (such as, for example, HPPD inhibitors, ALS inhibitors, for example primisulfuron, prosulfuron and trifloxysulfuron, EPSPS (5- enol-pyrovyl-shikimate-3-phosphate-synthase) inhibitors, GS (glutamine synthetase) inhibitors or PPO (protoporphyrinogen-oxidase) inhibitors) as a result of conventional methods of breeding or genetic engineering. An example of a crop that has been rendered tolerant to imidazolinones, e.g. imazamox, by conventional methods of breeding (mutagenesis) is Clearfield® summer rape (Canola). Examples of crops that have been rendered tolerant to herbicides or classes of herbicides by genetic engineering methods include glyphosate- and glufosinate-resistant maize varieties commercially available under the trade names RoundupReady® , Herculex I® and LibertyLink®. The term "useful plants" and/or “target crops” is to be understood as including those which naturally are or have been rendered resistant to harmful insects. This includes plants transformed by the use of recombinant DNA techniques, for example, to be capable of synthesising one or more selectively acting toxins, such as are known, for example, from toxin-producing bacteria. Examples of toxins which can be expressed include ^-endotoxins, vegetative insecticidal proteins (Vip), insecticidal proteins of bacteria colonising nematodes, and toxins produced by scorpions, arachnids, wasps and fungi. An example of a crop that has been modified to express the Bacillus thuringiensis toxin is the Bt maize KnockOut ^ (Syngenta Seeds). An example of a crop comprising more than one gene that codes for insecticidal resistance and thus expresses more than one toxin is VipCot ^ (Syngenta Seeds). Crops or seed material thereof can also be resistant to multiple types of pests (so-called stacked transgenic events when created by genetic modification). For example, a plant can have the ability to express an insecticidal protein while at the same time being herbicide tolerant, for example Herculex I ^ (Dow AgroSciences, Pioneer Hi-Bred International). The term "useful plants" and/or “target crops” is to be understood as including also useful plants which have been so transformed by the use of recombinant DNA techniques that they are capable of synthesising antipathogenic substances having a selective action, such as, for example, the so-called "pathogenesis-related proteins" (PRPs, see e.g. EP-A-0392225). Examples of such antipathogenic substances and transgenic plants capable of synthesising such antipathogenic substances are known, for example, from EP-A-0392225, WO 95/33818, and EP-A-0353191. The methods of producing such transgenic plants are generally known to the person skilled in the art and are described, for example, in the publications mentioned above. Toxins that can be expressed by transgenic plants include, for example, insecticidal proteins from Bacillus cereus or Bacillus popilliae; or insecticidal proteins from Bacillus thuringiensis, such as ^- endotoxins, e.g. Cry1Ab, Cry1Ac, Cry1F, Cry1Fa2, Cry2Ab, Cry3A, Cry3Bb1 or Cry9C, or vegetative insecticidal proteins (Vip), e.g. Vip1, Vip2, Vip3 or Vip3A; or insecticidal proteins of bacteria colonising nematodes, for example Photorhabdus spp. or Xenorhabdus spp., such as Photorhabdus luminescens, Xenorhabdus nematophilus; toxins produced by animals, such as scorpion toxins, arachnid toxins, wasp toxins and other insect-specific neurotoxins; toxins produced by fungi, such as Streptomycetes toxins, plant lectins, such as pea lectins, barley lectins or snowdrop lectins; agglutinins; proteinase inhibitors, such as trypsin inhibitors, serine protease inhibitors, patatin, cystatin, papain inhibitors; ribosome- inactivating proteins (RIP), such as ricin, maize-RIP, abrin, luffin, saporin or bryodin; steroid metabolism enzymes, such as 3-hydroxysteroidoxidase, ecdysteroid-UDP-glycosyl-transferase, cholesterol oxidases, ecdysone inhibitors, HMG-COA-reductase, ion channel blockers, such as blockers of sodium or calcium channels, juvenile hormone esterase, diuretic hormone receptors, stilbene synthase, bibenzyl synthase, chitinases and glucanases. Further, in the context of the present invention there are to be understood by ^-endotoxins, for example Cry1Ab, Cry1Ac, Cry1F, Cry1Fa2, Cry2Ab, Cry3A, Cry3Bb1 or Cry9C, or vegetative insecticidal proteins (Vip), for example Vip1, Vip2, Vip3 or Vip3A, expressly also hybrid toxins, truncated toxins and modified toxins. Hybrid toxins are produced recombinantly by a new combination of different domains of those proteins (see, for example, WO 02/15701). Truncated toxins, for example a truncated Cry1Ab, are known. In the case of modified toxins, one or more amino acids of the naturally occurring toxin are replaced. In such amino acid replacements, preferably non-naturally present protease recognition sequences are inserted into the toxin, such as, for example, in the case of Cry3A055, a cathepsin-G- recognition sequence is inserted into a Cry3A toxin (see WO03/018810). More examples of such toxins or transgenic plants capable of synthesising such toxins are disclosed, for example, in EP-A-0374753, WO93/07278, WO95/34656, EP-A-0427529, EP-A-451878 and WO03/052073. The processes for the preparation of such transgenic plants are generally known to the person skilled in the art and are described, for example, in the publications mentioned above. CryI-type deoxyribonucleic acids and their preparation are known, for example, from WO 95/34656, EP-A-0367 474, EP-A-0401979 and WO 90/13651. The toxin contained in the transgenic plants imparts to the plants tolerance to harmful insects. Such insects can occur in any taxonomic group of insects, but are especially commonly found in the beetles (Coleoptera), two-winged insects (Diptera) and butterflies (Lepidoptera). Transgenic plants containing one or more genes that code for an insecticidal resistance and express one or more toxins are known and some of them are commercially available. Examples of such plants are: YieldGard ^ (maize variety that expresses a Cry1Ab toxin); YieldGard Rootworm ^ (maize variety that expresses a Cry3Bb1 toxin); YieldGard Plus ^ (maize variety that expresses a Cry1Ab and a Cry3Bb1 toxin); Starlink ^ (maize variety that expresses a Cry9C toxin); Herculex I ^ (maize variety that expresses a Cry1Fa2 toxin and the enzyme phosphinothricine N-acetyltransferase (PAT) to achieve tolerance to the herbicide glufosinate ammonium); NuCOTN 33B ^ (cotton variety that expresses a Cry1Ac toxin); Bollgard I ^ (cotton variety that expresses a Cry1Ac toxin); Bollgard II® (cotton variety that expresses a Cry1Ac and a Cry2Ab toxin); VipCot ^ (cotton variety that expresses a Vip3A and a Cry1Ab toxin); NewLeaf ^ (potato variety that expresses a Cry3A toxin); NatureGard ^, Agrisure® GT Advantage (GA21 glyphosate-tolerant trait), Agrisure® CB Advantage (Bt11 corn borer (CB) trait) and Protecta ^. Further examples of such transgenic crops are: 1. Bt11 Maize from Syngenta Seeds SAS, Chemin de l'Hobit 27, F-31 790 St. Sauveur, France, registration number C/FR/96/05/10. Genetically modified Zea mays which has been rendered resistant to attack by the European corn borer (Ostrinia nubilalis and Sesamia nonagrioides) by transgenic expression of a truncated Cry1Ab toxin. Bt11 maize also transgenically expresses the enzyme PAT to achieve tolerance to the herbicide glufosinate ammonium. 2. Bt176 Maize from Syngenta Seeds SAS, Chemin de l'Hobit 27, F-31790 St. Sauveur, France, registration number C/FR/96/05/10. Genetically modified Zea mays which has been rendered resistant to attack by the European corn borer (Ostrinia nubilalis and Sesamia nonagrioides) by transgenic expression of a Cry1Ab toxin. Bt176 maize also transgenically expresses the enzyme PAT to achieve tolerance to the herbicide glufosinate ammonium. 3. MIR604 Maize from Syngenta Seeds SAS, Chemin de l'Hobit 27, F-31790 St. Sauveur, France, registration number C/FR/96/05/10. Maize which has been rendered insect-resistant by transgenic expression of a modified Cry3A toxin. This toxin is Cry3A055 modified by insertion of a cathepsin-G- protease recognition sequence. The preparation of such transgenic maize plants is described in WO 03/018810. 4. MON 863 Maize from Monsanto Europe S.A. 270-272 Avenue de Tervuren, B-1150 Brussels, Belgium, registration number C/DE/02/9. MON 863 expresses a Cry3Bb1 toxin and has resistance to certain Coleoptera insects. 5. IPC 531 Cotton from Monsanto Europe S.A. 270-272 Avenue de Tervuren, B-1150 Brussels, Belgium, registration number C/ES/96/02. 6. 1507 Maize from Pioneer Overseas Corporation, Avenue Tedesco, 7 B-1160 Brussels, Belgium, registration number C/NL/00/10. Genetically modified maize for the expression of the protein Cry1F for achieving resistance to certain Lepidoptera insects and of the PAT protein for achieving tolerance to the herbicide glufosinate ammonium. 7. NK603 × MON 810 Maize from Monsanto Europe S.A. 270-272 Avenue de Tervuren, B-1150 Brussels, Belgium, registration number C/GB/02/M3/03. Consists of conventionally bred hybrid maize varieties by crossing the genetically modified varieties NK603 and MON 810. NK603 × MON 810 Maize transgenically expresses the protein CP4 EPSPS, obtained from Agrobacterium sp. strain CP4, which imparts tolerance to the herbicide Roundup® (contains glyphosate), and also a Cry1Ab toxin obtained from Bacillus thuringiensis subsp. kurstaki which brings about tolerance to certain Lepidoptera, include the European corn borer. The term “locus” as used herein means fields in or on which plants are growing, or where seeds of cultivated plants are sown, or where seed will be placed into the soil. It includes soil, seeds, and seedlings, as well as established vegetation. The term “plants” refers to all physical parts of a plant, including seeds, seedlings, saplings, roots, tubers, stems, stalks, foliage, and fruits. The term “plant propagation material” is understood to denote generative parts of the plant, such as seeds, which can be used for the multiplication of the latter, and vegetative material, such as cuttings or tubers, for example potatoes. There may be mentioned for example seeds (in the strict sense), roots, fruits, tubers, bulbs, rhizomes and parts of plants. Germinated plants and young plants which are to be transplanted after germination or after emergence from the soil, may also be mentioned. These young plants may be protected before transplantation by a total or partial treatment by immersion. Preferably “plant propagation material” is understood to denote seeds. Pesticidal agents referred to herein using their common name are known, for example, from "The Pesticide Manual", 19th Ed., British Crop Protection Council 2021. The compounds of formula (I) as defined in the present invention may be used in unmodified form or, preferably, together with the adjuvants conventionally employed in the art of formulation. To this end they may be conveniently formulated in known manner to emulsifiable concentrates, coatable pastes, directly sprayable or dilutable solutions or suspensions, dilute emulsions, wettable powders, soluble powders, dusts, granulates, and also encapsulations e.g. in polymeric substances. As with the type of the compositions, the methods of application, such as spraying, atomising, dusting, scattering, coating or pouring, are chosen in accordance with the intended objectives and the prevailing circumstances. The compositions may also contain further adjuvants such as stabilizers, antifoams, viscosity regulators, binders or tackifiers as well as fertilizers, micronutrient donors or other formulations for obtaining special effects. Suitable carriers and/or adjuvants, e.g. for agricultural use, can be solid or liquid and are substances useful in formulation technology, e.g. natural or regenerated mineral substances, solvents, dispersants, wetting agents, tackifiers, thickeners, binders or fertilizers. Such carriers are for example described in WO 97/33890. Suspension concentrates are aqueous formulations in which finely divided solid particles of the active compound are suspended. Such formulations include anti-settling agents and dispersing agents and may further include a wetting agent to enhance activity as well an anti-foam and a crystal growth inhibitor. In use, these concentrates are diluted in water and normally applied as a spray to the area to be treated. The amount of active ingredient may range from 0.5% to 95% of the concentrate. Wettable powders are in the form of finely divided particles which disperse readily in water or other liquid carriers. The particles contain the active ingredient retained in a solid matrix. Typical solid matrices include fuller’s earth, kaolin clays, silicas and other readily wet organic or inorganic solids. Wettable powders normally contain from 5% to 95% of the active ingredient plus a small amount of wetting, dispersing or emulsifying agent. Emulsifiable concentrates are homogeneous liquid compositions dispersible in water or other liquid and may consist entirely of the active compound with a liquid or solid emulsifying agent, or may also contain a liquid carrier, such as xylene, heavy aromatic naphthas, isophorone and other non-volatile organic solvents. In use, these concentrates are dispersed in water or other liquid and normally applied as a spray to the area to be treated. The amount of active ingredient may range from 0.5% to 95% of the concentrate. Granular formulations include both extrudates and relatively coarse particles and are usually applied without dilution to the area in which treatment is required. Typical carriers for granular formulations include sand, fuller’s earth, attapulgite clay, bentonite clays, montmorillonite clay, vermiculite, perlite, calcium carbonate, brick, pumice, pyrophyllite, kaolin, dolomite, plaster, wood flour, ground corn cobs, ground peanut hulls, sugars, sodium chloride, sodium sulphate, sodium silicate, sodium borate, magnesia, mica, iron oxide, zinc oxide, titanium oxide, antimony oxide, cryolite, gypsum, diatomaceous earth, calcium sulphate and other organic or inorganic materials which absorb or which can be coated with the active compound. Granular formulations normally contain 5% to 25% of active ingredients which may include surface-active agents such as heavy aromatic naphthas, kerosene and other petroleum fractions, or vegetable oils; and/or stickers such as dextrins, glue or synthetic resins. Dusts are free-flowing admixtures of the active ingredient with finely divided solids such as talc, clays, flours and other organic and inorganic solids which act as dispersants and carriers. Microcapsules are typically droplets or granules of the active ingredient enclosed in an inert porous shell which allows escape of the enclosed material to the surroundings at controlled rates. Encapsulated droplets are typically 1 to 50 microns in diameter. The enclosed liquid typically constitutes 50 to 95% of the weight of the capsule and may include solvent in addition to the active compound. Encapsulated granules are generally porous granules with porous membranes sealing the granule pore openings, retaining the active species in liquid form inside the granule pores. Granules typically range from 1 millimetre to 1 centimetre and preferably 1 to 2 millimetres in diameter. Granules are formed by extrusion, agglomeration or prilling, or are naturally occurring. Examples of such materials are vermiculite, sintered clay, kaolin, attapulgite clay, sawdust and granular carbon. Shell or membrane materials include natural and synthetic rubbers, cellulosic materials, styrene-butadiene copolymers, polyacrylonitriles, polyacrylates, polyesters, polyamides, polyureas, polyurethanes and starch xanthates. Other useful formulations for agrochemical applications include simple solutions of the active ingredient in a solvent in which it is completely soluble at the desired concentration, such as acetone, alkylated naphthalenes, xylene and other organic solvents. Pressurised sprayers, wherein the active ingredient is dispersed in finely-divided form as a result of vaporisation of a low boiling dispersant solvent carrier, may also be used. Suitable agricultural adjuvants and/or carriers that are useful in formulating the compositions of the invention in the formulation types described above are well known to those skilled in the art. Liquid carriers that can be employed include, for example, water, toluene, xylene, petroleum naphtha, crop oil, acetone, methyl ethyl ketone, cyclohexanone, acetic anhydride, acetonitrile, acetophenone, amyl acetate, 2-butanone, chlorobenzene, cyclohexane, cyclohexanol, alkyl acetates, diacetonalcohol, 1,2-dichloropropane, diethanolamine, p-diethylbenzene, diethylene glycol, diethylene glycol abietate, diethylene glycol butyl ether, diethylene glycol ethyl ether, diethylene glycol methyl ether, N,N-dimethyl formamide, dimethyl sulfoxide, 1,4-dioxane, dipropylene glycol, dipropylene glycol methyl ether, dipropylene glycol dibenzoate, diproxitol, alkyl pyrrolidinone, ethyl acetate, 2-ethyl hexanol, ethylene carbonate, 1,1,1-trichloroethane, 2-heptanone, alpha pinene, d-limonene, ethylene glycol, ethylene glycol butyl ether, ethylene glycol methyl ether, gamma-butyrolactone, glycerol, glycerol diacetate, glycerol monoacetate, glycerol triacetate, hexadecane, hexylene glycol, isoamyl acetate, isobornyl acetate, isooctane, isophorone, isopropyl benzene, isopropyl myristate, lactic acid, laurylamine, mesityl oxide, methoxy-propanol, methyl isoamyl ketone, methyl isobutyl ketone, methyl laurate, methyl octanoate, methyl oleate, methylene chloride, m-xylene, n-hexane, n-octylamine, octadecanoic acid, octyl amine acetate, oleic acid, oleylamine, o-xylene, phenol, polyethylene glycol (PEG400), propionic acid, propylene glycol, propylene glycol monomethyl ether, p-xylene, toluene, triethyl phosphate, triethylene glycol, xylene sulfonic acid, paraffin, mineral oil, trichloroethylene, perchloroethylene, ethyl acetate, amyl acetate, butyl acetate, methanol, ethanol, isopropanol, and higher molecular weight alcohols such as amyl alcohol, tetrahydrofurfuryl alcohol, hexanol, octanol, etc., ethylene glycol, propylene glycol, glycerine and N-methyl-2-pyrrolidinone. Water is generally the carrier of choice for the dilution of concentrates. Suitable solid carriers include, for example, talc, titanium dioxide, pyrophyllite clay, silica, attapulgite clay, kieselguhr, chalk, diatomaxeous earth, lime, calcium carbonate, bentonite clay, fuller’s earth, cotton seed hulls, wheat flour, soybean flour, pumice, wood flour, walnut shell flour and lignin. A broad range of surface-active agents are advantageously employed in both said liquid and solid compositions, especially those designed to be diluted with carrier before application. These agents, when used, normally comprise from 0.1% to 15% by weight of the formulation. They can be anionic, cationic, non-ionic or polymeric in character and can be employed as emulsifying agents, wetting agents, suspending agents or for other purposes. Typical surface active agents include salts of alkyl sulfates, such as diethanolammonium lauryl sulphate; alkylarylsulfonate salts, such as calcium dodecylbenzenesulfonate; alkylphenol-alkylene oxide addition products, such as nonylphenol-C.sub.18 ethoxylate; alcohol-alkylene oxide addition products, such as tridecyl alcohol-C.sub. 16 ethoxylate; soaps, such as sodium stearate; alkylnaphthalenesulfonate salts, such as sodium dibutylnaphthalenesulfonate; dialkyl esters of sulfosuccinate salts, such as sodium di(2-ethylhexyl) sulfosuccinate; sorbitol esters, such as sorbitol oleate; quaternary amines, such as lauryl trimethylammonium chloride; polyethylene glycol esters of fatty acids, such as polyethylene glycol stearate; block copolymers of ethylene oxide and propylene oxide; and salts of mono and dialkyl phosphate esters. Other adjuvants commonly utilized in agricultural compositions include crystallisation inhibitors, viscosity modifiers, suspending agents, spray droplet modifiers, pigments, antioxidants, foaming agents, anti- foaming agents, light-blocking agents, compatibilizing agents, antifoam agents, sequestering agents, neutralising agents and buffers, corrosion inhibitors, dyes, odorants, spreading agents, penetration aids, micronutrients, emollients, lubricants and sticking agents. In addition, further, other biocidally active ingredients or compositions may be combined with the compositions of the invention and used in the methods of the invention and applied simultaneously or sequentially with the compositions of the invention. When applied simultaneously, these further active ingredients may be formulated together with the compositions of the invention or mixed in, for example, the spray tank. These further biocidally active ingredients may be fungicides, herbicides, insecticides, bactericides, acaricides, nematicides, plant growth regulators, and/or biologicals. The following combinations of a compound of formula I with another active substance in a weight ratio of 1:1 are preferred (where the abbreviation “TX” means “one compound selected from the compounds defined in the Tables 1.1 to 1.100, in the Tables 2.1 to 2.50, and Table A): (7E,9Z)-dodeca-7,9-dien-1-yl acetate + TX, (9Z,11E)-tetradeca-9,11-dien-1-yl acetate + TX, (9Z,12E)- tetradeca-9,12-dien-1-yl acetate + TX, (E)-6-methylhept-2-en-4-ol + TX, (E)-dec-5-en-1-yl acetate with (E)-dec-5-en-1-ol + TX, (E)-tridec-4-en-1-yl acetate + TX, (E,Z)-tetradeca-4,10-dien-1-yl acetate + TX, (Z)-dodec-7-en-1-yl acetate + TX, (Z)-hexadec-11-en-1-yl acetate + TX, (Z)-hexadec-11-enal + TX, (Z)- hexadec-13-en-11-yn-1-yl acetate + TX, (Z)-icos-13-en-10-one + TX, (Z)-tetradec-7-en-1-al + TX, (Z)- tetradec-9-en-1-ol + TX, (Z)-tetradec-9-en-1-yl acetate + TX, 1,2-dibromo-3-chloropropane + TX, 1,2- dichloropropane + TX, 1,2-dichloropropane with 1,3-dichloropropene + TX, 1,3-dichloropropene + TX, 14-methyloctadec-1-ene + TX, 1-hydroxy-1H-pyridine-2-thione + TX, 2-(octylthio)ethanol + TX, 2- chlorophenyl N-methylcarbamate (CPMC) + TX, 3-(4-chlorophenyl)-5-methylrhodanine + TX, 3,4- dichlorotetrahydrothiophene 1,1-dioxide + TX, 4-(quinoxalin-2-ylamino)benzenesulfonamide + TX, 4- methylnonan-5-ol with 4-methylnonan-5-one + TX, 5-methyl-6-thioxo-1,3,5-thiadiazinan-3-ylacetic acid + TX, 6-isopentenylaminopurine + TX, 8-hydroxyquinoline sulfate + TX, abamectin + TX, acequinocyl + TX, acetamiprid + TX, acetoprole + TX, acrinathrin + TX, acynonapyr + TX, Adoxophyes orana GV + TX, afidopyropen + TX, afoxolaner + TX, Agrobacterium radiobacter + TX, AKD-3088 + TX, alanycarb + TX, aldicarb + TX, aldoxycarb + TX, allethrin + TX, alpha-cypermethrin + TX, alphamethrin + TX, alpha-multistriatin + TX, Amblyseius spp. + TX, amidoflumet + TX, amino acids + TX, aminocarb + TX, Anagrapha falcifera NPV + TX, Anagrus atomus + TX, Aphelinus abdominalis + TX, Aphidius colemani + TX, Aphidoletes aphidimyza + TX, apholate + TX, Autographa californica NPV + TX, AZ 60541 + TX, azadirachtin + TX, azocyclotin + TX, Bacillus aizawai + TX, Bacillus chitinosporus AQ746 (NRRL Accession No B-21618) + TX, Bacillus firmus + TX, Bacillus kurstaki + TX, Bacillus mycoides AQ726 (NRRL Accession No. B-21664) + TX, Bacillus pumilus (NRRL Accession No B-30087) + TX, Bacillus pumilus AQ717 (NRRL Accession No. B-21662) + TX, Bacillus sp. AQ175 (ATCC Accession No.55608) + TX, Bacillus sp. AQ177 (ATCC Accession No.55609) + TX, Bacillus sp. AQ178 (ATCC Accession No. 53522) + TX, Bacillus sphaericus Neide + TX, Bacillus subtilis AQ153 (ATCC Accession No.55614) + TX, Bacillus subtilis AQ30002 (NRRL Accession No. B-50421) + TX, Bacillus subtilis AQ30004 (NRRL Accession No. B- 50455) + TX, Bacillus subtilis AQ713 (NRRL Accession No. B-21661) + TX, Bacillus subtilis AQ743 (NRRL Accession No. B-21665) + TX, Bacillus subtilis unspecified + TX, Bacillus thuringiensis AQ52 (NRRL Accession No. B-21619) + TX, Bacillus thuringiensis BD#32 (NRRL Accession No B-21530) + TX, Bacillus thuringiensis Berliner + TX, Bacillus thuringiensis subsp. Aizawai + TX, Bacillus thuringiensis subsp. Israelensis + TX, Bacillus thuringiensis subsp. Japonensis + TX, Bacillus thuringiensis subsp. Kurstaki + TX, Bacillus thuringiensis subsp. Tenebrionis + TX, Bacillus thuringiensis subspec. kurstaki BMP 123 + TX, Beauveria bassiana + TX, Beauveria brongniartii + TX, benclothiaz + TX, benomyl + TX, bensultap + TX, benzoximate + TX, benzpyrimoxan + TX, betacyfluthrin + TX, beta-cypermethrin + TX, bethoxazin + TX, bifenazate + TX, bifenthrin + TX, binapacryl + TX, bioallethrin + TX, bioresmethrin + TX, bis(tributyltin) oxide + TX, bisazir + TX, bistrifluron + TX, bisulflufen + TX, brevicomin + TX, broflanilide + TX, brofluthrinate + TX, bromoacetamide + TX, bromophos-ethyl + TX, bronopol + TX, busulfan + TX, butocarboxim + TX, butopyronoxyl + TX, butoxy(polypropylene glycol) + TX, butylpyridaben + TX, cadusafos + TX, calcium arsenate + TX, carbaryl + TX, carbofuran + TX, carbon disulfide + TX, carbosulfan + TX, cartap + TX, CAS number: 1594624-87-9 + TX, CAS number: 1922957-47-8 + TX, CAS number: 1255091-74-7 + TX, CAS number: 1365070-72-9 + TX, CAS number: 1445683-71-5 + TX, CAS number: 1445684-82-1 + TX, CAS number: 1594626-19-3 + TX, CAS number: 1594637-65-6 + TX, CAS number: 1632218-00-8 + TX, CAS number: 1808115-49-2 + TX, CAS number: 1922957-46-7 + TX, CAS number: 1922957-48- 9 + TX, CAS number: 1956329-03-5 + TX, CAS number: 1990457-52-7 + TX, CAS number: 1990457- 55-0 + TX, CAS number: 1990457-57-2 + TX, CAS number: 1990457-66-3 + TX, CAS number: 1990457-77-6 + TX, CAS number: 1990457-85-6 + TX, CAS number: 2032403-97-5 + TX, CAS number: 2044701-44-0 + TX, CAS number: 2095470-94-1 + TX, CAS Number: 2128706-04-5 + TX, CAS number: 2128706-05-6 + TX, CAS number: 2133042-31-4 + TX, CAS number: 2133042-44-9 + TX, CAS number: 2171099-09-3 + TX, CAS number: 2220132-55-6 + TX, CAS number: 2396747-83-2 + TX, CAS number: 2408220-91-5 + TX, CAS number: 2408220-94-8 + TX, CAS number: 2415706-16-8 + TX, Piperflanilide (CAS number: 2615135-05-0) + TX, CAS number: 2719848-60-7 + TX, CAS number: RNA (Leptinotarsa decemlineata-specific recombinant double-stranded interfering GS2) + TX, chlorantraniliprole + TX, chlordane + TX, chlorfenapyr + TX, chloropicrin + TX, chloroprallethrin + TX, chlorpyrifos + TX, chromafenozide + TX, Chrysoperla carnea + TX, clenpirin + TX, cloethocarb + TX, clothianidin + TX, codlelure + TX, codlemone + TX, copper acetoarsenite + TX, copper dioctanoate + TX, copper hydroxide + TX, copper sulfate + TX, cresol + TX, crufomate + TX, Cryptolaemus montrouzieri + TX, cuelure + TX, cyanofenphos + TX, cyantraniliprole + TX, cybutryne + TX, cyclaniliprole + TX, cyclobutrifluram + TX, cycloprothrin + TX, cycloxaprid + TX, Cydia pomonella GV + TX, cyenopyrafen + TX, cyetpyrafen + TX, cyflumetofen + TX, cyfluthrin + TX, cyhalodiamide + TX, cylohalothrin + TX, cypermethrin + TX, cyphenothrin + TX, cyproflanilide + TX, cyromazine + TX, cytokinins + TX, Dacnusa sibirica + TX, dazomet + TX, DBCP + TX, DCIP + TX, deltamethrin + TX, diafenthiuron + TX, dialifos + TX, diamidafos + TX, dibrom + TX, dibutyl adipate + TX, dibutyl phthalate + TX, dibutyl succinate + TX, dichlofenthion + TX, dichlone + TX, dichlorophen + TX, dicliphos + TX, dicloromezotiaz + TX, diethyltoluamide + TX, diflubenzuron + TX, Diglyphus isaea + TX, dimatif + TX, dimethoate + TX, dimethyl carbate + TX, dimethyl phthalate + TX, dimpropyridaz + TX, dinactin + TX, dinocap + TX, dinotefuran + TX, dioxabenzofos + TX, dipyrithione + TX, disparlure + TX, D-limonene + TX, dodec-8-en-1-yl acetate + TX, dodec-9-en-1-yl acetate + TX, dodeca-8,10-dien-1-yl acetate + TX, dodicin + TX, dominicalure + TX, doramectin + TX, emamectin + TX, emamectin benzoate + TX, empenthrin + TX, Encarsia formosa + TX, endothal + TX, endrin + TX, eprinomectin + TX, epsilon - momfluorothrin + TX, epsilon-metofluthrin + TX, Eretmocerus eremicus + TX, esfenvalerate + TX, ethion + TX, ethiprole + TX, ethoprophos + TX, ethyl 4-methyloctanoate + TX, ethyl hexanediol + TX, ethylene dibromide + TX, etofenprox + TX, etoxazole + TX, etpyrafen + TX, eugenol + TX, Extract of seaweed and fermentation product derived from melasse + TX, Extract of seaweed and fermentation product derived from melasse comprising urea + TX, Extract of seaweed and fermented plant products + TX, Extract of seaweed and fermented plant products comprising phytohormones, vitamins, EDTA-chelated copper, zinc, and iron + TX, famphur + TX, fenaminosulf + TX, fenamiphos + TX, fenazaquin + TX, fenfluthrin + TX, fenitrothion + TX, fenmezoditiaz + TX, fenobucarb + TX, fenothiocarb + TX, fenoxycarb + TX, fenpropathrin + TX, fenpyrad + TX, fenpyroximate + TX, fensulfothion + TX, fenthion + TX, fentin + TX, fentinacetate + TX, fenvalerate + TX, ferric phosphate + TX, fipronil + TX, flometoquin + TX, flonicamid + TX, fluacrypyrim + TX, fluazaindolizine + TX, fluazuron + TX, flubendiamide + TX, flubenzimine + TX, fluchlordiniliprole + TX, flucitrinate + TX, flucycloxuron + TX, flucythrinate + TX, fluensulfone [318290-98-1] + TX, fluensulfone + TX, flufenerim + TX, flufenprox + TX, flufiprole + TX, fluhexafon + TX, flumethrin + TX, fluopyram + TX, flupyradifurone + TX, flupyrimin + TX, flupyroxystrobin + TX, fluralaner + TX, fluvalinate + TX, fluxametamide + TX, formaldehyde + TX, fosthiazate + TX, fosthietan + TX, frontalin + TX, furfural + TX, gamma-cyhalothrin + TX, Gossyplure® (1:1 mixture of the (Z,E) and (Z,Z) isomers of hexadeca-7,11-dien-1-yl-acetate) + TX, grandlure + TX, grandlure I + TX, grandlure II + TX, grandlure III + TX, grandlure IV + TX, Granulovirus + TX, guadipyr + TX, GY-81 + TX, halfenprox + TX, halofenozide + TX, Harpin + TX, Helicoverpa armigera Nucleopolyhedrovirus + TX, Helicoverpa zea NPV + TX, Helicoverpa zea Nucleopolyhedrovirus + TX, Heliothis punctigera Nucleopolyhedrovirus + TX, Heliothis virescens Nucleopolyhedrovirus + TX, hemel + TX, hempa + TX, heptafluthrin + TX, heterophos + TX, Heterorhabditis bacteriophora and H. megidis + TX, hexalure + TX, hexamide + TX, hexythiazox + TX, Hippodamia convergens + TX, hydramethylnon + TX, hydrargaphen + TX, hydrated lime + TX, imicyafos + TX, imidacloprid + TX, imiprothrin + TX, Indazapyroxamet + TX, indoxacarb + TX, iodomethane + TX, iprodione + TX, ipsdienol + TX, ipsenol + TX, isamidofos + TX, isazofos + TX, isocycloseram + TX, Isoflualanam (CAS number: 2892524-05-7) + TX, isothioate + TX, ivermectin + TX, japonilure + TX, kappa-bifenthrin + TX, kappa-tefluthrin + TX, kasugamycin + TX, kasugamycin hydrochloride hydrate + TX, kinetin + TX, lambda-cyhalothrin + TX, ledprona + TX, lepimectin + TX, Leptomastix dactylopii + TX, lineatin + TX, litlure + TX, looplure + TX, lotilaner + TX, lufenuron + TX, Macrolophus caliginosus + TX, Mamestra brassicae NPV + TX, mecarphon + TX, medlure + TX, megatomoic acid + TX, metaflumizone + TX, metaldehyde + TX, metam + TX, metam-potassium + TX, metam-sodium + TX, Metaphycus helvolus + TX, Metarhizium anisopliae var. acridum + TX, Metarhizium anisopliae var. anisopliae + TX, Metarhizium spp. + TX, metepa + TX, methiocarb + TX, methiotepa + TX, methomyl + TX, methoquin-butyl + TX, methoxyfenozide + TX, methyl apholate + TX, methyl bromide + TX, methyl eugenol + TX, methyl isothiocyanate + TX, methylneodecanamide + TX, metofluthrin + TX, metolcarb + TX, mexacarbate + TX, milbemectin + TX, milbemycin oxime + TX, momfluorothrin + TX, morzid + TX, moxidectin + TX, muscalure + TX, Muscodor albus 620 (NRRL Accession No.30547) + TX, Muscodor roseus A3-5 (NRRL Accession No.30548) + TX, Myrothecium verrucaria composition + TX, nabam + TX, NC-184 + TX, Neem tree based products + TX, Neodiprion sertifer NPV and N. lecontei NPV + TX, nickel bis(dimethyldithiocarbamate) + TX, niclosamide + TX, niclosamide-olamine + TX, nicofluprole + TX, nitenpyram + TX, nithiazine + TX, nitrapyrin + TX, octadeca-2,13-dien-1-yl acetate + TX, octadeca-3,13-dien-1-yl acetate + TX, octhilinone + TX, omethoate + TX, orfralure + TX, Orius spp. + TX, oryctalure + TX, ostramone + TX, oxamate + TX, oxamyl + TX, oxazosulfyl + TX, oxolinic acid + TX, oxytetracycline + TX, Paecilomyces fumosoroseus + TX, Paecilomyces lilacinus + TX, parathion-ethyl + TX, Pasteuria nishizawae + TX, Pasteuria penetrans + TX, Pasteuria ramosa + TX, Pasteuria thornei + TX, Pasteuria usgae + TX, P- cymene + TX, penfluron + TX, pentachlorophenol + TX, permethrin + TX, phenothrin + TX, phorate + TX, phosphamidon + TX, phosphocarb + TX, Phytoseiulus persimilis + TX, picaridin + TX, pioxaniliprole + TX, piperazine + TX, piperonylbutoxide + TX, pirimicarb + TX, pirimiphos-ethyl + TX, pirimiphos-methyl + TX, Plutella xylostella Granulosis virus + TX, Plutella xylostella Nucleopolyhedrovirus + TX, Polyhedrosis virus + TX, potassium and molybdenum and EDTA-chelated manganese + TX, potassium ethylxanthate + TX, potassium hydroxyquinoline sulfate + TX, prallethrin + TX, probenazole + TX, profenofos + TX, profluthrin + TX, propargite + TX, propetamphos + TX, propoxur + TX, prothiophos + TX, protrifenbute + TX, pyflubumide + TX, pymetrozine + TX, pyraclofos + TX, pyrafluprole + TX, pyrethrum + TX, pyridaben + TX, pyridalyl + TX, pyridin-4-amine + TX, pyrifluquinazon + TX, pyrimidifen + TX, pyriminostrobin + TX, pyriprole [394730-71-3] + TX, pyriprole + TX, pyriproxyfen + TX, QRD 420 (a terpenoid blend) + TX, QRD 452 (a terpenoid blend) + TX, QRD 460 (a terpenoid blend) + TX, Quillaja saponaria + TX, quinoclamine + TX, quinonamid + TX, resmethrin + TX, Rhodococcus globerulus AQ719 (NRRL Accession No B-21663) + TX, sarolaner + TX, S- bioallethrin + TX, sebufos + TX, selamectin + TX, siglure + TX, silafluofen + TX, simazine + TX, sodium pentachlorophenoxide + TX, sordidin + TX, spidoxamat + TX, spinetoram + TX, spinosad + TX, spirobudifen + TX, spirodiclofen + TX, spiromesifen + TX, spiropidion + TX, spirotetramat + TX, Spodoptera exigua multicapsid nuclear polyhedrosis virus + TX, Spodoptera frugiperda Nucleopolyhedrovirus + TX, Steinernema bibionis + TX, Steinernema carpocapsae + TX, Steinernema feltiae + TX, Steinernema glaseri + TX, Steinernema riobrave + TX, Steinernema riobravis + TX, Steinernema scapterisci + TX, Steinernema spp. + TX, Streptomyces galbus (NRRL Accession No. 30232) + TX, Streptomyces sp. (NRRL Accession No. B-30145) + TX, streptomycin + TX, streptomycin sesquisulfate + TX, strychnine + TX, sulcatol + TX, sulfiflumin (CAS number: 2377084-09-6) + TX, sulfoxaflor + TX, tazimcarb + TX, tebufenozide + TX, tebufenpyrad + TX, tebupirimiphos + TX, tecloftalam + TX, tefluthrin + TX, temephos + TX, tepa + TX, terbam + TX, terbufos + TX, terpenoid blend + TX, tetrachlorantraniliprole + TX, tetrachlorothiophene + TX, tetradec-11-en-1-yl acetate + TX, tetradiphon + TX, tetramethrin + TX, tetramethylfluthrin + TX, tetranactin + TX, tetraniliprole + TX, theta- cypermethrin + TX, thiacloprid + TX, thiafenox + TX, thiamethoxam + TX, thiocyclam + TX, thiodicarb + TX, thiofanox + TX, thiohempa + TX, thiomersal + TX, thiometon + TX, thionazin + TX, thiophanate + TX, thiosultap + TX, thiotepa + TX, tigolaner + TX, tiorantraniliprole + TX, tioxazafen + TX, tolfenpyrad + TX, toxaphene + TX, tralomethrin + TX, transfluthrin + TX, tretamine + TX, triazamate + TX, triazophos + TX, triazuron + TX, tributyltin oxide + TX, trichlorfon + TX, trichloronate + TX, trichlorphon + TX, Trichogramma spp. + TX, trifenmorph + TX, trifluenfuronate + TX, triflumezopyrim + TX, trimedlure + TX, trimedlure A + TX, trimedlure B1 + TX, trimedlure B2 + TX, trimedlure C + TX, trimethacarb + TX, triphenyltin acetate + TX, triphenyltin hydroxide + TX, trunc-call + TX, tyclopyrazoflor + TX, Typhlodromus occidentalis + TX, uredepa + TX, Verticillium lecanii + TX, Verticillium spp. + TX, xylenols + TX, YI-5302 + TX, zeatin + TX, zeta-Cypermethrin + TX; N-[(1R)-1-benzyl-3-chloro-1-methyl-but-3-enyl]-8-fluoro-quinoline-3-carboxamide + TX, N-[(1S)-1- benzyl-3-chloro-1-methyl-but-3-enyl]-8-fluoro-quinoline-3-carboxamide + TX, N-ethyl-N’-[5-methoxy-2- methyl-4-[(2-trifuoromethyl)tetrahydrofuran-2-yl]phenyl]-N-methyl-formamidine (these compounds may be prepared from the methods described in WO2019/110427) + TX, (3',4',5'-trifluoro-biphenyl-2-yl)- amide + TX, (3-methylisoxazol-5-yl)-[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methanone (these compounds may be prepared from the methods described in WO 2017/220485) + TX, (4- phenoxyphenyl)methyl 2-amino-6-methyl-pyridine-3-carboxylate (this compound may be prepared from the methods described in WO 2014/006945) + TX, (5-methyl-2-pyridyl)-[4-[5-(trifluoromethyl)-1,2,4- oxadiazol-3-yl]phenyl]methanone + TX, (7E,9Z)-dodeca-7,9-dien-1-yl acetate + TX, (9Z,11E)-tetradeca- 9,11-dien-1-yl acetate + TX, (9Z,12E)-tetradeca-9,12-dien-1-yl acetate + TX, (E)-6-methylhept-2-en-4- ol + TX, (E)-dec-5-en-1-yl acetate with (E)-dec-5-en-1-ol + TX, (E)-tridec-4-en-1-yl acetate + TX, (E,Z)- tetradeca-4,10-dien-1-yl acetate, + TX, (R)-3-(difluoromethyl)-1-methyl-N-[1,1,3-trimethylindan-4- yl]pyrazole-4-carboxamide + TX, (Z)-dodec-7-en-1-yl acetate + TX, (Z)-hexadec-11-en-1-yl acetate + TX, (Z)-hexadec-11-enal + TX, (Z)-hexadec-13-en-11-yn-1-yl acetate + TX, (Z)-icos-13-en-10-one + TX, (Z)-tetradec-7-en-1-al + TX, (Z)-tetradec-9-en-1-ol + TX, (Z)-tetradec-9-en-1-yl acetate + TX, (Z,2E)-5- [1-(2,4-dichlorophenyl)pyrazol-3-yl]oxy-2-methoxyimino-N,3-dimethyl-pent-3-enamide (this compound may be prepared from the methods described in WO 2018/153707) + TX, (Z,2E)-5-[1-(4- chlorophenyl)pyrazol-3-yl]oxy-2-methoxyimino-N,3-dimethyl-pent-3-enamide + TX, , [2-[3-[2-[1-[2-[3,5- bis(difluoromethyl)pyrazol-1-yl]acetyl]-4-piperidyl]thiazol-4-yl]-4,5-dihydroisoxazol-5-yl]-3-chloro- phenyl] methanesulfonate + TX, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl- isoquinoline + TX, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline + TX, 1-(6,7- dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline + TX, 1-(6,7- dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,6-trifluoro-3,3-dimethyl-isoquinoline + TX, 1-(6-chloro-7-methyl- pyrazolo[1,5-a]pyridin-3-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline (these compounds may be prepared from the methods described in WO2017/025510) + TX, 1,1-bis(4-chlorophenyl)-2-ethoxyethanol + TX, 1,1-dichloro-2,2-bis(4-ethylphenyl)ethane + TX, 1,2-dibromo-3-chloropropane + TX, 1,2- dichloropropane with 1,3-dichloropropene + TX, 1,3-dichloropropene + TX, 1,3-dimethoxy-1-[[4-[5- (trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea + TX, 1-[2-[[1-(4-chlorophenyl)pyrazol-3- yl]oxymethyl]-3-methyl-phenyl]-4-methyl-tetrazol-5-one + TX, 10-dien-1-yl acetate + TX, 14- methyloctadec-1-ene + TX, 1-bromo-2-chloroethane + TX, 1-dichloro-1-nitroethane + TX, 1-hydroxy- 1H-pyridine-2-thione + TX, 1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3- yl]phenyl]methyl]urea + TX, 1-methyl-4-[3-methyl-2-[[2-methyl-4-(3,4,5-trimethylpyrazol-1- yl)phenoxy]methyl]phenyl]tetrazol-5-one + TX, 2- (difluoromethyl) - N- ((3R) - 1, 1, 3- trimethylindan- 4- yl) pyridine- 3- carboxamide + TX, 2- (difluoromethyl) - N- ((3R) - 1, 1, 3- trimethylindan- 4-yl) pyridine- 3- carboxamide + TX, 2-(1,3-dithiolan-2-yl)phenyl dimethylcarbamate + TX, 2-(2-butoxyethoxy)ethyl piperonylate + TX, 2-(2-butoxyethoxy)ethyl thiocyanate + TX, 2-(4,5-dimethyl-1,3-dioxolan-2-yl)phenyl methylcarbamate + TX, 2-(4-chloro-3,5-xylyloxy)ethanol + TX, 2-(difluoromethyl)-N-(3-ethyl-1,1- dimethyl-indan-4-yl)pyridine-3-carboxamide + TX, 2-(difluoromethyl)-N-[(3R)-3-ethyl-1,1-dimethyl- indan-4-yl]pyridine-3-carboxamide + TX, 2-(difluoromethyl)-N-[(3S)-3-ethyl-1,1-dimethyl-indan-4- yl]pyridine-3-carboxamide (this compound may be prepared from the methods described in WO 2014/095675) + TX, 2-(difluoromethyl)-N-[3-ethyl-1,1-dimethyl-indan-4-yl]pyridine-3-carboxamide + TX, 2-(octylthio)ethanol + TX, 2,2,2-trichloro-1-(3,4-dichlorophenyl)ethyl acetate + TX, 2,2-dichlorovinyl 2- ethylsulfinylethyl methyl phosphate + TX, 2,2-difluoro-N-methyl-2-[4-[5-(trifluoromethyl)-1,2,4- oxadiazol-3-yl]phenyl]acetamide + TX, 2,4-dichlorophenyl benzenesulfonate + TX, 2,6-Dimethyl-1H,5H- [1,4]dithiino[2,3-c:5,6-c']dipyrrole-1,3,5,7(2H,6H)-tetrone (this compound may be prepared from the methods described in WO 2011/138281) + TX, 2-[2-fluoro-6-[(8-fluoro-2-methyl-3- quinolyl)oxy]phenyl]propan-2-ol + TX, 2-[6-(4-bromophenoxy)-2-(trifluoromethyl)-3-pyridyl]-1-(1,2,4- triazol-1-yl)propan-2-ol (this compound may be prepared from the methods described in WO 2017/029179) + TX, 2-[6-(4-chlorophenoxy)-2-(trifluoromethyl)-3-pyridyl]-1-(1,2,4-triazol-1-yl)propan-2- ol (this compound may be prepared from the methods described in WO 2017/029179) + TX, 2- chlorovinyl diethyl phosphate + TX, 2-fluoro-N-methyl-N-1-naphthylacetamide + TX, 2-imidazolidone + TX, 2-isovalerylindan-1,3-dione + TX, 2-methyl(prop-2-ynyl)aminophenyl methylcarbamate + TX, 2-oxo- N-propyl-2-[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]acetamide (this compound may be prepared from the methods described in WO 2018/065414) + TX, 2-thiocyanatoethyl laurate + TX, 3- (4,4-difluoro-3,3-dimethyl-1-isoquinolyl)-7,8-dihydro-6H-cyclopenta[e]benzimidazole (these compounds may be prepared from the methods described in WO2016/156085) + TX, 3-(4,4-difluoro-3,4-dihydro- 3,3-dimethylisoquinolin-1-yl)quinolone + TX, 3-(4-chlorophenyl)-5-methylrhodanine + TX, 3- (difluoromethyl)-1-methyl-N-[1,1,3-trimethylindan-4-yl]pyrazole-4-carboxamide + TX, 3,4- dichlorotetrahydrothiophene 1,1-dioxide + TX, 3-[2-(1-chlorocyclopropyl)-3-(2-fluorophenyl)-2-hydroxy- propyl]imidazole-4-carbonitrile (this compound may be prepared from the methods described in WO 2016/156290) + TX, 3-[2-(1-chlorocyclopropyl)-3-(3-chloro-2-fluoro-phenyl)-2-hydroxy- propyl]imidazole-4-carbonitrile (this compound may be prepared from the methods described in WO 2016/156290) + TX, 3-bromo-1-chloroprop-1-ene + TX, 3-chloro-6-methyl-5-phenyl-4-(2,4,6- trifluorophenyl)pyridazine + TX, 3-difluoromethyl-1-methyl-1H-pyrazole-4-carboxylic acid + TX, 3-ethyl- 1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea + TX, 3-methyl-1- phenylpyrazol-5-yl dimethylcarbamate + TX, 4- (2- bromo- 4- fluorophenyl) - N- (2- chloro- 6- fluorophenyl) - 1, 3- dimethyl- 1H- pyrazol- 5- amine + TX, 4-(2,6-difluorophenyl)-6-methyl-5-phenyl- pyridazine-3-carbonitrile + TX, 4-(2-bromo-4-fluoro-phenyl)-N-(2-chloro-6-fluoro-phenyl)-2,5-dimethyl- pyrazol-3-amine + TX, 4-(quinoxalin-2-ylamino)benzenesulfonamide + TX, 4,4-difluoro-1-(5-fluoro-4- methyl-benzimidazol-1-yl)-3,3-dimethyl-isoquinoline + TX, 4,4-difluoro-3,3-dimethyl-1-(6- methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline + TX, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5- a]pyridin-3-yl)isoquinoline + TX, 4,4-dimethyl-2-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3- yl]phenyl]methyl]isoxazolidin-3-one + TX, 4-[[6-[2-(2,4-difluorophenyl)-1,1-difluoro-2-hydroxy-3-(1,2,4- triazol-1-yl)propyl]-3-pyridyl]oxy] benzonitrile + TX, 4-[[6-[2-(2,4-difluorophenyl)-1,1-difluoro-2-hydroxy- 3-(5-sulfanyl-1,2,4-triazol-1-yl)propyl]-3-pyridyl]oxy] benzonitrile + TX, 4-[[6-[2-(2,4-difluorophenyl)-1,1- difluoro-2-hydroxy-3-(5-thioxo-4H-1,2,4-triazol-1-yl)propyl]-3-pyridyl]oxy] benzonitrile + TX, 4-chloro-2- (2-chloro-2-methyl-propyl)-5-[(6-iodo-3-pyridyl)methoxy]pyridazin-3-one + TX, 4-chlorophenyl phenyl sulfone + TX, 4-methyl(prop-2-ynyl)amino-3,5-xylyl methylcarbamate + TX, 4-methylnonan-5-ol with 4- methylnonan-5-one + TX, 5-(1,3-benzodioxol-5-yl)-3-hexylcyclohex-2-enone + TX, 5,5-dimethyl-2-[[4- [5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]isoxazolidin-3-one + TX, 5,5-dimethyl-3- oxocyclohex-1-enyl dimethylcarbamate + TX, 5-amino-1,3,4-thiadiazole-2-thiol zinc salt (2:1) + TX, 5- methyl-6-thioxo-1,3,5-thiadiazinan-3-ylacetic acid + TX, 6-chloro-3-(3-cyclopropyl-2-fluoro-phenoxy)-N- [2-(2,4-dimethylphenyl)-2,2-difluoro-ethyl]-5-methyl-pyridazine-4-carboxamide (may be prepared from the methods described in WO 2020/109391) + TX, 6-chloro-3-(3-cyclopropyl-2-fluoro-phenoxy)-N-[2- (3,4-dimethylphenyl)-2,2-difluoro-ethyl]-5-methyl-pyridazine-4-carboxamide (may be prepared from the methods described in WO 2020/109391) + TX, 6-chloro-4,4-difluoro-3,3-dimethyl-1-(4- methylbenzimidazol-1-yl)isoquinoline + TX, 6-chloro-N-[2-(2-chloro-4-methyl-phenyl)-2,2-difluoro- ethyl]-3-(3-cyclopropyl-2-fluoro-phenoxy)-5-methyl-pyridazine-4-carboxamide (may be prepared from the methods described in WO 2020/109391) + TX, 6-ethyl-5,7-dioxo-pyrrolo[4,5][1,4]dithiino[1,2- c]isothiazole-3-carbonitrile + TX, 6-isopentenylaminopurine + TX, 8-fluoro-N-[(1R)-1-[(3- fluorophenyl)methyl]-1,3-dimethyl-butyl]quinoline-3-carboxamide + TX, 8-fluoro-N-[(1S)-1-[(3- fluorophenyl)methyl]-1,3-dimethyl-butyl]quinoline-3-carboxamide + TX, 8-hydroxyquinoline sulfate + TX, acethion + TX, acetoprole + TX, acibenzolar + TX, acibenzolar-S-methyl + TX, acrylonitrile + TX, Adoxophyes orana GV + TX, Agrobacterium radiobacter + TX, aldoxycarb + TX, aldrin + TX, allosamidin + TX, allyxycarb + TX, alpha-chlorohydrin + TX, alpha-ecdysone + TX, alpha-multistriatin + TX, aluminium phosphide + TX, Amblyseius spp. + TX, amectotractin + TX, ametoctradin + TX, amidithion + TX, amidothioate + TX, aminocarb + TX, aminopyrifen + TX, amisulbrom + TX, amiton + TX, amiton hydrogen oxalate + TX, amitraz + TX, anabasine + TX, Anagrapha falcifera NPV + TX, Anagrus atomus + TX, ancymidol + TX, anilazine + TX, anisiflupurin + TX, anthraquinone + TX, antu + TX, Aphelinus abdominalis + TX, Aphidius colemani + TX, Aphidoletes aphidimyza + TX, apholate + TX, aramite + TX, arsenous oxide + TX, athidathion + TX, Autographa californica NPV + TX, azaconazole + TX, azamethiphos + TX, azobenzene + TX, azothoate + TX, azoxystrobin + TX, Bacillus sphaericus Neide + TX, Bacillus thuringiensis delta endotoxins + TX, barium carbonate + TX, barium hexafluorosilicate + TX, barium polysulfide + TX, barthrin + TX, Bayer 22/190 + TX, Bayer 22408 + TX, Beauveria brongniartii + TX, benalaxyl + TX, benclothiaz + TX, benomyl + TX, benoxafos + TX, benthiavalicarb + TX, benzothiostrobin + TX, benzovindiflupyr + TX, benzyl benzoate + TX, beta-cyfluthrin + TX, beta- cypermethrin + TX, bethoxazin + TX, bioethanomethrin + TX, biopermethrin + TX, bis(2-chloroethyl) ether + TX, bis(tributyltin) oxide + TX, bisazir + TX, bisthiosemi + TX, bitertanol + TX, bixafen + TX, blasticidin-S + TX, borax + TX, bordeaux mixture + TX, boscalid + TX, brevicomin + TX, brodifacoum + TX, brofenvalerate + TX, bromadiolone + TX, bromethalin + TX, bromfenvinfos + TX, bromoacetamide + TX, bromocyclen + TX, bromo-DDT + TX, bromophos + TX, bromopropylate + TX, bromuconazole + TX, bronopol + TX, bufencarb + TX, bupirimate + TX, buprofezin + TX, busulfan + TX, but-3-ynyl N-[6- [[(Z)-[(1-methyltetrazol-5-yl)-phenyl-methylene]amino]oxymethyl]-2-pyridyl]carbamate + TX, butacarb + TX, butathiofos + TX, butocarboxim + TX, butonate + TX, butopyronoxyl + TX, butoxy(polypropylene glycol) + TX, butoxycarboxim + TX, butylpyridaben + TX, calcium arsenate + TX, calcium cyanide + TX, calcium polysulfide + TX, camphechlor + TX, captafol + TX, captan + TX, carbanolate + TX, carbendazim + TX, carbon disulfide + TX, carbon tetrachloride + TX, carbophenothion + TX, carboxin + TX, cartap hydrochloride + TX, CAS Number: 2132414-04-9 + TX, CAS Number: 2344721-61-3 + TX, cevadine + TX, chinomethionat + TX, chloralose + TX, chlorbenside + TX, chlorbicyclen + TX, chlordane + TX, chlordecone + TX, chlordimeform + TX, chlordimeform hydrochloride + TX, chlorfenethol + TX, chlorfenson + TX, chlorfensulfide + TX, chlorobenzilate + TX, chloroform + TX, chloroinconazide + TX, chloromebuform + TX, chloromethiuron + TX, chloroneb + TX, chlorophacinone + TX, chloropicrin + TX, chloropropylate + TX, chlorothalonil + TX, chlorphoxim + TX, chlorprazophos + TX, chlorthiophos + TX, chlozolinate + TX, cholecalciferol + TX, Chrysoperla carnea + TX, cinerin I + TX, cinerin II + TX, cinerins + TX, cismethrin + TX, cis-resmethrin + TX, clocythrin + TX, closantel + TX, codlelure + TX, codlemone + TX, copper acetoarsenite + TX, copper arsenate + TX, copper dioctanoate + TX, copper hydroxide + TX, copper naphthenate + TX, copper oleate + TX, copper oxide + TX, copper oxychloride + TX, copper sulfate + TX, coumachlor + TX, coumafuryl + TX, coumaphos + TX, coumatetralyl + TX, coumethoxystrobin (jiaxiangjunzhi) + TX, coumithoate + TX, coumoxystrobin + TX, cresol + TX, crimidine + TX, crotamiton + TX, crotoxyphos + TX, crufomate + TX, cryolite + TX, Cryptolaemus montrouzieri + TX, CS 708 + TX, cuelure + TX, cufraneb + TX, cyanofenphos + TX, cyanophos + TX, cyanthoate + TX, cyazofamid + TX, cybutryne + TX, cyclethrin + TX, cyclobutrifluram + TX, Cydia pomonella GV + TX, cyflufenamid + TX, cymiazole + TX, cymoxanil + TX, cyproconazole + TX, cyprodinil + TX, cythioate + TX, cytokinins + TX, Dacnusa sibirica + TX, DAEP + TX, dazomet + TX, DCIP + TX, DCPM + TX, DDT + TX, debacarb + TX, decarbofuran + TX, demephion + TX, demephion-O + TX, demephion-S + TX, demeton-methyl + TX, demeton-O + TX, demeton-O-methyl + TX, demeton-S + TX, demeton-S-methyl + TX, demeton-S-methylsulfon + TX, diamidafos + TX, dibutyl adipate + TX, dibutyl phthalate + TX, dibutyl succinate + TX, dicapthon + TX, dichlobentiazox + TX, dichlofenthion + TX, dichlofluanid + TX, dichlone + TX, dichlorophen + TX, dichlorvos + TX, dichlozoline + TX, dicliphos + TX, diclocymet + TX, diclomezine + TX, dicloran + TX, dicresyl + TX, dicyclanil + TX, dicyclopentadiene + TX, dieldrin + TX, dienochlor + TX, diethofencarb + TX, diethyl 5-methylpyrazol-3-yl phosphate + TX, diethyltoluamide + TX, difenacoum + TX, difenoconazole + TX, difethialone + TX, diflovidazin + TX, Diglyphus isaea + TX, dilor + TX, dimatif + TX, dimefluthrin + TX, dimefox + TX, dimetan + TX, dimethirimol + TX, dimethomorph + TX, dimethrin + TX, dimethyl carbate + TX, dimethyl phthalate + TX, dimethylvinphos + TX, dimetilan + TX, dimoxystrobin + TX, dinex + TX, dinex-diclexine + TX, diniconazole + TX, dinocap-4 + TX, dinocap-6 + TX, dinocton + TX, dinopenton + TX, dinoprop + TX, dinosam + TX, dinoseb + TX, dinosulfon + TX, dinoterbon + TX, diofenolan + TX, dioxabenzofos + TX, dioxathion + TX, diphacinone + TX, diphenyl sulfone + TX, dipymetitrone + TX, dipyrithione + TX, disparlure + TX, disulfiram + TX, dithianon + TX, dithicrofos + TX, DNOC + TX, dodec-8-en-1-yl acetate + TX, dodec-9-en-1-yl acetate + TX, dodeca-8 + TX, dodemorph + TX, dodicin + TX, dodine + TX, dofenapyn + TX, dominicalure + TX, doramectin + TX, DSP + TX, d-tetramethrin + TX, ecdysterone + TX, edifenphos + TX, EI 1642 + TX, EMPC + TX, Encarsia formosa + TX, endothal + TX, endothion + TX, enestroburin + TX, enoxastrobin + TX, EPBP + TX, epoxiconazole + TX, eprinomectin + TX, Eretmocerus eremicus + TX, ergocalciferol + TX, etaphos + TX, ethaboxam + TX, ethiofencarb + TX, ethirimol + TX, ethoate-methyl + TX, ethyl 1-[[4-[(Z)-2-ethoxy-3,3,3-trifluoro-prop-1- enoxy]phenyl]methyl]pyrazole-3-carboxylate (may be prepared from the methods described in WO 2020/056090) + TX, ethyl 1-[[4-[[2-(trifluoromethyl)-1,3-dioxolan-2-yl]methoxy]phenyl]methyl]pyrazole- 3-carboxylate (may be prepared from the methods described in WO 2020/056090) + TX, ethyl 1-[[4-[5- (trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylate + TX, ethyl 1-[[5-[5- (trifluoromethyl)-1,2,4-oxadiazol-3-yl]-2-thienyl]methyl]pyrazole-4-carboxylate (this compound may be prepared from the methods described in WO 2018/158365) + TX, ethyl 4-methyloctanoate + TX, ethyl formate + TX, ethyl hexanediol + TX, ethylene dibromide + TX, ethylene dichloride + TX, ethylene oxide + TX, etridiazole + TX, etrimfos + TX, eugenol + TX, EXD + TX, famoxadone + TX, farnesol + TX, farnesol with nerolidol + TX, fenamidone + TX, fenaminosulf + TX, fenaminstrobin + TX, fenarimol + TX, fenazaflor + TX, fenbuconazole + TX, fenbutatin oxide + TX, fenchlorphos + TX, fenethacarb + TX, fenfuram + TX, fenhexamid + TX, fenitrothion + TX, fenothiocarb + TX, fenoxacrim + TX, fenoxanil + TX, fenpiclonil + TX, fenpicoxamid + TX, fenpirithrin + TX, fenpropidin + TX, fenpropimorph + TX, fenpyrad + TX, fenpyrazamine + TX, fenpyroximate + TX, fenson + TX, fensulfothion + TX, fenthion + TX, fenthion-ethyl + TX, fentin + TX, fentrifanil + TX, ferbam + TX, ferimzone + TX, ferric phosphate + TX, flocoumafen + TX, florylpicoxamid + TX, fluazinam + TX, flubeneteram + TX, flubenzimine + TX, flucofuron + TX, flucycloxuron + TX, fludioxonil + TX, fluenetil + TX, flufenoxadiazam + TX, flufenoxystrobin + TX, fluindapyr + TX, flumetylsulforim + TX, flumorph + TX, fluopicolide + TX, fluopimomide + TX, fluopyram + TX, fluorbenside + TX, fluoroacetamide + TX, fluoroimide + TX, fluoxapiprolin + TX, fluoxastrobin + TX, fluoxytioconazole + TX, flupropadine + TX, flupropadine hydrochloride + TX, fluquinconazole + TX, flusilazole + TX, flusulfamide + TX, flutianil + TX, flutolanil + TX, flutriafol + TX, fluxapyroxad + TX, FMC 1137 + TX, folpet + TX, formaldehyde + TX, formetanate + TX, formetanate hydrochloride + TX, formparanate + TX, fosetyl-aluminium + TX, fosmethilan + TX, fospirate + TX, fosthietan + TX, frontalin + TX, fuberidazole + TX, furalaxyl + TX, furametpyr + TX, furathiocarb + TX, furethrin + TX, furfural + TX, gamma-HCH + TX, glyodin + TX, grandlure + TX, grandlure I + TX, grandlure II + TX, grandlure III + TX, grandlure IV + TX, guazatine + TX, guazatine acetates + TX, halfenprox + TX, HCH + TX, hemel + TX, hempa + TX, HEOD + TX, heptachlor + TX, heterophos + TX, Heterorhabditis bacteriophora and H. megidis + TX, hexaconazole + TX, hexadecyl cyclopropanecarboxylate + TX, hexalure + TX, hexamide + TX, HHDN + TX, Hippodamia convergens + TX, hydrargaphen + TX, hydrated lime + TX, hydrogen cyanide + TX, hymexazol + TX, hyquincarb + TX, imanin + TX, imazalil + TX, imibenconazole + TX, iminoctadine + TX, inpyrfluxam + TX, ipconazole + TX, ipfentrifluconazole + TX, ipflufenoquin + TX, iprobenphos + TX, iprodione + TX, iprovalicarb + TX, ipsdienol + TX, ipsenol + TX, IPSP + TX, isamidofos + TX, isazofos + TX, isobenzan + TX, isocarbophos + TX, isodrin + TX, isofenphos + TX, isofetamid + TX, isoflucypram + TX, isolane + TX, isoprothiolane + TX, isopyrazam + TX, isotianil + TX, isoxathion + TX, japonilure + TX, jasmolin I + TX, jasmolin II + TX, jodfenphos + TX, juvenile hormone I + TX, juvenile hormone II + TX, juvenile hormone III + TX, kadethrin + TX, kasugamycin + TX, kasugamycin hydrochloride hydrate + TX, kelevan + TX, kinetin + TX, kinoprene + TX, kresoxim-methyl + TX, lead arsenate + TX, Leptomastix dactylopii + TX, leptophos + TX, lindane + TX, lineatin + TX, lirimfos + TX, litlure + TX, looplure + TX, lvbenmixianan + TX, lythidathion + TX, Macrolophus caliginosus + TX, magnesium phosphide + TX, malonoben + TX, Mamestra brassicae NPV + TX, mancopper + TX, mancozeb + TX, mandestrobin + TX, mandipropamid + TX, maneb + TX, mazidox + TX, m-cumenyl methylcarbamate + TX, mecarbam + TX, mecarphon + TX, medlure + TX, mefentrifluconazole + TX, megatomoic acid + TX, menazon + TX, mepanipyrim + TX, meperfluthrin + TX, mephosfolan + TX, mepronil + TX, mercuric oxide + TX, mercurous chloride + TX, mesulfen + TX, mesulfenfos + TX, metalaxyl + TX, metam + TX, metam-potassium + TX, metam- sodium + TX, Metaphycus helvolus + TX, Metarhizium anisopliae var. acridum + TX, Metarhizium anisopliae var. anisopliae + TX, metarylpicoxamid + TX, metconazole + TX, metepa + TX, methacrifos + TX, methanesulfonyl fluoride + TX, methasulfocarb + TX, methiotepa + TX, methocrotophos + TX, methoprene + TX, methoquin-butyl + TX, methothrin + TX, methoxychlor + TX, methyl (Z)-2-(5- cyclohexyl-2-methyl-phenoxy)-3-methoxy-prop-2-enoate + TX, methyl (Z)-2-(5-cyclopentyl-2-methyl- phenoxy)-3-methoxy-prop-2-enoate (these compounds may be prepared from the methods described in WO2020/193387) + TX, methyl (Z)-2-[5-(3-isopropylpyrazol-1-yl)-2-methyl-phenoxy]-3-methoxy- prop-2-enoate + TX, methyl (Z)-3-methoxy-2-[2-methyl-5-(3-propylpyrazol-1-yl)phenoxy]prop-2-enoate + TX, methyl (Z)-3-methoxy-2-[2-methyl-5-(4-propyltriazol-2-yl)phenoxy]prop-2-enoate + TX, methyl (Z)- 3-methoxy-2-[2-methyl-5-[3-(trifluoromethyl)pyrazol-1-yl]phenoxy]prop-2-enoate (these compounds may be prepared from the methods described in WO2020/079111) + TX, methyl (Z)-3-methoxy-2-[2- methyl-5-[4-(trifluoromethyl)triazol-2-yl]phenoxy]prop-2-enoate + TX, methyl apholate + TX, methyl bromide + TX, methyl eugenol + TX, methyl isothiocyanate + TX, methyl N-[[4-[1-(2,6-difluoro-4- isopropyl-phenyl)pyrazol-4-yl]-2-methyl-phenyl]methyl]carbamate (may be prepared from the methods described in WO 2020/097012) + TX, methyl N-[[4-[1-(4-cyclopropyl-2,6-difluoro-phenyl)pyrazol-4-yl]-2- methyl-phenyl]methyl]carbamate (may be prepared from the methods described in WO 2020/097012) + TX, methyl N-[[5-[4-(2,4-dimethylphenyl)triazol-2-yl]-2-methyl-phenyl]methyl]carbamate + TX, methylchloroform + TX, methylene chloride + TX, methylneodecanamide + TX, metiram + TX, metolcarb + TX, metominostrobin + TX, metoxadiazone + TX, metrafenone + TX, metyltetraprole + TX, MGK 264 + TX, milbemycin oxime + TX, mipafox + TX, mirex + TX, monocrotophos + TX, morphothion + TX, morzid + TX, moxidectin + TX, muscalure + TX, myclobutanil + TX, myclozoline + TX, Myrothecium verrucaria composition + TX, N-((1R)-1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3- carboxamide (these compounds may be prepared from the methods described in WO2017/153380) + TX, N-((1S)-1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide (these compounds may be prepared from the methods described in WO2017/153380) + TX, N'-(2,5-dimethyl- 4-phenoxy-phenyl)-N-ethyl-N-methyl-formamidine + TX, N'-(2-chloro-5-methyl-4-phenoxy-phenyl)-N- ethyl-N-methyl-formamidine + TX, N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3- yl]phenyl]methyl]propanamide + TX, N,N-dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3- yl]phenyl]methyl]-1,2,4-triazol-3-amine (THESE COMPOUNDS may be prepared from the methods described in WO 2017/055473, WO 2017/055469, WO 2017/093348 and WO 2017/118689) + TX, N- [(1R)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoro-quinoline-3-carboxamide + TX, N-[(1R)-1-benzyl-1,3- dimethyl-butyl]-8-fluoro-quinoline-3-carboxamide + TX, N-[(1R)-1-benzyl-3,3,3-trifluoro-1-methyl- propyl]-8-fluoro-quinoline-3-carboxamide + TX, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoro- quinoline-3-carboxamide + TX, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-8-fluoro-quinoline-3-carboxamide + TX, N-[(1S)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoro-quinoline-3-carboxamide + TX, N-[(E)- methoxyiminomethyl]-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide + TX, N-[(Z)- methoxyiminomethyl]-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide + TX, N-[[4-[5- (trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propanamide + TX, N-[2-[2,4-dichloro- phenoxy]phenyl]-3-(difluoromethyl)-1-methyl-pyrazole-4-carboxamide + TX, N-[2-[2-chloro-4- (trifluoromethyl)phenoxy]phenyl]-3-(difluoromethyl)-1-methyl-pyrazole-4-carboxamide + TX, N'-[2- chloro-4-(2-fluorophenoxy)-5-methyl-phenyl]-N-ethyl-N-methyl-formamidine (this compound may be prepared from the methods described in WO 2016/202742) + TX, N'-[4-(4,5-dichlorothiazol-2-yl)oxy-2,5- dimethyl-phenyl]-N-ethyl-N-methyl-formamidine + TX, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy- ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidine + TX, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy- ethoxy)-3-pyridyl]-N-isopropyl-N-methyl-formamidine (these compounds may be prepared from the methods described in WO2015/155075) + TX, N'-[5-bromo-2-methyl-6-(2-propoxypropoxy)-3-pyridyl]- N-ethyl-N-methyl-formamidine (this compound may be prepared from the methods described in IPCOM000249876D) + TX, N'-[5-bromo-2-methyl-6-[(1R)-1-methyl-2-propoxy-ethoxy]-3-pyridyl]-N- ethyl-N-methyl-formamidine + TX, N'-[5-bromo-2-methyl-6-[(1S)-1-methyl-2-propoxy-ethoxy]-3-pyridyl]- N-ethyl-N-methyl-formamidine + TX, N'-[5-chloro-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N- ethyl-N-methyl-formamidine + TX, N-[N-methoxy-C-methyl-carbonimidoyl]-4-[5-(trifluoromethyl)-1,2,4- oxadiazol-3-yl]benzamide (these compounds may be prepared from the methods described in WO 2018/202428) + TX, N’-[4-(1-cyclopropyl-2,2,2-trifluoro-1-hydroxy-ethyl)-5-methoxy-2-methyl-phenyl]- N-isopropyl-N-methyl-formamidine (these compounds may be prepared from the methods described in WO2018/228896) + TX, nabam + TX, naftalofos + TX, naled + TX, naphthalene + TX, NC-170 + TX, Neodiprion sertifer NPV and N. lecontei NPV + TX, nerolidol + TX, N-ethyl-2-methyl-N-[[4-[5- (trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propanamide + TX, N-ethyl-N’-[5-methoxy-2- methyl-4-[(2-trifluoromethyl)oxetan-2-yl]phenyl]-N-methyl-formamidine + TX, nickel bis(dimethyldithiocarbamate) + TX, niclosamide-olamine + TX, nicotine + TX, nicotine sulfate + TX, nifluridide + TX, nikkomycins + TX, N-isopropyl-N’-[5-methoxy-2-methyl-4-(2,2,2-trifluoro-1-hydroxy-1- phenyl-ethyl)phenyl]-N-methyl-formamidine + TX, nithiazine + TX, nitrapyrin + TX, nitrilacarb + TX, nitrilacarb 1:1 zinc chloride complex + TX, nitrothal-isopropyl + TX, N-methoxy-N-[[4-[5-(trifluoromethyl)- 1,2,4-oxadiazol-3-yl]phenyl]methyl]cyclopropanecarboxamide + TX, N-methyl-4-[5-(trifluoromethyl)- 1,2,4-oxadiazol-3-yl]benzamide + TX, N-methyl-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3- yl]benzenecarbothioamide + TX, norbormide + TX, nuarimol + TX, O,O,O',O'-tetrapropyl dithiopyrophosphate + TX, octadeca-2,13-dien-1-yl acetate + TX, octadeca-3,13-dien-1-yl acetate + TX, octhilinone + TX, ofurace + TX, oleic acid + TX, omethoate + TX, orfralure + TX, Orius spp. + TX, oryctalure + TX, orysastrobin + TX, ostramone + TX, oxadixyl + TX, oxamate + TX, oxathiapiprolin + TX, oxine-copper + TX, oxolinic acid + TX, oxycarboxin + TX, oxydeprofos + TX, oxydisulfoton + TX, oxytetracycline + TX, paclobutrazole + TX, Paecilomyces fumosoroseus + TX, para-dichlorobenzene + TX, parathion + TX, parathion-methyl + TX, pefurazoate + TX, penconazole + TX, pencycuron + TX, penflufen + TX, penfluron + TX, pentachlorophenol + TX, pentachlorophenyl laurate + TX, penthiopyrad + TX, permethrin + TX, PH 60-38 + TX, phenamacril + TX, phenkapton + TX, phosacetim + TX, phosalone + TX, phosdiphen + TX, phosfolan + TX, phosglycin + TX, phosnichlor + TX, phosphamidon + TX, phosphine + TX, phosphorus + TX, phoxim-methyl + TX, phthalide + TX, Phytoseiulus persimilis + TX, picarbutrazox + TX, picaridin + TX, picoxystrobin + TX, pindone + TX, piperazine + TX, piperonyl butoxide + TX, piprotal + TX, pirimetaphos + TX, polychlorodicyclopentadiene isomers + TX, polychloroterpenes + TX, polynactins + TX, polyoxins + TX, potassium arsenite + TX, potassium ethylxanthate + TX, potassium hydroxyquinoline sulfate + TX, potassium thiocyanate + TX, pp'-DDT + TX, precocene I + TX, precocene II + TX, precocene III + TX, primidophos + TX, probenazole + TX, prochloraz + TX, proclonol + TX, procymidone + TX, profluthrin + TX, promacyl + TX, promecarb + TX, propamocarb + TX, propiconazole + TX, propineb + TX, propoxur + TX, propyl isomer + TX, proquinazid + TX, prothidathion + TX, prothioconazole + TX, prothiofos + TX, prothoate + TX, pydiflumetofen + TX, pyraclostrobin + TX, pyrametostrobin + TX, pyraoxystrobin + TX, pyrapropoyne + TX, pyraziflumid + TX, pyrazophos + TX, pyresmethrin + TX, pyrethrin I + TX, pyrethrin II + TX, pyrethrins + TX, pyribencarb + TX, pyridachlometyl + TX, pyridaphenthion + TX, pyridin-4-amine + TX, pyrifenox + TX, pyrimethanil + TX, pyrimitate + TX, pyrimorph + TX, pyrinuron + TX, pyriofenone + TX, pyrisoxazole + TX, pyroquilon + TX, quassia + TX, quinalphos + TX, quinalphos-methyl + TX, quinoclamine + TX, quinofumelin + TX, quinonamid + TX, quinothion + TX, quinoxyfen + TX, quintiofos + TX, quintozene + TX, R-1492 + TX, rafoxanide + TX, resmethrin + TX, Reynoutria sachalinensis extract + TX, ribavirin + TX, Rmetalaxyl + TX, rotenone + TX, ryania + TX, ryanodine + TX, S421 + TX, sabadilla + TX, schradan + TX, scilliroside + TX, seboctylamine + TX, sebufos + TX, sedaxane + TX, selamectin + TX, sesamex + TX, sesasmolin + TX, SI-0009 + TX, siglure + TX, simazine + TX, simeconazole + TX, sodium arsenite + TX, sodium cyanide + TX, sodium fluoride + TX, sodium fluoroacetate + TX, sodium hexafluorosilicate + TX, sodium pentachlorophenoxide + TX, sodium selenate + TX, sodium tetrathiocarbonate + TX, sodium thiocyanate + TX, sophamide + TX, sordidin + TX, spiroxamine + TX, SSI-121 + TX, Steinernema bibionis + TX, Steinernema carpocapsae + TX, Steinernema feltiae + TX, Steinernema glaseri + TX, Steinernema riobrave + TX, Steinernema riobravis + TX, Steinernema scapterisci + TX, Steinernema spp. + TX, streptomycin + TX, streptomycin sesquisulfate + TX, strychnine + TX, sulcatol + TX, sulcofuron + TX, sulcofuron-sodium + TX, sulfiram + TX, sulfluramid + TX, sulfotep + TX, sulfoxide + TX, sulfur + TX, sulfuryl fluoride + TX, sulprofos + TX, tar oils + TX, tau-fluvalinate + TX, tazimcarb + TX, TDE + TX, tebuconazole + TX, tebufloquin + TX, tebupirimfos + TX, tecloftalam + TX, temephos + TX, tepa + TX, TEPP + TX, terallethrin + TX, terbam + TX, tert-butyl N-[6-[[[(1-methyltetrazol-5-yl)- phenyl-methylene]amino]oxymethyl]-2-pyridyl]carbamate + TX, tetrachloroethane + TX, tetrachlorothiophene + TX, tetraconazole + TX, tetradec-11-en-1-yl acetate + TX, tetradifon + TX, tetramethylfluthrin + TX, tetrasul + TX, thallium sulfate + TX, thiabendazole + TX, thiafenox + TX, thiapronil + TX, thicrofos + TX, thifluzamide + TX, thiocarboxime + TX, thiocyclam + TX, thiocyclam hydrogen oxalate + TX, thiodiazole copper + TX, thiofanox + TX, thiohempa + TX, thiomersal + TX, thiometon + TX, thionazin + TX, thiophanate + TX, thiophanate-methyl + TX, thioquinox + TX, thiosultap + TX, thiosultap-sodium + TX, thiotepa + TX, thiram + TX, thuringiensin + TX, tiadinil + TX, tolclofos- methyl + TX, tolprocarb + TX, tolylfluanid + TX, tralomethrin + TX, transpermethrin + TX, tretamine + TX, triadimefon + TX, triadimenol + TX, triamiphos + TX, triarathene + TX, triazamate + TX, triazophos + TX, triazoxide + TX, triazuron + TX, tributyltin oxide + TX, trichlormetaphos-3 + TX, trichloronat + TX, Trichogramma spp. + TX, triclopyricarb + TX, tricyclazole + TX, tridemorph + TX, trifenmorph + TX, trifenofos + TX, trifloxystrobin + TX, triflumizole + TX, triforine + TX, trimedlure + TX, trimedlure A + TX, trimedlure B1 + TX, trimedlure B2 + TX, trimedlure C + TX, trimethacarb + TX, trinactin + TX, trinexapac + TX, triphenyltin acetate + TX, triphenyltin hydroxide + TX, triprene + TX, triticonazole + TX, trunc-call + TX, Typhlodromus occidentalis + TX, uredepa + TX, validamycin + TX, valifenalate + TX, vamidothion + TX, vaniliprole + TX, veratridine + TX, veratrine + TX, verbutin + TX, Verticillium lecanii + TX, vinclozoline + TX, warfarin + TX, XMC + TX, xylenols + TX, zeatin + TX, zetamethrin + TX, zhongshengmycin + TX, zinc naphthenate + TX, zinc phosphide + TX, zinc thiazole + TX, zineb + TX, ziram + TX, zolaprofos + TX; Acinetobacter lwoffii + TX, Acremonium alternatum + TX, Acremonium cephalosporium + TX, Acremonium diospyri + TX, Acremonium obclavatum + TX, Adoxophyes orana granulovirus (AdoxGV) (Capex®) + TX, Agrobacterium radiobacter strain K84 (Galltrol-A®) + TX, Alternaria alternate + TX, Alternaria cassia + TX, Alternaria destruens (Smolder®) + TX, Ampelomyces quisqualis (AQ10®) + TX, Aspergillus flavus AF36 (AF36®) + TX, Aspergillus flavus NRRL 21882 (Aflaguard®) + TX, Aspergillus spp. + TX, Aureobasidium pullulans + TX, Azospirillum (MicroAZ®, TAZO B®) + TX, Azotobacter + TX, Azotobacter chroocuccum (Azotomeal®) + TX, Azotobacter cysts (Bionatural Blooming Blossoms®) + TX, Bacillus amyloliquefaciens + TX, Bacillus cereus + TX, Bacillus chitinosporus strain AQ746 + TX, Bacillus chitinosporus strain CM-1 + TX, Bacillus circulans + TX, Bacillus firmus (BioSafe®, BioNem- WP®) in particular strain CNMC 1-1582 (e.g. VOTIVO® from BASF SE) + TX, Bacillus licheniformis strain 3086 (EcoGuard®, Green Releaf®) + TX, Bacillus licheniformis strain HB-2 (Biostart™ formerly Rhizoboost®) + TX, Bacillus macerans + TX, Bacillus marismortui + TX, Bacillus megaterium + TX, Bacillus mycoides strain AQ726 + TX, Bacillus papillae (Milky Spore Powder®) + TX, Bacillus pumilus spp. + TX, Bacillus pumilus strain AQ717 + TX, Bacillus pumilus strain GB34 (Yield Shield®) + TX, Bacillus pumilus strain QST 2808 (Sonata®, Ballad Plus®) + TX, Bacillus sphaericus (VectoLex®) + TX, Bacillus spp. + TX, Bacillus spp. strain AQ175 + TX, Bacillus spp. strain AQ177 + TX, Bacillus spp. strain AQ178 + TX, Bacillus subtilis strain AQ153 + TX, Bacillus subtilis strain AQ743 + TX, Bacillus subtilis strain QST 713 (CEASE®, Serenade®, Rhapsody®) + TX, Bacillus subtilis strain QST 714 (JAZZ®) + TX, Bacillus subtilis strain QST3002 + TX, Bacillus subtilis strain QST3004 + TX, Bacillus subtilis var. amyloliquefaciens strain FZB24 (Taegro®, Rhizopro®) + TX, Bacillus thuringiensis aizawai GC 91 (Agree®) + TX, Bacillus thuringiensis Cry 2Ae + TX, Bacillus thuringiensis Cry1Ab + TX, Bacillus thuringiensis israelensis (BMP123®, Aquabac®, VectoBac®) + TX, Bacillus thuringiensis kurstaki (Javelin®, Deliver®, CryMax®, Bonide®, Scutella WP®, Turilav WP ®, Astuto®, Dipel WP®, Biobit®, Foray®) + TX, Bacillus thuringiensis kurstaki BMP 123 (Baritone®) + TX, Bacillus thuringiensis kurstaki HD-1 (Bioprotec-CAF / 3P®) + TX, Bacillus thuringiensis strain AQ52 + TX, Bacillus thuringiensis strain BD#32 + TX, Bacillus thuringiensis tenebrionis (Novodor®, BtBooster) + TX, Bacillus thuringiensis var. aizawai (XenTari®, DiPel®) + TX, bacteria spp. (GROWMEND®, GROWSWEET®, Shootup®) + TX, bacteriophage of Clavipacter michiganensis (AgriPhage®, Bakflor®) + TX, Beauveria bassiana (Beaugenic®, Brocaril WP®) + TX, Beauveria bassiana GHA (Mycotrol ES®, Mycotrol O®, BotaniGuard®) + TX, Beauveria brongniartii (Engerlingspilz®, Schweizer Beauveria®, Melocont®) + TX, Beauveria spp. + TX, Botrytis cineria + TX, Bradyrhizobium japonicum (TerraMax®) + TX, Brevibacillus brevis + TX, Burkholderia cepacia (Deny®, Intercept®, Blue Circle®) + TX, Burkholderia gladii + TX, Burkholderia gladioli + TX, Burkholderia spp. + TX, Canadian thistle fungus (CBH Canadian Bioherbicide®) + TX, Candida butyri + TX, Candida famata + TX, Candida fructus + TX, Candida glabrata + TX, Candida guilliermondii + TX, Candida melibiosica + TX, Candida oleophila strain O + TX, Candida parapsilosis + TX, Candida pelliculosa + TX, Candida pulcherrima + TX, Candida reukaufii + TX, Candida saitoana (Bio-Coat®, Biocure®) + TX, Candida sake + TX, Candida spp. + TX, Candida tenius + TX, Cedecea davisae + TX, Cellulomonas flavigena + TX, Chaetomium cochliodes (Nova- Cide®) + TX, Chaetomium globosum (Nova-Cide®) + TX, Chromobacterium subtsugae strain PRAA4- 1T (Grandevo®) + TX, Cladosporium chlorocephalum + TX, Cladosporium cladosporioides + TX, Cladosporium oxysporum + TX, Cladosporium spp. + TX, Cladosporium tenuissimum + TX, Clonostachys rosea (EndoFine®) + TX, Colletotrichum acutatum + TX, Coniothyrium minitans (Cotans WG®) + TX, Coniothyrium spp. + TX, Cryptococcus albidus (YIELDPLUS®) + TX, Cryptococcus humicola + TX, Cryptococcus infirmo-miniatus + TX, Cryptococcus laurentii + TX, Cryptophlebia leucotreta granulovirus (Cryptex®) + TX, Cupriavidus campinensis + TX, Cydia pomonella granulovirus (CYD-X®, Madex®, Madex® Plus, Madex Max, Carpovirusine® + TX, Cylindrobasidium laeve (Stumpout®) + TX, Cylindrocladium + TX, Debaryomyces hansenii + TX, Drechslera hawaiinensis + TX, Enterobacter cloacae + TX, Enterobacteriaceae + TX, Entomophtora virulenta (Vektor®) + TX, Epicoccum nigrum + TX, Epicoccum purpurascens + TX, Epicoccum spp. + TX, Filobasidium floriforme + TX, Fusarium acuminatum + TX, Fusarium chlamydosporum + TX, Fusarium oxysporum (Fusaclean®, Biofox C®) + TX, Fusarium proliferatum + TX, Fusarium spp. + TX, Galactomyces geotrichum + TX, Gliocladium catenulatum (Primastop®, Prestop®) + TX, Gliocladium roseum + TX, Gliocladium spp. (SoilGard®) + TX, Gliocladium virens (Soilgard®) + TX, Granulovirus (Granupom®) + TX, Halobacillus halophilus + TX, Halobacillus litoralis + TX, Halobacillus trueperi + TX, Halomonas spp. + TX, Halomonas subglaciescola + TX, Halovibrio variabilis + TX, Hanseniaspora uvarum + TX, Helicoverpa armigera nucleopolyhedrovirus (Helicovex®) + TX, Helicoverpa zea nuclear polyhedrosis virus (Gemstar®) + TX, Isaria fumosorosea (previously known as Paecilomyces fumosoroseus strain, PFR- 97®, PreFeRal®) + TX, Isoflavone formononetin (Myconate®) + TX, Kloeckera apiculata + TX, Kloeckera spp. + TX, Lagenidium giganteum (Laginex®) + TX, Lecanicillium lecanii (formerly known as Verticillium lecanii (Mycotal®) conidia of strain KV01 (e.g. Vertalec® by Koppert/Arysta) + TX, Lecanicillium longisporum (Vertiblast®) + TX, Lecanicillium muscarium (Vertikil®) + TX, Lymantria Dispar nucleopolyhedrosis virus (Disparvirus®) + TX, Marinococcus halophilus + TX, Meira geulakonigii + TX, Metarhizium anisopliae (Destruxin WP®) + TX, Metarhizium anisopliae (Met52®) + TX, Metschnikowia fruticola (Shemer®) + TX, Metschnikowia pulcherrima + TX, Microdochium dimerum (Antibot®) + TX, Micromonospora coerulea + TX, Microsphaeropsis ochracea + TX, Muscodor albus 620 (Muscudor®) + TX, Muscodor roseus in particular strain A3-5 (Accession No. NRRL 30548) + TX, Mycorrhizae spp. (AMykor®, Root Maximizer®) + TX, Myrothecium verrucaria strain AARC-0255 (DiTera®, BROS PLUS®) + TX, Ophiostoma piliferum strain D97 (Sylvanex®) + TX, Paecilomyces farinosus + TX, Paecilomyces lilacinus strain 251 (MeloCon WG®) + TX, Paecilomyces linacinus (Biostat WP®) + TX, Paenibacillus polymyxa + TX, Pantoea agglomerans (BlightBan C9-1®) + TX, Pantoea spp. + TX, Pasteuria nishizawae in particular strain Pn1 (CLARIVA from Syngenta/ChemChina); + TX, Pasteuria spp. (Econem®) + TX, Penicillium aurantiogriseum + TX, Penicillium billai (Jumpstart®, TagTeam®) + TX, Penicillium brevicompactum + TX, Penicillium frequentans + TX, Penicillium griseofulvum + TX, Penicillium purpurogenum + TX, Penicillium spp. + TX, Penicillium viridicatum + TX, Phlebiopsis gigantean (Rotstop®) + TX, phosphate solubilizing bacteria (Phosphomeal®) + TX, Phytophthora cryptogea + TX, Phytophthora palmivora (Devine®) + TX, Pichia anomala + TX, Pichia guilliermondii + TX, Pichia membranaefaciens + TX, Pichia onychis + TX, Pichia stipites + TX, Pseudomonas aeruginosa + TX, Pseudomonas aureofasciens (Spot-Less Biofungicide®) + TX, Pseudomonas cepacia + TX, Pseudomonas chlororaphis (AtEze®) + TX, Pseudomonas corrugate + TX, Pseudomonas fluorescens (Zequanox®) + TX, Pseudomonas fluorescens strain A506 (BlightBan A506®) + TX, Pseudomonas putida + TX, Pseudomonas reactans + TX, Pseudomonas spp. + TX, Pseudomonas syringae (Bio-Save®) + TX, Pseudomonas viridiflava + TX, Pseudozyma flocculosa strain PF-A22 UL (Sporodex L®) + TX, Puccinia canaliculata + TX, Puccinia thlaspeos (Wood Warrior®) + TX, Pythium paroecandrum + TX, Pythium oligandrum (Polygandron®, Polyversum®) + TX, Pythium periplocum + TX, Rhanella aquatilis + TX, Rhanella spp. + TX, Rhizobia (Dormal®, Vault®) + TX, Rhizoctonia + TX, Rhodococcus globerulus strain AQ719 + TX, Rhodosporidium diobovatum + TX, Rhodosporidium toruloides + TX, Rhodotorula glutinis + TX, Rhodotorula graminis + TX, Rhodotorula mucilagnosa + TX, Rhodotorula rubra + TX, Rhodotorula spp. + TX, Saccharomyces cerevisiae + TX, Salinococcus roseus + TX, Sclerotinia minor (SARRITOR®) + TX, Sclerotinia minor + TX, Scytalidium spp. + TX, Scytalidium uredinicola + TX, Serratia marcescens + TX, Serratia plymuthica + TX, Serratia spp. + TX, Sordaria fimicola + TX, Spodoptera exigua nuclear polyhedrosis virus (Spod-X®, Spexit®) + TX, Spodoptera littoralis nucleopolyhedrovirus (Littovir®) + TX, Sporobolomyces roseus + TX, Stenotrophomonas maltophilia + TX, Streptomyces albaduncus + TX, Streptomyces exfoliates + TX, Streptomyces galbus + TX, Streptomyces griseoplanus + TX, Streptomyces griseoviridis (Mycostop®) + TX, Streptomyces hygroscopicus + TX, Streptomyces lydicus (Actinovate®) + TX, Streptomyces lydicus WYEC-108 (ActinoGrow®) + TX, Streptomyces violaceus + TX, Tilletiopsis minor + TX, Tilletiopsis spp. + TX, Trichoderma asperellum (T34 Biocontrol®) + TX, Trichoderma atroviride (Plantmate®) + TX, Trichoderma gamsii (Tenet®) + TX, Trichoderma hamatum TH 382 + TX, Trichoderma harzianum rifai (Mycostar®) + TX, Trichoderma harzianum T-22 (Trianum- P®, PlantShield HC®, RootShield®, Trianum-G® + TX, Trichoderma harzianum T-39 (Trichodex®) + TX, Trichoderma inhamatum + TX, Trichoderma koningii + TX, Trichoderma lignorum + TX, Trichoderma longibrachiatum + TX, Trichoderma polysporum (Binab T®) + TX, Trichoderma spp. LC 52 (Sentinel®) + TX, Trichoderma taxi + TX, Trichoderma virens (formerly Gliocladium virens GL-21) (SoilGuard®) + TX, Trichoderma virens + TX, Trichoderma viride + TX, Trichoderma viride strain ICC 080 (Remedier®) + TX, Trichosporon pullulans + TX, Trichosporon spp. + TX, Trichothecium roseum + TX, Trichothecium spp. + TX, Typhula phacorrhiza strain 94670 + TX, Typhula phacorrhiza strain 94671 + TX, Ulocladium atrum + TX, Ulocladium oudemansii (Botry-Zen®) + TX, Ustilago maydis + TX, various bacteria and supplementary micronutrients (Natural II®) + TX, various fungi (Millennium Microbes®) + TX, Verticillium chlamydosporium + TX, Vip3Aa20 (VIPtera®) + TX, Virgibaclillus marismortui + TX, Xanthomonas campestris pv. Poae (Camperico®) + TX, Xenorhabdus bovienii + TX, Xenorhabdus nematophilus + TX; AGNIQUE® MMF + TX, azadirachtin (Plasma Neem Oil®, AzaGuard®, MeemAzal®, Molt-X® e.g. AZATIN XL from Certis, US) + TX, Botanical IGR (Neemazad®, Neemix®) + TX, BugOil® + TX, canola oil (Lilly Miller Vegol®) + TX, Chenopodium ambrosioides near ambrosioides (Requiem®) + TX, Chrysanthemum extract (Crisant®) + TX, essentials oils of Labiatae (Botania®) + TX, extract of neem oil (Trilogy®) + TX, extracts of clove rosemary peppermint and thyme oil (Garden insect killer®) + TX, garlic + TX, Glycinebetaine (Greenstim®) + TX, kaolin (Screen®) + TX, lemongrass oil (GreenMatch®) + TX, Melaleuca alternifolia extract (also called tea tree oil) (Timorex Gold®) + TX, mixture of clove pepermint garlic oil and mint (Soil Shot®) + TX, mixture of clove rosemary and peppermint extract (EF 400®) + TX, mixture of rosemary sesame pepermint thyme and cinnamon extracts (EF 300®) + TX, neem oil + TX, Nepeta cataria (Catnip oil) + TX, Nepeta catarina + TX, nicotine + TX, oregano oil (MossBuster®) + TX, Pedaliaceae oil (Nematon®) + TX, pine oil (Retenol®) + TX, pyrethrum + TX, Quillaja saponaria (NemaQ®) + TX, Reynoutria sachalinensis (Regalia®, Sakalia®) + TX, rotenone (Eco Roten®) + TX, Rutaceae plant extract (Soleo®) + TX, soybean oil (Ortho ecosense®) + TX, storage glucam of brown algae (Laminarin®) + TX, thyme oil + TX; (E,Z)-7,9-Dodecadien-1-yl acetate + TX, (E,Z,Z)-3,8,11 Tetradecatrienyl acetate + TX, (Z,Z,E)-7,11,13- Hexadecatrienal + TX, 2-Methyl-1-butanol + TX, Biolure® + TX, blackheaded fireworm pheromone (3M Sprayable Blackheaded Fireworm Pheromone®) + TX, Calcium acetate + TX, Check-Mate® + TX, Codling Moth Pheromone (Paramount dispenser-(CM)/ Isomate C-Plus®) + TX, Entostat powder (extract from palm tree) (Exosex CM®) + TX, Grape Berry Moth Pheromone (3M MEC-GBM Sprayable Pheromone®) + TX, Lavandulyl senecioate + TX, Leafroller pheromone (3M MEC – LR Sprayable Pheromone®) + TX, Muscamone (Snip7 Fly Bait® + TX, Oriental Fruit Moth Pheromone (3M oriental fruit moth sprayable pheromone®) + TX, Peachtree Borer Pheromone (Isomate-P®) + TX, Scenturion® + TX, Starbar Premium Fly Bait®) + TX, Tomato Pinworm Pheromone (3M Sprayable pheromone®) + TX; Acerophagus papaya + TX, Adalia bipunctata (Adalia-System®) + TX, Adalia bipunctata (Adaline®) + TX, Adalia bipunctata (Aphidalia®) + TX, Ageniaspis citricola + TX, Ageniaspis fuscicollis + TX, Amblyseius andersoni (Anderline®, Andersoni-System®) + TX, Amblyseius californicus (Amblyline®, Spical®) + TX, Amblyseius cucumeris (Thripex®, Bugline cucumeris®) + TX, Amblyseius fallacis (Fallacis®) + TX, Amblyseius swirskii (Bugline swirskii®, Swirskii-Mite®) + TX, Amblyseius womersleyi (WomerMite®) + TX, Amitus hesperidum + TX, Anagrus atomus + TX, Anagyrus fusciventris + TX, Anagyrus kamali + TX, Anagyrus loecki + TX, Anagyrus pseudococci (Citripar®) + TX, Anicetus benefices + TX, Anisopteromalus calandrae + TX, Anthocoris nemoralis (Anthocoris-System®) + TX, Aphelinus abdominalis (Apheline®, Aphiline®), + TX, Aphelinus asychis + TX, Aphidius colemani (Aphipar®) + TX, Aphidius ervi (Aphelinus-System®) + TX, Aphidius ervi (Ervipar®) + TX, Aphidius gifuensis + TX, Aphidius matricariae (Aphipar-M®) + TX, Aphidoletes aphidimyza (Aphidend®, Aphidoline®) + TX, Aphytis lingnanensis + TX, Aphytis melinus + TX, Aprostocetus hagenowii + TX, Atheta coriaria (Staphyline®) + TX, Bombus spp. + TX, Bombus terrestris (Beeline®, Tripol®) + TX, Bombus terrestris (Natupol Beehive®) + TX, Cephalonomia stephanoderis + TX, Chilocorus nigritus + TX, Chrysoperla carnea (Chrysoline®, Chrysopa®) + TX, Chrysoperla rufilabris + TX, Cirrospilus ingenuus + TX, Cirrospilus quadristriatus + TX, Citrostichus phyllocnistoides + TX, Closterocerus chamaeleon + TX, Closterocerus spp. + TX, Coccidoxenoides perminutus (Planopar®) + TX, Coccophagus cowperi + TX, Coccophagus lycimnia + TX, Cotesia flavipes + TX, Cotesia plutellae + TX, Cryptolaemus montrouzieri (Cryptobug®, Cryptoline®) + TX, Cybocephalus nipponicus + TX, Dacnusa sibirica (Minusa®, DacDigline®, Minex®) + TX, Delphastus catalinae (Delphastus®) + TX, Delphastus pusillus + TX, Diachasmimorpha krausii + TX, Diachasmimorpha longicaudata + TX, Diaparsis jucunda + TX, Diaphorencyrtus aligarhensis + TX, Diglyphus isaea (Diminex®, Miglyphus®, Digline®) + TX, Diversinervus spp. + TX, Encarsia citrina + TX, Encarsia formosa (Encarsia max®, Encarline®, En- Strip®) + TX, Encarsia guadeloupae + TX, Encarsia haitiensis + TX, Episyrphus balteatus (Syrphidend®) + TX, Eretmoceris siphonini + TX, Eretmocerus californicus + TX, Eretmocerus eremicus (Enermix®, Ercal®, Eretline e®, Bemimix®) + TX, Eretmocerus hayati + TX, Eretmocerus mundus (Bemipar®, Eretline m®) + TX, Eretmocerus siphonini + TX, Exochomus quadripustulatus + TX, Feltiella acarisuga (Feltiline®) + TX, Feltiella acarisuga (Spidend®) + TX, Fopius arisanus + TX, Fopius ceratitivorus + TX, Formononetin (Wirless Beehome®) + TX, Franklinothrips vespiformis (Vespop®) + TX, Galendromus occidentalis + TX, Goniozus legneri + TX, Habrobracon hebetor + TX, Harmonia axyridis (HarmoBeetle®) + TX, Heterorhabditis bacteriophora (NemaShield HB®, Nemaseek®, Terranem-Nam®, Terranem®, Larvanem®, B-Green®, NemAttack ®, Nematop®) + TX, Heterorhabditis megidis (Nemasys H®, BioNem H®, Exhibitline hm®, Larvanem-M®) + TX, Heterorhabditis spp. (Lawn Patrol®) + TX, Hippodamia convergens + TX, Hypoaspis aculeifer (Aculeifer-System®, Entomite-A®) + TX, Hypoaspis miles (Hypoline m®, Entomite-M®) + TX, Lbalia leucospoides + TX, Lecanoideus floccissimus + TX, Lemophagus errabundus + TX, Leptomastidea abnormis + TX, Leptomastix dactylopii (Leptopar®) + TX, Leptomastix epona + TX, Lindorus lophanthae + TX, Lipolexis oregmae + TX, Lucilia caesar (Natufly®) + TX, Lysiphlebus testaceipes + TX, Macrolophus caliginosus (Mirical-N®, Macroline c®, Mirical®) + TX, Mesoseiulus longipes + TX, Metaphycus flavus + TX, Metaphycus lounsburyi + TX, Micromus angulatus (Milacewing®) + TX, Microterys flavus + TX, Muscidifurax raptorellus and Spalangia cameroni (Biopar®) + TX, Neodryinus typhlocybae + TX, Neoseiulus californicus + TX, Neoseiulus cucumeris (THRYPEX®) + TX, Neoseiulus fallacis + TX, Nesideocoris tenuis (NesidioBug®, Nesibug®) + TX, Ophyra aenescens (Biofly®) + TX, Orius insidiosus (Thripor-I®, Oriline i®) + TX, Orius laevigatus (Thripor-L®, Oriline l®) + TX, Orius majusculus (Oriline m®) + TX, Orius strigicollis (Thripor-S®) + TX, Pauesia juniperorum + TX, Pediobius foveolatus + TX, Phasmarhabditis hermaphrodita (Nemaslug®) + TX, Phymastichus coffea + TX, Phytoseiulus macropilus + TX, Phytoseiulus persimilis (Spidex®, Phytoline p®) + TX, Podisus maculiventris (Podisus®) + TX, Pseudacteon curvatus + TX, Pseudacteon obtusus + TX, Pseudacteon tricuspis + TX, Pseudaphycus maculipennis + TX, Pseudleptomastix mexicana + TX, Psyllaephagus pilosus + TX, Psyttalia concolor (complex) + TX, Quadrastichus spp. + TX, Rhyzobius lophanthae + TX, Rodolia cardinalis + TX, Rumina decollate + TX, Semielacher petiolatus + TX, Sitobion avenae (Ervibank®) + TX, Steinernema carpocapsae (Nematac C®, Millenium®, BioNem C®, NemAttack®, Nemastar®, Capsanem®) + TX, Steinernema feltiae (NemaShield®, Nemasys F®, BioNem F®, Steinernema- System®, NemAttack®, Nemaplus®, Exhibitline sf®, Scia-rid®, Entonem®) + TX, Steinernema kraussei (Nemasys L®, BioNem L®, Exhibitline srb®) + TX, Steinernema riobrave (BioVector®, BioVektor®) + TX, Steinernema scapterisci (Nematac S®) + TX, Steinernema spp. + TX, Steinernematid spp. (Guardian Nematodes®) + TX, Stethorus punctillum (Stethorus®) + TX, Tamarixia radiate + TX, Tetrastichus setifer + TX, Thripobius semiluteus + TX, Torymus sinensis + TX, Trichogramma brassicae (Tricholine b®) + TX, Trichogramma brassicae (Tricho-Strip®) + TX, Trichogramma evanescens + TX, Trichogramma minutum + TX, Trichogramma ostriniae + TX, Trichogramma platneri + TX, Trichogramma pretiosum + TX, Xanthopimpla stemmator + TX; abscisic acid + TX, Aminomite® + TX, BioGain® + TX, bioSea® + TX, CAS Number: 2643947-26-4 + TX, Chondrostereum purpureum (Chontrol Paste®) + TX, Colletotrichum gloeosporioides (Collego®) + TX, Copper Octanoate (Cueva®) + TX, Delta traps (Trapline d®) + TX, Erwinia amylovora (Harpin) (ProAct®, Ni-HIBIT Gold CST®) + TX, fatty acids derived from a natural by-product of extra virgin olive oil (FLIPPER®) + TX, Ferri-phosphate (Ferramol®) + TX, Funnel traps (Trapline y®) + TX, Gallex® + TX, Grower's Secret® + TX, Homo-brassonolide + TX, Iron Phosphate (Lilly Miller Worry Free Ferramol Slug & Snail Bait®) + TX, MCP hail trap (Trapline f®) + TX, Microctonus hyperodae + TX, Mycoleptodiscus terrestris (Des-X®) + TX, Nosema locustae (Semaspore Organic Grasshopper Control®) + TX, Pheromone trap (Thripline ams®) + TX, potassium bicarbonate (MilStop®) + TX, potassium iodide + potassiumthiocyanate (Enzicur®) + TX, potassium salts of fatty acids (Sanova®) + TX, potassium silicate solution (Sil-Matrix®) + TX, Spider venom + TX, Sticky traps (Trapline YF®, Rebell Amarillo®) + TX, SuffOil-X® + TX, Traps (Takitrapline y + b®) + TX; Bacillus mojavensis strain R3B (Accession No. NCAIM (P) B001389) (WO 2013/034938) from Certis USA LLC + TX, Bacillus pumilus, in particular strain BU F-33, having NRRL Accession No. 50185 (CARTISSA® from BASF, EPA Reg. No.71840-19) + TX, Bacillus subtilis CX-9060 from Certis USA LLC, Bacillus sp., in particular strain D747 (available as DOUBLE NICKEL® from Kumiai Chemical Industry Co., Ltd.), having Accession No. FERM BP-8234, U.S. Patent No.7,094,592 + TX, Bacillus subtilis strain BU1814, (VELONDIS® PLUS, VELONDIS® FLEX and VELONDIS® EXTRA from BASF SE) + TX, Bacillus subtilis var. amyloliquefaciens strain FZB24 having Accession No. DSM 10271 (available from Novozymes as TAEGRO® or TAEGRO® ECO (EPA Registration No.70127-5)) + TX, Bacillus subtilis, in particular strain QST713/AQ713 (having NRRL Accession No. B-21661 and described in U.S. Patent No.6,060,051, available as SERENADE® OPTI or SERENADE® ASO from Bayer CropScience LP, US) + TX, Paenibacillus polymyxa, in particular strain AC-1 (e.g. TOPSEED® from Green Biotech Company Ltd.) + TX, Paenibacillus sp. strain having Accession No. NRRL B-50972 or Accession No. NRRL B-67129, WO 2016/154297 + TX, Pantoea agglomerans, in particular strain E325 (Accession No. NRRL B-21856) (available as BLOOMTIME BIOLOGICAL™ FD BIOPESTICIDE from Northwest Agri Products) + TX, Pseudomonas proradix (e.g. PRORADIX® from Sourcon Padena) + TX; Aureobasidium pullulans, in particular blastospores of strain DSM14940, blastospores of strain DSM 14941 or mixtures of blastospores of strains DSM14940 and DSM14941 (e.g., BOTECTOR® and BLOSSOM PROTECT® from bio-ferm, CH) + TX, Pseudozyma aphidis (as disclosed in WO2011/151819 by Yissum Research Development Company of the Hebrew University of Jerusalem) + TX, Saccharomyces cerevisiae, in particular strains CNCM No.1-3936, CNCM No.1-3937, CNCM No.1-3938 or CNCM No.1-3939 (WO 2010/086790) from Lesaffre et Compagnie, FR + TX; Agrobacterium radiobacter strain K84 (e.g. GALLTROL-A® from AgBioChem, CA) + TX, Bacillus amyloliquefaciens isolate B246 (e.g. AVOGREEN™ from University of Pretoria) + TX, Bacillus amyloliquefaciens strain F727 (also known as strain MBI110) (NRRL Accession No. B-50768, WO 2014/028521) (STARGUS® from Marrone Bio Innovations) + TX, Bacillus amyloliquefaciens strain FZB42, Accession No. DSM 23117 (available as RHIZOVITAL® from ABiTEP, DE) + TX, Bacillus amyloliquefaciens, in particular strain D747 (available as Double Nickel™ from Kumiai Chemical Industry Co., Ltd., having accession number FERM BP-8234, US Patent No.7,094,592) + TX, Bacillus licheniformis FMCH001 and Bacillus subtilis FMCH002 (QUARTZO® (WG) and PRESENCE® (WP) from FMC Corporation) + TX, Bacillus licheniformis, in particular strain SB3086, having Accession No. ATCC 55406, WO 2003/000051 (available as ECOGUARD® Biofungicide and GREEN RELEAF™ from Novozymes) + TX, Bacillus methylotrophicus strain BAC-9912 (from Chinese Academy of Sciences’ Institute of Applied Ecology) + TX, Bacillus mycoides, isolate, having Accession No. B-30890 (available as BMJ TGAI® or WG and LifeGard™ from Certis USA LLC) + TX, Bacillus pumilus, in particular strain GB34 (available as Yield Shield® from Bayer AG, DE) + TX, Bacillus pumilus, in particular strain QST2808 (available as SONATA® from Bayer CropScience LP, US, having Accession No. NRRL B- 30087 and described in U.S. Patent No.6,245,551) + TX, Bacillus subtilis CX-9060 from Certis USA LLC + TX, Bacillus subtilis IAB/BS03 (AVIV™ from STK Bio-Ag Technologies, PORTENTO® from Idai Nature) + TX, Bacillus subtilis KTSB strain (FOLIACTIVE® from Donaghys) + TX, Bacillus subtilis strain BU1814, (available as VELONDIS® PLUS, VELONDIS® FLEX and VELONDIS® EXTRA from BASF SE) + TX, Bacillus subtilis strain GB03 (available as Kodiak® from Bayer AG, DE) + TX, Bacillus subtilis strain MBI 600 (available as SUBTILEX from BASF SE), having Accession Number NRRL B-50595, U.S. Patent No.5,061,495 + TX, Bacillus subtilis strain Y1336 (available as BIOBAC® WP from Bion- Tech, Taiwan, registered as a biological fungicide in Taiwan under Registration Nos.4764, 5454, 5096 and 5277) + TX, Bacillus subtilis var. amyloliquefaciens strain FZB24 having Accession No. DSM 10271 (available from Novozymes as TAEGRO® or TAEGRO® ECO (EPA Registration No.70127-5)) + TX, Bacillus subtilis Y1336 (available as BIOBAC® WP from Bion-Tech, Taiwan, registered as a biological fungicide in Taiwan under Registration Nos. 4764, 5454, 5096 and 5277) + TX, Paenibacillus epiphyticus (WO 2016/020371) from BASF SE + TX, Paenibacillus polymyxa ssp. plantarum (WO 2016/020371) from BASF SE + TX, Paenibacillus sp. strain having Accession No. NRRL B-50972 or Accession No. NRRL B-67129, WO 2016/154297 + TX, Pseudomonas chlororaphis strain AFS009, having Accession No. NRRL B-50897, WO 2017/019448 (e.g., HOWLER™ and ZIO® from AgBiome Innovations, US) + TX, Pseudomonas chlororaphis, in particular strain MA342 (e.g. CEDOMON®, CERALL®, and CEDRESS® by Bioagri and Koppert) + TX, Pseudomonas fluorescens strain A506 (e.g. BLIGHTBAN® A506 by NuFarm) + TX, Pseudomonas proradix (e.g. PRORADIX® from Sourcon Padena) + TX, Streptomyces griseoviridis strain K61 (also known as Streptomyces galbus strain K61) (Accession No. DSM 7206) (MYCOSTOP® from Verdera, PREFENCE® from BioWorks, cf. Crop Protection 2006, 25, 468-475) + TX, Streptomyces lydicus strain WYEC108 (also known as Streptomyces lydicus strain WYCD108US) (ACTINO-IRON® and ACTINOVATE® from Novozymes) + TX; Trichoderma atroviride strain T11 (IMI352941/ CECT20498) + TX, Ampelomyces quisqualis strain AQ10, having Accession No. CNCM 1-807 (e.g., AQ 10® by IntrachemBio Italia) + TX, Ampelomyces quisqualis, in particular strain AQ 10 (e.g. AQ 10® by IntrachemBio Italia) + TX, Aspergillus flavus strain NRRL 21882 (products known as AFLA-GUARD® from Syngenta/ChemChina) + TX, Aureobasidium pullulans, in particular blastospores of strain DSM 14941 + TX, Aureobasidium pullulans, in particular blastospores of strain DSM14940 + TX, Aureobasidium pullulans, in particular mixtures of blastospores of strains DSM14940 and DSM 14941 (e.g. Botector® by bio-ferm, CH) + TX, Chaetomium cupreum (Accession No. CABI 353812) (e.g. BIOKUPRUM™ by AgriLife) + TX, Chaetomium globosum (available as RIVADIOM® by Rivale) + TX, Cladosporium cladosporioides, strain H39, having Accession No. CBS122244, US 2010/0291039 (by Stichting Dienst Landbouwkundig Onderzoek) + TX, Coniothyrium minitans, in particular strain CON/M/91-8 (Accession No. DSM9660, e.g. Contans ® from Bayer CropScience Biologics GmbH) + TX, Cryptococcus flavescens, strain 3C (NRRL Y-50378), + TX, Dactylaria candida, Dilophosphora alopecuri (available as TWIST FUNGUS®), Fusarium oxysporum, strain Fo47 (available as FUSACLEAN® by Natural Plant Protection) + TX, Gliocladium catenulatum (Synonym: Clonostachys rosea f. catenulate) strain J1446 (e.g. Prestop ® by Lallemand) + TX, Gliocladium roseum (also known as Clonostachys rosea f rosea) strain IK726 (Jensen DF, et al. Development of a biocontrol agent for plant disease control with special emphasis on the near commercial fungal antagonist Clonostachys rosea strain ’IK726’, Australasian Plant Pathol. 2007,36(2):95-101) + TX, Gliocladium roseum (also known as Clonostachys rosea f rosea), in particular strain 321U from Adjuvants Plus, strain ACM941 as disclosed in Xue A.G. (Efficacy of Clonostachys rosea strain ACM941 and fungicide seed treatments for controlling the root tot complex of field pea, Can Jour Plant Sci 2003, 83(3): 519-524) + TX, Metschnikowia fructicola, in particular strain NRRL Y-30752 + TX, Microsphaeropsis ochracea, Penicillium steckii (DSM 27859, WO 2015/067800) from BASF SE + TX, mixtures of Trichoderma asperellum strain ICC 012 (also known as Trichoderma harzianum ICC012), having Accession No. CABI CC IMI 392716 and Trichoderma gamsii (formerly T. viride) strain ICC 080, having Accession No. IMI 392151 (e.g., BIO-TAM™ from Isagro USA, Inc. or BIODERMA® by Agrobiosol de Mexico, S.A. de C.V.) + TX, Penicillium vermiculatum + TX, Phlebiopsis gigantea strain VRA 1992 (ROTSTOP® C from Danstar Ferment) + TX, Pseudozyma flocculosa, strain PF-A22 UL (available as SPORODEX® L by Plant Products Co., CA) + TX, Saccharomyces cerevisiae strain LAS117 cell walls (CEREVISANE® from Lesaffre, ROMEO® from BASF SE) + TX, Saccharomyces cerevisiae strains CNCM No.1-3936, CNCM No.1-3937, CNCM No.1-3938, CNCM No.1-3939 (WO 2010/086790) from Lesaffre et Compagnie, FR + TX, Saccharomyces cerevisiae, in particular strain LASO2 (from Agro-Levures et Dérivés) + TX, Simplicillium lanosoniveum + TX, strain T34 (e.g. T34 Biocontrol by Biocontrol Technologies S.L., ES) or strain ICC 012 from Isagro + TX, strain WRL-076 (NRRL Y-30842), U.S. Patent No.7,579,183 + TX, Talaromyces flavus, strain V117b + TX, Trichoderma asperelloides JM41R (Accession No. NRRL B-50759) (TRICHO PLUS® from BASF SE) + TX, Trichoderma asperellum, in particular strain SKT-1, having Accession No. FERM P-16510 (e.g. ECO- HOPE® from Kumiai Chemical Industry) + TX, Trichoderma asperellum, in particular, strain kd (e.g. T- Gro from Andermatt Biocontrol) + TX, Trichoderma atroviride strain 77B (T77 from Andermatt Biocontrol) + TX, Trichoderma atroviride strain ATCC 20476 (IMI 206040) + TX, Trichoderma atroviride strain LC52 (e.g. Tenet by Agrimm Technologies Limited) + TX, Trichoderma atroviride strain LU132 (e.g. Sentinel from Agrimm Technologies Limited) + TX, Trichoderma atroviride strain NMI no. V08/002388 + TX, Trichoderma atroviride strain NMI no. V08/002389 + TX, Trichoderma atroviride strain NMI no. V08/002390 + TX, Trichoderma atroviride strain no. V08/002387 + TX, Trichoderma atroviride strain SKT-1 (FERM P-16510), JP Patent Publication (Kokai) 11-253151 A + TX, Trichoderma atroviride strain SKT-2 (FERM P-16511), JP Patent Publication (Kokai) 11-253151 A + TX, Trichoderma atroviride strain SKT-3 (FERM P-17021), JP Patent Publication (Kokai) 11-253151 A + TX, Trichoderma atroviride, in particular strain SC1 (Accession No. CBS 122089, WO 2009/116106 and U.S. Patent No.8,431,120 (from Bi-PA)) + TX, Trichoderma atroviride,strain CNCM 1-1237 (e.g. Esquive® WP from Agrauxine, FR) + TX, Trichoderma fertile (e.g. product TrichoPlus from BASF) + TX, Trichoderma gamsii (formerly T. viride) + TX, Trichoderma gamsii (formerly T. viride) strain ICC 080 (IMI CC 392151 CABI) (available as BIODERMA® by AGROBIOSOL DE MEXICO, S.A. DE C.V.), + TX, Trichoderma gamsii strain ICC080 (IMI CC 392151 CABI, e.g. BioDerma by AGROBIOSOL DE MEXICO, S.A. DE C.V.), + TX, Trichoderma harmatum + TX, Trichoderma harmatum, having Accession No. ATCC 28012 + TX, Trichoderma harzianum + TX, Trichoderma harzianum rifai T39 (e.g. Trichodex® from Makhteshim, US) + TX, Trichoderma harzianum strain Cepa SimbT5 (from Simbiose Agro), + TX, Trichoderma harzianum strain DB 103 (available as T-GRO® 7456 by Dagutat Biolab) + TX, Trichoderma harzianum strain ITEM 908 (e.g. Trianum-P from Koppert) + TX, Trichoderma harzianum strain T-22 (e.g. Trianum-P from Andermatt Biocontrol or Koppert) + TX, Trichoderma harzianum strain TH35 (e.g. Root-Pro by Mycontrol) + TX, Trichoderma polysporum strain IMI 206039 (e.g. Binab TF WP by BINAB Bio- Innovation AB, Sweden) + TX, Trichoderma stromaticum having Accession No. Ts3550 (e.g. Tricovab by CEPLAC, Brazil) + TX, Trichoderma virens (also known as Gliocladium virens) in particular strain GL-21 (e.g. SoilGard by Certis, US) + TX, Trichoderma virens strain G-41, formerly known as Gliocladium virens (Accession No. ATCC 20906) (e.g., ROOTSHIELD® PLUS WP and TURFSHIELD® PLUS WP from BioWorks, US) + TX, Trichoderma viride in particular strain B35 (Pietr et al., 1993, Zesz. Nauk. A R w Szczecinie 161: 125-137) + TX, Trichoderma viride strain TV1(e.g. Trianum-P by Koppert) + TX, Ulocladium oudemansii strain U3, having Accession No. NM 99/06216 (e.g., BOTRY-ZEN® by Botry-Zen Ltd, New Zealand and BOTRYSTOP® from BioWorks, Inc.) + TX, Verticillium albo-atrum (formerly V. dahliae) strain WCS850 having Accession No. WCS850, deposited at the Central Bureau for Fungi Cultures (e.g., DUTCH TRIG® by Tree Care Innovations) + TX, Verticillium chlamydosporium + TX; a mixture of Azotobacter vinelandii and Clostridium pasteurianum (available as INVIGORATE® from Agrinos) + TX, a mixture of Bacillus licheniformis FMCH001 and Bacillus subtilis FMCH002 (available as QUARTZO® (WG), PRESENCE® (WP) from FMC Corporation) + TX, Azorhizobium caulinodans, in particular strain ZB-SK-5 + TX, Azospirillum brasilense (e.g., VIGOR® from KALO, Inc.) + TX, Azospirillum lipoferum (e.g., VERTEX-IF™ from TerraMax, Inc.) + TX, Azotobacter chroococcum, in particular strain H23 + TX, Azotobacter vinelandii, in particular strain ATCC 12837 + TX, Bacillus amyloliquefaciens BS27 (Accession No. NRRL B-5015) + TX, Bacillus amyloliquefaciens in particular strain FZB42 (e.g. RHIZOVITAL® from ABiTEP, DE) + TX, Bacillus amyloliquefaciens in particular strain IN937a + TX, Bacillus amyloliquefaciens pm414 (LOLI-PEPTA® from Biofilm Crop Protection) + TX, Bacillus amyloliquefaciens SB3281 (ATCC # PTA-7542, WO 2017/205258) + TX, Bacillus amyloliquefaciens TJ1000 (available as QUIKROOTS® from Novozymes) + TX, Bacillus cereus family member EE128 (NRRL No. B-50917) + TX, Bacillus cereus family member EE349 (NRRL No. B-50928) + TX, Bacillus cereus in particular strain BP01 (ATCC 55675, e.g. MEPICHLOR® from Arysta Lifescience, US) + TX, Bacillus mycoides BT155 (NRRL No. B-50921) + TX, Bacillus mycoides BT46-3 (NRRL No. B-50922) + TX, Bacillus mycoides EE118 (NRRL No. B-50918) + TX, Bacillus mycoides EE141 (NRRL No. B-50916) + TX, Bacillus pumilus in particular strain GB34 (e.g. YIELD SHIELD® from Bayer Crop Science, DE), + TX, Bacillus pumilus in particular strain QST2808 (Accession No. NRRL No. B-30087) + TX, Bacillus siamensis in particular strain KCTC 13613T + TX, Bacillus subtilis in particular strain AQ30002 (Accession No. NRRL No. B-50421 and described in U.S. Patent Application No.13/330,576) + TX, Bacillus subtilis in particular strain AQ30004 (NRRL No. B-50455 and described in U.S. Patent Application No. 13/330,576) + TX, Bacillus subtilis in particular strain MBI 600 (e.g. SUBTILEX® from BASF SE) + TX, Bacillus subtilis rm303 (RHIZOMAX® from Biofilm Crop Protection) + TX, Bacillus subtilis strain BU1814 (available as TEQUALIS® from BASF SE) + TX, Bacillus tequilensis in particular strain NII-0943 + TX, Bacillus thuringiensis BT013A (NRRL No. B-50924) also known as Bacillus thuringiensis 4Q7 + TX, Bradyrhizobium japonicum (e.g. OPTIMIZE® from Novozymes) + TX, Delftia acidovorans in particular strain RAY209 (e.g. BIOBOOST® from Brett Young Seeds) + TX, Lactobacillus sp. (e.g. LACTOPLANT® from LactoPAFI) + TX, Mesorhizobium cicer (e.g., NODULATOR from BASF SE) + TX, Paenibacillus polymyxa in particular strain AC-1 (e.g. TOPSEED® from Green Biotech Company Ltd.) + TX, Pseudomonas aeruginosa in particular strain PN1 + TX, Pseudomonas proradix (e.g. PRORADIX® from Sourcon Padena) + TX, Rhizobium leguminosarium biovar viciae (e.g., NODULATOR from BASF SE) + TX, Rhizobium leguminosarum in particular bv. viceae strain Z25 (Accession No. CECT 4585) + TX, Serratia marcescens in particular strain SRM (Accession No. MTCC 8708), + TX, Sinorhizobium meliloti strain NRG-185-1 (NITRAGIN® GOLD from Bayer CropScience) + TX, Thiobacillus sp. (e.g. CROPAID® from Cropaid Ltd UK) + TX; Myrothecium verrucaria strain AARC-0255 (e.g. DiTera™ from Valent Biosciences) + TX, Penicillium bilaii strain ATCC 22348 (e.g. JumpStart® from Acceleron BioAg) + TX, Penicillium bilaii strain ATCC ATCC20851 + TX, Purpureocillium lilacinum (previously known as Paecilomyces lilacinus) strain 251 (AGAL 89/030550, e.g. BioAct from Bayer CropScience Biologics GmbH) + TX, Pythium oligandrum strain DV74 + TX, Pythium oligandrum strain M1 (ATCC 38472 e.g. Polyversum from Bioprepraty, CZ) + TX, Rhizopogon amylopogon (Myco-Sol from Agri-Enterprise, LLC, formerly Helena Chemical Company) + TX, Rhizopogon fulvigleba (e.g. Myco-Sol from Agri-Enterprise, LLC, formerly Helena Chemical Company) + TX, Talaromyces flavus strain V117b + TX, Trichoderma asperellum strain (Eco- T from Plant Health Products, ZA) + TX, Trichoderma asperellum strain kd (e.g. T-Gro from Andermatt Biocontrol) + TX, Trichoderma atroviride in particular strain no. V08/002387 + TX, Trichoderma atroviride strain CNCM 1-1237 (e.g. Esquive® WP from Agrauxine, FR) + TX, Trichoderma atroviride strain LC52 (also known as Trichoderma atroviride strain LU132, e.g. Sentinel from Agrimm Technologies Limited) + TX, Trichoderma atroviride strain no. NMI No. V08/002388 + TX, Trichoderma atroviride strain no. NMI No. V08/002389 + TX, Trichoderma atroviride strain no. NMI No. V08/002390 + TX, Trichoderma atroviride strain SC1 (described in WO2009/116106) + TX, Trichoderma harzianum strain 1295-22 + TX, Trichoderma harzianum strain ITEM 908 + TX, Trichoderma harzianum strain T-22 (e.g. Trianum-P from Andermatt Biocontrol or Koppert) + TX, Trichoderma harzianum strain TSTh20, + TX, Trichoderma virens strain GI-3 + TX, Trichoderma virens strain GL-21 (e.g. SoilGard® from Certis, USA) + TX, Trichoderma viride strain B35 (Pietr et al., 1993, Zesz. Nauk. A R w Szczecinie 161: 125-137) + TX, Verticillium albo-atrum (formerly V. dahliae) strain WCS850 (CBS 276.92, e.g. Dutch Trig from Tree Care Innovations) + TX; Agrobacterium radiobacter strain K84 (Galltrol from AgBiochem Inc.), + TX, Bacillus amyloliquefaciens in particular strain PTS-4838 (e.g. AVEO from Valent Biosciences, US), + TX, Bacillus mycoides, isolate J. (e.g. BmJ from Certis USA LLC), + TX, Bacillus sphaericus in particular Serotype H5a5b strain 2362 (strain ABTS-1743) (e.g. VECTOLEX® from Valent BioSciences, US), + TX, Bacillus thuringiensis israelensis strain BMP 144 (e.g. AQUABAC® by Becker Microbial Products IL) + TX, Bacillus thuringiensis subsp. aizawai strain GC-91 + TX, Bacillus thuringiensis subsp. aizawai, in particular serotype H-7 (e.g. FLORBAC® WG from Valent BioSciences, US) + TX, Bacillus thuringiensis subsp. aizawai, in particular strain ABTS-1857 (SD-1372, e.g. XENTARI® from Valent BioSciences) + TX, Bacillus thuringiensis subsp. israelensis (serotype H-14) strain AM65-52 (Accession No. ATCC 1276) (e.g. VECTOBAC® by Valent BioSciences, US) + TX, Bacillus thuringiensis subsp. kurstaki strain ABTS 351 + TX, Bacillus thuringiensis subsp. kurstaki strain BMP 123 (from Becker Microbial Products, IL, BARITONE from Bayer CropScience) + TX, Bacillus thuringiensis subsp. kurstaki strain EG 2348 (LEPINOX from Certis, US) + TX, Bacillus thuringiensis subsp. kurstaki strain EG 7841 (CRYMAX from Certis, US) + TX, Bacillus thuringiensis subsp. kurstaki strain HD-1 (e.g. DIPEL® ES from Valent BioSciences, US) + TX, Bacillus thuringiensis subsp. kurstaki strain PB 54 + TX, Bacillus thuringiensis subsp. kurstaki strain SA 11 (JAVELIN from Certis, US) + TX, Bacillus thuringiensis subsp. kurstaki strain SA 12 (THURICIDE from Certis, US) + TX, Bacillus thuringiensis subsp. tenebrionis strain NB 176 (SD-5428, e.g. NOVODOR® FC from BioFa DE) + TX, Bacillus thuringiensis var. Colmeri (e.g. TIANBAOBTC by Changzhou Jianghai Chemical Factory) + TX, Bacillus thuringiensis var. japonensis strain Buibui + TX, Bacillus thuringiensis var. kurstaki strain EVB-113-19 (e.g., BIOPROTEC® from AEF Global) + TX, Brevibacillus laterosporus + TX, Burkholderia spp. in particular Burkholderia rinojensis strain A396 (also known as Burkholderia rinojensis strain MBI 305) (Accession No. NRRL B-50319, WO 2011/106491 and WO 2013/032693, e.g. MBI206 TGAI and ZELTO® from Marrone Bio Innovations), + TX, Chromobacterium subtsugae in particular strain PRAA4-1T (e.g. MBI-203, e.g. GRANDEVO® from Marrone Bio Innovations) + TX, Lecanicillium muscarium Ve6 (MYCOTAL from Koppert) + TX, Paenibacillus popilliae (formerly Bacillus popilliae, e.g. MILKY SPORE POWDER™ or MILKY SPORE GRANULAR™ from St. Gabriel Laboratories) + TX, Serratia entomophila (e.g. INVADE® by Wrightson Seeds) + TX, Serratia marcescens in particular strain SRM (Accession No. MTCC 8708) + TX, Trichoderma asperellum (TRICHODERMAX from Novozymes) + TX, Wolbachia pipientis ZAP strain (e.g., ZAP MALES® from MosquitoMate) + TX; Beauveria bassiana strain ATCC 74040 (e.g. NATURALIS® from Intrachem Bio Italia) + TX, Beauveria bassiana strain ATP02 (Accession No. DSM 24665), Apopka 97 (PREFERAL from SePRO) + TX, Beauveria bassiana strain GHA (Accession No. ATCC74250, e.g. BOTANIGUARD® ES and MYCONTROL-O® from Laverlam International Corporation) + TX, Metarhizium anisopliae 3213-1 (deposited under NRRL accession number 67074 disclosed in WO 2017/066094, Pioneer Hi-Bred International) + TX, Metarhizium robertsii 15013-1 (deposited under NRRL accession number 67073) + TX, Metarhizium robertsii 23013-3 (deposited under NRRL accession number 67075) + TX, Paecilomyces lilacinus strain 251 (MELOCON from Certis, US) + TX; Cydia pomonella (codling moth) granulosis virus (GV) + TX, Helicoverpa armigera (cotton bollworm) nuclear polyhedrosis virus (NPV) + TX, of Adoxophyes orana (summer fruit tortrix) granulosis virus (GV) + TX, Spodoptera exigua (beet armyworm) mNPV + TX, Spodoptera frugiperda (fall armyworm) mNPV + TX; Burkholderia spp. in particular Burkholderia cepacia (formerly known as Pseudomonas cepacia) + TX, Gigaspora spp. + TX, Glomus spp. + TX, Laccaria spp. + TX, LactoBacillus buchneri + TX, Paraglomus spp. + TX, Pisolithus tinctorus + TX, Pseudomonas spp. + TX, Rhizobium spp. in particular Rhizobium trifolii + TX, Rhizopogon spp. + TX, Scleroderma spp. + TX, Streptomyces spp. + TX, Suillus spp. + TX, Agrobacterium spp. + TX, Azorhizobium caulinodans + TX, Azospirillum spp. + TX, Azotobacter spp. + TX, Bradyrhizobium spp. + TX, Gigaspora monosporum + TX; Allium sativum (NEMGUARD from Eco-Spray, BRALIC from ADAMA) + TX, Armour-Zen + TX, Artemisia absinthium + TX, Biokeeper WP + TX, Brassicaceae extract in particular oilseed rape powder or mustard powder + TX, Cassia nigricans + TX, Celastrus angulatus + TX, Chenopodium anthelminticum + TX, Chenopodium quinoa saponin extract from quinoa seeds (e.g. Heads Up® (Saponins of Quinoa) from Heads Up plant Protectants, CA) + TX, Chitin + TX, Dryopteris filix-mas + TX, Equisetum arvense + TX, Fortune Aza + TX, Fungastop + TX, Melaleuca alternifolia extract (TIMOREX GOLD from STK) + TX, naturally occurring Blad polypeptide extracted from Lupin seeds (FRACTURE® from FMC) + TX, naturally occurring Blad polypeptide extracted from Lupin seeds (PROBLAD® from Certis EU) + TX, Pyrethrins + TX, Quassia amara + TX, Quercus + TX, Quillaja extract (QL AGRI 35 from BASF) + TX, REGALIA MAXX from Marrone Bio) + TX, Requiem™ Insecticide + TX, Reynoutria sachalinensis extract (REGALLIA + TX, ryania/ryanodine + TX, Symphytum officinale + TX, Tanacetum vulgare + TX, Thymol + TX, Thymol mixed with Geraniol (CEDROZ from Eden Research) + TX, Thymol mixed with Geraniol and Eugenol (MEVALONE from Eden Research) + TX, Triact 70 + TX, TriCon + TX, Tropaeulum majus + TX, Urtica dioica + TX, Veratrin + TX, Viscum album + TX; mercuric oxide + TX, octhilinone + TX, thiophanate-methyl + TX; MGK 264 + TX, 2-(2-butoxyethoxy)ethyl piperonylate + TX, 2-isovalerylindan-1,3-dione + TX, 4- (quinoxalin-2-ylamino)benzenesulfonamide + TX, 5-(1,3-benzodioxol-5-yl)-3-hexylcyclohex-2-enone + TX, acibenzolar + TX, acibenzolar-S-methyl + TX, alpha-bromadiolone + TX, alpha-chlorohydrin + TX, aluminium phosphide + TX, anthraquinone + TX, antu + TX, arsenous oxide + TX, barium carbonate + TX, benoxacor + TX, bisthiosemi + TX, brodifacoum + TX, bromadiolone + TX, bromethalin + TX, calcium cyanide + TX, chloralose + TX, chlorophacinone + TX, cholecalciferol + TX, cloquintocet (including cloquintocet-mexyl) + TX, copper naphthenate + TX, copper oxychloride + TX, coumachlor + TX, coumafuryl + TX, coumatetralyl + TX, crimidine + TX, cyprosulfamide + TX, diazinon + TX, dichlormid + TX, dicyclopentadiene + TX, difenacoum + TX, difethialone + TX, diphacinone + TX, ergocalciferol + TX, farnesol + TX, farnesol with nerolidol + TX, fenchlorazole (including fenchlorazole- ethyl) + TX, fenclorim + TX, flocoumafen + TX, fluoroacetamide + TX, flupropadine + TX, flupropadine hydrochloride + TX, fluxofenim + TX, furilazole + TX, gamma-HCH + TX, guazatine + TX, guazatine acetates + TX, HCH + TX, hydrogen cyanide + TX, imanin + TX, iodomethane + TX, isoxadifen (including isoxadifen-ethyl) + TX, lindane + TX, magnesium phosphide + TX, MB-599 + TX, mefenpyr (including mefenpyr-diethyl) + TX, metcamifen + TX, methiocarb + TX, methyl bromide + TX, nerolidol + TX, norbormide + TX, petroleum oils + TX, phosacetim + TX, phosphine + TX, phosphorus + TX, pindone + TX, piperonyl butoxide + TX, piprotal + TX, potassium arsenite + TX, probenazole + TX, propyl isomer + TX, pyridin-4-amine + TX, pyrinuron + TX, Reynoutria sachalinensis extract + TX, ribavirin + TX, S421 + TX, scilliroside + TX, sesamex + TX, sesasmolin + TX, sodium arsenite + TX, sodium cyanide + TX, sodium fluoroacetate + TX, strychnine + TX, sulfoxide + TX, thallium sulfate + TX, thiram + TX, trimethacarb + TX, warfarin + TX, zinc naphthenate + TX, zinc phosphide + TX, ziram + TX. In addition, the compositions of the invention may also be applied with one or more systemically acquired resistance inducers (“SAR” inducer). SAR inducers are known and described in, for example, United States Patent No. US 6,919,298 and include, for example, salicylates and the commercial SAR inducer acibenzolar-S-methyl. The compounds of formula (I) as defined in the present invention are normally used in the form of compositions and can be applied to the crop area or plant to be treated, simultaneously or in succession with further compounds. These further compounds can be e.g. fertilizers or micronutrient donors or other preparations, which influence the growth of plants. They can also be selective herbicides or non- selective herbicides as well as insecticides, fungicides, bactericides, nematicides, molluscicides or mixtures of several of these preparations, if desired together with further carriers, surfactants or application promoting adjuvants customarily employed in the art of formulation. The compounds of formula (I) as defined in the present invention may be used in the form of (fungicidal) compositions for controlling or protecting against phytopathogenic microorganisms, comprising as active ingredient at least one compound of formula (I) as defined in the present invention or of at least one preferred individual compound as above-defined, in free form or in agrochemically usable salt form, and at least one of the above-mentioned adjuvants. The invention therefore provides a composition, preferably a fungicidal composition, comprising at least one compound of formula (I) as defined in the present invention, an agriculturally acceptable carrier and optionally an adjuvant. An agricultural acceptable carrier is for example a carrier that is suitable for agricultural use. Agricultural carriers are well known in the art. Preferably said composition may comprise at least one or more pesticidally active compounds, for example an additional fungicidal active ingredient in addition to the compound of formula (I) as defined in the present invention. A further aspect of invention is related to a method of controlling or preventing an infestation of plants, e.g. useful plants such as crop plants, propagation material thereof, e.g. seeds, harvested crops, e.g. harvested food crops, or of non-living materials by phytopathogenic or spoilage microorganisms or organisms potentially harmful to man, especially fungal organisms, which comprises the application of a compound of formula (I) as defined in the present invention or of a preferred individual compound as above-defined as active ingredient to the plants, to parts of the plants or to the locus thereof, to the propagation material thereof, or to any part of the non-living materials. Controlling or preventing means reducing infestation by insects or by phytopathogenic or spoilage microorganisms or organisms potentially harmful to man, especially fungal organisms, to such a level that an improvement is demonstrated. A preferred method of controlling or preventing an infestation of crop plants by phytopathogenic microorganisms, especially fungal organisms, which comprises the application of a compound of formula (I) as defined in the present invention, or an agrochemical composition which contains at least one of said compounds, is foliar application. The frequency of application and the rate of application will depend on the risk of infestation by the corresponding pathogen or insect. However, the compounds of formula (I) as defined in the present invention can also penetrate the plant through the roots via the soil (systemic action) by drenching the locus of the plant with a liquid formulation, or by applying the compounds in solid form to the soil, e.g. in granular form (soil application). In crops of water rice such granulates can be applied to the flooded rice field. The compounds of formula (I) as defined in any the present invention may also be applied to seeds (coating) by impregnating the seeds or tubers either with a liquid formulation of the fungicide or coating them with a solid formulation. A formulation, e.g. a composition containing the compound of formula (I) as defined in the present invention, and, if desired, a solid or liquid adjuvant or monomers for encapsulating the compound of formula (I) as defined in the present invention, may be prepared in a known manner, typically by intimately mixing and/or grinding the compound with extenders, for example solvents, solid carriers and, optionally, surface active compounds (surfactants). The application methods for the compositions, that is the methods of controlling pathogens of the abovementioned type, such as spraying, atomizing, dusting, brushing on, dressing, scattering or pouring - which are to be selected to suit the intended aims of the prevailing circumstances - and the use of the compositions for controlling pathogens of the abovementioned type are other subjects of the invention. Typical rates of concentration are between 0.1 and 1000 ppm, preferably between 0.1 and 500 ppm, of active ingredient. The rate of application per hectare is preferably 1g to 2000 g of active ingredient per hectare, more preferably 10 to 1000 g/ha, most preferably 10 to 600 g/ha. When used as seed drenching agent, convenient dosages are from 10mg to 1g of active substance per kg of seeds. When the combinations of the present invention are used for treating seed, rates of 0.001 to 50 g of a compound of formula (I) per kg of seed, preferably from 0.01 to 10g per kg of seed are generally sufficient. Suitably, a composition comprising a compound of formula (I) as defined in the present invention according to the present invention is applied either preventative, meaning prior to disease development or curative, meaning after disease development. The compositions of the invention may be employed in any conventional form, for example in the form of a twin pack, a powder for dry seed treatment (DS), an emulsion for seed treatment (ES), a flowable concentrate for seed treatment (FS), a solution for seed treatment (LS), a water dispersible powder for seed treatment (WS), a capsule suspension for seed treatment (CF), a gel for seed treatment (GF), an emulsion concentrate (EC), a suspension concentrate (SC), a suspo-emulsion (SE), a capsule suspension (CS), a water dispersible granule (WG), an emulsifiable granule (EG), an emulsion, water in oil (EO), an emulsion, oil in water (EW), a micro-emulsion (ME), an oil dispersion (OD), an oil miscible flowable (OF), an oil miscible liquid (OL), a soluble concentrate (SL), an ultra-low volume suspension (SU), an ultra-low volume liquid (UL), a technical concentrate (TK), a dispersible concentrate (DC), a wettable powder (WP) or any technically feasible formulation in combination with agriculturally acceptable adjuvants. Such compositions may be produced in conventional manner, e.g. by mixing the active ingredients with appropriate formulation inerts (diluents, solvents, fillers and optionally other formulating ingredients such as surfactants, biocides, anti-freeze, stickers, thickeners and compounds that provide adjuvancy effects). Also conventional slow release formulations may be employed where long lasting efficacy is intended. Particularly formulations to be applied in spraying forms, such as water dispersible concentrates (e.g. EC, SC, DC, OD, SE, EW, EO and the like), wettable powders and granules, may contain surfactants such as wetting and dispersing agents and other compounds that provide adjuvancy effects, e.g. the ondensation product of formaldehyde with naphthalene sulphonate, an alkylarylsulphonate, a lignin sulphonate, a fatty alkyl sulphate, and ethoxylated alkylphenol and an ethoxylated fatty alcohol. A seed dressing formulation is applied in a manner known per se to the seeds employing the combination of the invention and a diluent in suitable seed dressing formulation form, e.g. as an aqueous suspension or in a dry powder form having good adherence to the seeds. Such seed dressing formulations are known in the art. Seed dressing formulations may contain the single active ingredients or the combination of active ingredients in encapsulated form, e.g. as slow release capsules or microcapsules. In general, the formulations include from 0.01 to 90% by weight of active agent, from 0 to 20% agriculturally acceptable surfactant and 10 to 99.99% solid or liquid formulation inerts and adjuvant(s), the active agent consisting of at least the compound of formula (I) as defined in the present invention together with component (B) and (C), and optionally other active agents, particularly microbiocides or conservatives or the like. Concentrated forms of compositions generally contain in between about 2 and 80%, preferably between about 5 and 70% by weight of active agent. Application forms of formulation may for example contain from 0.01 to 20% by weight, preferably from 0.01 to 5% by weight of active agent. Whereas commercial products will preferably be formulated as concentrates, the end user will normally employ diluted formulations. Whereas it is preferred to formulate commercial products as concentrates, the end user will normally use dilute formulations. EXAMPLES The Examples which follow serve to illustrate the invention. Certain compounds of the invention can be distinguished from known compounds by virtue of greater efficacy at low application rates, which can be verified by the person skilled in the art using the experimental procedures outlined in the Examples,. Formulation Examples Wettable powders a) b) c) active ingredient [compound of formula (I)] 25 % 50 % 75 % sodium lignosulfonate 5 % 5 % - sodium lauryl sulfate 3 % - 5 % sodium diisobutylnaphthalenesulfonate - 6 % 10 % phenol polyethylene glycol ether - 2 % - (7-8 mol of ethylene oxide) highly dispersed silicic acid 5 % 10 % 10 % Kaolin 62 % 27 % - The active ingredient is thoroughly mixed with the adjuvants and the mixture is thoroughly ground in a suitable mill, affording wettable powders that can be diluted with water to give suspensions of the desired concentration. Powders for dry seed treatment a) b) c) active ingredient [compound of formula (I)] 25 % 50 % 75 % light mineral oil 5 % 5 % 5 % highly dispersed silicic acid 5 % 5 % - Kaolin 65 % 40 % - Talcum - 20% The active ingredient is thoroughly mixed with the adjuvants and the mixture is thoroughly ground in a suitable mill, affording powders that can be used directly for seed treatment. Emulsifiable concentrate active ingredient [compound of formula (I)] 10 % octylphenol polyethylene glycol ether 3 % (4-5 mol of ethylene oxide) calcium dodecylbenzenesulfonate 3 % castor oil polyglycol ether (35 mol of ethylene oxide) 4 % Cyclohexanone 30 % xylene mixture 50 % Emulsions of any required dilution, which can be used in plant protection, can be obtained from this concentrate by dilution with water. Dusts a) b) c) Active ingredient [compound of formula (I)] 5 % 6 % 4 % talcum 95 % - - Kaolin - 94 % - mineral filler - - 96 % Ready-for-use dusts are obtained by mixing the active ingredient with the carrier and grinding the mixture in a suitable mill. Such powders can also be used for dry dressings for seed. Extruder granules Active ingredient [compound of formula (I)] 15 % sodium lignosulfonate 2 % carboxymethylcellulose 1 % Kaolin 82 % The active ingredient is mixed and ground with the adjuvants, and the mixture is moistened with water. The mixture is extruded and then dried in a stream of air. Coated granules Active ingredient [compound of formula (I)] 8 % polyethylene glycol (mol. wt.200) 3 % Kaolin 89 % The finely ground active ingredient is uniformly applied, in a mixer, to the kaolin moistened with polyethylene glycol. Non-dusty coated granules are obtained in this manner. Suspension concentrate active ingredient [compound of formula (I)] 40 % propylene glycol 10 % nonylphenol polyethylene glycol ether (15 mol of ethylene oxide) 6 % Sodium lignosulfonate 10 % carboxymethylcellulose 1 % silicone oil (in the form of a 75 % emulsion in water) 1 % Water 32 % The finely ground active ingredient is intimately mixed with the adjuvants, giving a suspension concentrate from which suspensions of any desired dilution can be obtained by dilution with water. Using such dilutions, living plants as well as plant propagation material can be treated and protected against infestation by microorganisms, by spraying, pouring or immersion. Flowable concentrate for seed treatment active ingredient [compound of formula (I)] 40 % propylene glycol 5 % copolymer butanol PO/EO 2 % tristyrenephenole with 10-20 moles EO 2 % 1,2-benzisothiazolin-3-one (in the form of a 20% solution in water) 0.5 % monoazo-pigment calcium salt 5 % Silicone oil (in the form of a 75 % emulsion in water) 0.2 % Water 45.3 % The finely ground active ingredient is intimately mixed with the adjuvants, giving a suspension concentrate from which suspensions of any desired dilution can be obtained by dilution with water. Using such dilutions, living plants as well as plant propagation material can be treated and protected against infestation by microorganisms, by spraying, pouring or immersion. Slow Release Capsule Suspension 28 parts of a combination of the compound of formula (I) are mixed with 2 parts of an aromatic solvent and 7 parts of toluene diisocyanate/polymethylene-polyphenylisocyanate-mixture (8:1). This mixture is emulsified in a mixture of 1.2 parts of polyvinylalcohol, 0.05 parts of a defoamer and 51.6 parts of water until the desired particle size is achieved. To this emulsion a mixture of 2.8 parts 1,6-diaminohexane in 5.3 parts of water is added. The mixture is agitated until the polymerization reaction is completed. The obtained capsule suspension is stabilized by adding 0.25 parts of a thickener and 3 parts of a dispersing agent. The capsule suspension formulation contains 28% of the active ingredients. The medium capsule diameter is 8-15 microns. The resulting formulation is applied to seeds as an aqueous suspension in an apparatus suitable for that purpose. Analytical Methods: Throughout this description, temperatures are given in degrees Celsius (°C) and “mp.” means melting point. LC/MS means Liquid Chromatography Mass Spectrometry and the description of the apparatus and the method is as follows: Method A: Spectra were recorded on a Mass Spectrometer from Waters (Acquity QDa Mass Spectrometer) equipped with an electrospray source (Polarity: Positive and Negative Polarity Switch), Capillary: 0.8 kV, Cone range: 25 V, Extractor: V (No extractor voltage for QDa detector) Source Temperature: 120°C, Desolvation Temperature: 600°C, Cone Gas Flow: 50 L/h, Desolvation Gas Flow: 1000 L/h, Mass range: 110 to 850 Da) and an Acquity UPLC from Waters: Quaternary solvent manager, heated column compartment , diode-array detector. Column: Acquity UPLC HSS T3 C18, 1.8 µm, 30 x 2.1 mm, Temp: 40 °C, DAD Wavelength range (nm): 200 to 400, Solvent Gradient: A = water + 5% Acetonitrile + 0.1 % HCOOH, B= Acetonitrile + 0.05 % HCOOH: gradient: 0 min 10% B; 0.-0.2 min 10-50% B; 0.2-0.6 min 50-100% B; 0.6-1.3 min 100% B; 1.3-1.4 min 100-10% B; 1.4-1.6 min 10% B; Flow (mL/min) 0.6. Method B: Spectra were recorded on a Mass Spectrometer from Waters Corporation (SQD, SQDII or QDA Single quadrupole mass spectrometer) equipped with an electrospray source (Polarity: positive and negative ions), Capillary: 0.8-3.00 kV, Cone: 5-30 V, Source Temperature: 120-150°C, Desolvation Temperature: 350-600°C, Cone Gas Flow: 50-150 l/h, Desolvation Gas Flow: 650-1000 l/h, Mass range: 110 to 950 Da and an Acquity UPLC from Waters Corporation: Binary pump, heated column compartment , diode- array detector and ELSD. Column: Waters UPLC HSS T3, 1.8 µm, 30 x 2.1 mm, Temp: 60 °C, DAD Wavelength range (nm): 210 to 400, Runtime: 1.5 min; Solvents: A = water + 5% MeOH + 0.05 % HCOOH, B= Acetonitrile + 0.05 % HCOOH; Flow (mL/min) 0.85, Gradient: 10% B isocratic for 0.2 min, then 10-100% B in 1.0 min, 100% B isocratic for 0.2min, 100-10% B in 0.05 min, 10% B isocratic for 0.05 min. Method C: Spectra were recorded on a Mass Spectrometer from Agilent (Single quad mass spectrometer) equipped with a Multimode- Electron Spray and APCI (Polarity: positive and negative ions), Capillary: 4.00 kV, Corona Current 4.0 µA, Charging Voltage, 2.00 kV, Nitrogen Gas Flow: 12.0 L/min, Nebulizer Pressure: 40 psig, Mass range: 100 to 1000 m/z), dry gas temperature 250 °C, Vaporizer temperature 200 °C and an UPLC from Waters: quaternary pump, heated column compartment, Variable wave length detector. Column: X-Bridge BEH C18, 2.5 µm (2.1 * 50 mm), column Temp: Ambient, Wavelength (nm): 215 nm, Gradient: A = 0.05% TFA in water, B = 0.05% TFA in Acetonitrile. Gradient: time/%B: 0/5, 1/5, 5/70, 7/95, 8.5/95, 8.6/5, 10/5; Flow rate: 0.6 mL/min. The below Table A gathers for compounds of formula (I): - LC-MS data, such as retention time (RT), [M+H]+, - the type of method, and/or - melting point (mp). Table A: Compound RT [M+H] Method mp Molecule strutcure name (min) (measured) (°C) methyl N-[5-[6-[(4- 1.07 449 A 196 - fluoro-3-methyl- 198 phenyl)-methyl- carbamoyl]-8- 1 methyl- imidazo[1,2- b]pyridazin-3-yl]- 2- pyridyl]carbamate methyl N-[5-[6-(6- 1.12 461 A 224 - fluoro-3,4-dihydro- 226 2H-quinoline-1- carbonyl)-8- 2 methyl- imidazo[1,2- b]pyridazin-3-yl]- 2- pyridyl]carbamate methyl N-[5-[6-[(4- 1.03 435 A 198 - fluorophenyl)- 200 methyl- carbamoyl]-8- 3 methyl- imidazo[1,2- b]pyridazin-3-yl]- 2- pyridyl]carbamate Compound RT [M+H] Method mp Molecule strutcure name (min) (measured) (°C) methyl N-[5-[6-[(4- 1.05 465 A 223 - fluoro-3-methoxy- 225 phenyl)-methyl- carbamoyl]-8- methyl- imidazo[1,2- b]pyridazin-3-yl]- 2- pyridyl]carbamate methyl N-[5-[6-(6- 1.02 447 A 195 - fluoro-3,4-dihydro- 197 2H-quinoline-1- carbonyl)imidazo[ 1,2-b]pyridazin-3- yl]-2- pyridyl]carbamate methyl N-[5-[6-[(4- 0.99 421 A 208 - fluorophenyl)- 210 methyl- carbamoyl]imidaz o[1,2-b]pyridazin- 3-yl]-2- pyridyl]carbamate methyl N-[5-[6-[(4- 1.02 435 A fluoro-3-methyl- phenyl)-methyl- 187 - carbamoyl]imidaz 189 o[1,2-b]pyridazin- 3-yl]-2- pyridyl]carbamate Compound RT [M+H] Method mp Molecule strutcure name (min) (measured) (°C) methyl N-[5-[6-[(4- 1.05 451 A fluoro-3-methoxy- phenyl)-methyl- 202 - 8 carbamoyl]imidaz 205 o[1,2-b]pyridazin- 3-yl]-2- pyridyl]carbamate 3-(4- 6.51 420 C acetamidophenyl)- N-(4- chlorophenyl)-N- 230 - 9 methyl- 240 imidazo[1,2- a]pyrimidine-6- carboxamide 3-(4- acetamidophenyl)- N-(4- chlorophenyl)-N- 120 - 10 methyl- 125 imidazo[1,2- b]pyridazine-6- carboxamide Example 1: Preparation of methyl N-[5-[6-[(4-fluoro-3-methyl-phenyl)-methyl-carbamoyl]-8- methyl-imidazo[1,2-b]pyridazin-3-yl]-2-pyridyl]carbamate (Compound 1)
Figure imgf000136_0001
(Compound 1) Step A: Preparation of 6-chloro-8-methyl-imidazo[1,2-b]pyridazine (Compound X-1)
Figure imgf000137_0001
(Compound X-1) To a solution of 6-chloro-4-methyl-pyridazin-3-amine (5.00 g, 34.1 mmol, 1.00 equiv.) in isopropanol (100 mL) was added bromo acetaldehyde diethyl acetal (14.7 mL, 92.2 mmol, 2.70 equiv.). The reaction mixture was stirred at refluxed for 3 hours. The reaction mixture was diluted with water and extracted with ethyl acetate. The combined organic layers were washed with brine, dried over sodium sulfate, filtered, and concentrated under reduced pressure to afford 6-chloro-8-methyl-imidazo[1,2-b]pyridazine. LC-MS (method A): Rt 0.35 min, m/z = 168/170 (M+H)+ 1H-NMR (400 MHz, CDCl3, ppm) δ = 7.81 - 7.84 (m, 1 H), 7.63 - 7.67 (m, 1 H), 6.81 - 6.84 (m, 1 H), 2.57 - 2.61 (m, 3 H) Step B: Preparation of N-(4-fluoro-3-methyl-phenyl)-N,8-dimethyl-imidazo[1,2-b]pyridazine-6- carboxamide
Figure imgf000137_0002
A mixture of 6-chloro-8-methyl-imidazo[1,2-b]pyridazine (Compound X-1, 0.700 g, 4,17 mmol, 1.00 equiv.), 4-fluoro-N,3-dimethyl-aniline (0.58 g, 4.2 mmol, 1.0 equiv.), triethylamine (0.88 mL, 16 mmol, 1.1 equiv.), bis(benzonitrile)palladium chloride (0.246 g, 0.420 mmol, 0.100 equiv.) and 4,5- bis(diphenylphosphino)-9,9-dimethylxanthene (0.168 g, 0.420 mmol, 0.100 equiv.) in toluene (10.4 mL) in a high pressure vessel, was flushed with nitrogen. The vial was pressurized with nitrogen and then with CO gas. The reaction mixture was stirred at 110 °C for 12 hours.The reaction mixture was filtered through celite and concentrated under reduce pressure. The crude residue was purified over a silica gel cartridge (cyclohexane/ethyl acetate) to afford N-(4-fluoro-3-methyl-phenyl)-N,8-dimethyl-imidazo[1,2- b]pyridazine-6-carboxamide. LC-MS (method A): Rt 1.13 min, m/z = 297 (M+H)+ 1H-NMR (400 MHz, CDCl3, ppm) δ = 7.68 (br s, 2 H), 7.04 (br s, 2 H), 6.81 - 6.91 (m, 2 H), 3.48 (s, 3 H), 2.61 (s, 3 H), 2.15 - 2.20 (m, 3 H). Step C: Preparation of 3-bromo-N-(4-fluoro-3-methyl-phenyl)-N,8-dimethyl-imidazo[1,2-b]pyridazine-6- carboxamide
Figure imgf000138_0001
A solution of N-(4-fluoro-3-methyl-phenyl)-N,8-dimethyl-imidazo[1,2-b]pyridazine-6-carboxamide (0.400 g, 1.34 mmol, 1.00 equiv.) and N-bromosuccinimide (0.268 g, 1.47 mmol, 1.10 equiv.) in acetonitrile (5.36 mL) was stirred at room temperature for 16 hours. The reaction mixture was poured into water and extracted with ethyl acetate. The combined organic layers were washed with brine, dried over sodium sulfate, filtered, and concentrated under reduced pressure. The crude residue was purified over a silica gel cartridge (cyclohexane/ethyl acetate) to afford 3-bromo-N-(4-fluoro-3-methyl-phenyl)-N,8-dimethyl- imidazo[1,2-b]pyridazine-6-carboxamide. LC-MS (method A): Rt 1.13 min, m/z = 377/379 (M+H)+ 1H-NMR (400 MHz, CDCl3, ppm) δ = 7.55 - 7.65 (m, 1 H), 7.13 - 7.27 (m, 1 H), 7.04 (br d, J = 4.75 Hz, 1 H), 6.81 - 6.85 (m, 1 H), 6.78 (br d, J = 8.88 Hz, 1 H), 3.42 (s, 3 H), 2.57 (s, 3 H), 2.14 (s, 3 H) Step D: Preparation of methyl N-[5-[6-[(4-fluoro-3-methyl-phenyl)-methyl-carbamoyl]-8-methyl- imidazo[1,2-b]pyridazin-3-yl]-2-pyridyl]carbamate (Compound 1) To a mixture of 3-bromo-N-(4-fluoro-3-methyl-phenyl)-N,8-dimethyl-imidazo[1,2-b]pyridazine-6- carboxamide (0.200 g, 0.42 mmol, 1.00 equiv.), methyl N-[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2- yl)-2-pyridyl]carbamate (0.16 g, 0.55 mmol, 1.30 equiv.) and sodium carbonate (0.13 g, 1.27 mmol, 3.00 equiv.) in acetonitrile (3.39 mL) was added chloro(2-dicyclohexylphosphino-2',4',6'-triisopropyl-1,1'- biphenyl)[2-(2'-amino-1,1'-biphenyl)]palladium(II) (0.034 g, 0.042 mmol, 0.10 equiv.). The reaction mixture was degassed with argon and then stirred in the microwave at 80 °C for 2 hours. After cooling down to room temperature, the reaction mixture was filtered through a Celite pad and washed with methanol. The filtrate was concentrated under reduced pressure. The crude residue was purified over a silica gel cartridge (cyclohexane/ethyl acetate) to afford methyl N-[5-[6-[(4-fluoro-3-methyl-phenyl)- methyl-carbamoyl]-8-methyl-imidazo[1,2-b]pyridazin-3-yl]-2-pyridyl]carbamate. LC-MS (method A): Rt 1.07 min, m/z = 449 (M+H)+ 1H-NMR (400 MHz, DMSO-d6, ppm) δ = 10.41 (s, 1 H), 8.63 (s, 1 H), 8.20 (s, 1 H), 7.94 - 7.96 (m, 2 H), 7.41 - 7.43 (m, 2 H), 6.92 - 6.97 (m, 2 H), 3.72 (s, 3 H), 3.44 (s, 3 H), 2.61 (s, 3 H), 2.12 (m, 3 H). Example 2: Preparation of methyl N-[5-[6-(6-fluoro-3,4-dihydro-2H-quinoline-1-carbonyl)-8- methyl-imidazo[1,2-b]pyridazin-3-yl]-2-pyridyl]carbamate (Compound 2)
Figure imgf000139_0001
(Compound 2) Step A: Preparation of (6-fluoro-3,4-dihydro-2H-quinolin-1-yl)-(8-methylimidazo[1,2-b]pyridazin-6- yl)methanone
Figure imgf000139_0002
A mixture of 6-chloro-8-methyl-imidazo[1,2-b]pyridazine (Compound X-1) (0.500 g, 2.98 mmol, 1.00 equiv.), 6-fluoro-1,2,3,4-tetrahydroquinoline (0.47 g, 3.1 mmol, 1.1 equiv.) triethylamine (0.624 mL, 4.47 mmol, 1.50 equiv.), bis(benzonitrile)palladium chloride (0.120 g, 0.298 mmol, 0.100 equiv.) and 4,5- bis(diphenylphosphino)-9,9-dimethylxanthene (0.176 g, 0.300 mmol, 0.100 equiv.) in toluene (7.45 mL) in a high pressure vessel, was flushed with nitrogen. The vial was pressurized with nitrogen and then with CO gas. The reaction mixture was stirred at 110 °C for 6 hours. The reaction mixture was filtered through celite and concentrated under reduce pressure. The crude residue was purified over a silica gel cartridge (cyclohexane/ethyl acetate) to afford (6-fluoro-3,4-dihydro-2H-quinolin-1-yl)-(8- methylimidazo[1,2-b]pyridazin-6-yl)methanone. LC-MS (method A): Rt 1.06 min, m/z = 311 (M+H)+ Step B: Preparation of (3-bromo-8-methyl-imidazo[1,2-b]pyridazin-6-yl)-(6-fluoro-3,4-dihydro-2H- quinolin-1-yl)methanone
Figure imgf000139_0003
A solution of (6-fluoro-3,4-dihydro-2H-quinolin-1-yl)-(8-methylimidazo[1,2-b]pyridazin-6-yl)methanone (0.450 g, 1.23 mmol) and N-bromosuccinimide (0.246 g, 1.36 mmol, 1.10 equiv.) in acetonitrile (4.93 mL) was stirred at room temperature for 1 hour. The reaction mixture was poured into water and extracted with ethyl acetate. The combined organic layers were washed with brine, dried over sodium sulfate, filtered, and concentrated under reduced pressure. The crude residue was purified over a silica gel cartridge (cyclohexane/ethyl acetate) to afford (3-bromo-8-methyl-imidazo[1,2-b]pyridazin-6-yl)-(6- fluoro-3,4-dihydro-2H-quinolin-1-yl)methanone. LC-MS (method A): Rt 1.18 min, m/z = 389 (M+H)+ C: Preparation of methyl N-[5-[6-(6-fluoro-3,4-dihydro-2H-quinoline-1-carbonyl)-8-methyl- imidazo[1,2-b]pyridazin-3-yl]-2-pyridyl]carbamate (Compound 2) To a mixture of (3-bromo-8-methyl-imidazo[1,2-b]pyridazin-6-yl)-(6-fluoro-3,4-dihydro-2H-quinolin-1- yl)methanone (0.118 g, 0.300 mmol, 1.00 equiv.), methyl N-[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan- 2-yl)-2-pyridyl]carbamate (0.116 g, 0.390 mmol, 1.30 equiv.) and sodium carbonate (0.096 g, 0.91 mmol, 3.00 equiv.) in acetonitrile (2.42 mL) was added chloro(2-dicyclohexylphosphino-2',4',6'-triisopropyl-1,1'- biphenyl)[2-(2'-amino-1,1'-biphenyl)]palladium(II) (0.024 g, 0.03 mmol, 0.10 equiv.). The reaction mixture was degassed with argon and then stirred in the microwave at 80 °C for 2.5 hours. After cooling down to room temperature, the reaction mixture was filtered through a Celite pad and concentrated under reduced pressure. The crude residue was purified over a silica gel cartridge (cyclohexane/ethyl acetate) to afford methyl N-[5-[6-(6-fluoro-3,4-dihydro-2H-quinoline-1-carbonyl)-8-methyl-imidazo[1,2- b]pyridazin-3-yl]-2-pyridyl]carbamate as a yellow solid. LC-MS (method A): Rt 1.12 min, m/z = 461 (M+H)+ 1H-NMR (400 MHz, DMSO-d6, ppm) δ = 10.38 (s, 1 H), 8.60 - 8.70 (m, 1 H), 8.26 (s, 1 H), 7.85 (br d, J = 8.44 Hz, 2 H), 7.44 - 7.46 (m, 1 H), 7.11 - 7.17 (m, 2 H), 6.74 - 6.87 (m, 1 H), 3.86 (br t, J = 6.24 Hz, 2 H), 3.71 (s, 3 H), 2.87 (t, J = 6.54 Hz, 2 H), 2.66 (s, 3 H), 1.95 - 2.05 (m, 2 H). -8-
Figure imgf000140_0001
Step A: Preparation of N-(4-fluoro-3-methoxy-phenyl)-N,8-dimethyl-imidazo[1,2-b]pyridazine-6- carboxamide
Figure imgf000141_0001
A mixture of 6-chloro-8-methyl-imidazo[1,2-b]pyridazine (Compound X-1, 0.500 g, 2,98 mmol, 1.00 equiv.), 4-fluoro-3-methoxy-N-methyl-aniline (0.486 g, 3.13 mmol, 1.05 equiv.) triethylamine (0.627 mL, 4.47 mmol, 1.50 equiv.), bis(benzonitrile)palladium chloride (0.120 g, 0.30 mmol, 0.10 equiv.) and 4,5- bis(diphenylphosphino)-9,9-dimethylxanthene (0.176 g, 0.30 mmol, 0.10 equiv.) in toluene (7.45 mL) in a high pressure vessel, was flushed with nitrogen. The vial was pressurized with nitrogen and then with CO gas. The reaction mixture was stirred at 110 °C for 6 hours. The reaction mixture was filtered through celite and concentrated under reduce pressure. The crude residue was purified over a silica gel cartridge (cyclohexane/ethyl acetate) to afford N-(4-fluoro-3-methoxy-phenyl)-N,8-dimethyl-imidazo[1,2- b]pyridazine-6-carboxamide. LC-MS (method A): Rt 0.96 min, m/z = 315 (M+H)+ 1H-NMR (400 MHz, CDCl3, ppm) δ = 7.68 (br s, 2 H), 7.01 (br s, 1 H), 6.85 - 6.94 (m, 1 H), 6.75 - 6.84 (m, 1 H), 6.64 (br s, 1 H), 3.78 (br s, 3 H), 3.50 (s, 3 H), 2.60 (br s, 3 H). Step B: Preparation of 3-bromo-N-(4-fluoro-3-methoxy-phenyl)-N,8-dimethyl-imidazo[1,2-b]pyridazine- 6-carboxamide
Figure imgf000141_0002
A solution of N-(4-fluoro-3-methoxy-phenyl)-N,8-dimethyl-imidazo[1,2-b]pyridazine-6-carboxamide (0.662 g, 2.11 mmol, 1.00 equiv.) and N-bromosuccinimide (0.412 g, 2.32 mmol, 1.10 equiv.) in acetonitrile (8.42 mL) was stirred at room temperature for 1 hour. The reaction mixture was poured into water and extracted with ethyl acetate. The combined organic layers were washed with brine, dried over sodium sulfate, filtered, and concentrated under reduced pressure to afford 3-bromo-N-(4-fluoro-3- methoxy-phenyl)-N,8-dimethyl-imidazo[1,2-b]pyridazine-6-carboxamide. LC-MS (method A): Rt 1.08 min, m/z = 393/395 (M+H)+ Step C: Preparation of methyl N-[5-[6-[(4-fluoro-3-methoxy-phenyl)-methyl-carbamoyl]-8-methyl- imidazo[1,2-b]pyridazin-3-yl]-2-pyridyl]carbamate (Compound 4) To a mixture of 3-bromo-N-(4-fluoro-3-methoxy-phenyl)-N,8-dimethyl-imidazo[1,2-b]pyridazine-6- carboxamide (0.62 g, 1.6 mmol, 1.00 equiv.), methyl N-[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)- 2-pyridyl]carbamate (0.606 g, 2.05 mmol, 1.30 equiv.) and sodium carbonate (0.501 g, 4.73 mmol, 3.00 equiv.) in acetonitrile (12.6 mL) was added chloro(2-dicyclohexylphosphino-2',4',6'-triisopropyl-1,1'- biphenyl)[2-(2'-amino-1,1'-biphenyl)]palladium(II) (0.13 g, 0.15 mmol, 0.10 equiv.). The reaction mixture was degassed with argon and then stirred in the microwave at 80 °C for 2.5 hours. After cooling down to room temperature, the reaction mixture was filtered through a Celite pad and washed with methanol. The filtrate was washed with water, then brine, dried over sodium sulfate, filtered, and concentrated under reduced pressure. The crude residue was purified over a silica gel cartridge (cyclohexane/ethyl acetate) to afford methyl N-[5-[6-[(4-fluoro-3-methoxy-phenyl)-methyl-carbamoyl]-8-methyl-imidazo[1,2- b]pyridazin-3-yl]-2-pyridyl]carbamate as a yellow solid. LC-MS (method A): Rt 1.05 min, m/z = 465 (M+H)+ 1H-NMR (400 MHz, DMSO-d6, ppm) δ = 10.39 (s, 1 H), 8.71-8.60 (s, 1 H), 8.21 (s, 1 H), 7.94 (br s, 2 H), 7.42 (s, 1 H) 7.32 (br d, J = 7.20 Hz, 1 H), 6.95-7.05 (m, 1 H), 6.75-6.60 (m, 1 H), 3.68 - 3.80 (m, 6 H), 3.48 (s, 3 H), 2.54 - 2.68 (m, 3 H). Example 4: Preparation of methyl N-[5-[6-[(4-fluoro-3-methyl-phenyl)-methyl- carbamoyl]imidazo[1,2-b]pyridazin-3-yl]-2-pyridyl]carbamate (Compound 7)
Figure imgf000142_0001
(Compound 7) To a mixture of 3-bromo-N-(4-fluoro-3-methyl-phenyl)-N-methyl-imidazo[1,2-b]pyridazine-6- carboxamide (0.400 g, 1.10 mmol, 1.00 equiv.), 2-methoxycarbonylaminopyridine-5-boronic acid pinacol ester (0.419 g, 1.43 mmol, 1.30 equiv.) and sodium carbonate (0.350 g, 3.30 mmol, 3.00 equiv.) in acetonitrile (8.81 mL) was added chloro(2-dicyclohexylphosphino-2',4',6'-triisopropyl-1,1'-biphenyl)[2- (2'-amino-1,1'-biphenyl)]palladium(II) (0.089 g, 0.11 mmol, 0.10 equiv.). The reaction mixture was degassed with argon and then stirred in the microwave at 100 °C for 2 hours. After cooling down to room temperature, the reaction mixture was filtered through a Celite pad and washed with methanol. The filtrate was concentrated under reduced pressure. The crude residue was purified over a silica gel cartridge (ethyl acetate/ methanol) to afford methyl N-[5-[6-[(4-fluoro-3-methyl-phenyl)-methyl- carbamoyl]imidazo[1,2-b]pyridazin-3-yl]-2-pyridyl]carbamate as a yellow solid. LC-MS (method A): Rt 1.02 min, m/z = 435 (M+H)+ 1H-NMR (400 MHz, DMSO-d6, ppm) δ = 2.11 (br s, 3 H), 3.34 (s, 3 H), 3.72 (s, 3 H), 6.80-7.02 (m, 2 H), 7.49 (d, J = 9.38 Hz, 1 H), 7.50 (d, 1 H), 7.96 (br s, 2 H), 8.27 (br s, 2 H), 8.66 (s, 1 H), 10.41 (s, 1 H) Example 5: Preparation of methyl N-[5-[6-[(4-fluoro-3-methoxy-phenyl)-methyl- carbamoyl]imidazo[1,2-b]pyridazin-3-yl]-2-pyridyl]carbamate (Compound 8)
Figure imgf000143_0001
(Compound 8) Step A: Preparation of methyl 3-bromoimidazo[1,2-b]pyridazine-6-carboxylate
Figure imgf000143_0002
A solution of methyl imidazo[1,2-b]pyridazine-6-carboxylate (0.500 g, 2.76 mmol, 1.00 equiv.) and N- bromosuccinimide (0.547 g, 3.04 mmol, 1.10 equiv.) in acetonitrile (7 mL) was stirred at room temperature for 1 hour. The reaction mixture was poured into water and extracted with ethyl acetate. The combined organic layers were washed with brine, dried over sodium sulfate, filtered, and concentrated under reduced pressure to afford methyl 3-bromoimidazo[1,2-b]pyridazine-6-carboxylate. LC-MS (method A): Rt 0.96 min, m/z = 256/258 (M+H)+ 1H-NMR (400 MHz, CDCl3, ppm) δ = 4.08 (s, 3 H), 7.83 (d, J = 9.41 Hz, 1 H), 7.93 (s, 1 H), 8.06 (d, J = 9.41 Hz, 1 H) Step B: Preparation of 3-bromoimidazo[1,2-b]pyridazine-6-carboxylic acid
Figure imgf000143_0003
To a solution of methyl 3-bromoimidazo[1,2-b]pyridazine-6-carboxylate (0.700 g, 2.00 mmol, 1.00 equiv.) in water (4 mL) and methanol (10 mL) was added lithium hydroxide (0.100 g, 3.00 mmol, 1.10 equiv.). The reaction mixture was stirred at room temperature for 16 hours. The reaction mixture was concentrated under reduce pressure and adjusted to pH 4 with citric acid. The obtained solid was filtered off and dried under reduce pressure to 3-bromoimidazo[1,2-b]pyridazine-6-carboxylic acid. LC-MS (method B): Rt 0.27 min, m/z = 242/244 (M+H)+ 1H-NMR (400 MHz, DMSO-d6, ppm) δ = 7.78 (d, J = 9.51 Hz, 1 H), 8.07 (br s, 1 H), 8.30 (d, J = 9.51 Hz, 1 H), 13.98 -14.27 (m, 1 H) Step C: Preparation of 3-bromo-N-(4-fluoro-3-methoxy-phenyl)-N-methyl-imidazo[1,2-b]pyridazine-6- carboxamide
Figure imgf000144_0001
To a solution of 3-bromoimidazo[1,2-b]pyridazine-6-carboxylic acid (0.540 g, 2.12 mmol, 1.00 equiv.), 4-fluoro-3-methoxy-N-methyl-aniline (0.450 g, 2.75 mmol, 1.30 equiv.) and N-ethyl-N-isopropyl-propan- 2-amine (1.146 mL, 3.00 mmol, 6.36 equiv.) in acetonitrile (10.6 mL) was added 1-propanephosphonic anhydride 50% in ethyl acetate (1.33 mL, 4.24 mmol, 2.00 equiv.). The reaction mixture was stirred at room temperature for 16 hours. The reaction mixture was diluted with ethyl acetate and quenched with water. The combined organic layers were dried over sodium sulfate, filtered, and concentrated under reduced pressure. The crude residue was purified over silica gel cartridge (cyclohexane / ethyl acetate) to afford 3-bromo-N-(4-fluoro-3-methoxy-phenyl)-N-methyl-imidazo[1,2-b]pyridazine-6-carboxamide as a light yellow solid. LC-MS (method B): Rt 1.06 min, m/z = 379/381 (M+H)+ 1H-NMR (400 MHz, CDCl3, ppm) δ = 8.16 (br d, J = 9.51 Hz, 1 H), 7.92 (s, 1 H), 7.45 (br d, J = 9.26 Hz, 1 H), 7.27 (br d, J = 6.88 Hz, 1 H), 7.04 (br t, J = 10.07 Hz, 1 H), 6.71 - 6.83 (m, 1 H), 3.74 (s, 3 H), 3.44 (s, 3 H) Step D: Preparation of methyl N-[5-[6-[(4-fluoro-3-methoxy-phenyl)-methyl-carbamoyl]imidazo[1,2- b]pyridazin-3-yl]-2-pyridyl]carbamate (Compound 8) To a mixture of 3-bromo-N-(4-fluoro-3-methoxy-phenyl)-N-methyl-imidazo[1,2-b]pyridazine-6- carboxamide (0.200 g, 0.527 mmol, 1.00 equiv.), methyl N-[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan- 2-yl)-2-pyridyl]carbamate (0.220 g, 0.791 mmol, 1.500 equiv.) and sodium carbonate (0.167 g, 1.58 mmol, 3.00 equiv.) in acetonitrile (4.22 mL) and water (2.11 mL) was added chloro(2- dicyclohexylphosphino-2',4',6'-triisopropyl-1,1'-biphenyl)[2-(2'-amino-1,1'-biphenyl)]palladium(II) (0.043 g, 0.052 mmol, 0.10 equiv.). The reaction mixture was degassed with argon and then stirred in the microwave at 100 °C for 1 hour. After cooling down to room temperature, the reaction mixture was filtered through a Celite pad and washed with methanol. The filtrate was concentrated under reduced pressure. The crude residue was purified over a silica gel cartridge (ethyl acetate/ methanol) to afford methyl N-[5-[6-[(4-fluoro-3-methoxy-phenyl)-methyl-carbamoyl]imidazo[1,2-b]pyridazin-3-yl]-2- pyridyl]carbamateas a yellow solid. LC-MS (method A): Rt 1.06 min, m/z = 451 (M+H)+ 1H-NMR (400 MHz, DMSO-d6, ppm) δ = 3.45 - 3.52 (m, 3 H), 3.74 (br s, 6 H), 6.76 (br s, 1 H), 6.88 - 7.14 (m, 1 H), 7.33 (br d, J = 6.24 Hz, 1 H), 7.51 (br d, J = 9.05 Hz, 1 H), 7.87 - 8.07 (m, 2 H), 8.18 - 8.35 (m, 2 H), 8.70 (br s, 1 H), 10.31 - 10.52 (m, 1 H). 19F NMR (377 MHz, DMSO-d6, ppm) δ = -136.91 (s, 1 F) Example 6: Preparation of 3-(4-acetamidophenyl)-N-(4-chlorophenyl)-N-methyl-imidazo[1,2- Step A: Preparation of ethyl imidazo[1,2-a]pyrimidine-6-carboxylate To a solution of ethyl 2-aminopyrimidine-5-carboxylate (2.00 g, 12.0 mmol) in ethanol (15.0 mL) under argon was added 2-chloroacetaldehyde (4.70 g, 59.8 mmol, 5.00 equiv.). The mixture was stirred at 80 °C for 16 hours. The reaction mixture was concentrated under reduce pressure then diluted with aqueous sodium bicarbonate solution, then extracted with 10% methanol in dichloromethane. The organic layer was washed with water, then brine, dried over sodium sulfate, filtered, and concentrated under reduced pressure. The crude residue was purified over a silica gel cartridge (dichloromethane/ methanol) to afford ethyl imidazo[1,2-a]pyrimidine-6-carboxylate as an off-white solid. 1H-NMR (400 MHz, DMSO-d6, ppm) δ = 1.35 (d, 3 H), 4.39 (q, 2 H), 7.83 (s, 1 H), 8.05 (s, 1 H), 8.90 (s, 1 H), 9.68 (s, 1 H). Step B: Preparation of ethyl 3-bromoimidazo[1,2-a]pyrimidine-6-carboxylate
Figure imgf000145_0001
To stirred solution of ethyl imidazo[1,2-a]pyrimidine-6-carboxylate (20.0 mg, 0.105 mmol) in dichloromethane (2 mL) was added N-bromosuccinimide (27.9 mg, 0.157 mmol, 1.5 equiv.) at room temperature. The resulting reaction mixture was stirred at room temperature for 3 hours. The reaction mixture was concentrated under reduce pressure then purified over a silica gel cartridge (hexane/ethyl acetate) to afford ethyl 3-bromoimidazo[1,2-a]pyrimidine-6-carboxylate as an off-white solid. 1H-NMR (400 MHz, DMSO-d6, ppm) δ = 1.37 (d, 3 H), 4.41 (q, 2 H), 8.05 (s, 1 H), 8.95 (d, 1 H),9.05 (d, 1 H). Step C: Preparation of ethyl 3-(4-acetamidophenyl)imidazo[1,2-a]pyrimidine-6-carboxylate
Figure imgf000146_0001
To a stirred solution of ethyl 3-bromoimidazo[1,2-a]pyrimidine-6-carboxylate (300 mg, 1.09 mmol) in toluene (2.0 mL) and ethanol (1.0 mL) were added (4-acetamidophenyl)boronic acid (390 mg, 2.18 mmol, 2 equiv.), tris(o-tolyl)phosphine (36.4 mg, 0.120 mmol, 0.11 equiv.) and a solution of potassium fluoride (158 mg, 2.72 mmol, 2.50 equiv.) in water (0.50 mL) at room temperature. The mixture was degassed with argon for 2 minutes. Then tris(dibenzylideneacetone)dipalladium(0) (62.6 mg, 0.109 mmol, 0.10 equiv.) was added. The mixture was degassed with argon for another 1 minute and irradiated in microwave at 100 °C for 20 minutes. The reaction mixture was cooled down to room temperature and filtered through a pad of Celite. The filtrate was diluted with ethyl acetate and washed with water. The combined organic layers were dried over sodium sulfate, filtered, and concentrated under reduced pressure. The crude micture was purified over a silica gel cartridge (hexane/ethyl acetate) to afford ethyl 3-(4-acetamidophenyl)imidazo[1,2-a]pyrimidine-6-carboxylate as a pale yellow solid. 1H-NMR (400 MHz, DMSO-d6, ppm) δ = 1.35 (t, 3 H), 2.07 (s, 3 H), 4.39 (q, 2 H), 7.70 (m, 2 H), 7.92 (m, 2 H), 8.38 (s, 1 H), 8.87 (s, 1 H), 9.58 (m, 1 H), 10.1 (s, 1 H) Step D: Preparation of 3-(4-acetamidophenyl)imidazo[1,2-a]pyrimidine-6-carboxylic acid
Figure imgf000146_0002
Lithium hydroxide hydrate (13.6 mg, 0.323 mmol, 3 equiv.) was added to a stirred solution of ethyl 3-(4- acetamidophenyl)imidazo[1,2-a]pyrimidine-6-carboxylate (40.0 mg, 0.108 mmol) in tetrahydrofuran (1.0 mL) and water (1.0 mL). The mixture was stirred at room temperature for 3 hours. The reaction mixture was concentrated under reduce pressure and then diluted with ethyl acetate and water. The aqueous layer was acidified with 2 N HCl solution. The aqueous layer was extracted with dichloromethane. The organic layer was dried over sodium sulfate, filtered and concentrated under reduced pressure to afford 3-(4-acetamidophenyl)imidazo[1,2-a]pyrimidine-6-carboxylic acid as a pale yellow solid. 1H-NMR (400 MHz, DMSO-d6, ppm) δ = 2.03 (s, 3 H), 7.10-7.30 (m, 1 H), 7.60-7.70 (m, 2 H), 7.85-7.95 (m, 2 H), 8.27 (s, 1 H), 8.88 (s, 1 H), 9.12 (s, 1 H) Step E: Preparation of 3-(4-acetamidophenyl)-N-(4-chlorophenyl)-N-methyl-imidazo[1,2-a]pyrimidine-6- carboxamide (Compound 9) To a stirred solution of 3-(4-acetamidophenyl)imidazo[1,2-a]pyrimidine-6-carboxylic acid (30.0 mg, 0.0810 mmol) in N,N-dimethylformamide (4.00 mL) were added 4-chloro-N-methyl-aniline (11.5 mg, 0.0810 mmol, 1.00 equiv.) and [dimethylamino(triazolo[4,5-b]pyridin-3-yloxy)methylene]-dimethyl- ammonium hexafluorophosphate (46.2 mg, 0.122 mmol, 1.50 equiv.) followed by N,N- diisopropylethylamine (0.0282 mL, 0.162 mmol, 2.00 equiv.) at room temperature. The mixture was stirred at room temperature for 16 hours. The reaction mixture was concentrated under reduce pressure then purified over a reverse phase combiflash chromatography (water/acetonitrile) to afford 3-(4- acetamidophenyl)-N-(4-chlorophenyl)-N-methyl-imidazo[1,2-a]pyrimidine-6-carboxamide as a yellow solid. LC-MS (method C): Rt 6.51 min, m/z = 420 (M+H)+ 1H-NMR (400 MHz, DMSO-d6, ppm) δ = 2.05 (s, 3 H), 3.42 (s, 3 H), 7.33-7.42 (m, 4 H), 7.65-7.70 (m, 2 H), 7.85-7.92 (m, 2 H), 8.18 (m, 1 H), 8.29 (s, 1 H), 8.88 (s, 1 H), 9.12 (m, 1 H) Example 7: Preparation of 3-(4-acetamidophenyl)-N-(4-chlorophenyl)-N-methyl-imidazo[1,2- b]pyridazine-6-carboxamide (Compound 10)
Figure imgf000147_0001
(Compound 10) Step A: Preparation of ethyl imidazo[1,2-b]pyridazine-6-carboxylate
Figure imgf000147_0002
To a solution of ethyl 6-aminopyridazine-3-carboxylate (CAS 98548-01-7, 1.20 g, 7.18 mmol) in ethanol (20.0 mL) was added chloroacetaldehyde 50.0 % in water (7.50 mL, 35.9 mmol, 5.00 equiv.). The reaction mixture was stirred at 80 °C for 16 hours. The reaction mixture was concentrated under reduce pressure and the crude residue was purified was purified over a silica gel cartridge (dichloromethane/ methanol) to afford ethyl imidazo[1,2-b]pyridazine-6-carboxylate as an off white solid. 1H-NMR (400 MHz, CDCl3, ppm) δ = 1.48 (t, 3 H), 4.54 (q, 2 H), 7.79 (d, 1 H), 7.92 (s, 1 H), 8.08 (d, 1 H), 8.16 (s, 1 H) Step B: Preparation of ethyl 3-bromoimidazo[1,2-b]pyridazine-6-carboxylate
Figure imgf000148_0001
To an ice-cooled solution of ethyl imidazo[1,2-b]pyridazine-6-carboxylate (0.300 g, 1.57 mmol) in dimethylformamide (5.00 mL) was added N-bromosuccinimide (0.307 g, 1.73 mmol, 1.10 equiv.). The reaction mixture was stirred at 0 °C for 30 minutes. The reaction mixture was poured into water and extracted with ethyl acetate. The combined organic layers were washed with brine, dried over sodium sulfate, filtered, and concentrated under reduced pressure. The crude residue was purified over a silica gel cartridge (dichloromethane/methanol) to afford ethyl 3-bromoimidazo[1,2-b]pyridazine-6-carboxylate as an off white solid. 1H-NMR (400 MHz, CDCl3, ppm) δ = 1.49 (t, 3 H), 4.54 (q, 2 H), 7.80 (d, 1 H), 7.91 (s, 1 H), 8.07 (d, 1 H) Step C: Preparation of ethyl 3-(4-acetamidophenyl)imidazo[1,2-b]pyridazine-6-carboxylate
Figure imgf000148_0002
To a solution of ethyl 3-bromoimidazo[1,2-b]pyridazine-6-carboxylate (0.210 g, 0.778 mmol) in toluene (6.00 mL) and ethanol (4.00 mL) were added 4-acetamidophenylboronic acid (0.278 g, 1.56 mmol, 2.00 equiv.), tris(o-tolyl)phosphine (0.047 mg, 0.16 mmol, 0.20 equiv.), potassium fluoride (2.0 M in water, 2.5 mL, 1.94 mmol, 2.50 equiv.) and tris(dibenzylideneacetone)dipalladium(0) (71.2 mg, 0.0778 mmol, 0.10 equiv.). The reaction mixture was stirred in the microwave at 110 °C for 15 minutes. The reaction mixture was filtered through a Celite pad and washed with methanol. The filtrate was washed with water, then brine, dried over sodium sulfate, filtered, and concentrated under reduced pressure. The crude residue was purified over a reverse phase combiflash chromatography (10 to 100% acetonitrile in water) to afford ethyl 3-(4-acetamidophenyl)imidazo[1,2-b]pyridazine-6-carboxylate as a light yellow color solid. 1H-NMR (400 MHz, CDCl3, ppm) δ = 1.48 (t, 3 H), 2.11 (s, 3 H), 4.52 (q, 2 H), 7.70 (d, 2 H), 7.78 (d, 1 H), 8.09 (d, 1 H), 8.15-8.21 (m, 3 H) Step D: Preparation of 3-(4-acetamidophenyl)imidazo[1,2-b]pyridazine-6-carboxylic acid
Figure imgf000149_0001
To a solution of ethyl 3-(4-acetamidophenyl)imidazo[1,2-b]pyridazine-6-carboxylate (0.02 g, 0.0617 mmol, 1.00 equiv.) in tetrahydrofuran (0.50 mL), water (0.50 mL) and methanol (0.20 mL) was added lithium hydroxide hydrate (0.0077 g, 0.19 mmol, 3.0 equiv.). The reaction mixture was stirred at room temperature for 3 hours. The reaction mixture was concentrated under reduced pressure, dissolved in water and the pH was adjusted to pH 2 by using 1.0 N hydrogen chloride solution. The formed precipitate was washed with cold water and dried under reduce pressure to afford 3-(4- acetamidophenyl)imidazo[1,2-b]pyridazine-6-carboxylic acid as an off white solid. 1H-NMR (400 MHz, DMSO-d6, ppm) δ = 2.09 (s, 3 H), 7.71 - 7.78 (m, 3 H), 8.18 (s, 2 H), 8.31 (d, 1 H), 8.41 (s, 1 H) Step E: Preparation of 3-(4-acetamidophenyl)-N-(4-chlorophenyl)-N-methyl-imidazo[1,2-b]pyridazine-6- carboxamide (Compound 10) To a solution of 3-(4-acetamidophenyl)imidazo[1,2-b]pyridazine-6-carboxylic acid (0.030 g, 0.10 mmol), 4-chloro-N-methyl-aniline (0.0143 g, 0.101 mmol, 1.00 equiv.) and triethylamine (0.030 g, 0.304 mmol, 3.00 equiv.) in dichloromethane (3.00 mL) was added 1-propanephosphonic acid cyclic anhydride (50% in ethyl acetate, 0.193 g, 0.304 mmol, 3.00 equiv.). The reaction mixture was stirred at room temperature for 16 hours. The reaction mixture was diluted with water and extracted with dichloromethane. The combined organic layers were dried over sodium sulfate, filtered, and concentrated under reduced pressure. The crude residue was purified over a reverse phase combiflash chromatography (10 to 100% acetonitrile in water) to afford 3-(4-acetamidophenyl)-N-(4-chlorophenyl)-N-methyl-1,8a- dihydroimidazo[1,2-b]pyridazine-6-carboxamide as a light yellow solid. 1H-NMR (400 MHz, CDCl3, ppm) δ = 2.25 (s, 3 H), 3.52 (s, 3 H), 7.01 - 7.08 (m, 2 H), 7.15 – 7.20 (m, 2 H), 7.22 - 7.33 (m, 2 H), 7.40 - 7.49 (m, 2 H), 7.55 – 7.61 (m, 2 H), 8.00 (d, 2 H) Biological examples: The fungicidal activity of the compounds of the invention have been tested as follows: Phytophthora infestans / tomato / leaf disc preventative (late blight) Tomato leaf disks are placed on water agar in multiwell plates (24-well format) and sprayed with the formulated test compound diluted in water. The leaf disks are inoculated with a spore suspension of the fungus 1 day after application. The inoculated leaf disks are incubated at 16 °C and 75% rh under a light regime of 24 h darkness followed by 12 h light / 12 h darkness in a climate cabinet and the activity of a compound is assessed as percent disease control compared to untreated when an appropriate level of disease damage appears in untreated check leaf disks (5 - 7 days after application). The following compounds gave at least 80% control of Phytophthora infestans at 200 ppm when compared to untreated control under the same conditions, which showed extensive disease development: 2, 3, 4, 8 Plasmopara viticola / grape / leaf disc preventative (late blight) Grape vine leaf disks are placed on water agar in multiwell plates (24-well format) and sprayed with the formulated test compound diluted in water. The leaf disks are inoculated with a spore suspension of the fungus 1 day after application. The inoculated leaf disks are incubated at 19 °C and 80% rh under a light regime of 12 h light / 12 h darkness in a climate cabinet and the activity of a compound is assessed as percent disease control compared to untreated when an appropriate level of disease damage appears in untreated check leaf disks (6 - 8 days after application). The following compounds gave at least 80% control of Plasmopara viticola at 200 ppm when compared to untreated control under the same conditions, which showed extensive disease development: 1, 3, 4, 8 Pythium ultimum / liquid culture (seedling damping off) Mycelia fragments and oospores of a newly grown liquid culture of the fungus are directly mixed into nutrient broth (PDB potato dextrose broth). After placing a (DMSO) solution of test compound into a microtiter plate (96-well format), the nutrient broth containing the fungal mycelia/spore mixture is added. The test plates are incubated at 24 °C and the inhibition of growth is determined photometrically 2-3 days after application. The following compounds gave at least 80% control of Pythium ultimum at 20 ppm when compared to untreated control under the same conditions, which showed extensive disease development: 4, 8

Claims

Claims 1. A compound of formula (I)
Figure imgf000151_0001
wherein Z is O or S, and preferably Z is O; each A1 is N, or one A1 is N and one A1 is CR1; and preferably one A1 is N and one A1 is CR1; R1 are independently selected from hydrogen, hydroxy, halogen, CN, C1-6alkyl, C3-6cycloalkyl, C1- 6alkoxy-C1-6alkyl, C3-6cycloalkyl-C1-4alkyl, C1-6alkylsulfanyl, C1-6alkylsulfinyl, C1-6alkylsulfonyl, C1-6alkoxy, amino, and -NHC(O)C1-6alkyl; A2 are independently CR2 or N, with the proviso that no more than three A2 are N, preferably no more than two A2 are N, preferably no more than one A2 is N, and more preferably the four A2 are CR2; R2 are independently selected from hydrogen, hydroxy, halogen, CN, C1-6alkyl, C1-6alkoxy, C1-6alkoxy- C1-6alkyl, C1-6alkoxy-C1-6alkoxy, C2-6alkenyl, C2-6alkynyl, C3-6cycloalkyl, C3-6cycloalkyl-C1-6alkyl, C1- 6alkylsulfanyl, C1-6alkylsulfinyl, C1-6alkylsulfonyl, C1-6alkoxycarbonyl, C1-6alkylaminocarbonyl, diC1- 6alkylaminocarbonyl, and C1-6alkylcarbonyl, wherein each of the C1-6alkyl, C1-6alkoxy, C1-6alkoxy-C1- 6alkyl, C1-6alkoxy-C1-6alkoxy, C2-6alkenyl, C2-6alkynyl, C3-6cycloalkyl, C3-6cycloalkyl-C1-6alkyl, C1- 6alkylsulfanyl, C1-6alkylsulfinyl, C1-6alkylsulfonyl, C1-6alkoxycarbonyl, C1-6alkylaminocarbonyl, diC1- 6alkylaminocarbonyl, and C1-6alkylcarbonyl groups is optionally substituted with one to three substituents independently selected from halogen, hydroxy, and CN; A3 is CR3 or N; R3 is selected from hydrogen, hydroxy, halogen, CN, C1-6alkyl, C1-6alkoxy, C1-6alkoxy-C1-6alkyl, C1- 6alkoxy-C1-6alkoxy, C2-6alkenyl, C2-6alkynyl, C3-6cycloalkyl, C3-6cycloalkyl-C1-6alkyl, C1-6alkylsulfanyl, C1- 6alkylsulfinyl, C1-6alkylsulfonyl, amino, C1-6alkylamino, diC1-6-alkylamino, and C3-6cycloalkylamino, wherein each of the C1-6alkyl, C1-6alkoxy, C1-6alkoxy-C1-6alkyl, C1-6alkoxy-C1-6alkoxy, C2-6alkenyl, C2- 6alkynyl, C3-6cycloalkyl, C3-6cycloalkyl-C1-6alkyl, C1-6alkylsulfanyl, C1-6alkylsulfinyl, C1-6alkylsulfonyl, amino, C1-6alkylamino, diC1-6-alkylamino, and C3-6cycloalkylamino groups is optionally substituted with one to three substituents independently selected from halogen, hydroxy, and CN; A4 is CH or N; R4 is selected from C1-6alkyl, C1-6alkoxy-C1-6alkyl, C3-6cycloalkyl, C3-6cycloalkyl-C1-4alkyl, C2-6alkenyl, C2- 6alkynyl, C1-6alkoxy, C1-6alkylsulfanyl-C1-6alkyl, C1-6alkylsulfinyl-C1-6alkyl, C1-6alkylsulfonyl-C1-6alkyl, C1- 6alkoxycarbonyl-C1-6alkyl, C1-6alkylaminocarbonyl-C1-6alkyl, diC1-6alkylaminocarbonyl-C1-6alkyl, and CN, wherein each of the C1-6alkyl, C1-6alkoxy-C1-6alkyl, C3-6cycloalkyl, C3-6cycloalkyl-C1-4alkyl, C2-6alkenyl, C2- 6alkynyl, C1-6alkoxy, C1-6alkylsulfanyl-C1-6alkyl, C1-6alkylsulfinyl-C1-6alkyl, C1-6alkylsulfonyl-C1-6alkyl, C1- 6alkoxycarbonyl-C1-6alkyl, C1-6alkylaminocarbonyl-C1-6alkyl and diC1-6alkylaminocarbonyl-C1-6alkyl groups is optionally substituted with one to three substituents independently selected from halogen and CN; wherein A3 and R4 taken together optionally form a ring, preferably a 5-8-membered heterocycle, and more preferably a 6-membered heterocycle; and R5 is selected from C1-6alkyl, C1-6alkoxy, C3-6cycloalkyl, C3-6cycloalkyl-C1-6alkyl, C1-6alkoxyC1-6alkyl, C1- 6alkylamino, diC1-6alkylamino, C1-6alkoxyamino, and C1-6alkylC1-6alkoxyamino, wherein each of the C1- 6alkyl, C1-6alkoxy, C3-6cycloalkyl, C3-6cycloalkyl-C1-6alkyl, C1-6alkoxyC1-6alkyl, C1-6alkylamino, diC1- 6alkylamino, C1-6alkoxyamino, and C1-6alkylC1-6alkoxyamino groups is optionally substituted with one to three substituents independently selected from halogen and CN; or a salt or N-oxide thereof. 2. The compound according to claim 1, wherein R1 are independently selected from hydrogen, C1-6alkyl, C3-6cycloalkyl, C1-6alkoxy-C1-6alkyl, C3-6cycloalkyl-C1-4alkyl, and C1-6alkoxy, and more preferably R1 are independently selected from hydrogen and C1-6alkyl. 3. The compound according to claim 1 or 2, wherein R1 are independently selected from hydrogen and C1-6alkyl. 4. The compound according to any one of the preceding claims, wherein R2 are independently selected from hydrogen, hydroxy, halogen, CN, C1-6alkyl, C1-6alkoxy, C1-6alkoxy-C1-6alkyl, and C1-6alkoxy-C1- 6alkoxy, C1-6alkoxycarbonyl, C1-6alkylaminocarbonyl, diC1-6alkylaminocarbonyl, and C1-6alkylcarbonyl, wherein each of the C1-6alkyl, C1-6alkoxy, C1-6alkoxy-C1-6alkyl, C1-6alkoxy-C1-6alkoxy, C1-6alkoxycarbonyl, C1-6alkylaminocarbonyl, diC1-6alkylaminocarbonyl, and C1-6alkylcarbonyl groups is optionally substituted with one to three substituents independently selected from halogen, hydroxy, and CN. 5. The compound according to any one of the preceding claims, wherein R3 is selected from hydroxy, halogen, CN, C1-6alkyl, C1-6alkoxy, C1-6alkoxy-C1-6alkyl, C1-6alkoxy-C1-6alkoxy, C3-6cycloalkyl, C3- 6cycloalkyl-C1-6alkyl, amino, C1-6alkylamino, diC1-6-alkylamino, and C3-6cycloalkylamino, wherein each of the C1-6alkyl, C1-6alkoxy, C1-6alkoxy-C1-6alkyl, C1-6alkoxy-C1-6alkoxy, C3-6cycloalkyl, C3-6cycloalkyl-C1- 6alkyl, amino, C1-6alkylamino, diC1-6-alkylamino and C3-6cycloalkylamino groups is optionally substituted with one to three substituents independently selected from halogen, hydroxy, and CN. 6. The compound according to any one of the preceding claims, wherein four A2 are CR2 and A3 is N. 7. The compound according to any one of the claims 1 to 5, wherein
Figure imgf000153_0001
, and preferably the three A2 are CR2 and A3 is CR3. 8. The compound according to any one of the claims 1 to 5, wherein
Figure imgf000153_0002
preferably the three A2 are CR2 and A3 is CR3. 9. The compound according to any one of the claims 1 to 5, wherein four A2 are CR2 and A3 is CR3. 10. The compound according to claim 9, wherein
Figure imgf000153_0003
. 11. The compound according to any one of the preceding claims, wherein R4 is selected from C1-6alkyl, C1-6alkoxy-C1-6alkyl, C3-6cycloalkyl, C3-6cycloalkyl-C1-4alkyl, C2-6alkenyl, C2-6alkynyl, and C1-6alkoxy, wherein each of the C1-6alkyl, C1-6alkoxy-C1-6alkyl, C3-6cycloalkyl, C3-6cycloalkyl-C1-4alkyl, C2-6alkenyl, C2- 6alkynyl, and C1-6alkoxy groups is optionally substituted with one to three substituents independently selected from halogen and CN. 12. The compound according to any one of the preceding claims, wherein R5 is selected from C1-6alkyl, C1-6alkoxy, C3-6cycloalkyl, C3-6cycloalkyl-C1-6alkyl, and C1-6alkoxyC1-6alkyl, wherein each of said groups is optionally substituted with one to three substituents independently selected from halogen and CN. 13. A composition comprising a fungicidally effective amount of a compound as defined in any one of claims 1 to 12. 14. A composition according to claim 13, wherein the composition further comprises at least one compound selected among an additional active ingredient, an appropriate formulation inert, a carrier, an adjuvant, and any mixtures thereof. 15. A method of combating, preventing or controlling phytopathogenic diseases which comprises applying to a phytopathogen, to the locus of a phytopathogen, to a plant susceptible to attack by a phytopathogen, or to a plant propagation material thereof, a fungicidally effective amount of a compound according to any one of claims 1 to 12, or a composition comprising a compound according to any one of claims 1 to 12, or a composition according to claim 13 or 14. 16. A compound of formula (XXX)
Figure imgf000154_0001
wherein each A1 is N, or one A1 is N and one A1 is CR1; and preferably one A1 is N and one A1 is CR1; R1 are independently selected from hydrogen, hydroxy, halogen, CN, C1-6alkyl, C3-6cycloalkyl, C1- 6alkoxy-C1-6alkyl, C3-6cycloalkyl-C1-4alkyl, C1-6alkylsulfonyl, C1-6alkoxy, amino, and -NHC(O)C1-6alkyl; and preferably R1 are independently selected from hydrogen and C1-6alkyl; A4 is CH or N; and R5 is selected from C1-6alkyl, C1-6alkoxy, C3-6cycloalkyl, C3-6cycloalkyl-C1-6alkyl, C1-6alkoxyC1-6alkyl, C1- 6alkylamino, diC1-6alkylamino, C1-6alkoxyamino, and C1-6alkylC1-6alkoxyamino, wherein each of the C1- 6alkyl, C1-6alkoxy, C3-6cycloalkyl, C3-6cycloalkyl-C1-6alkyl, C1-6alkoxyC1-6alkyl, C1-6alkylamino, diC1- 6alkylamino, C1-6alkoxyamino, and C1-6alkylC1-6alkoxyamino groups is optionally substituted with one to three substituents independently selected from halogen and CN; or a salt or N-oxide thereof. 17. A compound of formula (XI)
Figure imgf000154_0002
wherein each A1 is N, or one A1 is N and one A1 is CR1; and preferably one A1 is N and one A1 is CR1; R1 are independently selected from hydrogen, hydroxy, halogen, CN, C1-6alkyl, C3-6cycloalkyl, C1- 6alkoxy-C1-6alkyl, C3-6cycloalkyl-C1-4alkyl, C1-6alkylsulfonyl, C1-6alkoxy, amino, and -NHC(O)C1-6alkyl; and preferably R1 are independently selected from hydrogen and C1-6alkyl; A2 are independently CR2 or N, with the proviso that no more than three A2 are N, preferably the four A2 are CR2; R2 are independently selected from hydrogen, hydroxy, halogen, CN, C1-6alkyl, C1-6alkoxy, C1-6alkoxy- C1-6alkyl, C1-6alkoxy-C1-6alkoxy, C3-6cycloalkyl, C1-6alkylsulfonyl, C1-6alkoxycarbonyl, C1- 6alkylaminocarbonyl, diC1-6alkylaminocarbonyl, and C1-6alkylcarbonyl, wherein each of the C1-6alkyl, C1- 6alkoxy, C1-6alkoxy-C1-6alkyl, C1-6alkoxy-C1-6alkoxy, C3-6cycloalkyl, C1-6alkylsulfonyl, C1-6alkoxycarbonyl, C1-6alkylaminocarbonyl, diC1-6alkylaminocarbonyl, and C1-6alkylcarbonyl groups is optionally substituted with one to three substituents selected from halogen, hydroxy, and CN; and preferably R2 are independently selected from hydrogen, halogen, CN, C1-6alkyl, C1-6alkoxy, and C1-6alkoxy-C1-6alkyl; A3 is CR3 or N; R3 is selected from hydrogen, halogen, CN, C1-6alkyl, C1-6alkoxy, C1-6alkoxy-C1-6alkyl, C3-6cycloalkyl, C1- 6alkylsulfonyl, amino, C1-6alkylamino, diC1-6-alkylamino, and C3-6cycloalkylamino, wherein each of the C1-6alkyl, C1-6alkoxy, C1-6alkoxy-C1-6alkyl, C3-6cycloalkyl, C1-6alkylsulfonyl, amino, C1-6alkylamino, diC1-6- alkylamino, and C3-6cycloalkylamino groups is optionally substituted with one to three substituents selected from halogen, hydroxy, and CN; and preferably R3 is hydrogen; R4 is selected from C1-6alkyl, C1-6alkoxy-C1-6alkyl, C3-6cycloalkyl, C3-6cycloalkyl-C1-4alkyl, C2-6alkenyl, C2- 6alkynyl, C1-6alkoxy, C1-6alkylsulfonyl-C1-6alkyl, C1-6alkoxycarbonyl-C1-6alkyl, C1-6alkylaminocarbonyl-C1- 6alkyl, diC1-6alkylaminocarbonyl-C1-6alkyl, and CN, wherein each of the C1-6alkyl, C1-6alkoxy-C1-6alkyl, C3-6cycloalkyl, C3-6cycloalkyl-C1-4alkyl, C2-6alkenyl, C2-6alkynyl, C1-6alkoxy, C1-6alkylsulfonyl-C1-6alkyl, C1- 6alkoxycarbonyl-C1-6alkyl, C1-6alkylaminocarbonyl-C1-6alkyl and diC1-6alkylaminocarbonyl-C1-6alkyl groups is optionally substituted with one to three substituents selected from halogen and CN; and preferably R4 is selected from C1-6alkyl, C1-6alkoxy-C1-6alkyl, C3-6cycloalkyl, C3-6cycloalkyl-C1-4alkyl, and C1-6alkoxy, wherein each of the C1-6alkyl, C1-6alkoxy-C1-6alkyl, C3-6cycloalkyl, C3-6cycloalkyl-C1-4alkyl, and C1-6alkoxy groups is optionally substituted with one to three substituents independently selected from halogen and CN; and wherein A3 and R4 taken together optionally form a ring, preferably a 6-membered heterocycle; or a salt or N-oxide thereof; or a compound of formula (II)
Figure imgf000156_0001
wherein each A1 is N, or one A1 is N and one A1 is CR1; and preferably one A1 is N and one A1 is CR1; R1 are independently selected from hydrogen, hydroxy, halogen, CN, C1-6alkyl, C3-6cycloalkyl, C1- 6alkoxy-C1-6alkyl, C3-6cycloalkyl-C1-4alkyl, C1-6alkylsulfonyl, C1-6alkoxy, amino, and -NHC(O)C1-6alkyl; and preferably R1 are independently selected from hydrogen and C1-6alkyl; A2 are independently CR2 or N, with the proviso that no more than three A2 are N, preferably the four A2 are CR2; R2 are independently selected from hydrogen, hydroxy, halogen, CN, C1-6alkyl, C1-6alkoxy, C1-6alkoxy- C1-6alkyl, C1-6alkoxy-C1-6alkoxy, C3-6cycloalkyl, C1-6alkylsulfonyl, C1-6alkoxycarbonyl, C1- 6alkylaminocarbonyl, diC1-6alkylaminocarbonyl, and C1-6alkylcarbonyl, wherein each of the C1-6alkyl, C1- 6alkoxy, C1-6alkoxy-C1-6alkyl, C1-6alkoxy-C1-6alkoxy, C3-6cycloalkyl, C1-6alkylsulfonyl, C1-6alkoxycarbonyl, C1-6alkylaminocarbonyl, diC1-6alkylaminocarbonyl, and C1-6alkylcarbonyl groups is optionally substituted with one to three substituents selected from halogen, hydroxy, and CN; and preferably R2 are independently selected from hydrogen, halogen, CN, C1-6alkyl, C1-6alkoxy, and C1-6alkoxy-C1-6alkyl; A3 is CR3 or N; R3 is selected from hydrogen, halogen, CN, C1-6alkyl, C1-6alkoxy, C1-6alkoxy-C1-6alkyl, C3-6cycloalkyl, C1- 6alkylsulfonyl, amino, C1-6alkylamino, diC1-6-alkylamino, and C3-6cycloalkylamino, wherein each of the C1-6alkyl, C1-6alkoxy, C1-6alkoxy-C1-6alkyl, C3-6cycloalkyl, C1-6alkylsulfonyl, amino, C1-6alkylamino, diC1-6- alkylamino, and C3-6cycloalkylamino groups is optionally substituted with one to three substituents selected from halogen, hydroxy, and CN; and preferably R3 is hydrogen; R4 is selected from C1-6alkyl, C1-6alkoxy-C1-6alkyl, C3-6cycloalkyl, C3-6cycloalkyl-C1-4alkyl, C2-6alkenyl, C2- 6alkynyl, C1-6alkoxy, C1-6alkylsulfonyl-C1-6alkyl, C1-6alkoxycarbonyl-C1-6alkyl, C1-6alkylaminocarbonyl-C1- 6alkyl, diC1-6alkylaminocarbonyl-C1-6alkyl, and CN, wherein each of the C1-6alkyl, C1-6alkoxy-C1-6alkyl, C3-6cycloalkyl, C3-6cycloalkyl-C1-4alkyl, C2-6alkenyl, C2-6alkynyl, C1-6alkoxy, C1-6alkylsulfonyl-C1-6alkyl, C1- 6alkoxycarbonyl-C1-6alkyl, C1-6alkylaminocarbonyl-C1-6alkyl and diC1-6alkylaminocarbonyl-C1-6alkyl groups is optionally substituted with one to three substituents selected from halogen and CN; and preferably R4 is selected from C1-6alkyl, C1-6alkoxy-C1-6alkyl, C3-6cycloalkyl, C3-6cycloalkyl-C1-4alkyl, and C1-6alkoxy, wherein each of the C1-6alkyl, C1-6alkoxy-C1-6alkyl, C3-6cycloalkyl, C3-6cycloalkyl-C1-4alkyl, and C1-6alkoxy groups is optionally substituted with one to three substituents independently selected from halogen and CN; wherein A3 and R4 taken together optionally form a ring, preferably a 6-membered heterocycle; and X is Cl, Br or I; or a salt or N-oxide thereof.
PCT/EP2024/059884 2023-04-13 2024-04-11 Imidazo bicyclic derivatives Ceased WO2024213664A1 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
KR1020257037423A KR20250169286A (en) 2023-04-13 2024-04-11 imidazolic bicyclic derivatives
AU2024251657A AU2024251657A1 (en) 2023-04-13 2024-04-11 Imidazo bicyclic derivatives
CN202480022808.1A CN120981461A (en) 2023-04-13 2024-04-11 Imidazolidinedicyclic derivatives
IL323692A IL323692A (en) 2023-04-13 2025-09-29 Imidazo bicyclic derivatives
MX2025011788A MX2025011788A (en) 2023-04-13 2025-10-02 Imidazo bicyclic derivatives
CONC2025/0015578A CO2025015578A2 (en) 2023-04-13 2025-11-10 Bicyclic imidazo derivatives

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP23167800 2023-04-13
EP23167800.4 2023-04-13

Publications (1)

Publication Number Publication Date
WO2024213664A1 true WO2024213664A1 (en) 2024-10-17

Family

ID=86007632

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2024/059884 Ceased WO2024213664A1 (en) 2023-04-13 2024-04-11 Imidazo bicyclic derivatives

Country Status (9)

Country Link
KR (1) KR20250169286A (en)
CN (1) CN120981461A (en)
AR (1) AR132358A1 (en)
AU (1) AU2024251657A1 (en)
CO (1) CO2025015578A2 (en)
IL (1) IL323692A (en)
MX (1) MX2025011788A (en)
TW (1) TW202506677A (en)
WO (1) WO2024213664A1 (en)

Citations (67)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0353191A2 (en) 1988-07-29 1990-01-31 Ciba-Geigy Ag DNA sequences encoding polypeptides having beta-1,3-glucanase activity
EP0367474A1 (en) 1988-11-01 1990-05-09 Mycogen Corporation Novel bacillus thuringiensis isolate denoted b.t. ps81gg, active against lepidopteran pests, and a gene encoding a lepidopteran-active toxin
EP0374753A2 (en) 1988-12-19 1990-06-27 American Cyanamid Company Insecticidal toxines, genes coding therefor, antibodies binding them, transgenic plant cells and plants expressing these toxines
EP0392225A2 (en) 1989-03-24 1990-10-17 Ciba-Geigy Ag Disease-resistant transgenic plants
WO1990013651A1 (en) 1989-05-09 1990-11-15 Imperial Chemical Industries Plc Bacterial genes
EP0401979A2 (en) 1989-05-18 1990-12-12 Mycogen Corporation Novel bacillus thuringiensis isolates active against lepidopteran pests, and genes encoding novel lepidopteran-active toxins
EP0427529A1 (en) 1989-11-07 1991-05-15 Pioneer Hi-Bred International, Inc. Larvicidal lectins and plant insect resistance based thereon
EP0451878A1 (en) 1985-01-18 1991-10-16 Plant Genetic Systems, N.V. Modifying plants by genetic engineering to combat or control insects
US5061495A (en) 1988-03-07 1991-10-29 Agricultural Genetics Company Limited Antibiotic derived from b. subtilis
WO1993007278A1 (en) 1991-10-04 1993-04-15 Ciba-Geigy Ag Synthetic dna sequence having enhanced insecticidal activity in maize
WO1995033818A2 (en) 1994-06-08 1995-12-14 Ciba-Geigy Ag Genes for the synthesis of antipathogenic substances
WO1995034656A1 (en) 1994-06-10 1995-12-21 Ciba-Geigy Ag Novel bacillus thuringiensis genes coding toxins active against lepidopteran pests
WO1997033890A1 (en) 1996-03-11 1997-09-18 Novartis Ag Pyrimidin-4-one derivatives as pesticide
JPH11253151A (en) 1997-11-13 1999-09-21 Kumiai Chem Ind Co Ltd Rice seedling raising disease control agent
WO2000015615A1 (en) 1998-09-15 2000-03-23 Syngenta Participations Ag Pyridine ketones useful as herbicides
US6060051A (en) 1997-05-09 2000-05-09 Agraquest, Inc. Strain of bacillus for controlling plant diseases and corn rootworm
US6245551B1 (en) 1999-03-30 2001-06-12 Agraquest, Inc. Strain of Bacillus pumilus for controlling plant diseases caused by fungi
WO2002015701A2 (en) 2000-08-25 2002-02-28 Syngenta Participations Ag Bacillus thuringiensis crystal protein hybrids
WO2003000051A2 (en) 2001-06-22 2003-01-03 Drahos David J Novel biofungicide
WO2003018810A2 (en) 2001-08-31 2003-03-06 Syngenta Participations Ag Modified cry3a toxins and nucleic acid sequences coding therefor
WO2003052073A2 (en) 2001-12-17 2003-06-26 Syngenta Participations Ag Novel corn event
EP1431299A1 (en) * 2001-09-04 2004-06-23 Sumitomo Chemical Company, Limited IMIDAZO(1,2-a)PYRIMIDINES AND FUNGICIDE COMPOSITIONS CONTAINING THE SAME
US6919298B2 (en) 2002-04-04 2005-07-19 Valent Biosciences Corporation Enhanced herbicide composition
US7094592B2 (en) 2001-11-26 2006-08-22 Kumiai Chemical Industry Co., Ltd. Bacillus sp. D747 strain, plant disease controlling agents and insect pest controlling agents using the same and control method using the agents
US7579183B1 (en) 2006-12-01 2009-08-25 The United States Of America As Represented By The Secretary Of Agriculture Saprophytic yeast, Pichia anomala
WO2009116106A1 (en) 2008-03-21 2009-09-24 Trentino Sviluppo S.P.A. Trichoderma atroviride sc1 for biocontrol of fungal diseases in plants
WO2010086790A1 (en) 2009-01-27 2010-08-05 Lesaffre Et Compagnie Saccharomyces cerevisiae strains with phytosanitary capabilities
US20100291039A1 (en) 2007-12-14 2010-11-18 Kohl Jurgen Anton Novel micro-organisms controlling plant pathogens
WO2011106491A2 (en) 2010-02-25 2011-09-01 Marrone Bio Innovations, Inc. Isolated bacterial strain of the genus burkholderia and pesticidal metabolites therefrom
WO2011138281A2 (en) 2010-05-06 2011-11-10 Bayer Cropscience Ag Process for the preparation of dithiine tetracarboxydiimides
WO2011151819A2 (en) 2010-06-01 2011-12-08 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Pseudozyma aphidis as a biocontrol agent against various plant pathogens
WO2013032693A2 (en) 2011-08-27 2013-03-07 Marrone Bio Innovations, Inc. Isolated bacterial strain of the genus burkholderia and pesticidal metabolites therefrom-formulations and uses
WO2013034938A2 (en) 2011-09-08 2013-03-14 Szegedi Tudományegyetem A copper resistant, fengycin-producing bacillus mojavensis strain for controlling vegetable pathogens, its use and compositions containing it
WO2014006945A1 (en) 2012-07-04 2014-01-09 アグロカネショウ株式会社 2-aminonicotinic acid ester derivative and bactericide containing same as active ingredient
WO2014028521A1 (en) 2012-08-14 2014-02-20 Marrone Bio Innovations, Inc. Bacillus sp. strain with antifungal, antibacterial and growth promotion activity
WO2014078813A1 (en) * 2012-11-19 2014-05-22 Irm Llc Compounds and compositions for the treatment of parasitic diseases
WO2014095675A1 (en) 2012-12-19 2014-06-26 Bayer Cropscience Ag Difluoromethyl-nicotinic-indanyl carboxamides as fungicides
WO2015067800A1 (en) 2013-11-11 2015-05-14 Basf Se Antifungal penicillium strains, fungicidal extrolites thereof, and their use
WO2015155075A1 (en) 2014-04-11 2015-10-15 Syngenta Participations Ag Fungicidal n'-[2-methyl-6-[2-alkoxy-ethoxy]-3-pyridyl]-n-alkyl-formamidine derivatives for use in agriculture
WO2016020371A1 (en) 2014-08-04 2016-02-11 Basf Se Antifungal paenibacillus strains, fusaricidin-type compounds, and their use
WO2016154297A1 (en) 2015-03-26 2016-09-29 Bayer Cropscience Lp A novel paenibacillus strain, antifungal compounds, and methods for their use
WO2016156085A1 (en) 2015-03-27 2016-10-06 Syngenta Participations Ag Microbiocidal heterobicyclic derivatives
WO2016156290A1 (en) 2015-04-02 2016-10-06 Bayer Cropscience Aktiengesellschaft Novel 5-substituted imidazole derivatives
WO2016202742A1 (en) 2015-06-15 2016-12-22 Bayer Cropscience Aktiengesellschaft Halogen-substituted phenoxyphenylamidines and the use thereof as fungicides
WO2017019448A1 (en) 2015-07-24 2017-02-02 AgBiome, Inc. Modified biological control agents and their uses
WO2017025510A1 (en) 2015-08-12 2017-02-16 Syngenta Participations Ag Microbiocidal heterobicyclic derivatives
WO2017029179A1 (en) 2015-08-14 2017-02-23 Bayer Cropscience Aktiengesellschaft Triazole derivatives, intermediates thereof and their use as fungicides
WO2017055469A1 (en) 2015-10-02 2017-04-06 Syngenta Participations Ag Microbiocidal oxadiazole derivatives
WO2017055473A1 (en) 2015-10-02 2017-04-06 Syngenta Participations Ag Microbiocidal oxadiazole derivatives
WO2017066094A1 (en) 2015-10-12 2017-04-20 Pioneer Hi-Bred International, Inc. Biologicals and their use in plants
WO2017093348A1 (en) 2015-12-02 2017-06-08 Syngenta Participations Ag Microbiocidal oxadiazole derivatives
WO2017118689A1 (en) 2016-01-08 2017-07-13 Syngenta Participations Ag Microbiocidal oxadiazole derivatives
WO2017153380A1 (en) 2016-03-10 2017-09-14 Syngenta Participations Ag Microbiocidal quinoline (thio)carboxamide derivatives
WO2017205258A1 (en) 2016-05-26 2017-11-30 Novozymes Bioag A/S Bacillus and lipochitooligosaccharide for improving plant growth
WO2017220485A1 (en) 2016-06-21 2017-12-28 Syngenta Participations Ag Microbiocidal oxadiazole derivatives
WO2018065414A1 (en) 2016-10-06 2018-04-12 Syngenta Participations Ag Microbiocidal oxadiazole derivatives
WO2018153707A1 (en) 2017-02-22 2018-08-30 Basf Se Crystalline forms of a strobilurin type compound for combating phytopathogenic fungi
WO2018158365A1 (en) 2017-03-03 2018-09-07 Syngenta Participations Ag Microbiocidal oxadiazole derivatives
WO2018202428A1 (en) 2017-05-02 2018-11-08 Basf Se Fungicidal mixture comprising substituted 3-phenyl-5-(trifluoromethyl)-1,2,4-oxadiazoles
WO2018228896A1 (en) 2017-06-14 2018-12-20 Syngenta Participations Ag Fungicidal compositions
WO2019110427A1 (en) 2017-12-04 2019-06-13 Syngenta Participations Ag Microbiocidal phenylamidine derivatives
WO2020056090A1 (en) 2018-09-14 2020-03-19 Fmc Corporation Fungicidal halomethyl ketones and hydrates
WO2020079111A1 (en) 2018-10-18 2020-04-23 Syngenta Crop Protection Ag Microbiocidal compounds
WO2020097012A1 (en) 2018-11-06 2020-05-14 Fmc Corporation Substituted tolyl as fungicides
WO2020109391A1 (en) 2018-11-28 2020-06-04 Bayer Aktiengesellschaft Pyridazine (thio)amides as fungicidal compounds
WO2020193387A1 (en) 2019-03-22 2020-10-01 Syngenta Crop Protection Ag Fungicidal compounds
WO2023061838A1 (en) * 2021-10-14 2023-04-20 Syngenta Crop Protection Ag Imidazo[1,2-a]pyridine derivatives

Patent Citations (68)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0451878A1 (en) 1985-01-18 1991-10-16 Plant Genetic Systems, N.V. Modifying plants by genetic engineering to combat or control insects
US5061495A (en) 1988-03-07 1991-10-29 Agricultural Genetics Company Limited Antibiotic derived from b. subtilis
EP0353191A2 (en) 1988-07-29 1990-01-31 Ciba-Geigy Ag DNA sequences encoding polypeptides having beta-1,3-glucanase activity
EP0367474A1 (en) 1988-11-01 1990-05-09 Mycogen Corporation Novel bacillus thuringiensis isolate denoted b.t. ps81gg, active against lepidopteran pests, and a gene encoding a lepidopteran-active toxin
EP0374753A2 (en) 1988-12-19 1990-06-27 American Cyanamid Company Insecticidal toxines, genes coding therefor, antibodies binding them, transgenic plant cells and plants expressing these toxines
EP0392225A2 (en) 1989-03-24 1990-10-17 Ciba-Geigy Ag Disease-resistant transgenic plants
WO1990013651A1 (en) 1989-05-09 1990-11-15 Imperial Chemical Industries Plc Bacterial genes
EP0401979A2 (en) 1989-05-18 1990-12-12 Mycogen Corporation Novel bacillus thuringiensis isolates active against lepidopteran pests, and genes encoding novel lepidopteran-active toxins
EP0427529A1 (en) 1989-11-07 1991-05-15 Pioneer Hi-Bred International, Inc. Larvicidal lectins and plant insect resistance based thereon
WO1993007278A1 (en) 1991-10-04 1993-04-15 Ciba-Geigy Ag Synthetic dna sequence having enhanced insecticidal activity in maize
WO1995033818A2 (en) 1994-06-08 1995-12-14 Ciba-Geigy Ag Genes for the synthesis of antipathogenic substances
WO1995034656A1 (en) 1994-06-10 1995-12-21 Ciba-Geigy Ag Novel bacillus thuringiensis genes coding toxins active against lepidopteran pests
WO1997033890A1 (en) 1996-03-11 1997-09-18 Novartis Ag Pyrimidin-4-one derivatives as pesticide
US6060051A (en) 1997-05-09 2000-05-09 Agraquest, Inc. Strain of bacillus for controlling plant diseases and corn rootworm
JPH11253151A (en) 1997-11-13 1999-09-21 Kumiai Chem Ind Co Ltd Rice seedling raising disease control agent
WO2000015615A1 (en) 1998-09-15 2000-03-23 Syngenta Participations Ag Pyridine ketones useful as herbicides
US6245551B1 (en) 1999-03-30 2001-06-12 Agraquest, Inc. Strain of Bacillus pumilus for controlling plant diseases caused by fungi
WO2002015701A2 (en) 2000-08-25 2002-02-28 Syngenta Participations Ag Bacillus thuringiensis crystal protein hybrids
WO2003000051A2 (en) 2001-06-22 2003-01-03 Drahos David J Novel biofungicide
WO2003018810A2 (en) 2001-08-31 2003-03-06 Syngenta Participations Ag Modified cry3a toxins and nucleic acid sequences coding therefor
EP1431299A1 (en) * 2001-09-04 2004-06-23 Sumitomo Chemical Company, Limited IMIDAZO(1,2-a)PYRIMIDINES AND FUNGICIDE COMPOSITIONS CONTAINING THE SAME
US7094592B2 (en) 2001-11-26 2006-08-22 Kumiai Chemical Industry Co., Ltd. Bacillus sp. D747 strain, plant disease controlling agents and insect pest controlling agents using the same and control method using the agents
WO2003052073A2 (en) 2001-12-17 2003-06-26 Syngenta Participations Ag Novel corn event
US6919298B2 (en) 2002-04-04 2005-07-19 Valent Biosciences Corporation Enhanced herbicide composition
US7579183B1 (en) 2006-12-01 2009-08-25 The United States Of America As Represented By The Secretary Of Agriculture Saprophytic yeast, Pichia anomala
US20100291039A1 (en) 2007-12-14 2010-11-18 Kohl Jurgen Anton Novel micro-organisms controlling plant pathogens
WO2009116106A1 (en) 2008-03-21 2009-09-24 Trentino Sviluppo S.P.A. Trichoderma atroviride sc1 for biocontrol of fungal diseases in plants
US8431120B2 (en) 2008-03-21 2013-04-30 Trentino Sviluppo S.P.A. Trichoderma atroviride SC1 for biocontrol of fungal diseases in plants
WO2010086790A1 (en) 2009-01-27 2010-08-05 Lesaffre Et Compagnie Saccharomyces cerevisiae strains with phytosanitary capabilities
WO2011106491A2 (en) 2010-02-25 2011-09-01 Marrone Bio Innovations, Inc. Isolated bacterial strain of the genus burkholderia and pesticidal metabolites therefrom
WO2011138281A2 (en) 2010-05-06 2011-11-10 Bayer Cropscience Ag Process for the preparation of dithiine tetracarboxydiimides
WO2011151819A2 (en) 2010-06-01 2011-12-08 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Pseudozyma aphidis as a biocontrol agent against various plant pathogens
WO2013032693A2 (en) 2011-08-27 2013-03-07 Marrone Bio Innovations, Inc. Isolated bacterial strain of the genus burkholderia and pesticidal metabolites therefrom-formulations and uses
WO2013034938A2 (en) 2011-09-08 2013-03-14 Szegedi Tudományegyetem A copper resistant, fengycin-producing bacillus mojavensis strain for controlling vegetable pathogens, its use and compositions containing it
WO2014006945A1 (en) 2012-07-04 2014-01-09 アグロカネショウ株式会社 2-aminonicotinic acid ester derivative and bactericide containing same as active ingredient
WO2014028521A1 (en) 2012-08-14 2014-02-20 Marrone Bio Innovations, Inc. Bacillus sp. strain with antifungal, antibacterial and growth promotion activity
WO2014078813A1 (en) * 2012-11-19 2014-05-22 Irm Llc Compounds and compositions for the treatment of parasitic diseases
WO2014095675A1 (en) 2012-12-19 2014-06-26 Bayer Cropscience Ag Difluoromethyl-nicotinic-indanyl carboxamides as fungicides
WO2015067800A1 (en) 2013-11-11 2015-05-14 Basf Se Antifungal penicillium strains, fungicidal extrolites thereof, and their use
WO2015155075A1 (en) 2014-04-11 2015-10-15 Syngenta Participations Ag Fungicidal n'-[2-methyl-6-[2-alkoxy-ethoxy]-3-pyridyl]-n-alkyl-formamidine derivatives for use in agriculture
WO2016020371A1 (en) 2014-08-04 2016-02-11 Basf Se Antifungal paenibacillus strains, fusaricidin-type compounds, and their use
WO2016154297A1 (en) 2015-03-26 2016-09-29 Bayer Cropscience Lp A novel paenibacillus strain, antifungal compounds, and methods for their use
WO2016156085A1 (en) 2015-03-27 2016-10-06 Syngenta Participations Ag Microbiocidal heterobicyclic derivatives
WO2016156290A1 (en) 2015-04-02 2016-10-06 Bayer Cropscience Aktiengesellschaft Novel 5-substituted imidazole derivatives
WO2016202742A1 (en) 2015-06-15 2016-12-22 Bayer Cropscience Aktiengesellschaft Halogen-substituted phenoxyphenylamidines and the use thereof as fungicides
WO2017019448A1 (en) 2015-07-24 2017-02-02 AgBiome, Inc. Modified biological control agents and their uses
WO2017025510A1 (en) 2015-08-12 2017-02-16 Syngenta Participations Ag Microbiocidal heterobicyclic derivatives
WO2017029179A1 (en) 2015-08-14 2017-02-23 Bayer Cropscience Aktiengesellschaft Triazole derivatives, intermediates thereof and their use as fungicides
WO2017055469A1 (en) 2015-10-02 2017-04-06 Syngenta Participations Ag Microbiocidal oxadiazole derivatives
WO2017055473A1 (en) 2015-10-02 2017-04-06 Syngenta Participations Ag Microbiocidal oxadiazole derivatives
WO2017066094A1 (en) 2015-10-12 2017-04-20 Pioneer Hi-Bred International, Inc. Biologicals and their use in plants
WO2017093348A1 (en) 2015-12-02 2017-06-08 Syngenta Participations Ag Microbiocidal oxadiazole derivatives
WO2017118689A1 (en) 2016-01-08 2017-07-13 Syngenta Participations Ag Microbiocidal oxadiazole derivatives
WO2017153380A1 (en) 2016-03-10 2017-09-14 Syngenta Participations Ag Microbiocidal quinoline (thio)carboxamide derivatives
WO2017205258A1 (en) 2016-05-26 2017-11-30 Novozymes Bioag A/S Bacillus and lipochitooligosaccharide for improving plant growth
WO2017220485A1 (en) 2016-06-21 2017-12-28 Syngenta Participations Ag Microbiocidal oxadiazole derivatives
WO2018065414A1 (en) 2016-10-06 2018-04-12 Syngenta Participations Ag Microbiocidal oxadiazole derivatives
WO2018153707A1 (en) 2017-02-22 2018-08-30 Basf Se Crystalline forms of a strobilurin type compound for combating phytopathogenic fungi
WO2018158365A1 (en) 2017-03-03 2018-09-07 Syngenta Participations Ag Microbiocidal oxadiazole derivatives
WO2018202428A1 (en) 2017-05-02 2018-11-08 Basf Se Fungicidal mixture comprising substituted 3-phenyl-5-(trifluoromethyl)-1,2,4-oxadiazoles
WO2018228896A1 (en) 2017-06-14 2018-12-20 Syngenta Participations Ag Fungicidal compositions
WO2019110427A1 (en) 2017-12-04 2019-06-13 Syngenta Participations Ag Microbiocidal phenylamidine derivatives
WO2020056090A1 (en) 2018-09-14 2020-03-19 Fmc Corporation Fungicidal halomethyl ketones and hydrates
WO2020079111A1 (en) 2018-10-18 2020-04-23 Syngenta Crop Protection Ag Microbiocidal compounds
WO2020097012A1 (en) 2018-11-06 2020-05-14 Fmc Corporation Substituted tolyl as fungicides
WO2020109391A1 (en) 2018-11-28 2020-06-04 Bayer Aktiengesellschaft Pyridazine (thio)amides as fungicidal compounds
WO2020193387A1 (en) 2019-03-22 2020-10-01 Syngenta Crop Protection Ag Fungicidal compounds
WO2023061838A1 (en) * 2021-10-14 2023-04-20 Syngenta Crop Protection Ag Imidazo[1,2-a]pyridine derivatives

Non-Patent Citations (14)

* Cited by examiner, † Cited by third party
Title
"The Pesticide Manual", 2021, BRITISH CROP PROTECTION COUNCIL
BECKERS IGOR ET AL: "Dual ligand approach increases functional group tolerance in the Pd-catalysed C-H arylation of N -heterocyclic pharmaceuticals", CHEMICAL SCIENCE, vol. 14, no. 5, 1 February 2023 (2023-02-01), United Kingdom, pages 1176 - 1183, XP093177265, ISSN: 2041-6520, Retrieved from the Internet <URL:https://pubs.rsc.org/en/content/articlepdf/2023/sc/d2sc04911b> DOI: 10.1039/D2SC04911B *
CHEM. SOC. REV., vol. 38, 2009, pages 606
CHEM. SOC. REV., vol. 40, 2011, pages 5084
CROP PROTECTION, vol. 25, no. 2643947-26-4, 2006, pages 468 - 475
DATABASE REGISTRY [online] Chemical Abstract Service, Columbus, Ohio, US; 13 December 2023 (2023-12-13), XP093177252, retrieved from https://stn.org/stn/# Database accession no. 3016602-76-6 *
DATABASE REGISTRY [online] Chemical Abstract Service, Columbus, Ohio, US; 18 December 2022 (2022-12-18), XP093177281, retrieved from https://stn.org/stn/# Database accession no. 2870811-83-7 *
DATABASE REGISTRY [online] Chemical Abstract Service, Columbus, Ohio, US; 25 April 2019 (2019-04-25), XP093177239, retrieved from https://stn.org/stn/# Database accession no. 2305449-72-1 *
DATABASE REGISTRY [online] Chemical Abstract Service, Columbus, Ohio, US; 3 January 2020 (2020-01-03), XP093177245, retrieved from https://stn.org/stn/# Database accession no. 2398966-16-8 *
DATABASE REGISTRY [online] Chemical Abstract Service, Columbus, Ohio, US; 6 April 2023 (2023-04-06), XP093177283, retrieved from https://stn.org/stn/# Database accession no. 2919437-74-2 *
J. MED. CHEM., vol. 32, no. 12, 1989, pages 2561 - 73
JENSEN DF ET AL.: "Development of a biocontrol agent for plant disease control with special emphasis on the near commercial fungal antagonist Clonostachys rosea strain 'IK726", AUSTRALASIAN PLANT PATHOL., vol. 36, no. 2, 2007, pages 95 - 101
PIETR ET AL., ZESZ. NAUK. A R W SZCZECINIE, vol. 161, 1993, pages 125 - 137
XUE A.G.: "Efficacy of Clonostachys rosea strain ACM941 and fungicide seed treatments for controlling the root tot complex of field pea", CAN JOUR PLANT SCI, vol. 83, no. 3, 2003, pages 519 - 524

Also Published As

Publication number Publication date
IL323692A (en) 2025-11-01
MX2025011788A (en) 2025-11-03
CN120981461A (en) 2025-11-18
CO2025015578A2 (en) 2025-11-19
TW202506677A (en) 2025-02-16
AU2024251657A1 (en) 2025-10-09
KR20250169286A (en) 2025-12-02
AR132358A1 (en) 2025-06-18

Similar Documents

Publication Publication Date Title
AU2022364034B2 (en) Imidazo[1,2-a]pyridine derivatives
WO2021244951A9 (en) Fungicidal compositions
WO2024126407A1 (en) Benzimidazole derivatives
AU2022325463B2 (en) Fungicide mixture
EP4634178A1 (en) Imidazo[1,2-a]pyridine derivatives
AU2024251657A1 (en) Imidazo bicyclic derivatives
WO2024213659A1 (en) Imidazo[1,2-a]pyrazine derivatives
WO2024213651A1 (en) Imidazo[1,2-a]pyridine derivatives
WO2024213650A1 (en) Imidazo[1,2-a]pyridine derivatives
WO2024213653A1 (en) Imidazo[1,2-a]pyridine derivatives
WO2024213663A1 (en) Pyrazolo[1,5-a]pyridine derivatives
AU2024300580A1 (en) Benzimidazole derivatives
WO2025257023A1 (en) Fungicidal compositions
WO2024213656A1 (en) Imidazo[1,2-a]pyrazine derivatives
AU2024255817A1 (en) Fungicidal compositions
WO2025257024A1 (en) Fungicidal compositions
WO2024213662A1 (en) Pyrazolo[1,5-a]pyridine derivatives

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 24719136

Country of ref document: EP

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: AU2024251657

Country of ref document: AU

Ref document number: 825363

Country of ref document: NZ

WWP Wipo information: published in national office

Ref document number: 825363

Country of ref document: NZ

WWE Wipo information: entry into national phase

Ref document number: 323692

Country of ref document: IL

WWE Wipo information: entry into national phase

Ref document number: MX/A/2025/011788

Country of ref document: MX

ENP Entry into the national phase

Ref document number: 2024251657

Country of ref document: AU

Date of ref document: 20240411

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 2501006950

Country of ref document: TH

REG Reference to national code

Ref country code: BR

Ref legal event code: B01A

Ref document number: 112025021764

Country of ref document: BR

WWE Wipo information: entry into national phase

Ref document number: 202517101838

Country of ref document: IN

WWP Wipo information: published in national office

Ref document number: MX/A/2025/011788

Country of ref document: MX

ENP Entry into the national phase

Ref document number: 1020257037423

Country of ref document: KR

Free format text: ST27 STATUS EVENT CODE: A-0-1-A10-A15-NAP-PA0105 (AS PROVIDED BY THE NATIONAL OFFICE)

WWE Wipo information: entry into national phase

Ref document number: KR1020257037423

Country of ref document: KR

WWE Wipo information: entry into national phase

Ref document number: 202592944

Country of ref document: EA

WWE Wipo information: entry into national phase

Ref document number: 2024719136

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: DE

ENP Entry into the national phase

Ref document number: 2024719136

Country of ref document: EP

Effective date: 20251113

ENP Entry into the national phase

Ref document number: 2024719136

Country of ref document: EP

Effective date: 20251113

ENP Entry into the national phase

Ref document number: 2024719136

Country of ref document: EP

Effective date: 20251113

ENP Entry into the national phase

Ref document number: 2024719136

Country of ref document: EP

Effective date: 20251113

WWP Wipo information: published in national office

Ref document number: 202517101838

Country of ref document: IN

ENP Entry into the national phase

Ref document number: 2024719136

Country of ref document: EP

Effective date: 20251113